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Abstract
Environmental biofilms are abundant and represent the most prevalent growth 
mode of microorganisms. In humans, biofilms are frequently encountered and 
responsible for numerous infections which can be difficult to treat since biofilms 
tend to be more resistant to antimicrobial agents and host immune defences.
The focus of this study was to characterise two biofilms associated with specific 
human infections, namely oral candidosis and chronic wound infection. In vitro 
biofilms using microorganisms from these infections were generated using 
microtitre plates, a constant depth film fermenter (CDFF) and reconstituted 
human epithelial tissue (RHE).
Confocal laser scanning microscopy of Candida biofilms on RHE showed strain- 
dependent tissue invasion, with differences also evident in surface colonisation 
and Candida morphology. Hyphal elements invaded epithelial cells and
exhibited budding within the tissues. A relationship between high candidal 
tissue invasion and consistent expression of secreted aspartyl proteinase (SAP) 
genes 4-6 was found. There was no correlation between level of invasion and 
expression of phospholipase and agglutinin-like sequence (ALS) genes. These 
results demonstrate strain variation by Candida which relate to pathogenic 
potential.
Biofilms of the chronic wound bacteria, Pseudomonas aeruginosa, 
Staphylococcus aureus, Streptococcus oralis and Micrococcus luteus, showed 
species variation occurred in the extent of biofilm formation with antagonism 
evident in mixed species biofilms. Importantly, the pathogenic species of P. 
aeruginosa and S. aureus often inhibited biofilm formation by the commensal 
species (M. luteus and S. oralis). Susceptibility of wound bacterial biofilms to 
povidone iodine was reduced compared with planktonic cells. Up-regulation of 
biofilm genes by P. aeruginosa (alginate genes) and S. aureus (ica genes) was 
evident in the biofilm models. Extrapolation of results to chronic wound 
environments does require additional research on wound tissue, but the ability of 
the pathogenic species to antagonise commensal species could explain biofilm 
succession within a wound, possibly promoting a chronic wound phenotype.
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Overview of the thesis structure
The focus of the present study was to characterise in vitro, two clinically 
important biofilms associated with human infections, namely oral candidosis 
and chronic wound infection.
In the first instance, confocal laser scanning microscopy was used to 
examine infection of an oral epithelium by Candida albicans strains from 
different oral conditions (Chapter 2) and to determine whether inherent strain 
differences existed that could relate to infection type. Reverse transcription 
polymerase chain reaction (RT-PCR) was used to detect products from 
recognised virulence gene families (Chapter 3).
Having established appropriate methodologies, the second part of the thesis 
focused on chronic wound biofilms. Biofilm formation and bacterial 
interaction was characterised in different models, including a microtitre plate 
assay and a constant depth film fermenter (CDFF) (Chapter 4). The CDFF 
was also used to determine susceptibility of biofilms to povidone iodine 
(PVP1). Spatial distribution and biofilm architecture within established 
biofilms from the CDFF and on a reconstituted human epidermis were 
studied by fluorescent in situ hybridisation (Chapter 5). The spatial 
detection/association of microorganisms on actual wound biopsies was also 
assessed.
In the final part of the study, expression of specific genes associated with 
biofilms was assessed for planktonic and biofilm growth phases. This 
approach involved RT-PCR and microarray analysis (undertaken at the 
Health Protection Agency in Col indale) (Chapter 6).
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Chapter 1 
Literature Review
1.1 INTRODUCTION
1.1.1 The concept of biofilm growth
Microbiology based research has in the past primarily focused on the in vitro 
study of monotypic organisms grown in liquid media. The study of such ’free 
growing* or planktonic organisms has undoubtedly been of value in 
expanding our knowledge on the physiology and biochemistry of 
microorganisms. However, in recent years, the concept of microbial growth 
occurring as a biofilm rather than a planktonic growth phase has been 
recognised and become the focus of much research (Percival and Bowler, 
2004; Wilson, 2001).
The classic definition of a biofilm is that of a “community of microorganisms 
often adhered to a surface and encased in an extracellular polysaccharide 
matrix (EPS) or “glycocalyx” (Kumamoto and Marcelo, 2005; O'Toole et al., 
2000a) (Fig.1.1). Whilst much is still to be learnt about the differences 
between biofilm and planktonic (free form) growth phases, what is apparent 
is that the two forms differ markedly in terms of behaviour, structure and 
physiology (Table 1.1).
1.1.2 Prevalence of biofilms in humans
Biofilms are ubiquitous, and in humans a wide range of surfaces are 
available for microbial attachment and subsequent biofilm formation. Typical 
examples of biofilms include: bacterial plaque on both the enamel of teeth 
(Costerton et al., 1999) and on the acrylic of denture prostheses (Douglas, 
2003; Ramage et al., 2006); candidal biofilms on the oral and vaginal mucosa 
and on prosthetic hip joints (Garcia-Sanchez et al., 2004; Kumamoto and 
Marcelo, 2005; Wilson, 2001), and the microflora located in chronic wounds 
(James et al., 2007; Percival and Bowler, 2004; Percival and Rogers, 2005; 
Rhoads et al., 2007).
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Coccus;
Staphyloccus aureus
Bacillus;
Pseudomonas
aeruginosa
Fig. 1.1 Im age of a mixed biofim generated in the CDFF, day 3. Scanning 
electron microscopy image (SEM ).
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Table 1.1 Comparison of biofilm and planktonic lifestyles
Characteristic_______________________________________________
Physiological
Free growing often in aqueous environment
Metabolic products continously removed from the milieu,
Stresses of physical, chemical and biological nature
Slow growth
Found ubiquitously
Generally higher resistance to antibiotics, hydrogen peroxide, phagocytosis
Stress conditions, lower metabolic activity (e.g. decreased nutrient accessibility, 
limitation of oxygen, increased osmotic pressure, pH variation, problems with 
accumulation of waste metabolites)
Bacteria develop stress responses within biofilms
Source of many infections
Display unique gene expression patterns
Attachment can influence metabolic activities
Secreted virulence factors
Structural
Attached to a solid substrate
Many cells are dormant, likely to be smaller, not actively engaged in cell division
Flagella function in transport and initiation of cell-to-surface interactions and 
detachment
Lifestyle References
Planktonic
Planktonic
Biofilm
Biofilm
Biofilm
Biofilm
Biofilm
Biofilm
Biofilm
Biofilm
Biofilm & 
Planktonic
Biofilm
Biofilm
Biofilm
(Wilson, 2001)
(Anwar et al., 1990; Costerton et al., 1987; Van Loosdrecht et al., 
1990)
(Brown et al., 1988)
(Costerton et al., 1995; O'Toole and Kolter, 1998; Potera, 1996)
(Ashby et al., 1994; Cochran et al., 2000; Gander, 1996; Hassett 
et al., 1999; Hoyle and Costerton, 1991; Jensen et al., 1990; 
Schierholz et al., 1999)
(Anwar et al., 1990; Beloin and Ghigo, 2005; Costerton et al., 
1987; Van Loosdrecht et al., 1990)
(Beloin and Ghigo, 2005)
(Lewis, 2001)
(Davies, 2003)
(Breznak, 1984, Costerton et al., 1987, Van Loosdrecht et al., 
1990)
(Davies et al., 1998)
(Costerton etal., 1987)
(Anwar et al., 1992; Rhoads et al., 2007)
(Sauer et al., 2002)
Importantly, all these biofilms can act as reservoirs of infection and lead to 
human disease. Indeed, biofilm related infections are extremely prevalent 
and it has been estimated that over 65% of all hospital infections have a 
biofilm origin (Costerton et al., 1999; Donlan, 2001; Donlan and Costerton, 
2002; Douglas, 2003; Ramage et al., 2006). Table 1.2 outlines some 
clinically significant examples of biofilms and these are discussed in more 
detail later in this Literature Review (section 1.6). Of additional significance, 
is that once established, biofilm originating infections can be very difficult to 
combat due to the resilience of this growth phase against removal by host 
defence mechanisms and antimicrobial agents. A greater understanding of 
the biofilm lifestyle could enhance our knowledge of pathogenic processes 
and possibly lead to novel and effective control strategies designed to 
improve the management of patients with biofilm infections (Donlan, 2002).
1.2 CHARACTERISTICS OF BIOFILMS
1.2.1. Biofilm formation
The formation of a mature biofilm is a multistage process and dependent on 
a number of variables, including the type of bacterial species present, the 
composition of the surface to which attachment occurs, environmental factors 
and the expression of biofilm essential genes (Carpentier and Cerf, 1993; 
Dunne, 2002). Figure 1.2 shows a schematic diagram of the various stages 
of biofilm formation consisting of attachment, colonisation and growth 
phases.
1.2.1.1 Initial adhesion
The mechanism of initial adhesion of a microorganism to a surface is 
dependant on both physical and chemical interactions. Primary adhesion 
between bacteria and abiotic surfaces is generally mediated by non-specific 
(e.g. hydrophobic) interactions, whereas adhesion to living tissue tends to be 
accomplished through specific molecular (lectin, ligand, or adhesion) 
mechanisms (Carpentier and Cerf, 1993; Dunne, 2002).
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Table 1.2. Clinically significant examples of biofilm infections.
Infection or 
disease
Common bacterial species Reference 
involved
Dental caries 
Periodontitis
Otitis media
Streptococcus spp., 
Fusobacterium nucleatum, 
Porphyromonas gingivalis, 
Bacteroides forsythus, 
Prevotella intermedia
Streptococcus pneumoniae, 
Haemophilus influenzae, 
Moraxella catarrhalis, S. 
aureus, S. epidermidis, P. 
aeruginosa
Cystic fibrosis P. aeruginosa, Burkholderia 
cepacia
Chronic
wounds
Staphylococci, streptococci, 
enterococci, facultative 
gram-negative bacilli, 
anaerobic bacteria such as 
Fusobacterium spp. and 
peptostreptoocci
(Kenney and Ash, 1969; 
Mira et al., 2004; Socransky 
etal., 1998)
(Ehrlich et al., 2002; Fergie 
et al., 2004; Ferguson et al., 
1986)
(Bagge et al., 2004a;
Hentzer et al., 2001)
(Bjarnsholt et al., 2008; 
Davies et al., 2001; Hansson 
etal., 1995; Hill et al., 2003; 
James et al., 2007; Percival 
and Bowler, 2004; Serralta 
et al., 2001)
Infection associated with foreign body material
Urinary
catheters
Native valve 
endocarditis 
(NVE)
Proteus mirabilis, Morganella (Stickler, 2005; Stickler,
morganii, P. aeruginosa, 2002; Stickler et al., 1999;
Klebsiella pneumoniae, Trautner and Darouiche,
Proteus vulgaris 2004; Tunney et al., 1999)
Streptococci, staphylococci, (Braunwald, 1997; Donlan
Gram negative bacteria, and Costerton, 2002)
fungi______________
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Attachment Colonisation Growth of
m ature biofilm
Fluid
Planktonic
cells
Surface
Fig. 1.2 Schem atic diagram showing the various stages of biofilm formation 
consisting of attachment, colonisation and growth phases. Bacteria are  
depicted in red and the extracellular polysaccharide matrix of the biofilm is 
depicted in yellow.
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Primary adhesion is reversible and in biological systems occurs between a 
conditioned surface and a planktonic microorganism. In the case of a 
biomaterial, conditioning represents the modification of the native surface 
through the adsorption of water, proteins, lipids, extracellular matrix 
molecules, complement, fibronectin and inorganic salts. This conditioning 
film may change the affinity of an organism to attach to the surface (Dunne, 
2002).
In the initial stages of the adherence process, the organism needs to be in 
close proximity to the surface, either through random transportation in a 
stream of fluid or in a direct way via chemotaxis and motility (Dunne, 2002). 
In the case of P. aeruginosa biofilms, flagella motility is required to promote 
this primary adhesion (Dunne, 2002; O'Toole and Kolter, 1998a). Once in 
the vicinity of the host surface, bacterial attachment is mediated by multiple 
adherence factors (known collectively as adhesins), which can overcome any 
net repulsion between the two surfaces that may be present due to electrical 
charges (Boland et al., 2000; Carpentier and Cerf, 1993). The final 
determination of the initial adhesion depends on electrostatic and 
hydrophobic interactions, van der Waals forces, temperature and the 
hydrodynamic forces between the two surfaces (An et al., 2000; Carpentier 
and Cerf, 1993; Dunne, 2002).
Attachment is a complex progress regulated by diverse variables. Cell 
surface structures such as fimbriae, other proteins, lipopolysaccharide (LPS), 
EPS and flagella all play an important role. Attachment to hydrophobic 
substrata seems to be associated with cell surface polymer structures such 
as fimbriae, other proteins and cell wall components of certain Gram- 
negative bacteria (mycolic acids), while EPS and LPS are more important in 
attachment to hydrophilic materials (Donlan, 2002).
1.2.1.2 Secondary bacterial adhesion
Secondary bacterial adhesion involves covalent interaction between specific 
adhesins and receptors on cell surfaces (An et al., 2000). Bacteria and host 
surfaces generally express multiple adhesins and receptors respectively
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(Table 1.3). The levels and activities of these components are modulated in 
response to different environmental and external conditions, nutrient sources 
available, static conditions or fluid flow (Dunne, 2002; Jenkinson et al., 2003). 
Certain adhesins are regulated at the transcriptional level, permitting 
organisms to switch from sessile to planktonic forms under different 
environmental influences (An et al., 2000; Ziebuhr et al., 1999). 
Staphylococcus epidermidis and S. aureus produce a polysaccharide 
intercellular adhesion (PIA) which is associated with cell-to-ce!l adhesion and 
subsequent biofilm formation (Cramton et al., 1999; Heilmann et al., 1996; 
Mack et al., 1996; Mack et al., 1994). Pseudomonas aeruginosa exhibits a 
surface-associated motion known as “twitching motility”, where monolayer 
cells “walk” via twitching motility to form cellular aggregates on surfaces that 
eventually differentiate into microcolonies (Dunne, 2002). It has been shown 
that mutants deficient in type IV pili form monolayers but not cellular 
aggregates (Dunne, 2002).
1.2.2 Biofilm structure
As already stated, bacteria that form biofilms exist in two forms, planktonic or 
sessile. Those bacteria that are sessile attach to a surface, aggregate and 
form a matrix to produce a biofilm (Costerton et al., 1999). Attached bacteria 
multiply and encase their colonies with the generated ‘slimy’ matrix. The 
matrix surrounding the biofilm primarily consists of exopolysaccharides often 
collectively referred to as the glycocalyx.
Biofilms are heterogeneous environments and the consensus is that they 
comprise of aggregates of microbial cells within the glycocalyx, with 
interstitial voids and channels separating the microcolonies (Fig. 1.3a) 
(Sutherland, 2001). The planktonic population exists in the liquid state 
surrounding the biofilm. Importantly, sessile and planktonic bacteria of the 
same species have been shown to have different phenotypes.
9
Table 1.3 Examples of adhesins known to be involved in biofilm formation.
Microorganism Adhesin Reference
Escherichia coli Fimbrial component H 
(FimH)
(Schembri and Klemm, 
2001)
Streptococcus mutans Ag I /II; receptor 
Salivary pellicle
(Hajishengallisetal., 
1992; Hamadaetal., 
2004; Prakobphol et al., 
2000)
Pseudomonas
aeruginosa
Twitching motility:
Type IV pili; Flagella 
motility, Fimbriae
(O'Toole and Kolter, 
1998a; Valletetal., 
2004; Vallet et al., 
2001)
Staphylococcus aureus Polysaccharide 
intercellular adhesin 
(PIA)
(Arciola et al., 2001; 
Cramton etal., 1999; 
Knobloch et al., 2002; 
Martin-Lopez et al., 
2002; Yazdani et al., 
2006)
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1 BULK FLUID
STREAMERCELL CLUSTER
CHANNEL
>•: 19W5 CENTER FOR BIOflLM ENGINEERING MONTANA STATE UNIVERSITY BOZEMAN
Fig. 1 .3a A  3-dimensional structure of a biofilm including formation of distinct 
water channels. (Adapted from the Centre for Biofilm Engineering, Montana  
University, Bozeman; www.erc.m ontana.edu).
Fig. 1.3b Mixed biofilm generated in the Constant Depth Film Fermenter, 
stained with universal bacterial peptide nucleic acid probe (PNA, Bac- 
Uni1CY3-red). Arrows indicate water channels. (This study).
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Figure 1.3b shows a mixed biofilm consisting of P. aeruginosa, S. aureus, 
Micrococcus luteus and Streptococcus oralis generated in the laboratory 
using the constant depth film fermenter (Chapter 3) over a five day incubation 
period. This image clearly depicts the water channels (spaces devoid of 
bacteria) which allow diffusion of nutrients and gases. This biofilm structure 
is typical of other descriptions found in the literature (Davey and O'Toole, 
2000; Donlan, 2002).
1.2.3 Physiological properties of biofilms
The physiology of biofilm cells is extremely complex and profoundly different 
from those organisms grown planktonically (Costerton et al., 1987). The 
physiological status of biofilm cells is heterogeneous and determined by the 
location of each individual cell within the multiple layers of cells that form the 
biofilm (Anwar et al., 1992a). Surface biofilm cells are metabolically active 
and tend to be large in size since these have easy access to nutrients and 
oxygen, and have fewer problems with the discharge of metabolic waste 
products (Anwar et al., 1992a). The surface-associated biofilm cells are 
most likely to have properties similar to planktonically cultured cells. 
Sternberg et al (1999) has shown that cells at the base of the biofilm have 
reduced metabolic rates compared with cells at or near the surface, and 
highlights the importance of nutrient availability as a crucial factor influencing 
metabolic activity (Davies, 2003).
1.3 MICROBIAL INTERACTIONS WITHIN BIOFILMS
1.3.1 Microbial cell coaggregation
Biofilms can be comprised of single or mixed species populations. During 
the adhesion process, planktonic bacteria can form aggregates, thereby 
'sticking* to neighbouring cells in a process known as coaggregation (Dunne, 
2002).
Coaggregation is defined as the specific cell-to-cell recognition that occurs 
between both intra and inter species (Kolenbrander et al., 2006). This
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mechanism of adhesion is highly specific and considered to have a role in the 
development of multi-species biofilms in many different environments. 
Coaggregation has been shown to be highly specific in dental plaque 
bacteria and mediated by growth phase-dependent adhesion-receptor 
interactions (Rickard et al., 2003a; Rickard et al., 2002; Rickard et al., 
2003b).
Away from the oral cavity, coaggregation has also recently been reported for 
bacterial members of the urogenital flora (Reid et al., 1988), lactobacilli from 
the crops of chickens (Vandevoorde et al., 1992) and in aquatic biofilm- 
forming bacteria (Buswell et al., 1997; Rickard et al., 2000). The 
phenomenon has been attributed with enabling the survival of anaerobic 
species in an oxygenated environment by ensuring close association with 
certain aerobic species (Bradshaw et al., 1998).
Coaggregation may provide additional benefits to the interacting species 
beyond promoting adherence and facilitating bacterial succession (Bradshaw 
et al., 1998). It seems to promote a nutritionally beneficial, communal 
relationship, where metabolic cooperation results in the liberation of 
additional nutrients, which may help maintain the characteristic diversity of 
many biofilm communities (Rickard et al., 2003a).
1.3.2 Competitive interactions
Microorganisms in a biofilm are in close proximity to one another and 
therefore interact as a consequence. These interactions can be beneficial to 
one or more of the interacting populations, whilst others can be antagonistic 
(James et al., 1995; Stewart et al., 1997).
Donlan (2002) suggested that P. aeruginosa is competitive in mixed biofilms 
despite its slower growth rate compared with other bacteria because it is able 
to rapidly colonise the surface of the substratum. Pseudomonas aeruginosa 
therefore could provide the base layer of biofilms with other more rapidly 
growing bacteria producing surface microcolonies (Donlan, 2002).
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1.3.3 Synergistic interactions
It is thought that synergistic mechanisms play a role in mixed species biofilms 
(Hofstad, 1992). Synergistic effects include oxygen consumption by aerobes 
thereby increasing the redox potential and allowing anaerobes to proliferate, 
as well as nutrient production and impairment of host immune response. 
Polymicrobial interactions may well play a crucial role for biofilms in delayed 
wound healing. For example, less invasive microorganisms can act 
synergistically with more virulent ones (Bowler, 2003).
113.4 Quorum sensing
Quorum sensing (QS) can be defined as a cell-to-cell communication system 
utilising chemical messages that allows a single bacterium to interact with its 
neighbours (Jones, 2005) and serves to regulate colonisation and virulence 
factor expression (Yarwood and Schlievert, 2003). Quorum sensing 
chemicals are often referred to as microbial pheromones or autoinducers 
(Jones, 2005). Bacteria release these pheromones into the environment and 
effectively the level released relates to the population density. Quorum 
sensing communication is coordinated by small, diffusible signal molecules. 
Gram-negative bacteria typically produce acylated homoserine lactones 
(AHLs, Fig. 1.4a) whereas Gram-positive bacteria use small cyclic peptides 
(Fig. 1.4b) (Donabedian, 2003; Smith and Iglewski, 2003).
In the natural environment, there are many different types of biofilm 
communities, all of which require the coordination of the constituent cells’ 
behaviour. As environmental conditions can change rapidly, microorganisms 
need to respond quickly to adapt to these changes. Examples where such 
adaptations are needed include responding appropriately to the availability of 
nutrients and protecting against other ‘in-coming’ and potentially competitive 
microorganisms, host defence mechanisms or antimicrobial agents. The cell­
cell signalling system helps bacteria to survive various stresses in a cell- 
density-dependent manner and regulates the expression of genes that also 
influence their ability to cause disease (Marsh, 2004).
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aBasic structure of the AHL signal molecule 
R1-H, OH orO  
R2=C,-C-fi
R2
3-oxo-C12-homoseri ne lactone
C4-homoserine lactone
b
YST^DFIIjl
s-c=o
GVNACSSLF
\ 1
s^c=o
YINCDFLL
\ I
s-c=o
YSTCYFIM
\ 1s-c=o
A *  alanine M = methionine
C ■ cysteine N a asparagine
D *  aspartic acid S = serine
F *  phenylalanine I  = threonine
G *  glycine V = valine
1 *  isoleucine Y *  tyrosine
L *  leucine
Fig. 1.4 Bacterial quorum sensing molecules a) homoserine lactones of P. 
aeruginosa and b) cyclic peptides of S. aureus (adapted from Donabedian, 
2003; Rasmussen and Givskov, 2006).
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For pathogenic bacteria to cause infection, coordination of virulence factors 
may be required to avoid associated host immune responses.
1.3.4.1 Quorum sensing by Pseudomonas aeruginosa
Pseudomonas aeruginosa has at least two quorum sensing systems which 
interact with each other, the LasR-LasI and the RhIR-Rhll with the cognate 
signal molecules N-(3-oxo-dodecanoyl)-L-homoserine lactone (3-oxo-C12- 
HSL; HSL for homoserine lactone usually referred to as PAI-1) and N- 
butanoyl-L-homoserine lactone (C4-HSL) (Donabedian, 2003; Rasmussen 
and Givskov, 2006). It has been shown that the gene product of Iasi 
produces a diffusible molecule (PAI-1) which could activate the LasR protein 
(Donabedian, 2003). The two systems are linked with the las system being 
the first part of the signalling cascade positively regulating expression of both 
rhIR and rhll (Fig. 1.6).
A third non-AHL dependent QS system has been identified which relies on 
the signal molecule heptyl-3-hydroxy-4-quinolone (PQS) and is interspaced 
between the las and the rhl system.
Pseudomonas aeruginosa produces many extracellular virulence factors 
including alkaline protease, toxin A, and two different elastases (as the 
products of the lasA and lasB genes). The LasR protein enhances the 
transcription of the genes which encode those virulence factors. Lasl is 
necessary for the production of the same virulence factors. A normal and 
dense biofilm formation of P. aeruginosa depends on the synthesis of PAI-1. 
Bacteria lacking the lasl gene produce a loose and easily disrupted biofilm 
(Donabedian, 2003). As expected for a density-dependent gene system, the 
expression of lasl and rhll is greatest at the base of the biofilm and 
decreases as the height of the biofilm increases (De Kievit et al., 2001a). 
Pseudomonas aeruginosa isolated from urinary catheters (Stickler et al., 
1998), contact lenses (Zhu et al., 2001) and cystic fibrosis (Singh et al.,
2000) all produce these quorum-sensing molecules.
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Fig. 1.5 Hierarchical organisation of P. aeruginosa quorum sensing system. 
LasR activates the expression of lasl to generate 3-oxo-C 12-H C L (also 
known as PAI-1). The LasR /3-oxo-C 12-H SL complex drives the expression 
of multiple target genes. The RhIR protein drives the expression of rhll, and 
hence C 4-H S L (also known as PAI-2) and the R hlR /C 4-H SL complex is 
responsible for controlling multiple target genes. LasR /3-oxo-C 12-H SL also 
regulates the expression of rhll.
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A study using the burn mouse model showed that QS plays a significant role 
in wound infections (Rasmussen and Givskov, 2006). However, if the mice 
were infected with QS mutants (deletion of synthase genes in P. aeruginosa, 
e.g. lasl deletion mutant, lasl rhll deletion mutant), the immune response 
appeared to develop quicker, the polymorphonuclear leukocytes (PMLs) 
responded with the development of stronger oxidative bursts and antibodies 
accumulated faster at the infected lung site (Bjarnsholt et al., 2005; Smith et 
al., 2002; Wu et al., 2001). In addition to the role of QS in the virulence and 
pathogenesis of P. aeruginosa, other pathogenic organisms, including 
Serratia liquefaciens and Chromobacterium violaceum (both of which are 
human pathogens), and Agrobacterium tumefaciens and Erwinia carotovora 
(both of which are plant pathogens) have also been shown to encode QS 
signalling pathways (Rasmussen and Givskov, 2006; Sheng and Citovsky, 
1996; Whitehead et al., 2002).
1.3.4.2 Quorum sensing by Staphylococcus aureus
In the case of S. aureus, the accessory gene regulator (agr) controls the 
coordinated production of virulence factors. The agr signalling system (Fig. 
1.6) consists of a classical two-component system; AgrC as the signal 
receptor and AgrA as the response regulator. The system serves as a QS 
regulon to autoinduce RNAIII, the principal effector of the agr response. An 
autoinducing peptide (AIP) encoded within the agrD drives the agr signalling 
system (Ben Ayed et al., 2006; Shopsin et al., 2003). The peptide quorum 
sensing molecule is actively secreted by an ATP-binding cassette exporter. 
The receptor for the peptide is a histidine protein kinase molecule which 
spans the staphylococcal cell membrane. The agrD gene codes for a 
peptide which is cleaved by the AgrB protein to form the cyclic octapeptide. 
The AgrC protein acts as the transmembrane receptor for the secreted 
peptide. The receptor-ligand pair then phosphorylates the product of the 
agrA gene which in turn allows the transcription of many staphylococcal 
virulence genes, such as alpha, beta and delta toxins (Donabedian, 2003). 
Table 1.4 summarises factors which regulate quorum sensing.
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Fig. 1.6 Quorum sensing in S. aureus.
The agr locus consists of two divergent transcriptional units. The left operon 
is expressed from the P2 promoter and consists of agrABCD, which encode  
the proteins that are responsible for generating and sensing the peptide 
signal molecule; the right RNAIII operon is transcribed from the P3 promoter. 
The Q S peptide is derived from the gene product of agrD by the action of the 
AgrB protein, which is responsible for the export of the peptide out of the cell. 
Once a critical concentration is reached, the peptide interacts with the AgrC  
m em brane associated sensor protein, causing it to autophosphorylate. The  
phosphate is then transferred to the response regulator and in its 
phosphorylated state AgrA then activates expression of RNAIII, which 
m ediates the changes in expression of multiple target genes. Since the 
genes responsible for peptide production (agrBD) are also activated, this 
results in the production of more peptide signal and the generation of an 
autoinduction feedback loop.
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Table 1.4. Quorum sensing systems and the factors they regulate
Organism Quorum Sensing Systems Used Factors Regulated by 
Quorum Sensing
Reference
Pseudomonas
aeruginosa
lasl-lasR via rhll-rhlR.
Pseudomonas quinolone signal (PQS).
Involved in
• Biofilm formation and architecture
• Virulence factor production, including elastase, 
alkaline protease, hydrogen cyanide, exotoxin A, 
catalase, pyocyanin, lectins, superoxide dismutase
• Pathogenesis of P. aeruginosa
(Donabedian,
2003)
(Rasmussen and 
Givskov, 2006) 
(Heurlier et al., 
2006)
Staphyiococcus
aureus
agr (accessory gene regulator) quorum 
sensing system, shown to be expressed 
in several infection models.
Involved in
• Virulence factor production, attachment and dispersal
• Tissue colonisation and enhancement in biofilm 
formation
(Donabedian,
2003) (Camara et 
al., 2002)
(Vuong et al., 2003)
Vibrio cholera HapR and CqsA
Involved in
• Expression of genes, when density of its species is 
sufficiently high
• Depth of biofilm
(Zhu and 
Mekalanos, 2003) 
(Donabedian, 
2003)
1.4 BIOFILM STABILITY
1.4.1 Resistance of biofilms against host defence mechanisms
Bacteria within a biofilm generate a protected microenvironment through the 
production of an extracellular biofilm matrix. This matrix is composed of a 
mixture of components, including EPS, proteins and nucleic acids. The 
biofilm matrix is a complex structure encompassing of water channels that 
permit transfer of nutrients and waste products (Fig. 1.3a). The most widely 
studied of these components is EPS (Table 1.5). Bacterial generated EPS 
would appear to be the key component in affording biofilm protection against 
host defences (Davey and O'Toole, 2000). The fact that biofilm-based 
infections are rarely resolved, even in individuals with competent innate and 
adaptive immune responses, highlights the high degree of resistance 
exhibited (Stewart and Costerton, 2001). It has been shown that biofilms are 
resistant against the host cellular defence system (the phagocytic and 
immune responses) (Todar, 2005) and the adaptive and innate immunity 
(lysozyme, lactoferrin, Toll-like receptors) (Hiemstra, 2001).
1.4.2 Resistance of biofilms against antimicrobial agents
The nature of the biofilm structure and the physiological attributes of 
microorganisms within the biofilm create an intrinsic resistance to 
antimicrobial agents (antibiotics, disinfectants, germicides or antifungals). 
Mechanisms responsible for resistance may be by one or more of the 
following: a) reduced penetration of the antimicrobial agent into the biofilm 
matrix, b) altered growth rate of biofilm organisms and c) other physiological 
changes due to the biofilm mode of growth (Fig.1.7); (Donlan and Costerton, 
2002).
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Table 1.5 Typical components of a biofilm matrix.
Component Percentage of matrix (%)
Water up to 97
Microbial cells 2-5 (polymicrobial)
Polysaccharides (monosaccharides, 1-2 (neutral & polyanionic)
heteropolysaccharides)
Proteins (extracellular & resulting <1-2 (including enzymes)
from lysis)
Nucleic acids <1-2 (from lysed cells)
Ions Bound and free
Adapted from Sutherland 2001.
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Multidrug resistance
efflux pump
Antibiotic
concentration
Quorum
sensingNutrient & oxygen 
concentration
Gene expression: 
Agr, lea, Sigma B,
Dormant cells 
(biofilm phenotype)
Fig. 1.7 A schematic drawing of mechanisms that can contribute to the 
resistance of biofilm-grown bacteria to antimicrobial agents.
The EPS is represented in yellow and the bacteria as blue ovals. In general, 
biofilms are characterised by their heterogeneity which includes nutrients, 
waste products and oxygen (illustrated in violet and green areas). 
Resistance include increased cell density and physical exclusion of the 
antimicrobial agent. The microorganism in the biofilm can undergo 
physiological changes to improve resistance (biofilm phenotype, induction of 
stress response rpoS, increasing expression of multiple drug resistance 
pumps and activation of the Q S system).
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Biofilm-grown bacteria can be up to 1000 times more resistant to antibiotics 
than their planktonic equivalents (Hoyle and Costerton, 1991; Mah and 
O'Toole, 2001). Whilst biofilm cells themselves employ a variety of 
mechanisms to resist the action of antimicrobial agents (Mah et al., 2003) 
studies have also shown that a number of other factors could contribute to 
the antimicrobial resistance properties of biofilms (Percival and Bowler, 
2004). Some details of these mechanisms are discussed below.
1.4.2.1 Reduced penetration of an antibiotic into the biofilm matrix
Enhanced antimicrobial resistance by biofilms could relate to a reduced 
ability of the antimicrobial to gain access to the microorganisms located 
within the matrix of the biofilm. A reduced penetration of the agent through 
the matrix could arise through chemical interaction with extracellular biofilm 
components or adsorption to anionic polysaccharides. It has been shown 
that P-lactamase producing organisms increase enzyme production in 
response to antibiotic exposure (Bagge et al., 2004a). (3 -lactamase also 
accumulates in the biofilm matrix due to secretion or cell lysis, deactivating 13- 
lactam antibiotics in the surface layers more rapidly than the rate they diffuse 
into the biofilm (Anderl et al., 2003). A recent study identified that biofilm 
penetration of positively charged aminoglycosides is retarded through binding 
to negatively charged matrices, such as alginate produced by P. aeruginosa 
biofilms (Walters III et al., 2003). It has been suggested that this retardation 
could provide more time for bacteria to conduct adaptive stress responses 
(Fux et al., 2005). Another study showed that extracellular slime derived from 
coagulase-negative staphylococci reduced the effect of glycopeptide 
antibiotics, even in planktonic cultures (Fux et al., 2005; Konig et al., 2001). 
In addition, Mah et al (2003) showed that bacteria within a biofilm may 
actively employ distinct mechanisms such as sequestering antibiotics, such 
as tobramycin, in the periplasm to prevent them from reaching their target 
sites. Whilst this may occur, it is known that the biofilm matrix does not form 
a completely impenetrable barrier to antimicrobial agents (Percival and 
Bowler, 2004).
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1.4.2.2 Growth rate of bacteria in biofilms
Antibiotics are generally more effective in killing actively reproducing cells. 
Hence, reduced activity of microorganisms within a biofilm could render these 
cells less susceptible to antimicrobial agents. It has been known for 
sometime that non-dividing bacteria escape the killing effects of antibiotics 
targeted against growth-specific factors (Davies, 2003). Antibiotics, such as 
ampicillin and penicillin, which target cell-wall synthesis, are not able to kill 
non-dividing cells (Costerton et al., 1999; Stewart and Costerton, 2001). 
Whilst cephalosporins and fluoroquinolones, are cidal to non-growing cells, 
they do have greater activity against rapidly growing bacteria. Therefore, the 
presence of bacteria that are growing slowly in a biofilm state may contribute 
to their reduced susceptibility to antibiotics (Costerton et al., 1999). The 
likely location of slow-growing bacteria in a biofilm is in the lower region of 
the biofilm (Davies, 2003). Cells deep within the biofilm are more likely to be 
metabolically inactive, because of reduced access to essential nutrients and 
gaseous exchange. Embedded biofilm cells are at the stage of dormancy 
and these cells are phenotypically equipped to persist even in the most 
hostile environments (Anwar et al., 1992b; Rhoads et al., 2007). These 
‘persister cells’ are defined as a small and slow-growing subpopulation of the 
biofilm which have differentiated into an inactive, but highly protected state 
(Roberts and Stewart, 2005). It has been estimated that these 
subpopulations represent 0.1-10% of all cells in the biofilm and it has been 
hypothesised that they can survive an enormous antimicrobial challenge, 
subsequently allowing this subpopulation to reseed the biofilm once use of 
antibiotics is ceased (Harrison et al., 2005; Roberts and Stewart, 2005).
1.4.2.3 Induction of a biofilm phenotype to resist antimicrobials
Once microorganisms attach a surface they may express a general and more 
virulent biofilm phenotype compared to planktonically grown identical cells 
(Mah and O'Toole, 2001; Saye, 2007). Gilbert et al (1997) suggested that a 
biofilm-specific phenotype may be induced in a subpopulation of the biofilm. 
These subpopulations have been shown to express active mechanisms to 
reduce the efficacy of antibiotics, such as the expression of bacterial
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periplasmic glucans to bind to and physically sequester antibiotics (Gilbert et 
al., 1997; Maira-Litran et al., 2000; Percival and Bowler, 2004). Once 
microorganisms attach a surface some genes are turned on whilst others are 
turned off (Stewart and Costerton, 2001).
It has been documented that altered gene expression by organisms within a 
biofilm or a general stress response of a biofilm could reduce susceptibility to 
antimicrobial agents (Brown and Barker, 1999). In theory, the bacterial cell 
has a small number of target sites for antibiotics. It could therefore be that 
biofilm cells use specific genes to phenotypically alter these target sites to 
protect themselves (Saye, 2007). Exact details about the physiological 
changes that occur during the transition from a planktonic to a biofilm state is 
not known. It has been suggested that multidrug resistance efflux pumps 
(MDR) may substantially contribute to the resistance of biofilms (De Kievit et 
al., 2001b; Mah and O'Toole, 2001). However, studies have shown that 
expression of well characterised multidrug efflux (MDR) pumps does not 
increase in P. aeruginosa biofilms (De Kievit et al., 2001b).
1.5 GENE EXPRESSION ASSOCIATED WITH BIOFILM DEVELOPMENT
For the initiation of biofilm formation, microorganisms must be able to attach 
to and move on surfaces, sense their cell density and generate a 3- 
dimensional structure of cells encased in exopolysaccharides (O'Toole et al., 
2000a). These processes are all thought to be controlled via differential gene 
expression (Table 1.6), which differs markedly from that of planktonic 
microorganisms (Beloin and Ghigo, 2005). A pioneering study showed that 
compared to planktonic cultures maintained in steady state, P. aeruginosa 
biofilms (6 day old biofilm) differed in gene expression by 1% (Stanley et al., 
2003; Whiteleyetal., 2001).
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Table 1.6 Genes involved in biofilm formation (Adapted from Beloin and Ghigo 2005)
Regulatory genes Function Bacterial species
Gram positive bacteria
icaADBC Mediates cell-cell adhesion S. aureus
Accessory gene regulator (agr) Regulates virulence factors / S. aureus
Involved in detachment process S. epidermidis
Staphylococcal accessory gene regulator (sarA) Production of surface associated & S. aureus
secreted virulence factors
SigmaB Activates biofilm formation S. epidermidis
Gram negative bacteria
rpoS Reduces/increases depth of biofilm E. coli
rpoS Reduces depth of the biofilm P. aeruginosa
Cm Activation of type IV motility P. aeruginosa
mvaT Reduces adhesion via cup gene repression P. aeruginosa
rpoN Role in initial adhesion & biofilm formation P. aeruginosa
1.5.1 Gene expression in S. aureus biofilms
Staphylococcus aureus is a significant bacterial pathogen of humans 
responsible for a wide variety of infections and a major source of patient 
morbidity (Beenken et al., 2004; Yazdani et al., 2006). Biofilm formation by 
staphylococci develops in two stages: primary attachment followed by cell­
cell adhesion and accumulation (Gotz, 2002). The second phase of biofilm 
formation requires the polysaccharide intercellular adhesin (PIA) (Vuong et 
al., 2003).
Staphylococcus aureus adheres to surfaces through the production of a 
capsular polysaccharide/adhesin (PS/A). A multilayer biofilm is formed 
following S. aureus multiplication, which also results in the production of a 
PIA (Beenken et al., 2004; Rohde et al., 2005; Yazdani et al., 2006). PIA is a 
homoglycan consisting of p-1,6-linked polymeric N-acetylglucosamine 
residues (Beenken et al., 2004; Mack et al., 1996). Control of PIA production 
is dependent upon the genes within the icaADBC operon (Heilmann et al., 
1996; Yazdani et al., 2006) which is also known as a key virulence 
determinant for S. epidermidis (Arciola et al., 2001; Conlon et al., 2002a; 
Conlon et al., 2002b).
Whilst there are strain dependent differences (Beenken et al., 2004; Cramton 
et al., 1999; Rohde et al., 2001), most S. aureus strains appear to contain the 
entire ica operon (Cramton et al., 1999; Fowler et al., 2001; Rohde et al., 
2001). Vandecasteele et al. (2003) showed that ica expression was 
associated with the initial colonisation of S. epidermidis in an infection model 
but not with long term persistence. Frebourg et al. (2000) have indicated the 
possible value of targeting the ica locus as a diagnostic marker to distinguish 
between invasive and contaminating isolates of S. epidermidis. Regulation of 
ica expression and the ability to form a biofim also involves other regulatory 
elements. Among these additional regulatory loci are the accessory gene 
regulator (agr, section 1.3.4.2) and the staphylococcal regulator (sarA) 
(Beenken et al., 2004; Patti et al., 1994). It has been suggested that sarA 
modulates biofilm production. Studies have confirmed that sarA mutants
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have a reduced capacity to form a biofilm. Hence, sarA would presumably 
be required for production of an activator of biofilm formation or a required 
effector molecule (Beenken et al., 2004; Patti et al., 1994).
In S. aureus proteolysis also plays a pivotal role in its pathogenicity (Rohde 
et al., 2005). The expression of staphylococcal proteases is under 
environmental control of quorum sensing circuits like agr and sar (Lindsay 
and Foster, 1999; Rohde et al., 2005), potentially linking Aap (accumulation 
associated protein) processing with these global regulators of staphylococcal 
virulence. The differential expression of protease activity contributes to the 
adaptation of the pathogen to a changing environment by altering the 
adhesive properties to extracellular matrix proteins (Karlsson et al., 2001; 
McAleese et al., 2001; McGavin et al., 1997; Rohde et al., 2005; Savolainen 
etal.,2001).
Staphylococcus aureus adherence is also promoted by cell wall adhesins 
(Fluckiger et al., 2005). More specifically, a group of surface-exposed 
proteins collectively referred to as MSCRAMMs (microbial surface 
components recognising adhesive matrix molecules) interact with a number 
of host proteins, such as fibronectin, fibrinogen, collagen, vitronectin and 
laminin (Beenken et al., 2004; Harris et al., 2002; Patti et al., 1994).
1.5.2 Gene expression in P. aeruginosa biofilms
Pseudomonas aeruginosa is a commensal of humans and a recognised 
opportunistic pathogen with great adaptability and metabolic versatility in 
individuals whose defence systems are impaired (Bagge et al., 2004b; 
Wilson, 2001). This organism is particularly associated with morbidity and 
mortality in patients with cystic fibrosis (CF). Alginate expression by P. 
aeruginosa is considered as an important virulence factor of this bacterium, 
as it is thought to have a protective function against an environment that is 
high in oxidative stress and against attack by immune system components 
(Krieg et al., 1988; Simpson et al., 1988; Simpson et al., 1989). Possible 
roles of alginate could therefore be to serve as a barrier to phagocytosis and
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as a substance that neutralizes oxygen radicals (Edwards and Saunders,
2001). Alginate is a viscous exopolysaccharide, consisting of D-mannuronic 
and L-guluronic acids (Hershberger et al., 1995). Studies have shown that P. 
aeruginosa strains isolated from the lungs of CF patients, have a mucoid 
phenotype and exhibit production of the exopolysaccharide alginate 
(Edwards and Saunders, 2001).
Pseudomonas aeruginosa can also express genes coding for extracellular 
appendages, such as flagella and type IV pili, which play a role in biofilm 
formation (section 1.2.1.1), in bacterial conjugation for plasmid transfer and 
other pathogenic adaptations (Finelli et al., 2003; Goodman and Lory, 2004; 
O'Toole and Kolter, 1998a; Vallet et al., 2004). Flagellar motility appears to 
be required for approaching surfaces and counteracting repulsive forces. 
Twitching motility is mediated by type IV pili and is required for subsequent 
spreading over a surface (Vallet et al., 2004). It has been shown that type IV 
pili play a role in microcolony formation (O'Toole and Kolter, 1998a) and in a 
recent study 3 genes from different chromosomal regions involved in type IV 
pilus production (pilB, pilY2 and pilP) were up-regulated in 8h developing 
biofilms (Waite et al., 2005). Using infected animal models such, 
appendages are directly implicated in virulence and serve as pattern 
recognition molecules for host defences (Mah et al., 2003; Van Bambeke et 
al., 2003).
Biofilm formation is controlled by a number of different regulators. Vallet et 
al. (2004) identified gene clusters, namely the cup (chaperone-usher 
pathways), consisting of cupA, cupB and cupC, which may be involved in the 
assembly of novel P. aeruginosa fimbrial structures (Croft et al., 2000; Vallet 
et al., 2001). The cupA gene cluster is required for adhesion to inert surfaces 
and likely to be important in the initiation of biofilm formation. The two 
additional gene clusters cupB and cupC have no obvious influence on 
surface attachment (Vallet et al., 2004; Vallet et al., 2001). Another 
regulatory factor, Crc (catabolite repression control) protein which plays a 
role in the regulation of carbon metabolism is necessary for biofilm formation
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(O'Toole et al., 2000b). It has been suggested that Crc controls the 
transcription of genes required for type IV pilus biogenesis. Therefore, Crc 
may be part of a signal transduction pathway; it can sense and respond to 
nutritional signals and may play a role in the organisms’ transition from 
planktonic to biofilm growth. However, additional work is needed to 
determine the precise mechanism by which Crc is regulated (Finelli et al., 
2003; O'Toole et al., 2000b).
Friedman and Kolter (2004) identified the pel (pellicle formation) gene cluster 
and revealed its involvement in the formation of biofilms by demonstrating 
that pel mutants were unable to form a robust and shear force resistant 
biofilm. It was hypothesised that the pel genes are involved in the production 
of a novel glucose rich polysaccharide component that contributes to the 
formation of a matrix material that encases the cells and holds them together 
in a resistant biofilm. Another study by Vasseur et al. (2005) showed that the 
pel genes probably influence the initiation of the biofilm formation process 
and the irreversible attachment on abiotic surfaces.
The stationary sigma factor rpoS (Table 1.6) is thought to play a central role 
in development of starvation-mediated general resistance in Escherichia coli 
(Lange and Hengge-Aronis, 1994; Xu et al., 2001). It is believed that it could 
also contribute to P. aeruginosa biofilm resistance (Fig. 1.7); (Jorgensen et 
al., 1999; Xu et al., 2001).
It is important to highlight that bacteria are subject to an array of stresses 
within their natural environment and it has been demonstrated that stationary 
phase (starving) cells survive better than their exponential phase 
counterparts (Xu et al., 2001). Bacteria in a biofilm and planktonic state are 
capable of turning on stress-response genes and switching to more 
environmental tolerant phenotypes upon thereby resisting environments poor 
in nutritional quality, high cell density, and extremes in temperature, pH or 
osmolarity (Novick, 2003).
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It is thought that the control of key biofilm gene patterns present promising 
targets to characterise the biofilm mode of growth and offer excellent 
opportunities to overcome antibiotic tolerance in biofilm-related infections.
To compare gene expression patterns in biofilms with those in planktonic 
cultures, a multitude of strategies have been used, such as microarray 
studies and real time PCR (Fux et al., 2005). Such strategies are discussed 
in more detail in Chapter 6.
1.6 ROLE OF BIOFILMS IN NON ORAL INFECTION
1.6.1 Native Valve Endocarditis (NVE)
Native valve endocarditis is a condition that results from the interaction of 
bacteria, the vascular endothelium and pulmonic valves of the heart. The 
causes of NVE are varied, but the condition is frequently associated with 
streptococci, staphylococci, Gram-negative bacteria and also fungi 
(Braunwald, 1997). These microorganisms gain access to the blood and the 
heart via the oropharynx, gastrointestinal and urinary tract. Once the intact 
endothelium is damaged, microorganisms adhere to it and non-bacterial 
thrombotic endocarditis (NBTE) develops at the injury. At the point of injury, 
the thrombus develops, which is an accumulation of platelets, fibrin and red 
blood cells (Donlan and Costerton, 2002). Treatment is less effective due to 
a combination of mass transfer limitations and inherent resistance of biofilm 
organisms (Donlan and Costerton, 2002).
1.6.2 Otitis Media
Otitis media (OM) is an infection or inflammation of the middle ear. This 
inflammation often begins when infections that cause sore throats, colds, or 
other respiratory or breathing problems spread to the middle ear. OM 
infections can be of viral or bacterial origin and involve the inflammation of 
the mucoperiosteal lining. The bacteria that cause OM include 
Streptococcus pneumoniae, Haemophilus influenza, Moraxella catarrhalis, 
group A p-haemolytic streptococci, enteric bacteria, S. aureus, S. epidermidis
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and P. aeruginosa (Ferguson et al., 1986). Although most effusions from 
acute OM are culture-positive for bacteria, the majority of chronic effusions 
are culture-negative and resistant to antibiotic treatment (Ehrlich et al., 2002). 
Tympanostomy tubes are implanted to alleviate pressure build-up and 
hearing loss. Unfortunately, these too are subject to contamination and 
biofilms build up (Donlan and Costerton, 2002).
1.6.3 Cystic Fibrosis
Cystic Fibrosis (CF) is a relatively common disease caused by mutations in 
the gene encoding the cystic fibrosis transmembrane conductance regulator 
(CFTR), a phosphorylation-regulated Cl' channel in the apical membrane of 
involved epithelia (Hilman, 1997; Mathee et al., 1999; Sferra and Collins, 
1993). In CF patients, the constant flow of mucus which removes debris and 
bacteria is excessively thick and sticky. It is an ideal environment for 
bacterial growth, resulting in frequent bacterial chest infection and 
pneumonia (BUPA, 2006).
The bacterium most frequently responsible for the morbidity and mortality 
seen in CF patients, is P. aeruginosa, although other bacterial species have 
also been implicated e.g. Burkholderia cepacia (Bagge et al., 2004b; 
Hershberger et al., 1995; Mathee et al., 1999; Stapper et al., 2004). In CF, 
bacteria colonise and infect the chronic airway, which progressively destroys 
the lung and often leads to respiratory failure (Mathee et al., 1999). The 
colonisation of the CF airways occurs early in the lifetime of the individual 
(Hoiby, 1974). The environment in the CF lungs causes P. aeruginosa to 
switch to a mucoidy phenotype (Doggett, 1969; Hentzer et al., 2001; lacocca 
et al., 1963). Pseudomonas aeruginosa adapts to the inflammatory defence 
system of CF patients and occupies specific niches, forming mucoid biofilms 
or microcolonies that reflect particular conditions.
The mucoid phenotype of P. aeruginosa is caused by an overproduction of 
alginate, which is an exopolysaccharide consisting of mannuronic acid and 
guluronic acid monomers (Hentzer et al., 2001). Alginate has a protective
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function and the switch to mucoidy is also thought to promote persistence of 
P. aeruginosa (Hentzer et al., 2001; Krieg et al., 1988; Simpson et al., 1988; 
Simpson et al., 1989). Evidence to support the case that CF is a biofilm 
disease include its innate resistance to antibiotics, demonstration of 
aggregates of bacteria embedded in EPS and, also that CF sputum contains 
the two principal P. aeruginosa quorum sensing signal molecules, 30C12- 
HSL and C4-HSL (Fergie et al., 2004; Singh et al., 2000). It has been shown 
that P. aeruginosa in CF patients also carry mutations in the mucA gene 
which directs bacteria to produce alginate, which is an oxygen scavenger. 
The phenotype change protects P. aeruginosa against phagocytosis and 
other inflammatory host defence mechanisms (Stapper et al., 2004).
1.7 INDWELLING MEDICAL DEVICE RELATED INFECTIONS
Microbial biofilms often develop on, or within indwelling medical devices e.g. 
contact lenses, central venous catheters, mechanical heart valves, 
pacemakers, peritoneal dialysis catheters, prosthetic joints, urinary catheters 
and voice prostheses (Table 1.7) (Donlan, 2001). There are a number of key 
organisms that cause biofilms on these surfaces. Staphylococcus spp. (S. 
aureus, S. epidemnidis) which are frequent members of the commensal 
microflora of the skin, can form biofilms on implantable medical devices, such 
as intravenous catheters, and hip and knee joint prostheses (Bayston, 1999; 
Habash and Reid, 1999; Khardori and Yassien, 1995). Staphylococcus 
epidermidis, S. aureus, Streptococcus spp., Escherichia coli, Proteus 
mirabilis, Enterococcus faecalis, P. aeruginosa, K. pneumoniae, other Gram- 
negative bacteria and Candida spp. are the primary organisms responsible 
for central venous catheter, mechanical heart valve or urinary catheter 
biofilms. These organisms may originate from a patient’s normal skin 
microflora, from the environment, from an invasive procedure such as dental 
work or other indwelling devices.
Microorganisms usually gain access to the catheter or medical device by 
migration externally from the skin along the exterior catheter surface or 
internally from the catheter hub or port (Maki, 1994).
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Table 1.7 Biofilms on medical devices.
Category Biofilm on medical 
devices
Reference
Category 1 Prosthetic heart valves (Donlan and Costerton, 2002)
Endotracheal tubes (Ramage etal., 2006)
Prosthetic joints (Ramage et al., 2006)
Dentures prostheses (Ramage et al., 2006)
Neurosurgical shunts (Ramage et al., 2006)
Category 2 Central venous (Donlan and Costerton, 2002;
catheters Ramage et al., 2006)
Category 3 Urinary catheters (Donlan and Costerton, 2002; 
Moore et al., 2002)
Contact lenses (Donlan and Costerton, 2002; 
Stickler, 2005; Stickler et al., 
1998)
Voice box prostheses (Ramage et al., 2006)
According to their degree of implantation 3 categories of prosthetic devices 
are established. Category 1: totally implanted; Category 2: partially 
implanted and Category 3: not implanted.
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Implantation of mechanical heart valves causes tissue damage, and 
circulating platelets and fibrin tend to accumulate where the valve has been 
attached. Once the tissue is damaged, it facilitates a greater tendency for 
microorganisms to colonise these locations (Anwar et al., 1992a). The 
resulting biofilms develop on the heart tissue (Carrel et al., 1998; Illingworth 
et al., 1999) surrounding the prosthesis or the sewing cuff fabric used to 
attach the device to the tissue (Donlan, 2001; Karchmer and Gibbons, 1994).
1.7.1 Urinary Catheters
Urinary catheters are used to remove and monitor urine production from 
impaired patients. Urinary catheters also facilitate repair of the urethra after 
surgical procedures and are used to manage urinary retention and 
incontinence in the elderly and disabled patients (Moore and Lindsay, 2001; 
Stickler, 2005). Biofilms associated with urinary catheters are particularly 
important because they cause infections in 10-50% of patients who undergo 
catheterisation (Mulhall et al., 1988; Stickler, 2002). Proteus mirabilis, 
Morganella morganii, P. aeruginosa, K. pneumoniae and Proteus vulgaris, 
are commonly found in urinary catheter biofilms. A number of these bacteria 
(e.g. P. mirabilis) express urease, an enzyme which hydrolyses urea found in 
the urine, resulting in the production of ammonia. Ammonia causes an 
increase in the pH of the urine, which in turn allows mineral precipitation 
including that of calcium and magnesium phosphates, leading to blockage of 
the catheter and infection (Stickler et al., 1999; Tunney et al., 1999). The 
problem is compounded because these organisms tend to be antibiotic 
resistant and as a biofilm forms within the catheter, they are less susceptible 
to host defences and antimicrobial treatments (Trautner and Darouiche, 
2004).
Unfortunately, urinary catheters also provide a passageway for bacteria from 
a heavily contaminated external skin site to a vulnerable body cavity. 
Polymicrobial communities develop as time goes by, but the initial infections 
are usually by single bacterial species (Stickler, 2005).
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1.7.2 Ventilator associated pneumonia
Patients requiring airway management can develop ventilator-associated 
pneumonia (VAP). VAP involves infection of the lower respiratory tract and 
can cause morbidity and mortality in intensive care settings (Brennan et al., 
2004). Biofilms occur on the endotracheal tubes which are an important 
factor promoting the occurrence of VAP (Iregui and Kollef, 2002). 
Microorganisms associated with VAP are Gram negative organisms including 
P. aeruginosa, Enterobacteriaceae, Haemophilus, and Acinetobacter spp. 
Gram-positive organisms include S. aureus, Streptococcus spp., 
Streptococcus pneumoniae and methicillin resistant S. aureus (MRSA) 
strains. It has been suggested that VAP associated pathogens have differing 
levels of virulence, with the highest mortality associated with P. aeruginosa 
and MRSA (Brennan et al., 2004).
1.7.3 Contact lens infections
Bacterial biofilms on contact lenses and storage cases may be a risk factor 
for corneal infection (Dyavaiah et al., 2007; McLaughlin et al., 1998). In 
several studies, such biofilms contained multiple species of bacteria and 
fungi including P. aeruginosa, S. aureus, S. epidermidis, E. coli, Proteus, 
Candida and Fusarium spp. (Donlan and Costerton, 2002; Dyavaiah et al., 
2007). It has been suggested that improper lens cleaning regimens are 
contributing factors for corneal infections (Dyavaiah et al., 2007; Ifejika et al., 
2000).
1.7.4 Denture-based infections
Candida associated denture stomatitis is a common and multifactorial 
disease (Ramage et al., 2006), associated with poor denture fitting, denture 
cleanliness, trauma, oral bacteria, immune defects and the presence of C. 
albicans. Attachment and colonisation of C. albicans is supported by the 
roughness of the surface and by cracks within the acrylic (Ramage et al., 
2006).
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1.8 ORAL BIOFILMS AND THEIR ROLE IN INFECTION
1.8.1 The oral microflora
The oral microflora is regarded to be the most diverse microbial population in 
humans and contains at least 350 different cultivable bacterial genera. It has 
been estimated that many more bacterial groups remain uncultivable from 
this environment (Bagg et al., 2003). The multiplicity of microbial groups 
reflects the diversity between these habitats. In the oral cavity, there are 
unique habitats for bacterial colonisation, including the teeth, mucosal 
surfaces and gingival crevices.
Normally there exists a harmonious relationship between the normal oral 
microflora and the host, which can be disturbed by changes affecting the 
stability of the bacterial population. For example, the use of broad spectrum 
antibiotics, a carbohydrate rich diet and poor oral hygiene can all influence 
the composition of the microflora. Changes may lead to mucosal infection 
and increase the prevalence of both dental caries and periodontal disease 
(Bagg et al., 2003). The normal oral flora maintains a balance within the oral 
cavity, helping to prevent oral infections such as candidiosis and periodontal 
diseases.
1.8.2 Composition of the oral microflora
Microorganisms present in the mouth are commonly referred to as 
commensal organisms but can be responsible for two of the most frequent 
forms of human diseases, namely dental caries and periodontal disease. 
There is evidence that overall some bacteria (S. mutans, Lactobacillus and 
perhaps Actinomyces spp.) are more important than others in dental caries, 
purulent oral infections and infective endocarditis.
1.8.3 Dental plaque
Plaque is a complex, metabolically interconnected, highly organised bacterial 
ecosystem (Marsh and Martin, 1992). Plaque probably represents the most 
widely studied naturally occurring biofilm. As a result of bacterial attachment
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to the tooth surface and subsequent proliferation of these cells dental plaque 
is formed. Plaque (Fig. 1.8) is comprised of plaque bacteria (60-70% of the 
plaque volume), salivary polymers and bacterial extracellular products. 
Primary plaque formers such as Streptococcus spp. are the first to colonise 
the salivary pellicle that is initially present on the tooth surface. Once a 
streptococcal layer has formed, secondary plaque formers such as 
Actinomyces spp. colonise the developing biofilm (Kolenbrander et al., 2006). 
Bacteria within plaque may reach a thickness of 300-500 cells on the surface 
of teeth and the close proximity to dental and supporting tissues may 
promote oral disease. It has been estimated that undisturbed plaque is 
suitable for the growth of anaerobes (Kenney and Ash, 1969). 
Fusobacterium nucleatum bacteria act as coaggregation bridges between 
non-coaggregating aerobes and anaerobes (Kolenbrander et al., 2006). 
Plaque is most prominent on the back molars, just above the gingival line on 
all teeth and at the edges of restorations.
There is a high species diversity in plaque that can be explained by the 
spatial heterogeneity within the biofilm allowing bacteria to co-exist at the 
same site where they would not normally be able to. Plaque formation is 
initiated by the weak attachment of the streptococcal cells to salivary 
glycoproteins, forming a pellicle on the surface of the teeth. This is followed 
by a stronger attachment by means of ‘sticky’ extracellular polymers of 
glucose (glucans) which are synthesised by bacteria from dietary sugars 
(principally sucrose). Glycosyl transferase is an enzyme on the surface of S. 
mutans which converts sucrose to dextran polymers (glucans) and promotes 
the attachment of bacterial cells to the tooth surface. As the complexity of 
the plaque increases, the niches available for colonisation decrease and the 
community becomes relatively stable, reaching a steady state. This stability 
is thought to be important in maintaining the balance between periodontal 
health and disease (Socransky, 1970).
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Fig. 1.8 An oral plaque biofilm on teeth A) unstained and stained with iodine 
B). Adapted from the Centre for Biofilm Engineering, Montana University, 
Bozeman; w ww.erc.m ontana.edu.
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1.8.4 Dental plaque and caries
Microorganisms are a prerequisite for the development of dental caries 
(Samaranayake, 2006a). Dental caries is defined as the localized dissolution 
of the enamel or root surface by acid derived from the microbial degradation 
of dietary carbohydrates. It is a multifactorial plaque related chronic infection 
of the enamel, cementum or dentine. The initial caries lesion is characterised 
by a “white spot”, and represents enamel damage by lactic acid and other 
organic acids which accumulate in dental plaque. Acidogenic bacteria in the 
plaque produce lactic acid from the fermentation of sugars and other 
carbohydrates in the diet of the host. Streptococcus mutans is primarily 
associated with the initiation of dental caries, but other lactic acid bacteria, 
such as Lactobacillus spp. are also implicated (Todar, 2006).
1.8.5 Dental plaque and periodontal disease
Periodontal disease can be defined as the bacterial mediated destruction of 
supporting structures of the teeth including the gingivae, periodontal ligament 
and the alveolar bone, and can be classified into gingivitis and periodontitis 
(Samaranayake, 2006b). Periodontal disease is an inflammatory condition of 
the periodontum and develops from a pre-existing gingivitis. However, not 
every case of gingivitis develops into periodontitis. It causes bleeding in the 
gingiva, mobility of the teeth and ultimately leads to teeth loss (You et al., 
2004).
Microbiological evidence suggests that there is not one single pathogen 
associated with the destructive periodontal disease, moreover groups of 
bacteria may be associated and acting synergistically (Socransky et al., 
1998). To elucidate the pathogenesis of periodontal disease, an 
understanding of ecological factors such as microbial diversity, microbial 
succession, microbial interactions and conditions for maintaining a balance 
between health and disease is required. However, the complex nature of 
these ecological factors prevents straightforward analysis and thus progress 
is slow. The bacteria that have been associated with periodontal destruction 
are Porphyromonas gingivalis, Bacteroides forsythus, Prevotella intermedia,
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Peptostreptococcus (Micromonas) micros, Eubacterium nodatum,
Capnocytophaga spp., Eikenella corrodens, and Fusobacterium nucleatum 
(Socransky et al., 1998).
1.8.6 Oral candidosis
The yeast Candida albicans is a common, human commensal organism that 
inhabits the oral cavity, gastrointestinal tract, female genital tract and the skin 
(Jayatilake et al., 2005; Samaranayake, 2006a). Candida albicans is an 
important cause of superficial infection of mucosal membranes and systemic 
disease in humans (Sherman et al., 2002). Four clinical forms of primary oral 
candidosis are traditionally recognised (Fig. 1.9); pseudomembranous 
candidosis, acute erythematous candidosis, chronic erythematous candidosis 
and chronic hyperplastic candidosis (CHC). Other oral infections associated 
with Candida include angular cheilitis and median rhomboid glossits
Candida albicans possesses a number of virulence attributes, including the 
ability to adhere to host tissues, to produce extracellular proteinases, 
phospholipases and lipases and to reversibly switch between the two 
morphology forms, a unicellular yeast form and a filamentous, growth form, 
e.g. hyphal (Calderone and Fonzi, 2001; Jayatilake et al., 2005; 
Samaranayake, 2006a).
1.8.6.1 Pseudomembranous candidosis
Pseudomembranous candidosis (Fig. 1.9a) is also commonly referred to by 
the generic term, ‘oral thrush’. This infection classically presents as white 
patches on the surface of the oral mucosa or the tongue and is characterised 
by being amenable to removal following gentle scraping. The removed white 
pseuodmembranes consist of desquamated epithelial cells, fibrin and fungal 
hyphae (Akpan and Morgan, 2002). This form of infection is commonly found 
in infants, the elderly and terminally ill patients, particularly with underlying 
conditions such as leukaemia and HIV (Farah et al., 2000).
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Fig. 1.9 Oral candidosis infections (a) acute/chronic pseudomembranous 
candidosis (b) acute erythematous candidosis, (c) chronic erythematous 
candidosis, (d) chronic hyperplastic candidosis. Courtesy of Prof. M. Lewis 
at the Cardiff Dental School.
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1.8.6.2 Acute erythematous candidosis (acute atrophic candidosis)
Acute erythematous candidosis (Fig. 1.9b) is associated with the use of 
broad spectrum antibiotics or steroid therapy. Clinically it presents as a 
reddening of the oral mucosa similar to that seen in patients with low serum 
levels of vitamin B12, low folate and low ferritin (Akpan and Morgan, 2002). 
It is believed that the antimicrobial therapy alters the normal oral bacterial 
community and allows C. albicans numbers to increase (Farah et al., 2000).
1.8.6.3 Chronic erythematous candidosis (chronic atrophic candidosis)
Chronic erythematous candidosis (Fig. 1.9c) is associated with the wearing of 
denture prostheses and results in mucosal edema of the palate. In this 
infection, other factors such as bacterial accumulation reduced salivary 
protection and mechanical irritation may be implicated. A poor fitting denture 
and poor oral hygiene is associated with this type of infection (Akpan and 
Morgan, 2002). The patient usually does not have any symptoms but may 
complain of slight soreness (Farah et al., 2000). It presents in approximately 
50% of all denture wearers (Farah et al., 2000).
1.8.6.4 Chronic hyperplastic candidosis (CHC)
CHC (Fig. 1.9d) presents as white lesions on the oral mucosa. It is distinct 
from the other forms of oral candidoses as it is characterised by hyphal 
penetration of the oral epithelium (Sitheeque and Samaranayake, 2003) and 
the presence of an associated inflammatory cell infiltrate (Williams et al., 
1997).
Importantly, CHC is also implicated in the development of squamous cell 
carcinoma (SCC) at the lesional site (Banoczy, 1977; Krogh et al., 1987; 
Williams et al., 2001). The host factors implicated in CHC include tobacco 
smoking, denture wearing, and regular alcohol intake (Arendorf et al., 1983). 
However, it is also possible that Candida express specific virulence attributes 
that promote this infection. Since hyphal invasion of the epithelium is a 
distinguishing feature of CHC, expression of certain C. albicans virulence 
factors may be enhanced for CHC strains compared with others.
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1.8.6.5 Angular cheilitis
Angular cheilitis is a clinical term used to describe painful erythematous 
lesions affecting the angles of the mouth. The condition seems to be 
associated with the wearing of removable dentures (Samaranayake and 
MacFarlane, 1990a), and is often accompanied by the presence of chronic 
erythematous candidosis (Farah et al., 2000). Other microorganisms are 
frequently present in this infection, such as Staphylococcus aureus and 
Streptococcus spp. (Akpan and Morgan, 2002).
1.8.6.6 Median rhomboid glossits
Median rhomboid glossits presents on the tongue as a chronic symmetrical 
shaped area consisting of atrophic filiform papillae. Recovery of Candida 
from this area is high. The exact cause of this infection is not known, 
although hormonal links, tobacco smoking and the use of inhaled steroids 
have been suggested (Samaranayake and MacFarlane, 1990b).
1.8.7 Predisposing host factors to oral candidosis
Oral candidosis has frequently been described as a ‘disease of the diseased’. 
Whilst the incidence of normal commensal carriage of Candida in the mouth 
is high, such individuals will not suffer infection unless otherwise debilitated. 
The transition of Candida from a harmless commensal member of the 
microflora to a disease causing organism is complex, involving a variety of 
both local and systemic host factors. Several of these factors are discussed 
below, and presented in Table 1.8.
1.8.7.1 Damage to the oral mucosal
In the mouth the oral mucosa provides a primary host defence mechanism by 
acting as a mechanical barrier to Candida. However, damage to the oral 
mucosa can occur through denture wearing, which has an association with 
chronic erythematous candidosis and CHC (Arendorf et al., 1983). It has 
also been shown that the wearing of dentures produces an anaerobic 
microenvironment beneficial to the growth of Candida due to its associated 
low oxygen levels and low pH (Ruby and Barbeau, 2002).
45
Table 1.8 Host related factors associated with the development of oral 
candidiosis.
Local factors Systemic factors Miscellaneous factors
Mucosal damaae! Extremes of age Tobacco smoking
denture wearing
Saliva Hormonal chanaes Nutritional status
reduced flow of saliva, diabetes mellitus vitamin deficiency
acidic pH mineral deficiency
reduced antibodies carbohydrate rich diets
Commensal flora. Immune status Antibiotic therapy
inhibition of candidal immunodeficiency Corticosteroid therapy
adherence by oral immunosuppression Cytotoxic drugs and
bacterial flora radiotherapy
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Furthermore oral hygiene levels in many denture wearers can be poor, due to 
inadequate cleaning regimes, particularly for individuals who wear their 
dentures through the night (Eppstein, 1990; Guida, 1988).
1.8.7.2 Effect of saliva
The constant flushing action of saliva can remove Candida cells prior to their 
attachment to oral surfaces. Furthermore, antimicrobial proteins in saliva 
such as lactoferrin, sialoperoxidase, lysozyme, histidine-rich polypeptides, 
and specific anti-Candida antibodies, can contribute to the killing and removal 
of organisms from the mucosa and prevent overgrowth of Candida. 
Therefore, drugs that reduce salivary secretions or radiotherapy of the head 
and neck can lead to an increased risk of oral candidosis (Akpan and 
Morgan, 2002). Sjogren’s syndrome is one of the most common systemic 
conditions associated with xerostomia and salivary dysfunction (Turner and 
Ship, 2007). It has been shown that this condition favours increased oral 
carriage of Candida (Sitheeque and Samaranayake, 2003). Colonisation of 
the denture acrylic surface by Candida is also favoured by the relatively low 
saliva flow under the surfaces of the denture fittings which limits removal of 
otherwise poorly attached yeast (Eppstein, 1990; Guida, 1988).
1.8.7.3 Commensal microflora
It is a well-documented problem that patients receiving broad spectrum 
antibiotics are highly likely to develop oral candidosis (Farah et al., 2000). A 
reduction in the bacterial component of the oral microflora reduces the 
competition for nutrients and adherence sites. Generally, the infection acute 
erythematous candidosis is the form of oral candidosis that follows (section 
1.8.6 .2).
1.8.7.4 Diabetes mellitus
Diabetes mellitus has been associated with the occurrence of high levels of 
candidal colonisation and oral candidosis (Manfredi et al., 2002; Sitheeque 
and Samaranayake, 2003). Several reasons for the high oral candidal 
carriage in diabetics have been suggested. Firstly, high salivary glucose
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levels in diabetics may favour the growth of yeasts (Sitheeque and 
Samaranayake, 2003). Furthermore, adherence of Candida to buccal 
epithelial cells (BEC) from diabetics has been demonstrated to be greater 
than to cells originating from non-diabetic controls (Sitheeque and 
Samaranayake, 2003). This could be due to intrinsic qualitative changes in 
the cell surface receptors of diabetics that modulate yeast adhesion 
(Sitheeque and Samaranayake, 2003).
1.8.7.5 Nutritional status
Oral candidosis is also associated with mineral and vitamin deficiencies, and 
carbohydrate rich diets of infected patients (Sitheeque and Samaranayake,
2003). On the basis of animal models, deficiencies in vitamins A, B1 and B2 
are generally implicated with predisposition to oral candidosis (Akpan and 
Morgan, 2002). Iron deficiency can cause epithelial abnormalities such as 
hyperkeratonisis and atrophy, through alterations in the kinetics of the rapidly 
dividing cells of the oral mucosa, which in turn, result from an impairment of 
iron-dependent enzymes (Sitheeque and Samaranayake, 2003). Iron- 
deficiency could also influence oral carriage of Candida through the 
impairment of iron-dependent host enzymes, depression of host cell- 
mediated immunity (CMI) or by reducing antibody production (Sitheeque and 
Samaranayake, 2003).
1.9 CHRONIC WOUNDS AND THE ROLE OF BACTERIA
Chronic wounds are defined as those wounds that do not heal within an 
expected time frame. These chronic wounds are a serious health concern 
with substantial morbidity and are a source of frustration to both physician 
and patient due to lengthy treatments, treatment failures and long periods of 
patient compliance.
Chronic wounds include chronic venous leg ulcers (CVLUs; Fig. 1.10), 
diabetic foot ulcers and pressure sores. CVLUs are non-healing wounds that 
occur due to a breakdown in the underlying physiology of the leg.
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Fig. 1.10 Examples of Chronic Venous Leg Ulcers (CVLU).
Courtesy of the Wound Healing Research Unit Clinic at the University 
Hospital W ales, Cardiff.
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The breakdown is associated with venous, arterial or metabolic factors 
(Bowler et al., 2001; Howell-Jones et al., 2005; Thomas and Harding, 2002). 
Treatment costs are almost £1 billion each year to the NHS, which will only 
increase with the increasingly aged population of the UK. Chronic wounds 
are characterised by oedema, severe pain, erythema and strong odour and 
affect more than 1% of the UK population (Thomas and Harding, 2002). 
These wounds tend to occur in individuals with an increased risk of bacterial 
invasion as a result of poor local factors (arterial insufficiency, venous 
hypertension, trauma) or systemic disease such as diabetes mellitus and 
rheumatoid arthritis (Falanga, 1993).
1.9.1 Course of normal wound healing
In healthy individuals the normal wound healing process involves a complex 
series of events including cell proliferation, migration, differentiation and 
remodelling that can be summarised into overlapping phases. However in 
chronic wounds, factors such as systemic illness, poor nutrition, vascular 
insufficiency and bacterial interference influence the normal wound healing 
process (Jones et al., 2004; Rhoads et al., 2007). The time of healing in 
chronic wounds is extended as shown in Fig. 1.11. The inflammatory phase 
begins at time of injury and serves to cleanse the wound of bacteria and 
debris; this phase can take up to 25 days.
The exposed extracellular matrix triggers the coagulation cascade, 
plasminogen cascade and others. These cascades along with the exposed 
extracellular matrix and microorganisms that find their way back into the 
wound; stimulate the innate immune system. Polymorphonuclear cells arrive 
first with preprogrammed apoptosis. Macrophages follow and finalise the 
cleanup of pathogens, remove devitalized tissue and clean host agents such 
as polymorphonuclear cells by phagocytosis and down-regulate acute 
inflammatory signals (Rhoads et al., 2007; Schultz et al., 2004). In the 
proliferative phase, a process of deposition between angiogenesis, 
fibroblasts, fibronectin and collagen takes place and can take up to 25 days 
to complete.
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Fig. 1.11 Course of normal wound healing. Adapted from Asmussen and 
Soellner (1993).
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Cytokines are controlling factors for granulation tissue formation. These 
small molecules direct the endothelial cell neovascularisation of the wound 
bed and also direct fibroblasts to deposit the new extracellular matrix 
materials. The remodelling phase which succeeds the proliferation phase, 
can take up to 12 months (Rhoads et al., 2007).
1.9.2 The significance of bacteria in chronic wounds
Open skin wounds are often colonised with microorganisms, having lost 
many of the protective defence mechanisms of intact skin (Edwards and 
Harding, 2004). Chronic wounds harbour a diverse, often dense and complex 
polymicrobial microflora of potentially pathogenic organisms (both aerobic 
and anaerobic species). The wound environment provides support for 
bacterial survival as it is both moist and warm plus there is a good nutrient 
supply from exuded wound fluid. As a result wounds are susceptible to 
microbial contamination from both exogenous and endogenous sources 
including the nose, skin, mouth and the gut (Percival and Bowler, 2004).
There is evidence that microorganisms in chronic wound biofilms contribute 
to the non-healing phenotype (Hill et al., 2003). Cultural analyses have 
documented that pseudomonads, staphylococci (present in >70% of wounds) 
and anaerobic species such as Peptostreptococcus spp. are the bacterial 
groups most frequently recovered from chronic wounds (Hansson et al., 
1995; Hill et al., 2003). Polymicrobial interactions may play a crucial role in 
delayed wound healing. Moreover, less invasive microorganisms may act 
synergistically with more virulent ones (Bowler, 2003). However, although 
significant in inhibiting the wound healing process, the importance of 
individual species or microbial density in relation to healing is unclear. 
Nevertheless, bacteria play an important role in wounds and possess indirect 
and direct mechanisms to impair wound healing (Stephens et al., 2003).
It has been shown that all wounds are colonised by bacteria, although not all 
wounds are infected (Bowler, 2003). One of the most difficult clinical 
judgements facing the clinician is determining whether a wound is purely
52
colonised by bacteria or whether there are signs of infection. However, often 
the lines between colonisation and the beginnings of infection are blurred and 
correct diagnosis is wholly dependent upon the experience and skill of the 
clinician.
To reduce the bioburden (the bacterial load in chronic wounds) and improve 
the wound healing process, the use of antimicrobial therapies are necessary. 
It is important to note that many patients with chronic wounds are often 
elderly and hence may also have underlying conditions which make them 
immunocompromised. Howell-Jones et al. (2006; 2005) showed that over­
prescribing of antibiotics seems typical in this particular group of patients. 
Therefore, an understanding of the physiology and interactions within multi­
species biofilms may aid the development of more effective methods of 
treating infected and poorly healing wounds (Edwards and Harding, 2004).
1.9.3 Biofilms and wounds
There is now evidence to show that bacteria are able to form biofilms within 
the wound environment (James et al., 2007; Mertz, 2003; Percival and 
Bowler, 2004). It has recently been suggested that both acute partial 
thickness wounds (Serralta et al., 2001) and chronic human wounds (Bello et 
al., 2001) may harbour bacterial biofilms growing on the wound surface. In 
acute wounds, a study involving a pig model inoculated with a laboratory 
strain of P. aeruginosa showed that two distinct bacterial populations were 
present in the wound (Serralta et al., 2001). The first population was loosely 
associated with the wound and was readily washed off. In contrast, the 
second population was more firmly anchored and could only be removed by 
significant scrubbing with detergent. The authors suggest that the loosely 
associated wound population were planktonically growing cells, whereas 
those that could only be removed by mechanical and chemical means were 
biofilm associated.
A second study showed that in vitro biofilms could easily be grown using 
wound isolates. For example, P. aeruginosa from a human burn wound
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formed mature biofilms within 10h as visualised by light microscopy 
(Harrison-Balestra et al., 2003). Scanning electron micrograph (SEM) 
images of S. aureus biofilms in acute wounds have also been produced 
(Welsh et al., 2005). In contrast, fewer studies have been done with chronic 
wounds. EPS has been visualised by epifluoresence and light microscopy on 
chronic wound smears (Bello et al., 2001; Ricotti et al., 2003) and a biofilm 
has been demonstrated on a dermal model (Mertz, 2003). Moreover, 
Akiyama et al. (2002) demonstrated that S. aureus can assemble a 
glycocalyx on the surface of traumatic wounds in mice and that the biofilm 
could be visualised using confocal laser scanning microscopy.
From the above studies it is clear that bacteria can persist within a wound 
and establish a biofilm community which can overcome the host’s natural 
defences and antimicrobial therapy. Whilst the impaired immune system 
tries to prepare the wound for proliferation of healing, the body cannot 
successfully complete the inflammatory phase. Therefore, the wound 
remains in the inflammatory phase, unless successful therapeutic strategies 
can be applied to eliminate the infection (Rhoads et al., 2007; Schultz et al.,
2004).
1.10 MANAGEMENT OF BIOFILM INFECTIONS
Viewing bacteria from the perspective of multicellular behaviour is altering 
our view of microbiology and of Koch’s postulates. It is evident that 99.9% of 
organisms prefer attachment, and that bacterial cells have the ability to 
aggregate into particular three-dimensional assemblages (Davey and 
O'Toole, 2000). Biofilms have been recognised as being important in human 
disease and the number of biofilm-associated diseases seems to be 
increasing (Davies, 2003). It is important to understand the characteristics of 
the biofilm mode of growth and the various aspects of biofilm formation. To 
successfully treat biofilm infections, knowledge of the phenotype of the 
bacterial population is required. This is important as antibiotic treatments 
may not be totally effective if more than one phenotype exists. Some cells 
might, remain intact which are able to re-colonise a wound and debilitate the
54
host once the antimicrobial treatment has finished (Brooun et al., 2000; 
Davies, 2003; Spoering and Lewis, 2001).
A key factor to combating biofilm infections is to understand the physiology of 
biofilm development. Davies (2003) suggested that chemotherapeutic 
agents could be developed to promote or prevent transition from one stage of 
biofilm maturation to the next by targeting unique biofilm regulatory or 
signalling molecules. Specific agents might be discovered or developed 
which will interfere with the production of virulence factors, or promote or 
inhibit the shedding of biofilm bacteria (Davies, 2003).
As mentioned before (section 1.4.2), biofilm resistance depends on 
aggregation of bacteria into multicellular communities. Therefore, one 
antimicrobial strategy might be to develop therapies to disrupt the 
multicellular structure of the biofilm. It could be that host defences might be 
able to resolve the infection once the multicellularity of the biofilm is reduced, 
and then the effectiveness of antibiotics might be restored (Stewart and 
Costerton, 2001). Other potential therapies include enzymes that dissolve 
the matrix polymers of the biofilm, chemical reactions that block biofilm matrix 
synthesis, and analogues of microbial signalling molecules that interfere with 
cell-to-cell communication, required for normal biofilm formation (Nemoto et 
al., 2000; Parsek and Greenberg, 2000; Yasuda et al., 1993). Already, a 
number of QS inhibitors have been identified such as the inhibitory peptide 
RNAIII, which inhibits the agr system of Gram-positive bacteria (Rhoads et 
al., 2007). In P. aeruginosa, furanones derived from plants have been 
demonstrated to block AHL pathways (Heurlier et al., 2006).
For in vivo indwelling device-associated infections, effective, preventive and 
therapeutic strategies still need to be developed. One such therapy could be 
the production of materials with anti-adhesive surfaces, for example heparin 
(Tenke et al., 2004). Tenke et al. (2004) showed that on heparin-coated 
catheter stents, no biofilm formation was evident between 6-8 weeks, 
whereas uncoated tubes got obstructed within 2-3 weeks. Heparin coating
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seems one possible solution, but further development of materials resisting 
bacterial colonisation is needed (Tenke et al., 2004).
Progress has already been made, but the future of biofilm research and 
management relies upon collaborative efforts to fully explore these complex 
systems of the microbial world.
1.11 RESEARCH INTO BIOFILMS
Biofims have a great importance for public health because of their significant 
role in certain infectious diseases and in medical device-related infections. A 
greater understanding of biofilm processes will hopefully lead to novel and 
effective strategies for biofilm control resulting in improvement in patient 
management (Donlan, 2002). To enable easier study of bacterial attachment 
and colonisation, a variety of direct and indirect experimental observation 
methods have been developed. Direct methods mainly consist of microscopy 
techniques, which permit visualisation of the biofilms, while indirect methods 
estimate the numbers of adherent microbes in situ (Djordjevic et al., 2002; Jin 
et al., 2003). Standard plate counts, roll techniques and sonication are 
indirect methods that first detach the microorganisms from the surface prior 
to enumeration. Other indirect methods (radio-labelled bacteria, enzyme- 
linked immunosorbent assays (ELISAs), biologic assays, stained bacterial 
films and microtitre plate procedures) estimate the number of attached 
organisms in situ by measuring some attribute of the attached organism (An 
and Friedman, 2000; Djordjevic et al., 2002).
1.11.1 Microtitre plate assays
A microtitre plate assay is typically an indirect method for the estimation of 
bacteria in vitro and can be modified for various biofilm formation procedures 
(An and Friedman, 2000). Typically, this semi-quantitative method for 
measuring biofilm formation involves growing bacterial cultures in individual 
wells of a 96-well polystyrene plate before fixing and staining with 1 % crystal 
violet solution. It is a simple and sensitive assay, which permits the 
simultaneous quantification of an organism. It is also widely used for
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susceptibility testing of biofilms (Casey et al., 2004; McBride et al., 2005).
1.11.2 Colorimetric methods using XTT
In the XTT assay, a microtitre plate assay is often used and the biofilm 
quantified by reduction of the tetrazolium salt 2,3-bis(2-methoxy-4-nitro-5- 
sulfophenyl)-5-[(phenylamino)carbonyl]-2H-tetrazolium hydroxide (XTT). 
XTT is reduced to the XTT formazan product by the mitochondrial 
dehydrogenases of metabolically active cells. The colorimetric change 
produced is proportional to the number of living cells which therefore can be 
indirectly quantified (Hawser and Douglas, 1994; Jin et al., 2003; Kuhn et al., 
2002a).
1.11.3 Flow cells
Flow cells are small continuous-flow systems with a viewing port that allows 
direct observation of the biofilm using microscopy and image analysis without 
disrupting the community (Davey and O'Toole, 2000). Biofilms are usually 
grown on microscope glass coverslips in three or more channel chambers. 
The inoculum is added to each channel and the cells are allowed to attach to 
the substratum for a specific time before a fluid is injected covering the 
surface (Hancock and Klemm, 2006). Fresh medium enters the system, 
passes through the cell and is collected as waste. The medium is not 
recycled through the flow cell. Slides can be removed without stopping the 
flow, thus, diminishing the possibility of contamination and disturbance of the 
biofilm (Battin et al., 2003; Caiazza and O'Toole, 2003; Davey and O'Toole, 
2000; Davies et al., 1998; Pereira et al., 2000; Sauer et al., 2002).
1.11.4 Constant Depth Film Fermenter (CDFF)
In recent years, complex instruments have been developed to generate 
biofilms in vitro. The constant depth film fermenter (CDFF; Fig. 1.12) was 
originally developed to model dental plaque biofilms (McBain et al., 2003; 
Wilson, 1999) and has since been used to model water system bacteria 
(Allan et al., 2002).
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The CDFF allows multiple biofilms of uniform depth to be produced for 
sequential analysis whilst maintaining key parameters including nutrient 
source, temperature, oxygen availability and substrata. Other advantages of 
the CDFF include, the adaptation to use any substratum material, controlling 
medium flow rate and the addition of supplements or antimicrobials to 
examine their effects on biofilm formation.
The rotating turntable of the CDFF typically holds 15 polytetrafluoroethylene 
(PTFE) pans located flush around the rim, with each pan holding five 
cylindrical holes containing recessed PTFE plugs. The plugs are recessed to 
a uniform depth, on top of which the bacteria are able to form biofilms. After 
inoculation, sterile media flows over the biofilms, and excess growth is 
removed by scraper blades which sit flush with the top of the pans, hence 
keeping the biofilms at a constant depth.
1.11.5 Confocal laser scanning microscopy (CLSM)
Studies of microbial biofilms and their formation have been performed by 
using light, scanning and transmission electron microscopy. Besides these 
established techniques, CLSM offers the possibility of detailed visualisation 
of “thick” and “organised” microbiological samples in cases in which the 
application of conventional phase contrast or fluorescent microscopy is 
limited (Auschill et al., 2002; Auschill et al., 2001; Wood et al., 2000). CLSM 
allows the elimination of ‘out-of-focus’ light as well as horizontal and vertical 
optical sectioning. More recently, CLSM has become standard in 
microbiology for the assessment of undisturbed biofilms (Costerton et al., 
1995; Lawrence et al., 1991; Wagner et al., 1994). CLSM now permits the 
acquisition of high resolution images and, by generating focused images 
through thick specimens at various depths, 3-D reconstructions can also be 
achieved (Fig. 1.13).
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a b
Fig. 1.12 a) The Constant Depth Film Ferm enter (CDFF); b) close up of the 
rotating turntable; c) PTFE pan with 5 recessed plugs; d) close-up of the  
scrapper blade
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8. Detector
7. Detector 
pinholes
4. Beam 
splitter
3. Laser 
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1. Laser
2. Lens
5. Objective
6. Sample
Fig. 1.13 Confocal Laser Scanning Microscopy 
Adapted from Leica, www.leica-microsystems.com.
For the CLSM  imaging a laser is used as a light source (1). The laser beam  
(1) is focused by using a lens (2) and a laser pinhole (3). The laser beam  is 
reflected by a beam splitter (4) through an objective lens (5) and onto the 
sam ple (6) in the focal plane. The beam splitter (4) separates the laser light 
from the emitted light coming from the sample. W hen the sample (6) is 
exposed to a laser of a particular wavelength, substances (e.g. Alexa 594) in 
the R H E are excited and emit a response emission of different wavelengths. 
Then the beam splitter (4) allows only that wavelength which corresponds to 
the response emission to reach the detector pinhole (7). This emitted light 
passes through the pinhole (7) and is then recorded by the detector (8).
60
1.11.6 Fluorescence in situ hybridisation (FISH)
FISH is a frequently used and culture -  independent approach for detecting 
and visualising microorganisms. Bacteria and Archaea contain 5S, 16S and 
23S ribosomal Ribonucleic acid (rRNAs) with lengths of approximately 120, 
1500 and 3000 nucleotides. In the vast majority of applications FISH probes 
have been designed to specifically target 16S rRNA (Amann, 2001). A 
typical FISH protocol includes fixation and permeabilisation of the sample, 
hybridisation of the probe, a washing step to remove unbound probe and the 
detection of labelled cells by microscopy (Amann, 2001).
Peptide nucleic acid (PNA) molecules are pseudopeptides that obey Watson- 
Crick base-pairing rules for hybridisation to complementary nucleic acid 
targets (Egholm et al., 1993; Nielsen and Haaima, 1997). PNA probes are 
extremely efficient at hybridisation (having high specificities, strong affinities, 
rapid kinetics) due to their uncharged, neutral backbones (Oliveira et al., 
2002). PNA probes penetrate the hydrophobic cell wall of bacteria to a 
greater extent than that of DNA oligonucleotides, because of their relatively 
hydrophobic character. The FISH technique and application is discussed in 
more details in Chapter 5.
1.12 SUMMARY
Microorganisms are capable of growing in both a free form (planktonic) or as 
biofilms attached to solid surfaces. Biofilms are defined as communities of 
microorganisms, often adhered to a surface and encased within an 
extracellular polysaccharide matrix (Kumamoto and Marcelo, 2005). 
Examples of surfaces supporting biofilm growth include inanimate 
environmental materials, biomaterials interfacing with host tissue and 
systems, or the host tissue itself. The behaviour and phenotype of microbes 
existing in either planktonic and biofilm states is known to differ significantly 
and this is perhaps best exemplified by studies on antimicrobial efficacy 
against the different growth phases (Hill et al., 2003).
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In the oral environment candidal biofilms on prostheses and the oral mucosa 
have been associated with infection (Kumamoto and Marcelo, 2005). Intra­
oral biofilms can develop on the tooth enamel, oral mucosa or on introduced 
oral prostheses and these can all provide a reservoir of potentially 
pathogenic organisms promoting dental caries and periodontal disease. 
Furthermore, in the case of oral tissue, certain microorganisms such as yeast 
of the genus Candida have been shown to actually invade the tissue, 
invoking a pathogenic effect. Similarly, within a chronic wound, it may well 
be the case that the occurrence of a biofilm results in clinical problems due to 
existence of the microbes in a more persistent state. Examples of clinically, 
important biofilms include Proteus mirabilis on urinary tract catheters 
(Stickler, 2005), Candida spp. on denture surfaces and bacteria 
(polymicrobial) within chronic wounds (Hill et al., 2003). Significantly, when 
biofilms are present on the surface of medical devices, a failure of the device 
can occur, as encountered in the blocking of urinary catheters and the 
obstruction of airways within artificial voice box prostheses (Douglas, 2003; 
Van der Mei et al., 2000). Furthermore, biofilms tend to exhibit heightened 
resistance to antibiotics, possibly by diffusion limitation or the presence of 
biochemically inert microbes within the biofilm (Donlan and Costerton, 2002).
The clinical significance of biofilms provides the basis for this PhD and 
consequently the aim was to characterise specific biofilms that are involved 
in human infection, specifically those biofilms associated with chronic wounds 
and oral candidosis.
1.13 AIMS AND OBJECTIVES OF STUDY
The aims of this study were to examine the in vitro properties of C. albicans 
biofilms and also biofilms of bacteria recovered from the chronic wound 
environment. The underlying hypothesis of this work was that clinically 
important biofilms associated with infections have characteristics and 
features that promote their virulence and resistance to both host defences 
and administered antimicrobial agents. Specifically the aims were:
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1. To determine the structural properties of C. albicans biofilm generated 
in an in vitro model of oral candidosis.
2. To analyse C. albicans virulence gene expression within developed 
biofilms.
3. To examine the relative in vitro biofilm-forming ability of selected 
bacterial strains originating from chronic wound environments.
4. To investigate the spatial distribution and structure of in vitro chronic 
wound biofilms.
5. To look at gene expression of chronic wound biofilm organisms.
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Chapter 2 
Biofilm formation and oral 
epithelium infection by Candida
albicans
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2.1 Introduction
The genus Candida comprises of over 150 species of ‘yeast-Hke’ fungi, 
several of which can exist as either harmless commensals or as opportunistic 
pathogens of humans. Candida infection (candidosis, sing; candidoses, pi.), 
has been reported at most body sites, with superficial infections of the oral 
and vaginal mucosa the most frequently encountered. Although, Candida 
albicans is generally isolated from 80% of all oral candidoses, this organism 
is also prevalent as a harmless member of the oral microflora. It is estimated 
that commensal carriage rate in humans is between 35 and 55%. Whilst C. 
albicans is the most frequent cause of human fungal infection resulting in a 
mortality rate of 30-50% in immunocompromised patients with systemic 
infection, the pathogenesis of this organism remains unclear (Mukherjee et 
al., 2003; Odds, 1988).
2.1.1 Non-oral infection
Candidoses are primarily superficial infections, occurring on moist and warm 
mucosal membranes such as in the mouth and vagina. In women using oral 
contraceptives, candidal vulvovaginitis is common. Vulvovaginitis is 
accompanied by a thick discharge, vaginal itching and discomfort 
(Samaranayake, 2006). Candidosis can also develop at a variety of other 
body locations including the skin, in the gut, bone joints, nails and urinary 
tract (Table 2.1).
2.1.1.1 Candida and implantable medical device associated infection
Introduction of artificial materials at various body locations has been 
accompanied by the ability of microorganisms, including Candida spp. to 
colonise and form biofilms (Ramage et al., 2006). Devices such as shunts, 
artificial prostheses, stents, implants, endotracheal tubes, pacemakers and 
various catheter types have been shown to support Candida colonisation and 
biofilm formation (Ramage et al., 2006).
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Table 2.1 Body locations for Candida infection and specific candidoses.
Candidosis location Disease
Genitalia Vulvovaginal candidosis
Candida balanoposthitis
Skin Candida onychia
Candida paronychia
Gastrointestinal tract Oesophageal candidosis
Respiratory tract Laryngeal candidosis
Pulmonary candidosis
Urinary tract Candida cystitis
Candida urethritis
Eye Candida infections of the cornea
Candida conjunctivitis
Bones and joints Candida arthritis
Candida osteomyelitis
Oral mucosa Oral candidosis
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2.1.1.2 Central venous catheters
Yeasts, mainly Candida, are the third leading cause of intravascular catheter- 
related infections, with the second highest colonisation to infection rate and 
the overall highest crude mortality rate in the USA and Western Europe 
(Ramage et al., 2006). Studies have shown that biofilms are present in all 
central venous catheters, on both the inner lumen and outside the catheter 
(Raad, 1998).
2.1.1.3 Voice box prostheses
A voice box prosthesis is a device fitted following a total laryngectomy. A 
total laryngectomy involves the removal of the larynx from the throat and is 
performed as part of the surgical treatment for laryngeal cancer. The 
procedure leads to loss of natural speech, is very traumatic for the patient 
and presents a lifelong challenge for communication (Dijk et al., 2000). 
Silicone rubber voice prostheses fitted in patients are subject to rapid 
microbial colonisation and biofilm formation, mainly by Candida spp. The 
problem is exacerbated due to the lack of salivary flow to remove loosely 
attached organisms. The biofilm causes malfunction, increased airflow 
resistance and leakage of the valves of the prosthesis, which then needs to 
be surgically replaced (Ell, 1996; Neu et al., 1994; Ramage et al., 2006).
2.1.2 Candida and oral candidosis
As already mentioned, C. albicans is an important cause of superficial 
infection of mucosal membranes and systemic disease in humans (Sherman 
et al., 2002). Four clinical forms of primary oral candidosis are recognised; 
acute/chronic pseudomembranous candidosis, acute erythematous 
candidosis, chronic erythematous candidosis, and chronic hyperplastic 
candidosis (CHC; Chapter 1, Fig. 1.9, section 1.8.6) (Axell et al., 1997).
2.1.2.1 Pseudomembranous candidosis
Pseudomembranous candidosis (PMC) is also synonymous with the term 
“oral thrush” and is traditionally regarded as an acute infection characterised 
by the presence of non-adherent white pseudomembranes on the oral
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mucosa. Primarily, PMC occurs with extremes of age e.g. in the new-born 
and elderly, or in patients suffering from a systemic debilitating disease. The 
persistence of PMC in HIV-infected or otherwise debilitated individuals has 
led to the occurrence of chronic PMC. The lesions of PMC can be scraped 
off with a swab to expose the underlying erythematous mucosa. The 
removed white pseudomembranes consist of desquamated epithelial cells, 
fibrin and fungal hyphae. Diagnosis is usually straightforward and can be 
confirmed microbiologically either by staining a smear from the affected area 
or by culturing a swab or an oral rinse (Akpan and Morgan, 2002).
2.1.2.2 Acute erythematous candidosis
Acute erythematous candidosis is most frequently seen on the dorsum of the 
tongue in patients receiving prolonged antibiotic therapy. It presents as a 
red, painful area of the mucosa and may also be seen with patients in 
conjunction with low serum vitamin B12, low folate and low ferritin 
concentrations (Akpan and Morgan, 2002). It is believed that broad spectrum 
antibiotic therapy reduces the normal numbers of the oral bacterial 
community and allows C. albicans to overgrow in the mouth (Farah et al., 
2000). Diagnosis of acute erythematous candidosis can be confirmed 
through use of a swab from the tongue or buccal mucosa and confirmation of 
Candida presence by culture and identification (Akpan and Morgan, 2002).
2.1.2.3 Chronic erythematous candidosis
Chronic erythematous candidosis (denture stomatitis) is the most frequently 
occurring form of oral candidosis and is present in up to 65% of denture 
wearers (Akpan and Morgan, 2002). This form of oral candidosis is believed 
to be promoted through the occurrence of tissue damage caused by frictional 
irritation of the palatal mucosa by the denture. A poor fitting denture and 
poor oral hygiene is associated with this infection. Diagnosis requires 
isolation and culture of Candida from the denture surface (Akpan and 
Morgan, 2002).
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2.1.2.4 Chronic hyperplastic candidiosis
Chronic hyperplastic candidiosis (CHC) is a distinct form of oral candidosis 
and is characterised by hyphal penetration of the oral epithelium (Sitheeque 
and Samaranayake, 2003) and the presence of an inflammatory cell infiltrate 
(Williams et al., 1997). Of particular concern with CHC is the potential risk of 
squamous cell carcinoma (SCC) development at the lesional site (Banoczy, 
1977; Krogh et al., 1987a; Williams et al., 2001). The presence of Candida is 
associated with an increased incidence of malignant transformation. The 
exact role of Candida in the development of oral cancer is unclear but might 
be related to the organism’s ability to generate carcinogenic nitrosamines 
from salivary precursor molecules (Krogh et al., 1987b; Sitheeque and 
Samaranayake, 2003). In addition, specific C. albicans strains are known to 
promote neoplastic change, which highlights the potential role of these 
organisms in malignant transformation (Krogh et al., 1987a). It is also 
important to note that the lifestyle for both promotion of Candida carriage and 
oral cancer are similar which makes establishing an association difficult 
(Sitheeque and Samaranayake, 2003).
2.1.3 Candida virulence factors associated with oral candidosis
In addition to host factors (Chapter 1, section 1.8.7) Candida itself expresses 
specific virulence attributes that promote oral infection. No single 
predominant virulence factor has been associated with Candida, although 
many factors have been implicated in its pathogenicity (Table 2.2).
2.1.3.1 Adherence
Adherence of Candida to the oral mucosa is an important initial step in the 
establishment of infection and therefore, candidal adhesion to buccal 
epithelial cells (BECs) (Nair and Samaranayake, 1996; Tsang and 
Samaranayake, 1999; Verran et al., 2007), to denture acrylic (Bulad et al., 
2004; Verran and Maryan, 1997) and silicone rubber (Price et al., 2002; Price 
et al., 2005) have been extensively studied.
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Table 2.2 Virulence factors associated with Candida albicans.
Virulence factor Effect
Adherence Promotes retention in the mouth
Expression of cell surface adhesion 
molecules
Evasion of host defences Promotes retention in the mouth
High frequency phenotypic switching
Hyphal development
Secreted aspartyl proteinases (SAP)
Invasion and destruction of host tissue Enhances pathogenicity and
promotes retention in the mouth
Hyphal development
Secreted aspartyl proteinase production
(SAP)
Phospholipase production_____________________________________________
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Candida albicans must first adhere to the epithelium to colonise, infect or 
invade tissues (Vargas et al., 1994). Attachment of Candida cells can be 
mediated by both non-specific and specific factors (Table 2.3). Non specific 
factors include relative cell surface hydrophobicity and electrostatic forces 
(Ramage et al., 2005). Specific factors include adhesins, such as serum 
proteins (fibrinogen and fibronectin) and salivary factors (Ramage et al., 
2005). Hence, specific C. albicans adherence is mediated by both protein 
and carbohydrate factors and is a complex phenomenon, with strain variation 
evident (Ramage et al., 2005).
2.1.3.2 Morphology
Candida albicans has the ability to grow in different morphological forms 
including budding yeast cells, pseudohyphae and true filamentous hyphae 
(Fig. 2.1). Once C. albicans attaches to host surfaces, it can switch from its 
yeast morphology to a filamentous form which may promote adhesion and 
penetration of the epithelium and increased resistance to phagocytosis by 
host immune cells. It has also been suggested that filamentous forms of 
Candida secrete higher quantities of hydrolytic enzymes (Senet, 1998) 
(section 2.1.3.4). It is generally believed that the budding yeast form is 
predominant in commensal carriage whilst the hyphal form predominates in 
tissue penetration. Although others have demonstrated that both forms can 
be associated with commensalism and disease (Soil, 2002). It has been 
observed that hyphae grow by tip extension and generate significant 
pressure for tissue invasion (Gow et al., 2002).
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Table 2.3 Adhesion factors associated with Candida albicans.
Non-specific factors Receptor Reference
Electrostatic interactions 
Hydrophobic interactions
Specific factors
Proteins (mannoproteins, 
fibrinogen, fibronectin, 
Fibrillar adhesins) 
Proteins of the ALS gene 
family________________
Binds to complement 
receptors and 
membranes on host 
cells and to fucosyl 
receptors__________
(Ramage et al., 2005) 
(Chaffin et al., 1998; 
Ramage et al., 2005)
(Chaffin et al., 1998; 
Holmes et al., 1996; 
Hostetter, 1994; 
Ramage et al., 2005)
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Fig. 2.1 Candida albicans stained with calcofluor white illustrating the 
different morphological forms including yeast (a) and hyphae (b). Courtesy of 
Dr D Williams at the Cardiff Dental School.
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2.1.3.3 Phenotypic switching
Candida albicans has the ability to rapidly and reversibly switch between the 
yeast budding form and a hyphal growth form (Gow, 1997; Soil, 1986). 
Various studies have demonstrated that high frequency switching affects a 
variety of virulence features, including the bud-hypha transition (Anderson et 
al., 1989), antigenicity (Anderson et al., 1990), adhesion (Kennedy et al., 
1988; Vargas et al., 1994), sensitivity to neutrophils and oxidants (Kolotila 
and Diamond, 1990), secretion of proteinase (Soli et al., 1989; Vargas et al., 
2000) and drug susceptibility (Soil et al., 1989; Vargas et al., 2000). The 
morphogenic transition between yeast and hyphal forms is often stimulated 
by growth in the host, correlated with invasion and associated with 
pathogenesis (Gow et al., 2002). In vitro high frequency switching can be 
detected by colony morphologies of strains grown on amino acid-rich Lee’s 
medium supplemented with arginine and a limiting concentration of zinc (Soli, 
1992).
2.1.3.4 Production of hydrolytic enzymes
Destruction of host tissues by C. albicans is believed to occur through the 
activity of hydrolytic enzymes produced by the organism. Most of these 
enzymes are extracellularly secreted by C. albicans. The most frequently 
studied of these enzymes are secreted aspartyl proteinases (SAPs) (Hube 
and Naglik, 2001; Naglik et al., 2004). Hydrolytic enzymes contribute to host 
tissue invasion by digesting or destroying cell membranes and by degrading 
host surface molecules. There is some evidence that hydrolytic enzymes are 
able to damage cells and molecules of the host immune system thereby 
avoiding or resisting antimicrobial activity (Schaller et al., 2005a).
In addition to SAPs, phospholipases (PLs) contribute to the pathogenicity of 
C. albicans by damaging host-cell membranes, which aids the fungus by 
facilitating host tissue invasion (Borst and Fluit, 2003). Details on Candida 
hydrolytic enzymes and associated genes are discussed in detail in Chapter 
3, section 3.1.1.
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2.1.4 Models to assess Candida biofilm formation
In this present study the primary aim was to compare the ability of different C. 
albicans strains to grow as biofilms and determine whether any observed 
differences with respect to the biofilm growth related to their origin of 
infection. A suitable model for this had therefore to be adopted.
In recent years a large number of experimental model systems have been 
designed to study Candida grown in the biofilm state (Table 2.4). Many of 
these have already been highlighted in the Literature Review (section 1.11) 
of this thesis. The availability of well-characterised, reproducible biofilm 
models is essential to understand the nature of Candida biofilms and to 
perform studies of biofilm formation and antifungal drug resistance (Chandra 
et al., 2001a). Many of the models outlined in Table 2.4 are sufficient for 
device infection studies but not for tissue infections. However, the recent use 
of a reconstituted human oral epithelium system is adequate to study tissue 
infections and closely resembles the healthy human epithelium (Jayatilake et 
al., 2005).
2.1.4.1 Reconstituted human oral epithelium (RHE)
The human oral mucosa is composed of an outermost layer of stratified 
squamous epithelium similar to the stratified squamous epithelia found in the 
rest of the body. It has a mitotically active basal cell layer, a number of 
differentiating intermediate layers and a superficial layer, where cells are 
shed from the surface of the epithelium (Giannola et al., 2007). SkinEthic 
Laboratories cultivate a 0.5 cm2 reconstituted human epithelium (RHE) in 
vitro on a polycarbonate filter at the air liquid interface in chemically defined 
medium lacking antibiotics for 5 days (Fig. 2.2). The transformed human 
keratinocytes of the cell line TR146, from a squamous cell carcinoma of the 
buccal mucosa form an epithelial tissue devoid of stratum corneum, yet 
histologically resembling the mucosa of the oral cavity.
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Table 2.4 Models and methods to assess Candida biofilm formation.
Models References
Adherence assay (buccal 
and vaginal epithelial cells)
(Abu-Elteen, 2000; Nikawa et al., 2006; 
Skoutelis et al., 1995)
Microtitre plate assay (Ramage et al., 2001a; Ramage et al., 2001b)
Discs (Hawser and Douglas, 1994)
Perfused biofilm fermenter (Baillie and Douglas, 1998; Gilbert et al., 
1989)
Microfermenter model (Garcia-Sanchez et al., 2004)
Polymethylmethacrylate and 
silicone elastomer
(Chandra et al., 2001a; Chandra et al., 2001b)
Hydroxyapatite and acrylic (Chandra et al., 2001b; Henriques et al., 
2003; Ramage et al., 2001a)
Constant Depth 
Fermenter
Film (Lamfon et al., 2005; Lamfon et al., 2003; 
Lamfon et al., 2004; Pratten et al., 2003)
Reconstituted Human 
Epithelium (RHE)
Oral (Giannola et al., 2007; Jayatilake et al., 2005; 
Schaller et al., 2001; Schaller et al., 2005b)
Animal models (Adams and Jones, 1971; Budtz-Jorgensen, 
1971; Garcia-Sanchez et al., 2004; Jones and 
Adams, 1970; Samaranayake and 
Samaranayake, 2001; Shakir et al., 1981; 
Shakir etal., 1986)
Methods
Roll plate method (Maki et al., 1997; Storti et al., 2003)
Enumeration of viable cells (Burton et al., 2007; Djordjevic et al., 2002; 
Jin et al., 2003; Li et al., 2003)
Total biomass determination (Hawser and Douglas, 1994)
Microscopical analysis (Caddy et al., 2003; Chandra et al., 2001a; 
Harrison et al., 2007; LaFleur et al., 2006; 
Mendez-Vilas et al., 2007)
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Fig. 2.2 a) Reconstituted human oral epithelium (SkinEthic Laboratories, 
Nice, France); b) Oral epithelium ex vivo (SkinEthic Laboratories, Nice, 
France).
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In recent years, this RHE (SkinEthic Laboratories, Nice, France) has 
successfully been used to investigate mechanisms of tissue degradation by 
Candida (Jayatilake et al., 2005; Schaller et al., 2001; Schaller et al., 1999; 
Schaller et al., 1998) and examine the response of tissue to infection 
(Schaller et al., 2005b). Indeed, previous studies using Periodic Acid Schiff 
(PAS) staining to profile C. albicans RHE infection have suggested that strain 
differences exist between C. albicans isolates with respect to tissue invasion 
(Bartie et al., 2004).
In general, this approach provides a number of advantages compared to 
other in vitro models. The stratified cultured TR146 cell layers are analogous 
to normal human buccal epithelium with the cells are able to grow on the 
polycarbonate permeable inserts to form cell layers resembling the stratified 
human buccal tissue. So overall, the model has similar morphology, ultra­
structure and permeability barrier properties to intact buccal mucosa 
(Jacobsen et al., 1999). The RHE has also been used to perform 
permeability studies of drugs in a well-defined environment (Giannola et al., 
2007; Jacobsen et al., 1999). Importantly, when using any model system, 
one has to be aware of its limitations e.g. in the case of the RHE, the 
epithelium cannot recover after destruction nor can it elicit a full immune 
response.
2.1.5 Methods of analysing the developed Candida biofilms
Once a biofilm has been generated, it can be characterised using a variety of 
approaches including the assessment of cell number either through counting 
the total number of cells (live or dead) or by viable count estimation. Other 
characteristics that can be measured include the analysis of biofilm 
associated gene expression (Chapter 3), or investigating the actual 
architecture of the biofilm that develops. In this present Chapter, the aim was 
the latter and therefore a microscopical analysis was selected. Several 
options were available as outlined below.
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2.1.6 Microscopical analysis
Scanning electron microscopy (SEM) techniques have been used to observe 
biofilms (or more often adherent cells) because of the high magnification and 
image contrast that can be achieved. However, sample preparation 
(dehydration of the samples) may cause problems leading to false artifactual 
observations (Caddy et al., 2003). Another disadvantage of SEM is that 
detail on the exact architecture of biofilms is difficult to obtain.
Inverted light microscopy has also been used, e.g. to measure adherence of 
C. albicans to acrylic (Williams et al., 1998). Recently, Harrison et al. (2007) 
used the inverted light microscope to examine C. albicans and C. tropicalis 
biofilms cultivated at the bottom of microtitre plate wells (Harrison et al., 
2007). The benefits of such an approach are that visualisation of the biofilm 
in a liquid environment can be undertaken without disturbing the architecture.
The atomic force microscope (AFM) has become an important tool for 
investigating biological materials such as tissues, yeast, bacteria and their 
biological constituents. It can provide real-time in situ quantitative 
morphological information, as well as measure the interaction forces between 
a sharp tip and the surface of interest. The probe of interest should be 
positioned on the stage of the AFM to be scanned and has to be fixed by 
chemical treatment so force applied by the AFM tip does not induce 
movement of the sample. Surface modifications include polyethyleneimine 
(PEI), silanisation or poly-L-lysine treatment to immobilise microbes onto the 
surface (Mendez-Vilas et al., 2007; Schar-Zammaretti and Ubbink, 2003; 
Velegol and Logan, 2002). However, one of the limitations of the AFM is that 
all these methods can alter the surface physiochemical properties of the cells 
(Mendez-Vilas et al., 2007).
Fluorescent microscopy can be used to evaluate the morphology of biofilms 
(Chandra et al., 2001a; Kuhn et al., 2002b), and this is of particular value for 
live/dead determination of biofilm cells and the specific detection of individual 
group members in biofilm consortia (LaFleur et al., 2006). Furthermore, cells
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can be detected when present on an opaque surface. The disadvantage of 
standard fluorescent microscopy is that it cannot generate focused images 
through very thick specimens.
Confocal laser scanning microscopy is a microscopy method that permits the 
acquisition of high resolution images and 3-D reconstructions. This 
technique has the advantages of fluorescence microscopy but significantly 
can also generate focused images through thick specimens at various 
depths. The CLSM procedure involves images being taken ‘point-by-point’ 
and then reconstructed using a computer, rather than projected through an 
eyepiece. Particulars of this method are discussed in detail in Chapter 1, 
section 1.11.5. Due to the significant advantages of CLSM over other 
microscopical methods, it was chosen to study the Candida biofilms 
generated in this study.
2.2 Aims
With regards to oral candidosis, the question that remains to be answered is 
why individuals present with such different infections, which are all seemingly 
caused by the same fungus. It is evident that C. albicans is an extremely 
heterogeneous species whose strains differ phenotypically and genotypically. 
Strain variation could determine which type of infection develops and whether 
the host actually manages to combat the colonising strain or whether it is 
retained as a commensal strain.
The hypothesis of this study was that different strains of C. albicans develop 
specific biofilm growth forms on a Reconstituted Human Oral Epithelium 
which are directly associated with their origin of infection. For example, if 
isolates originated from an invasive candidosis such as CHC, the resulting 
biofilm/infection would differ compared to another strain from a more 
superficial mucosal infection such as PMC. To test this hypothesis, the 
specific aims were:
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1. To develop a suitable in vitro biofilm model for C. albicans infection using 
the RHE.
2. To infect this model with a range of C. albicans strains isolated from 
various forms of oral candidosis.
3. To compare the following parameters of RHE infection: extent of RHE 
colonisation; type of candidal morphology involved in the infection; degree of 
RHE tissue invasion exhibited and the pattern of tissue invasion.
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2.3 Materials and Methods
2.3.1 Identification of test isolates
Nineteen isolates of C. albicans from four distinct clinical conditions (normal 
oral mucosa, n=4; non-CHC oral candidoses, n=4; CHC, n=8; SCC 
(squamous cell carcinoma), n=3) were obtained either by imprint culture from 
patients with defined lesions or concentrated rinse culture for isolates from 
non-defined infection sites. The strains were collected between 1993 until 
2001 as part of the routine microbiological service at the Cardiff Dental 
School. Details of these isolates are presented in Table 2.5. Identification of 
C. albicans was based on germ-tube formation and biochemical profiling 
using the API 32C system (bioMerieux, Basingstoke, UK).
2.3.2 In vitro RHE infection model
2.3.2.1 Preparation of Candida albicans
Candida albicans strains were cultured on Sabouraud Dextrose Agar (SDA; 
LAB M, Bury, UK) at 37°C for 24 h. The resulting growth was used to 
inoculate 10 ml of Yeast Nitrogen Base (YNB; BD Diagnostics, Cowley, UK) 
medium supplemented with 0.5% glucose (w/v). This medium was then 
incubated for 12 h at 37°C. Yeast cells were harvested by centrifugation and 
washed (*3) with phosphate buffered saline (PBS). The resulting yeast cells 
were enumerated using a haemocytometer and a total of either 4x107 yeast 
cells or 2x106 yeast cells was added to the RHE (SkinEthic Laboratories, 
Nice, France; section 2.3.2.2). The initial morphology of the inoculum was 
determined using a light microscope at original magnifications of x400 and 
x600 (Carl Zeiss Ltd., Welwyn Garden City, UK).
2.3.2.2 Preparation of RHE
The RHE was supplied by SkinEthic Laboratories (Nice, France) and was 
generated by culturing transformed human keratinocytes derived from the 
cell line TR146 originally obtained from a squamous cell carcinoma of the 
buccal mucosa.
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Table 2.5 Candida albicans isolates and source.
Candida albicans strain Isolate source
135BM2/94 CHC-SCC, buccal mucosal
970/00 CAC, oral mucosa
PTR/94 CHC, buccal mucosa
324LA/94 CHC, commissure
1190/97 CHC, buccal mucosa
705/93 CHC, buccal mucosa
DW1/93 Normal oral mucosa
PB1/93 Normal oral mucosa
243/00 Lichen planus
455rgh/94 CHC, tongue
LR1/93 Normal oral mucosa
289T/00 SCC, tongue
480/00 SCC, oral mucosa
819/99 Keratosis, sublingual
408/99 SCC, tongue
848/99 CHC, tongue
458R/94 CHC, buccal mucosa
WK1/93 Normal oral mucosa
40/01 PMC, palate
CHC, Chronic hyperplastic candidosis; SCC, Squamous cell carcinoma; 
CAC, Chronic atrophic candidosis; PMC, Pseudomembranous candidosis.
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Cultures were incubated in serum-free conditions in a chemically defined 
MCDB-153 medium containing 5 |jg ml'1 insulin and 1.5 mM calcium chloride 
on a 0.5 cm2 microporous polycarbonate filter for 5 days. The MCDB-153 
medium comprised of essential amino acids, vitamins, inorganic salts, 
organic compounds and trace elements. The RHE in vitro model and all 
culture media were prepared for this study without antibiotics and 
antimycotics.
Immediately after receipt of the RHE from the supplier, the tissue was 
removed from the agarose-nutrient solution in the shipping multiwell plate 
and placed in a fresh 6-well tissue culture plate previously filled with 100 pi of 
SkinEthic maintenance medium.
2.3.2.3 Culture of infected RHE
Infected RHE was incubated for 24 h (for 4x107 yeast cells) or 12 h (for 2x106 
yeast cells) at 37°C in a humidified atmosphere enriched with 5% C 02. After 
incubation, the tissue was bisected; one portion was used for CLSM analysis 
and the other for RT-PCR (Chapter 3, section 3.3.4). A non-infected control 
was included for comparison and in all cases, the experiments were repeated 
on a minimum of two occasions.
2.3.2.4 RHE processing for Confocal Laser Scanning Microscopy 
(CLSM)
Three processing protocols were assessed in this study and included the 
analysis of fresh (unprocessed) tissue, frozen fixed tissue and formalin fixed 
tissue.
2.3.2.4.1 Fresh tissue
The fresh tissue portion used for CLSM was placed on a microscope slide, 
and overlaid with 20 pi concanavalin A lectin (0.025% w/v in PBS) 
conjugated with the fluorescent tag, Alexa 594 (Sigma, Poole, UK). After 30 
min incubation at room temperature, the lectin solution was removed and the 
tissue washed once using distilled H20. Finally, the tissue was overlaid with
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5 pi of vectashield (Vector Laboratories Ltd, Peterborough, UK). A coverslip 
was placed on top of the preparation and sealed with nail varnish.
2.3.2.4.2 Frozen fixed tissue
Specimens of infected tissue were also frozen using isopentane (100%) 
cooled in liquid nitrogen. Fresh specimens were placed in aluminium foil and 
lowered into the isopentane solution for 30 s until frozen. The tissue in the 
foil was then stored at -80°C in cryotubes until required for staining and 
CLSM analysis. To visualise the infecting C. albicans, sections were directly 
labelled with 20 pi of Alexa 594-conjugated concanavalin A lectin (Molecular 
Probes) at 0.025% w/v in PBS for 20 min at room temperature.
2.3.2.4.3 Formalin fixed tissue
Infected tissue was fixed in 2% (v/v in FfeO) paraformaldehyde solution for 24 
h and embedded in paraffin wax using standard histological techniques. 
Sections (20 pm) were cut and placed on to Histobond+ coated microscope 
slides (Raymond A Lamb, East Sussex, UK), de-waxed and processed 
through xylene and ethanol to water before fluorescent labelling.
2.3.2.4.4 Immunohistochemistry on fixed tissue
To identify epithelial cells within the RHE, sections were also labelled with a 
pan-cytokeratin antibody using an indirect immunofluorescent labelling 
procedure. Sections were first heated in citrate buffer for 10 min at 95°C, 
washed in PBS and blocked with normal goat serum (Sigma-Aldrich, Dorset, 
UK) using a 1:20 dilution in PBS for 30 min, prior to primary antibody 
staining. Sections were then incubated overnight at 4°C with a mouse 
monoclonal pan-cytokeratin primary antibody (Santa Cruz Biotechnology, Inc; 
Heidelberg, Germany) used at a 1:50 dilution in PBS. After washing, sections 
were fluorescently labelled with Alexa 488-conjugated goat anti-mouse 
secondary antibody (5 pg ml"1; Invitrogen) for 30 min at room temperature.
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For nuclear context, the sections were counterstained with Hoechst 33258 
(Sigma) 1|jg ml'1 for 20 min, before washing in PBS. Tissues were then 
mounted using vectashield fade-retarding mountant.
2.3.2.5 Confocal Laser Scanning Microscopy (CLSM)
Stained sections were viewed and analysed by CLSM using a Leica TCS 
SP2 AOBS spectral confocal microscope (Leica, Wetzlar, Germany). The 
sections were scanned through the full depth of the tissue using appropriate 
settings for single, double or triple channel fluorescence recordings of Alexa 
594 alone; Alexa 594 and Hoechst 33258; or Alexa 594, Hoechst 33258 and 
Alexa 488 as detailed in Table 2.6. For multi-channel recordings, 
fluorochromes were scanned sequentially to eliminate spectral overlap 
between probes. Selected images were presented either as single confocal 
optical sections or maximum intensity type reconstructions.
2.3.2.6 Criteria of biofilm parameters examined
The parameters of the biofillms examined were I) the level of C. albicans 
colonisation on the RHE, II) the morphology of the infecting C. albicans and, 
III) the extent and pattern of any tissue invasion by the organism. “High 
invaders” were defined as those strains that readily penetrated the RHE 
within the incubation time period. These were in contrast to “low invaders” 
where only superficial invasion on the RHE was noted. “Non-invaders” did 
not display any evidence of tissue penetration.
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Table 2.6 Excitation and Emission spectra for the 3 fluorochromes used for 
CLSM.
Fluorochrome Laser Excitation Line Emissions Detected
(nm) (nm)
Hoechst 33258 405 410-480
Alexa 488 488 500-550
Alexa 594 546 600-660
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2.4 Results
2.4.1 Infection of the RHE model
Preliminary studies with the two inoculum levels and incubation times 
showed that a high inoculum (4x107) and longer incubation time (24 h) 
caused an excessive level of tissue destruction with many of the tested 
strains. As a consequence, the lower inoculum (2x106) level and shorter 
incubation time (12 h) proved more suitable for strain comparisons with 
respect to the chosen measured parameters. The following results are 
based on these optimal infection conditions. Furthermore, detection of 
Candida was achieved with all three processing methods with no apparent 
differences in staining quality or alterations in tissue morphology. Formalin 
fixed tissue was however easiest to handle and to store, and so the reported 
results are also based on this tissue processing approach.
2.4.2 Comparison of planktonic morphology and biofilm morphology
For the majority of strains tested, the morphological form of the Candida 
strain was the same regardless of whether culture occurred in the presence 
(biofilm form) or absence (planktonic form) of the RHE. Six strains 
(324LA/94, PB1/93, 455rgh/94, LR1/93, 819/99 and 40/01) out of 19 
exhibited a different morphology between the two different culture conditions 
(Table 2.7).
2.4.3 In vitro RHE infection
2.4.3.1 Extent of colonisation of the surface of the RHE
The majority of C. albicans strains (n=17/19) invaded the RHE (Table 2.7) 
and CLSM showed the presence of both yeast and hyphae on the RHE 
surface. The results were consistent between the three separately repeated 
experiments.
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Table 2.7 Candida albicans invasion of reconstituted human oral epithelium  
(RHE) as determined by confocal laser scanning microscopy (CLSM ).
Candida
albicans
strain
Isolate source Surface
colonisation
(biofilm
formation)
Strain morphology in 
presence of tissue  
(without tissue*)
Invasion
135BM2/94 CHC-SCC, buccal mucosal +++ Yeast and hyphae high
970/00 CAC, oral mucosa +++ Predominantly hyphae high
PTR/94 CHC, buccal mucosa +++ Yeast and hyphae high
324LA/94 CHC, commissure +++ Yeast and hyphae 
(predominantly yeast)
high
1190/97 CHC, buccal mucosa +++ Yeast and hyphae high
705/93 CHC, buccal mucosa +++ Yeast and hyphae low
DW1/93 Normal oral mucosa ++ Yeast and hyphae low
PB1/93 Normal oral mucosa ++ Yeast and hyphae 
(predominantly yeast)
low
243/00 Lichen planus ++ Yeast and hyphae low
455rgh/94 CHC, tongue ++ Predominantly yeast 
(yeast and hyphae)
low
LR1/93 Normal oral mucosa ++ Predominantly yeast 
(yeast and hyphae)
low
289T/00 SCC, tongue ++ Predominantly yeast low
480/00 SCC, oral mucosa ++ Yeast and hyphae low
819/99 Keratosis, sublingual ++ Predominantly yeast 
(yeast and hyphae)
low
408/99 SCC, tongue ++ Predominantly yeast low
848/99 CHC, tongue ++ Predominantly yeast low
458R/94 CHC, buccal mucosa ++ Predominantly yeast low
WK1/93 Normal oral mucosa + Predominantly yeast none
40/01 PMC, palate + Predominantly yeast 
(yeast and hyphae)
none
CHC, Chronic hyperplastic candidosis; SCC, Squamous cell carcinoma; 
CAC, Chronic atrophic candidosis; PMC, Pseudomembranous candidosis;
+, sparsely colonised; ++, moderately colonised; +++, extensively colonised, 
highlighted  morphological findings indicate differences observed between  
the two different culture environments.
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Figure 2.3a shows a more extensive surface colonisation with more hyphal 
development and Figure 2.3b shows an example of sparse surface 
colonisation of the RHE.
In some cases, hyphal and yeast growth degraded the epithelial layers of the 
RHE and, therefore, the cell numbers and the incubation time was reduced 
as highlighted earlier.
2.4.3.2 Invasion of the biofilm in the RHE
By decreasing the yeast inoculum level and reducing the incubation time, a 
better analysis of the direction of hyphal penetration and determination of any 
budding occurring within the tissue was possible. Figures 2.4a-2.6a illustrate 
the different forms of Candida infection (24h and a high inoculum 4x107) of 
the RHE and depict variation in the extent of both tissue invasion and the 
actual pattern of hyphal invasion within the tissue.
The 19 C. albicans strains were categorised as either “high invaders”, “low 
invaders” or “non-invaders” (Table 2.7). CLSM showed the presence of both 
yeast budding and hyphae on the RHE surface and within the tissue. Hyphal 
growth forms were most frequently detected within the tissues. Figures 2.4a- 
2.6a illustrate infection of RHE (24h, with a high inoculum 4x107 level) and 
Fig. 2.4b-2.10 illustrate infection of the RHE (12h, with a lower inoculum 
2x106 level) and the pattern of hyphal invasion. Five strains out of 19 were 
‘high invaders’, where extensive surface colonisation and large numbers of 
hyphae occurred within the tissue (Fig. 2.4b and 2.5b). This contrasted with 
‘low invader’ or ‘none invader’, where yeast predominated for 10 of the 14 
isolates and little or no invasion was evident (Fig. 2.6b and 2.7a and b). The 
RHE was approximately 50-60 pm thick and the ‘high invaders’ penetrated 
through the whole thickness of the tissue. The extent of RHE invasion was 
therefore isolate-dependent and consistent over repeat experiments for each 
given isolate (Table 2.7).
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Fig. 2.3 Surface colonisation of two strains of C. albicans on RHE tissue 
a) strain 455rgh/94 illustrating an extensive surface colonisation, yeast and 
hyphae are evident, and b) strain W K1/91 illustrating a sparse surface 
colonisation, primarily only yeast.
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Fig. 2 .4  Infection of RHE by C. albicans high invader strain (135B M 2/94) and 
visualised using CLSM a) 24h incubation, stained with ConA-Alexa 594 (red) 
and b) 12h incubation, triple stained The nuclei are stained with Hoechst 
(blue), the epithelial cells are stained with pan-cytokeratin antibody -  Alexa 
488  (green) and the Candida are stained with ConA-Alexa 594 (red) showing 
the pattern of hyphal invasion and surface colonisation.
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Fig. 2 .5  Infection of RHE by C. albicans high invader strain (P TR /94) and 
visualised using CLSM a) 24h incubation, stained with ConA-Alexa 594 (red) 
and b) 12h incubation, triple stained The nuclei are stained with Hoechst 
(blue), the epithelial cells are stained with pan-cytokeratin antibody -  Alexa 
488 (green) and the Candida are stained with ConA-Alexa 594 (red) showing 
the pattern of hyphal invasion and surface colonisation.
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Fig. 2 .6  Infection of RHE by C. albicans low invader strain (705/93) and 
visualised using CLSM a) 24h incubation, stained with ConA-Alexa 594 (red) 
and b) 12h incubation, triple stained. The nuclei are stained with Hoechst 
(blue), the epithelial cells are stained with pan-cytokeratin antibody -  Alexa 
488 (green) and the Candida are stained with ConA-Alexa 594 (red) showing 
the pattern of hyphal invasion and surface colonisation.
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Fig. 2.7 Candida albicans infected oral epithelium showing the pattern of 
hyphal invasion; a) low invasion by strain PB1/93; b) no-invasion by strain 
40/01 The nuclei are stained with Hoechst (blue), the epithelial cells are 
stained with pan-cytokeratin antibody -  Alexa 488 (green) and the Candida 
are stained with ConA-Alexa 594 (red).
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2.4.3.3 Pattern of tissue invasion
CLSM analysis of triple stained tissue shows that hyphae were actually 
capable of moving both around and directly through individual epithelial cells 
(strains 135BMS2/94 and PTR/94; Fig. 2.8) respectively. CLSM analysis 
revealed that hyphal penetration of the RHE tissue occurred both vertically 
and horizontally within the RHE. Hyphae that were seen to pass through all 
the epithelial layers subsequently spread and grew horizontally across the 
bottom of the RHE (Fig. 2.9). For example, strain 243/00 (Fig.2.9a) 
demonstrated a ‘horizontal pathway’ of hyphal invasion whilst strain 
135BM2/94 (Fig. 2.9b) exhibited a vertical path of hyphal invasion. These 
strains reverted to the yeast morphology once total tissue invasion had 
occurred. In the case of ‘high invading’ isolates (e.g. 135BM2/94, PTR/94 
and 1190/97), a more direct and vertical invasion profile occurred (Fig. 2.9b), 
possibly suggesting that these strains were less impeded by the tissue. 
Significantly, the latter three isolates all originated from cases of CHC. 
Furthermore, it was also evident that 4 of the 5 strains classed as ‘high 
invaders’ originated from CHC infection. It was also apparent for some 
strains that yeast growth occurred within the RHE, with growth originating 
from the budding of hyphal branches (Fig. 2.10a and 2.10b).
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Fig. 2.8 Tracking of invading C. albicans hyphae a) strain 135BM 2/94 and b) 
strain PTR /94 during infection of RHE, illustrates hyphae directly penetrating 
epithelial cells as well as circumventing them. Arrows indicate an example of 
hyphal invasion. The nuclei are stained with Hoechst (blue), the epithelial 
cells are stained with pan-cytokeratin antibody -  Alexa 488  (green) and the 
Candida are stained with ConA-Alexa 594 (red).
__ *3
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Fig. 2 .9  Pattern of Candida albicans hyphal invasion of infected RHE a) 
heterogenous hyphal network during C. albicans infection by strain 243/00; b) 
vertical hyphal invasion during C. albicans infection by strain 135BM 2/94.
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Fig. 2 .10 (a) Nuclear penetration by hyphae of strain 1190/97, (b) nuclear 
penetration and budding of yeast from hyphal branch by strain 135BM 2/94. 
Arrows indicate the example of hyphal invasion type; * indicates budding.
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2.5 Discussion
The pathogenic behaviour of opportunistic Candida species is dependent on 
expression of certain virulence factors (e.g. hydrolytic enzymes) (Schaller et 
al., 2002). Recently, the organisms ability to form biofilms has been 
recognised as one of these factors (Ramage et al., 2005; Richard et al., 
2005). Candida albicans is dimorphic, (i.e. it is capable of reversible 
transition between a yeast and hyphal form) and the morphogenic transition 
between these forms is often stimulated by growth in the host and associated 
with host tissue invasion (Gow et al., 2002). It has been suggested that 
hyphae grow by tip extension and can generate significant tip pressures for 
penetration (Gow et al., 2002). The underlying hypothesis for this present 
study was that different strains of C. albicans from specific types of oral 
infection would produce distinct characteristics of RHE infection and biofilm 
formation. To compare biofilm formation and subsequent tissue invasion by 
C. albicans, the use of the RHE model together with CLSM was chosen. 
Previous studies using the multilayered RHE model have shown its 
histological similarity with healthy oral epithelium and also described the 
biofilm-like infection of the tissue by C. albicans (Jayatilake et al., 2005).
Compared with standard light microscopy, CLSM provides much more 
detailed information on C. albicans tissue invasion. Previous use of CLSM to 
assess C. albicans interaction with oral epithelium has been limited. Studies 
involving infection of the FaDu oropharyngeal epithelial cell line (isolated from 
a pharyngeal squamous cell carcinoma, American Type Culture Collection) 
with C. albicans have previously described the use of CLSM in determining 
fungal-epithelial cell interaction mechanisms (Park et al., 2005). Additional 
work examining endothelial infection by C. albicans using CLSM has 
elegantly revealed a self-induced endocytotic mechanism exhibited by 
candidal hyphae as a means of tissue invasion (Phan et al., 2005).
The commercially available RHE employed in this present study has been 
used with success as a basis for in vitro Candida infection models. A 
possible limitation of the RHE system is the lack of certain host immune
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responses. It has however been shown that pro-inflammatory cytokine 
responses by in vitro epithelial cell lines including RHE infected with Candida, 
appear to be maintained, and have actually been shown to vary with C. 
albicans of different invasive potential and virulence (Schaller et al., 2002; 
Villar et al., 2005). This present Chapter describes for the first time the 
CLSM based characterisation of actual tissue infection and biofilm formation 
by Candida.
Using conventional microscopy procedures, it has previously been difficult to 
ascertain the manner by which hyphae migrate through tissue. The CLSM 
approach used in this study, conclusively demonstrated that, in addition to 
being able to move between epithelial cell junctions, hyphae can track 
directly through keratinocytes. Epithelial cell penetration was also more 
strongly associated with strains that demonstrated the vertical invasion profile 
depicted in Fig. 2.9b compared with the less direct invasion profile seen in 
Fig. 2.9a. The exact mechanism of hyphal penetration remains unclear. It 
may occur either through pressure exerted from the growing tip of the hyphae 
or as mentioned earlier by inducing an endocytosis process, alternatively, 
invasion may be facilitated by extracellular hydrolytic enzymes promoting the 
passage of hyphae.
It is also important to mention that biofilm structure and the proportions of 
yeast- and hyphal- cells are strongly influenced by parameters such as 
medium composition, temperature and the nature of the substratum 
(Kumamoto, 2002). The key component of invasive growth is hyphal 
penetration. The RHE model used in this study showed strain differences 
between the 19 strains and was highly suitable for characterisation.
The levels of candidal invasion reported in this present study were largely 
comparable to those previously found by the research group at the Cardiff 
Dental School using standard light microscopy and PAS histological staining 
analysis (Bartie et al., 2004). This was reassuring, particularly as the 
methods of assessment between the two studies were different and were
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performed by separate operators. All isolates previously deemed to be ‘high 
invaders’ (Bartie et al., 2004) were also identified as such in this present 
study. In addition, three of the four isolates originating from normal healthy 
oral mucosa exhibited low RHE invasion and two of these were also 
previously considered to be low invaders (Bartie et al., 2004). This latter 
finding for commensal strains could indicate a limited ability of such isolates 
to produce the necessary virulence attributes required for invasion. This was 
also reflected by the relatively low level of RHE colonisation by these 
isolates, together with an apparent reduced ability to produce hyphal forms. 
It is, however, worth noting that invasion, albeit at a low level, did occur with 
three of the four commensal isolates and it is therefore possible that given an 
appropriate oral environment, these 'commensal' isolates could instigate 
infection. Overall, the ability of C. albicans to invade appeared to correlate 
with the isolates’ capacity to exhibit yeast/hyphal transition.
Interestingly, in all but one case, the ‘high invaders’ revealed a predominance 
of hyphae within the tissue. This was not surprising, as movement of yeast 
from the surface of the RHE would have been physically difficult, as 
traditionally, yeast are considered to lack the migratory ability possessed by 
hyphal elements (Gow et al., 2002). For a number of tissues, yeast 
predominated on the surface of the RHE, whilst hyphae predominated within 
and below the tissue. This would suggest that either the epithelium provided 
a trigger for morphological transition following contact or that only hyphae 
penetrated the tissue and thus predominated due to this selective process. 
To support the latter, previous work using CLSM to study endothelium 
invasion by C. albicans has shown that hyphae can induce their own 
endocytosis, an ability not possessed by yeast (Phan et al., 2005). For most 
strains used in the present study, the same morphological type was evident 
in either the presence or absence of tissue (Table 2.7) and would suggest 
that hyphal morphology was not induced through contact with the epithelium 
and supports the view that hyphae are the principle invasive forms of C. 
albicans.
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Four of the five strains classed in this study as ‘high invaders’ (135BM2/94, 
PTR/94, 324LA/94, 1190/97) originated from CHC and this might suggest an 
inherently greater ability of these strains to invade the oral epithelium. A 
particular pathogenic feature of C. albicans that is essential to the 
development of CHC is the ability to invade the oral mucosa. Furthermore, 
this feature of mucosal invasion is notably distinct from other forms of oral 
candidosis and indeed serves as a diagnostic marker of CHC (see section 
2.1.2.4). The fact that four other CHC strains were ‘low invaders’ again 
highlights the undoubted importance of additional host factors in the 
development of CHC infection. Indeed, studies performed by Soil (2002) 
emphasise the importance of candidal adaptation to host environments as 
being critical in determining whether commensalism or virulence results. 
Evidence from complex DNA profiling of C. albicans populations currently 
suggests the absence of true commensal and pathogenic strains, and 
advocates rapid phenotypic adaptation as a key component in promoting a 
particular oral status (Soil, 2002). The advantage of the current model is that 
strain differences can be ascertained under the standardised conditions 
used. An ability to associate invasive features with the clinical origin of the 
isolates would be a significant advantage, as it would enable the early 
identification of strains with the potential to cause CHC, and possibly 
influence patient management.
2.6 Summary
A suitable method of assessing biofilm formation and tissue infection by C. 
albicans using an in vitro tissue model using CLSM has been developed. 
Using this RHE model we have shown that strain differences exist and may 
relate to the clinical origin of Candida. The differences evident related to 
adhesion, invasion and hyphal formation. Candida hyphae were seen to 
develop as a complex network of filaments within the tissue and were seen to 
physically penetrate cells and exhibit budding within the tissue. In summary:
1) A suitable in vitro biofilm model for C. albicans infection was established 
using the RHE.
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2) Seventeen out of 19 C. albicans strains invaded the RHE. Using this 
model it has been shown that strain differences exist and may relate to the 
clinical origin of the Candida. Factors associated with C. albicans in addition 
to those of the host could therefore be important in the progression of oral 
infections such as CHC.
3) Strain variation was evident based on the level of adherence, tissue 
penetration and pattern of invasion. Heterogeneous tissue invasion was 
evident. Candida hyphae develop as a complex network of filaments within 
the tissue and are seen to physically penetrate the cells (nuclei) and exhibit 
budding within the tissue.
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Chapter 3 
Expression of Candida albicans 
virulence genes in an in vitro 
tissue model
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3.1 Introduction
Candida albicans is an opportunistic fungal pathogen of humans and as a 
result causes infection only in suitably debilitated individuals. It is not 
surprising therefore that no single predominant virulence factor is currently 
recognised for this normally harmless organism. However, a number of 
putative virulence factors have been proposed.
Candida albicans produces a variety of secreted hydrolytic enzymes (Hube et 
al., 1994; Hube et al., 2000; Ibrahim et al., 1995; Monod et al., 1998) that 
may enable it to persist and cause disease within a suitably compromised 
host (Schofield et al., 2003). Differences in such gene expression may be 
key to the pathogenic potential of a given strain. Furthermore, even for 
individual strains, gene expression can give rise to phenotypic differences as 
seen between biofilm and planktonic cells. Candida albicans infections (see 
Chapter 2, section 2.1.2) are common, debilitating and an important clinical 
problem (Naglik et al., 2004). In the case of oral infections, Candida biofilm 
formation is considered to be a key factor in the cause of the infection, e.g. 
denture stomatitis is associated with candidal biofilms on the acrylic surfaces 
of the denture (Douglas, 2003). The adherence of Candida to oral mucosal 
surfaces is critical for the persistence of the organism in the mouth 
(Sitheeque and Samaranayake, 2003). Pseudomembranous candidosis 
could be considered to be a complex biofilm, although this concept has still 
not been well recognized (Jin et al., 2003).
It remains unclear whether ‘biofilm-like’ growth imposes a significant change 
in C. albicans physiology and whether this change is reflected in a particular 
pattern of gene expression, although some differential properties of biofilms 
have been observed and several gene expression changes have been 
reported. Genome-wide approaches are now available that allow this 
question to be more fully investigated (Berman and Sudbery, 2002; Garcia- 
Sanchez et al., 2004). Previous studies, using microarray technology, 
assessed C. albicans biofilm transcriptional profiles to identify which genes 
were involved in the biofilm development process (Cao et al., 2005; Garcia-
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Sanchez et al., 2004; Murillo et al., 2005). The data from this previous study 
suggest that the sulphur-amino acid biosynthesis pathway was an important 
feature of C. albicans biofilms (Garcia-Sanchez et al., 2004).
3.1.1 Candida virulence factors and associated gene families
3.1.1.1 Secreted aspartyl proteinase (SAP) production
Proteinases are classified on the basis of their catalytic mechanism and at 
present four classes are recognised: I) serine, II) cysteine, III) metallo and, 
IV) aspartyl proteinases.
Aspartyl proteinases are ubiquitous in nature and are involved in a myriad of 
biochemical processes. Aspartyl proteinases include HIV aspartyl 
proteinase, and pepsin and rennin in humans (Naglik et al., 2004). It is these 
aspartyl proteinases that are associated with C. albicans virulence. 
Candidal-proteinases all have a broad spectrum of activity, and salivary 
proteins such as mucin, lactoferrin and secretory immunoglobulin A (slgA) 
are all degraded by these enzymes. Based on current data, the main roles of 
candidal aspartyl proteinases are to provide nutrition for the cells, to aid 
penetration and invasion and to evade immune responses (Naglik et al., 
2003). MacDonald and Odds (1983) first demonstrated the relationship 
between proteinase production and pathogenicity using chemically induced 
mutants of C. albicans with decreased proteolytic activity. These mutants 
were shown to be less virulent in murine models compared with the wild type 
strains. Figure 3.1 shows a hypothetical model for the correlation of SAP 
gene expression with function in C. albicans pathogenicity.
In recent years there has been a relatively large amount of work aimed at 
studying SAPs of C. albicans. At present, 10 different genes have been 
identified that encode for C. albicans SAPs (Hube, 1996; Hube et al., 1997; 
Sanglard et al., 1997). One explanation for the existence of the 10 different 
SAP genes may be the necessity for specific and optimised proteinase 
production during different stages of an infection (Hube and Naglik, 2001).
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Biofilm formation
SAP5, SAP6 and SAP9 
are more highly expressed 
in biofilms compared with 
planktonic ells
Adhesion
SAP1 to SAP3 are 
involved in 
adhesion to BECs
Phenotypic switching
SAP1 and SAP3 are 
expressed in opaque but 
not in white cells (WO-1 
strain). Other SAP specific 
expression profiles in other 
switching strains are highly 
likely
Cavitation
SAP1 possesses the ability to 
cavitate skin; pepstatin A 
inhibits cavitation
Sap gene 
family
Dimorphism
Expression of SAP4, 
SAP5 and SAP6 is hyphal 
specific
Interaction with the host immune system
SAP2 hydrolyses proteins of the immune 
system. SAP4-6 are necessary for survival 
and escape from macrophages
Invasion / Tissue damage
Sap1-3 are critical for 
mucosal infection and 
probably contribute to 
systemic infections 
Sap4-6 contribute to systemic 
infections
Nutrient acquisition
Secreted proteinases hydrolyse 
complex protein and provide 
nitrogen for the cells
Fig. 3.1 Correlation of SAP gene expression with function in C. albicans pathogenicity. (Adapted from Naglik et al. (2004).
The SAPs are essential for growth when protein is the sole nitrogen source 
(Hube et al., 1994; Naglik et al., 2004). SAPs are characterised by 
functioning in an acidic environment and being inhibited by pepstatin A, a 
hexapeptide from Streptomyces (Hoegl et al., 1996; Watts et al., 1998). It 
has been reported that pepstatin A blocks invasion of host tissue by hyphal 
cells at neutral pH and reduces the adherence of yeast cells to various cell 
types (Watts et al., 1998). Candida albicans is not the only Candida species 
known to produce extracellular proteinases. Candida tropicalis is thought to 
possess four SAP genes (Zaugg et al., 2001), whereas C. parapsilosis 
possesses at least two SAP genes (De Viragh et al., 1993). Proteolytic 
activity has also been found in vitro by Candida dubliniensis (Monod and 
Borg-von, 2002).
One approach to study the role and expression of SAPs involves the 
proteolytic degradation of bovine serum albumin (BSA) which is 
spectrophotometrically assessed by determining the generation of 
trichloroacetic acid (TCA) soluble BSA fragments (Hube et al., 1997; 
Kuriyama et al., 2003). Reverse-transcriptase polymerase chain reaction 
(RT-PCR) has also been used to detect mRNA products from SAP genes 
(section 3.3.6).
3.1.1.2 Phospholipase (PL) expression
Phospholipases represent a heterogeneous group of enzymes with the ability 
to hydrolyse phospholipids into fatty acids and other lipophilic products. 
Besides C. albicans, PLs are also considered to be virulence factors for other 
fungi, e.g. Aspergillus fumigatus or Cryptococcus neoformans and for many 
pathogenic bacteria, e.g. Pseudomonas species, Staphylococcus aureus etc. 
(Schaller et al., 2005).
Candida albicans can exhibit lipolytic activity through the production of four 
classes of phospholipases termed A, B, C and D (Barrett-Bee et al., 1985). 
As these enzymes degrade phospholipids to release free fatty acids, damage 
to host cell membranes and membrane bound vesicles can therefore 
theoretically occur, which could promote cell lysis or expose receptors to
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facilitate adherence. Samaranayake et al (1984) examined 41 oral isolates 
of Candida species, and found that 79% of C. albicans isolates produced 
extracellular phospholipase, which was not detectable in isolates of C. 
tropicalis, C. glabrata or C. parapsilosis. However, subsequent studies have 
shown that C. glabrata, C. parapsilosis, C. tropicalis, C. lusitaniae and C. 
/cruse/can all secrete phospholipases (Schaller et al., 2005).
It is important to note that phospholipase activity is inversely proportional to 
the glucose or galactose concentration in the growth medium 
(Samaranayake et al., 1984) and appears to be greatest at the tip region of 
hyphae (Pugh and Cawson, 1975). In addition, high phospholipase activity 
positively correlates with enhanced adherence of C. albicans buccal epithelial 
cells (BEC) and increased virulence in mice (Barrett-Bee et al., 1985). 
Moreover, it has been demonstrated that blood isolates of C. albicans from 
patients with systemic candidosis produce significantly more phospholipase 
than commensal strains and are more invasive in mouse models (Ibrahim et 
al., 1995).
A study by Price et al (1982) demonstrated extracellular phospholipase 
production by C. albicans isolated from urine, blood and wounds, involving a 
simple egg-yolk agar plate assay. In this method, Candida were cultured on 
egg yolk agar, incubated for 48h at 37°C and any hydrolysis of lipid 
substrates present in egg-yolk resulted in the formation of a calcium complex 
with fatty acids released by the action of the secreted enzymes (Price et al., 
1982). Furthermore, molecular techniques (such as RT-PCR, Northern- and 
Western- blot analysis) can also be used to detect phospholipase gene 
expression in C. albicans.
3.1.1.3 Agglutinin-like-sequence (ALS) gene expression
Candida albicans, like many fungi, contain a family of cell-wall glycoproteins, 
known as adhesins that confer unique adhesion properties (Guar and SA, 
1997; Hoyer, 2001; Verstrepen et al., 2004). Eight Candida ALS genes 
(ALS1 to ALS7 and ALS9) encoding large glycoproteins have been shown to 
promote candidal adhesion to host surfaces (Guar and SA, 1997; Hoyer,
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2001). Although these proteins share a similar three-domain structure, 
sequence differences between the ALS proteins can be large, suggesting 
that the proteins may have different functions (Hoyer, 2001). The gene 
family is called ALS due to the resemblance of domains of its encoded 
proteins to a-agglutinin, a cell-surface adhesion glycoprotein in 
Saccharomyces cerevisiae (Hoyer et al., 1995). In S. cerevisiae, 
heterologous expression of ALS confers an adherence phenotype, 
suggesting ALS proteins function in adhesion to host surfaces, which could 
correlate with Candida pathogenesis (Calderone and Braun, 1991; Fu et al., 
1998; Guar and SA, 1997). Similar to the SAP gene family, ALS genes are 
differentially expressed under various conditions and growth phases 
including morphological switching, growth medium composition and strain 
type of C. albicans (Hoyer et al., 1998a; Hoyer et al., 1998b; Hube et al., 
1994).
It has been suggested that the ALS gene family is important in C. albicans 
pathogenesis (Hoyer, 2001). Green et al. (2004) used an RT-PCR assay for 
ALS genes to analyse C. albicans RNA expression from in vitro models of 
oral candidosis and denture and catheter biofilms. In the study by Green et 
al. (2004) an infected RHE model was used and consistent expression of 
ALS1, ALS2, ALS3 and ALS4 was found as destruction of the RHE 
progressed in contrast to the more sporadic detection of ALS6 and ALS7 
gene. Another study focused on human clinical vaginal specimens and two 
models of vaginal candidosis (Cheng et al., 2005). In this work ALS1, ALS2, 
ALS3 and ALS9 were detected most frequently and expression of ALS4 and 
ALS5 were detected least frequently (Cheng et al., 2005). It has been 
proposed that Candida virulence properties may act synergistically to 
enhance the virulence properties of C. albicans (Felk et al., 2002; Korting et 
al., 2003; Schroppel et al., 2000; Schweizer et al., 2000; Srikantha et al., 
2000; Staib et al., 2002).
3.1.1.4 Morphology controlling genes
The morphological flexibility of C. albicans is regulated by a number of 
possible cross-talking signal transduction pathways (Ernst, 2000; Felk et al.,
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2002). Efg1 and Cph1 are key transcriptional factors that regulate the yeast- 
to-hypha transition and are therefore considered to be important virulence 
attributes (Felk et al., 2002; Lo et al., 1997). It is also believed that these 
factors, and especially Efg1, regulate the expression of hyphal-associated 
genes, e.g. SAP4-SAP6. The relevance of these genes for Candida 
infections was studied using strains which lacked functional Efg1, Cph1 or 
both factors during interaction of the oral epithelium and polymorphonuclear 
neutrophils (PMNs). These studies confirmed that Efg1 was a key regulator 
for virulence during interaction with human epithelial cells and PMNs by 
regulating dimorphism and by influencing the expression of hyphal- 
dependent and hyphal-independent aspartyl proteinase genes during 
experimental oral infection (Korting et al., 2003).
3.1.2 Reconstituted human epithelium
In the present Chapter, a human in vitro tissue model was used to investigate 
the expression of SAPs, PL and ALS by C. albicans strains. The RHE used 
is a 0.5 cm2 epithelium reconstituted by airlifted culture of transformed human 
keratinocytes derived from a squamous cell carcinoma (SCC) of the buccal 
mucosa (as previously described in Chapter 2). Previous investigations have 
used in vitro models of oral candidosis based on the RHE model. SAP gene 
expression has previously been examined in this commercially available RHE 
to assess the role of the genes in tissue invasion (Schaller et al., 1998). 
These experiments showed temporal expression of SAP genes (SAP1, 
SAP3, SAP6, SAP8, and SAP2) for C. albicans SC5314. Although the 
hydrolytic enzymes in vivo have not been well-defined, possible roles for 
them include the acquisition of nutrients (Hube et al., 1994), promotion of 
adherence (Watts et al., 1998) and degradation of gastric mucosa (Colina et 
al., 1996; Mukherjee et al., 2001). SAPs have also been implicated in both 
the evasion and destruction of host immune system molecules (Hube, 1996).
The RHE model has previously proved to be very effective for the direct 
observation of C. albicans virulence gene expression but nevertheless the 
data has to be interpreted carefully. The model does not wholly represent 
the in vivo situation in human patients. Parameters such as pH changes,
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nutrient limitation, competition with the oral flora, and cell-mediated and 
cytokine responses are likely to have a profound effect on the ability of C. 
albicans to grow unchallenged on the mucosal surface (as in the models) and 
also to provide strong local pressures that may influence the differential 
expression of the SAP gene family (Naglik et al., 2003). However, studies 
have shown that proinflammatory cytokine responses by in vitro epithelial cell 
lines, including RHE infected with Candida, appear to be maintained and 
actually have been shown to vary with C. albicans strains with different 
invasive potential and virulence (Schaller et al., 2002; Villar et al., 2005).
3.2 AIMS
The RHE provides an in vitro model that allows study of the organism in an 
environment closer to that of the in vivo situation than previously used 
approaches. Culture of Candida on the RHE results in a “biofilm”-like 
appearance of growth as evident in Chapter 2 of this thesis and by other 
studies (Schaller et al., 1999; Schaller et al., 1998). The hypothesis of this 
study was that mRNA transcripts of specific virulence genes correlated with 
the type of infection and colonisation profiles of C. albicans in the RHE model 
as described in Chapter 2. To test this hypothesis, the specific aims were:
1. To investigate whether candidal biofilms on the RHE exhibited a different 
profile of virulence gene expression compared with equivalent cultures 
without the RHE.
2. To determine whether the presence of mRNA from the gene families 
correlated with the profile of infection and biofilm formation for the different 
strains.
3. To compare a range of C. albicans strains from different oral conditions, to 
ascertain whether inherent strain differences exist with respect to gene 
expression.
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3.3 Materials and Methods
3.3.1 Preparation of C. albicans for infection of RHE
Candida albicans strains (n=19) were cultured on Sabouraud Dextrose Agar 
(SDA; LAB M, Bury, UK) at 37°C for 24 h. Subcultures were used to 
inoculate 10 ml of Yeast Nitrogen Base (YNB; BD Diagnostics, Cowley, UK) 
medium supplemented with 0.5% glucose (w/v). This medium was then 
incubated for 12 h at 37°C. Yeast cells were harvested by centrifugation and 
washed (*3) with phosphate buffered saline (PBS). The resulting yeast cells 
were enumerated using a haemocytometer and a total of 4x107 yeast cells in 
maintenance medium were added to a microtitre plate well containing RHE in 
a CO2 humidified atmosphere and incubated at 37°C for 24 h. The 
preparation of RHE for use in these experiments was as previously described 
in Chapter 2 (sections 2.3.2.1; 2.3.2.3 and 2.3.2.4).
3.3.2. Preparation of C. albicans for control gene expression 
comparison (without RHE)
In addition to C. albicans infecting the RHE, gene expression was also 
assessed for strains of C. albicans cultured in the tissue maintenance 
medium under an identical culture environment, but in the absence of the 
RHE tissue.
3.3.3 RNA extraction protocols for C. albicans
Two basic approaches were initially evaluated for RNA extraction from C. 
albicans. These were the use of Ultraspec (Biotecx Laboratories, Texas, 
USA) reagent and also the use of the RNeasy mini kit (Qiagen, West Sussex, 
UK) with physical disruption using a bead-beater. To assess these RNA 
extraction protocols a standardised preparation of C. albicans was prepared 
that would induce mRNA expression of SAP, PL and ALS genes. Briefly, 
these cells were prepared as follows.
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All C. albicans isolates (n=19) were cultured on Sabouraud Dextrose Agar 
(SDA) at 37°C overnight, then subcultured into yeast extract peptone 
dextrose (YEPD) broth (1% w/v yeast extract, Oxoid; 2% w/v peptone, Oxoid; 
2% w/v dextrose) at 37°C for 24 h. A 200-pl volume of the suspension was 
inoculated into 5 ml of yeast carbon base-bovine serum albumin (YCB -  
BSA) medium (1.17% w/v yeast carbon base; Becton Dickinson, Oxford, UK; 
1% w/v glucose; 0.5% w/v bovine serum albumin; Sigma, Poole, UK; pH 5.6). 
Cultures were incubated at 37°C for 24 h.
For all RNA extraction protocols diethyl-pyrocarbonate (DEPC) treated water 
was used which was prepared by treating 1 L of distilled H2O, with 2 ml of 
DEPC and incubating overnight at 37°C. After incubation the DEPC H20  
was autoclaved at 126°C for 30 min, to remove the DEPC.
3.3.3.1 Ultraspec RNA extraction
A 1.5-ml volume from the overnight YCB-BSA culture was centrifuged, the 
broth was removed and 1 ml of Ultraspec (Biotecx Laboratories Inc., 
Houston, USA) and 1.5-ml volume of sterile glass beads (0.5 mm diameter; 
Sigma, UK) were added and vortexed for 30 min at 4°C. The supernatant 
was transferred to a fresh 1.5 ml Eppendorf tube containing chloroform (200 
pi) and the mixture was shaken vigorously. The preparation was placed on 
ice for 5 min, centrifuged at 12,000 g for 3 min and the RNA (top aqueous 
layer) was removed into a fresh Eppendorf tube. An equal volume of 
isopropanol (Sigma, UK) was added and the preparation centrifuged at 
12,000 g for 10 min. The supernatant was decanted and the RNA pellet was 
washed twice with 75 % ethanol and air-dried in an incubator. The RNA 
pellet was suspended in 30 pi of DEPC treated water.
3.3.3.2 RNeasy RNA extraction
For this protocol, sterile glass beads were initially placed in a small bottle to 
which 100 ml DEPC H20  was added and incubated overnight at 37°C. After 
incubation, the water was removed and the beads dried in an oven at 150°C.
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Subsequently RLT extraction medium (Qiagen, Crawley, UK) and prepared 
glass beads (approx. 500 pi) were added to the prepared C. albicans and 
the mix was homogenised twice for 30 s using a Mini-Bead Beater-8 (Stratech 
Scientific Ltd., Soham, UK; Fig. 3.2). After cell disruption, the RNeasy Mini 
Kit (Qiagen) was used to complete total RNA extraction according to the 
manufacturers’ recommended protocol.
3.3.4 Processing of infected RHE tissue for RNA extraction
After 24 h infection the RHE for RT-PCR was stored in a 2 ml microtube with 
RNAIater® (Ambion Europe Ltd, Huntington, UK) solution before RNA 
extraction and was maintained at -80 °C, until required. RNA extraction was 
then undertaken using one of the two protocols outlined above.
3.3.5 cDNA synthesis from extracted RNA
Potential DNA contamination was first removed from samples using RNase- 
free DNase I treatment following the manufacturer’s instructions (Qiagen). 
cDNA synthesis involved the use of an oligo dT primer (250 ng, 5 pi per 
reaction; Promega, Southampton, UK), with Moloney Murine Leukemia Virus- 
Reverse Transcriptase (400 U, 2 pi per reaction; MMLV-RT, Promega). After 
incubation at 42°C for 1 h, the cDNA-RNA hybrid was denatured at 95°C for 
5 min.
3.3.6 PCR on cDNA samples
PCR targeted a number of virulence gene families including secreted aspartyl 
proteinase (SAPs), phospholipases (PLs), and agglutinin-like sequence 
(ALS) genes. For each gene a specific primer pair was used to yield an 
amplicon of distinct size (Table 3.1a-c). The reaction conditions (Table 3.2) 
were as previously described for SAPs (Monod et al., 1998; Monod et al., 
1994), PLs (Niewerth and Korting, 2001; Sugiyama et al., 1999), and ALS 
genes (Green et al., 2004). Control S14 (Cairns et al., 1997) primers were 
also used to detect human rRNA and additional primers were employed for 
the amplification of the candidal elongation factor 1(3 (EFB1) RNA (Schofield 
et al., 2003). The S14 control was used to confirm RNA recovery from the
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tissue, whilst EFB1 provided an ideal control gene for candidal RT-PCR as it 
is believed to be universally expressed by all forms of C. albicans (Schofield
et al., 2003).
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Fig. 3.2 Mini-BeadBeater-8 (Stratech Scientific Ltd.)
117
Table 3.1a Primers used to amplify hydrolytic enzyme (SAPs, PLs and ALS)
gene sequences.
Primer Sequence (5’-3’) 
Forward/Reverse
Target Expected 
product size (bp)
SAP1a F 
SAP 1a R
ATG CCT TCC AAG CTG AAT TG 
CGT AGC TCA ACG GAG CAG TA
Secreted aspartyl 
proteinases gene 1
150
SAP1b F 
SAP1b R
GAC AAA TCA TTT TCG GTG GG 
GCA GCA ATG TTT GAA GCA GA
Secreted aspartyl 
proteinases gene 1
527
SAP2a F 
SAP2a R
CAA TGA AGC CGG TGG TAG TT 
CAT TAT CAA CCC CAC CGA AA
Secreted aspartyl 
proteinases gene 2
140
SAP2b F 
SAP2b R
CAA TGA AGC CGG TGG TAG TT 
AAA GAA GCA GCA AAT TCG GA
Secreted aspartyl 
proteinases gene 2
459
SAP3a F 
SAP3aR
CAA GGT GTT GCT GAT CAA 
GTG
TCA GAA GCT GGA ACG GAA AT
Secreted aspartyl 
proteinases gene 3
152
SAP3bF 
SAP3bR
TGT GAG AAC CTC CTT CCC AG 
TCT CTT GAC GTT GAC GTT GG
Secreted aspartyl 
proteinases gene 3
365
SAP4F 
SAP4 R
AAT GAT GTG GGC AAA AGA GG 
ACA CCA CCA ATA CCA ACG GT
Secreted aspartyl 
proteinases gene 4
329
SAP5F
SAP5R
ATT AAT TGA TGC GGC TCC AG 
ACA CCA CCA ATA CCA ACG GT
Secreted aspartyl 
proteinases gene 5
498
SAP6F
SAP6R
TCC AAA CCA ACG AAG CTA CC 
GCA GGA ACG GAG ATC TTG AG
Secreted aspartyl 
proteinases gene 6
445
SAP7 F 
SAP7R
AGT GCA CAT TTC CCT AAC GC 
GAG CCA GGA GCA GTT GAT TC
Secreted aspartyl 
proteinases gene 7
434
SAP8F
SAP8R
TTT GAC CGC ATT ACC AAT CA 
CAG CAG CCA ATT TAT CAG CA
Secreted aspartyl 
proteinases gene 8
161
SAP9F
SAP9R
CCA TAG AAA CCG ACG AGG AA 
CAC CAG AAC CAC CCT CAG TT
Secreted aspartyl 
proteinases gene 9
153
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Table 3.1b Primers used to amplify hydrolytic enzyme (PLs & controls) gene
sequences.
Primer Sequence (5’-3’) 
Forward/Reverse
Target Expected
product
size
(bp)
PLB1 F 
PLB1 R
CAA CGA AGC GGT GTT GTC TA 
TTG CTG CCA GAA CTT TTG AA
Phospholipase 
gene B1
150
PLB2F
PLB2R
GGC CAG ATG GAT CAG CTT TA 
AAG TTC TGG GCA TCA CAT CC
Phospholipase 
gene B2
154
PLCF
PLCR
GGT TCA ATT CGG CTG GTG AT 
TTG TTC ACC GGA ATG TCA AA
Phospholipase 
gene C
150
PLDF
PLDR
GAC AAA GCA GCG CCT AAA TC 
CCC TTT TCC TGG TTT TGG AT
Phospholipase 
gene D
148
EFB1 F 
EFB1 R
GAA CGA ATT CTT GGC TGA C 
CAT CAG AAC CGA ACA AGT C
C. albicans 
elongation factor
1P
242
S14F
S14R
CAG GTC CAG GGG TCT TGG TCC 
GGC AGA CCG AGA TGA ATC CTC A
Human control 
ribosomal RNA
143
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Table 3.1c Primers used to amplify hydrolytic enzyme (ALS) gene
sequences.
Primer Sequence (5’-3’) 
Forward/Reverse
Target Expected
product
size
(bp)
ALS1 F GAC TAG TGA ACC AAC AAA TAC CAG A Agglutinin-like 318
ALS1 R CCA GAA GAA ACA GCA GGT GA sequence gene 1
ALS2F CCA AGT ATT AAC AAA GTT TCA ATC Agglutinin-like 366
ALS2R ACT TATTCT CAA TCT TAA ATT GAA CGG CTT AC sequence gene 2
ALS3F CCA CTT CAC AAT CCC CAT C Agglutinin-like 342
ALS3R CAG CAG TAG TAA CAG TAG TAG TTT CATC sequence gene 3
ALS4F CCC AGT CTT TCA CAA GCA GTA AAT Agglutinin-like 356
ALS4R GTA AAT GAG TCA TCA ACA GAA GCC sequence gene 4
ALS5F TGA CTA CTT CCA GAT TTA TGC CGA G Agglutinin-like 318
ALS5R ATT GAT ACT GGT TAT TAT CTG AGG GAG AAA sequence gene 5
ALS6F GAC TCC ACA ATC ATC TAG TAG CTT Agglutinin-like 152
ALS6R GGTTTCAA TTG TCA CAT CAT CTT TTG TTG C sequence gene 6
ALS7F GAA GAG AAC TAG CGT TTG GTC TAG Agglutinin-like 206
ALS7R TTG TTGG CAT ACT CCA ATC ATT TAT TTC A sequence gene 7
ALS9F CCA TAT TCA GAA ACA AAG GGT TC Agglutinin-like 198
ALS9R AAC TGA AAC TGC TGG ATT TGG sequence gene 9
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Table 3.2 RT-PCR conditions used for the gene targets.
SAPs, PLB1, 
PLD, S14, EFB1
SAP3, PLB2, 
PLC
ALS
Denaturing step 95°C (5 min) 95°C (5 min) 95°C (5 min)
Cycles 40 40 40
Denaturing
temp.
94°C (1 min) 94°C (1 min) 94°C (30 s)
Annealing temp. 55°C (1 min) 48°C (1 min) 58°C (30 s)
Extension temp. 72°C (1 min) 72°C (1 min) 72°C (30 s)
Final extension 72°C (10 min) 72°C (10 min) 72°C (7 min)
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Controls for each reaction included tissue extracts not treated with reverse 
transcriptase (to establish that genomic DNA amplification was not occurring) 
and a water template control.
3.3.7 Gel electrophoresis of PCR products
PCR products (10 pi) were visualised following standard gel electrophoresis 
in a 0.75 % agarose gel (Sigma, UK) with ethidium bromide staining (10 pg 
pi'1). Gel images were obtained using a Gel-Doc 2000 (Bio-Rad, Hemel- 
Hempstead, UK) and the average band densities for each PCR product were 
measured using the Discovery Series™ Quantity One® (Bio-Rad) software. 
Estimation of semi-quantitative values involved defining lanes and bands on 
the gel image following the Quantity One user guide. After defining lanes, a 
lane-based background subtraction was performed with bands identified 
using the Detect Bands command and then the values of a standard (a 
quantitative MassRuler DNA Ladder; low range, Fermentas, York, UK) being 
entered. The values of the experimental bands were then determined using 
this standard. The DNA concentration of each PCR product was then 
expressed as a percentage relative to that of the matched housekeeping 
gene (EFB1) amplified for each strain.
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3.4 Results
3.4.1 RNA extraction-comparison of the methods
It was not possible to extract RNA from C. albicans using the ultraspec 
method. For this study RNA extraction was most consistently obtained using 
physical cell disruption and the RNeasy mini kit method (section 3.3.3). 
Subsequent results are therefore based on the latter RNA extraction protocol.
3.4.2 Control gene expression
For all RT-PCRs, control gene expression was routinely detected by EFB1 
and S14 primers (Fig. 3.3 - 3.4).
3.4.2.1 SAP gene expression by C. albicans cultures without RHE 
(maintenance medium alone)
Sixteen out of 19 strains expressed SAP1-3. The non-invasive strains 
(WK1/93; 40/01) did not express SAP1-3. SAP4-6 was expressed by 10 out 
of 19 strains. The non-invasive strains (WK1/93; 40/01) did not express 
SAP4-6. None of the tested strains expressed SAP7. SAP8 was expressed 
by all strains except non invading strain WK1/93. SAP9 was expressed by 7 
strains out of 19 (Table 3.3).
3.4.2.2 PLs gene expression by C. albicans cultures without RHE 
(maintenance medium alone)
PLs gene expression (Table 3.3) appeared to be more frequently detected in 
Candida isolates without the RHE. Six strains out of 19 strains expressed 
PLB1, PLB2 and PLD, whilst 6 expressed PLC. The non-invasive strains 
(WK1/93 and 40/01) did not express PLB2 and PLC. When cultured without 
the RHE, 44 PL amplicons were evident (with multiple genes expressed by 
individual strains).
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Fig. 3.3 Agarose gel showing typical R T-PC R  products of EFB1 Candida 
control gene expressed during RHE infection.
Lanes: M, low range MassRuler DNA ladder (Fermentas, UK); RHE infected 
with C. albicans strains: 1, DW 1/93; 2, PB1/93; 3, W K1/93; 4, LR1/93; 5,
H20 ;  6, pure RNA; 7, 289T/00; 8, 480/00, 9, 819/99; 10, 970/00; 11, 40/01;
12, 705/93, 13, 458R/94; 14, 324LA/94.
EFB1  
(242 bp)
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Fig. 3.4 Agarose gel showing typical R T-PC R  products of S14 human control 
gene expressed during RHE infection.
Lanes: M, 100-bp ladder; RHE infected with C. albicans strains: 1, 
135BM 2/94; 2, 819/99; 3, 970/00; 4, 40/01; 5, 848/99; 6, 458R /94; 7, 
324LA/94; 8 ,1 1 90 /9 7 ; 9, H20 .
.S14 
(143 bp)
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3.4.2.3 ALS gene expression by C. albicans cultures without RHE 
(maintenance medium alone)
RT-PCR revealed a wide range of ALS gene expression (Table 3.3) for the 
19 C. albicans strains without the RHE. Seventeen strains expressed ALS1 
and ALS3. Sixteen strains expressed ALS4 and eleven strains ALS2. There 
was no expression detected for ALS5, whilst ALS6, ALS7 and ALS9 were 
rarely encountered. It was apparent that when compared with gene 
expression in the RHE medium (section 3.4.3), a large number of differences 
in ALS gene expression were encountered. These included 36 instances of 
no ALS gene expression and 11 cases of ALS gene expression without the 
RHE, mostly ALS4, ALS6, ALS7 and ALS9. Detection of these genes was 
mostly attributable in three strains PTR/94, 243/00 and 408/99 which did not 
correlate to their respective invasiveness (Chapter 2).
3.4.3 Gene expression within the RHE model
3.4.3.1 SAP gene expression within the RHE model
RT-PCR analysis (Table 3.4; Fig. 3.5 - 3.6) revealed a wide range of SAP 
gene expression for the 19 C. albicans strains tested in the RHE infected 
model. SAP1-3, SAP4-6 and SAP8 transcripts were frequently detected, 
whilst SAP7 (3 out of 19) was rarely encountered. SAP1-3 and SAP8 were 
produced by 18 out of 19 strains in the presence of RHE. However, a less 
consistent expression of SAP4-6 (13 out of 19) and SAP9 (6 out of 19) 
occurred. Expression of SAP4-6 with all high invading strains was evident. 
These genes were not however expressed by the two non-invasive strains 
(WK1/93 and 40/01).
3.4.3.2 PL gene expression within RHE model
Phospholipase gene expression in the RHE model (Table 3.4; Fig. 3.7) did 
not appear to readily correlate with the level of RHE invasion and was 
detected in 11 out of the 19 strains tested in the infection model. When 
cultured in the presence of RHE, 23 PL amplicons were evident (multiple 
genes expressed by individual strains).
126
Table 3.3 Putative virulence gene expression (SAP, PLs, ALS) for C. albicans cultured in tissue maintenance medium alone.
SAP genes 1-9 Phospholipase genes (B-D) Agglutinin-like sequence genes (ALS1-9)
Candida strain 1-3 4-6 7 8 9 B1 B2 c D ALS1 ALS2 ALS3 ALS4 ALS5 ALS6 ALS7 ALS9
135BM2/94a l 1 1 + l 1 - B + + + + - 1 + 1
970/00a + + - + - + + 1 1 + + + + - 1 + +
PTR/94a + + - + - - 1 1 - + 1 + 1 - - 1 -
324LA/94a + + - + - + 1 - 1 - 1 + - - - - -
1190/97a + + - + I - - 1 1 + + + + - 1 1 I
705/936 + + - + I + 1 1 + + + + + - 1 + 1
DW1/93b - 1 - + 1 i 1 - ■ + + + + - 1 l 1
PB1/936 + + - 1 + + + + + + 1 + + - - l 1
243/006 + + - + + + 1 1 ■ + + + 1 - 1 I 1
455rgh/94b + + - + 1 + + - i + + + + - - - -
LR1/936 + 1 - + - + + + + + i + + - - I I
289T/006 + 1 1 + - i - - - + i + + 1 - l l
480/00b + 1 - + - - 1 - - + i + + l - + l
819/99b + - - + 1 1 1 - 1 + i 1 - - - 1 -
408/99b + + - + 1 1 1 1 - + + + 1 - - 1 1
848/99b + - - + 1 + 1 - - + + + + - - 1 -
458R/94b i - - + - i 1 - - + + + + - - + -
WK1/93C I - 1 1 - i - - - + I 1 1 - I + -
40/01° i - - + 1 i - - 1 1 i + + 1 - + 1
+ Detected; - not detected; aHighly invasive strain; bLow invading strain; cNon-invasive strain; for all RT-PCRs control gene expression was routinely detected. 
Values highlighted in M l show where differences in gene expression occurred compared to strains grown in the RHE model (Table 3.4).
Table 3.4 Putative virulence gene expression (SAP, PLs, ALS) for C. albicans cultured during RHE infection.
SAP genes 1-9 Phospholipase genes (B-D) Agglutinin-like sequence genes (ALS1-9)
Candida strain 1-3 4-6 7 8 9 B1 B2 c D ALS1 ALS2 ALS3 ALS4 ALS5 ALS6 ALS7 ALS9
135BM2/943 i 1 1 + 1 1 - - 1 + + + + - 1 + 1
970/003 + + - + - + + 1 1 + + + + - 1 + +
PTR/943 + + - + - - 1 1 - + i + 1 - - 1 -
324LA/943 + + - + - + 1 - 1 - i + - - - - -
1190/973 + + - + 1 - - 1 1 + + + + - 1 1 1
705/93b + + - + 1 + 1 1 + + + + + - 1 + 1
DW1/93b - 1 - + 1 i 1 - 1 + + + + - 1 1 1
PB1/93b + + - I + + + + + + i + + - - 1 1
243/00b + + - + + + 1 1 1 + + + l - 1 1 1
455rgh/94b + + - + 1 + + - 1 + + + + - - - -
LR1/93b + 1 - + - + + + + + 1 + + - - 1 1
289T/006 + 1 i + - i - - - + 1 + + I - 1 1
480/00b + 1 - + - - 1 - - + 1 + + i - + 1
819/99b + - - + 1 1 1 - I + 1 1 + - - 1 -
408/99b + + - + 1 1 1 1 - + + + l - - 1 I
848/99b + - - + 1 + 1 - - + + + + - - 1 -
458R/946 i - - + - I 1 - - + + + + - - + -
WK1/930 i - i i - i - - - + 1 i l - I + -
40/01° i - - + I I - - 1 1 1 + + 1 - + i
Detected; - not detected; aHighly invasive strain; bLow invading strain; cNon-invasive strain; for all RT-PCRs control gene expression was routinely detected. Values 
highlighted in show where differences in gene expression occurred compared to the same strains cultured in maintenance medium (Table 3.3).
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(140 bp)
Fig. 3.5 Agarose gels showing typical RT-PCR products of candidal 
virulence genes (SAP1 and SAP2) expressed during RHE infection.
Lanes M, low range MassRuler DNA ladder; RHE infected with C. albicans 
strains: 1, PB1/93; 2, LR1/93; 3, 408/99; 4, 819/99; 5, 970/00; 6, 243/00; 7, 
PTR/94; 8, 705/93; 9, 848/99; 10, 324LA/94; 11, 455rgh/94; 12, 1190/97; 13, 
H20; 14, PB1/93; 15, 408/99.
For each strain, band density was expressed as a percentage relative to that 
of the matched EFB1 amplicon (Fig. 3.3).
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SAP5 *" ■*
(498 bp) (445 bp)
Fig. 3.6 Agarose gels showing typical RT-PCR products of candidal 
virulence genes (SAP5, and SAP6) expressed during RHE infection.
Lanes M, low range MassRuler DNA ladder; RHE infected with C. albicans 
strains: 1, DW1/93; 2, LR1/93; 3, 408/99; 4, 243/00; 5, PTR/94; 6, 455rgh/94; 
7, 1190/97; 8, H20; 9, DW1/93; 10, PB1/93; 11, LR1/93; 12, 408/99; 13, 
243/00; 14, 705/93; 15, 455rgh/94.
For each strain, band density was expressed as a percentage relative to that 
of the matched EFB1 amplicon (Fig. 3.3).
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Fig. 3.7 Agarose gels showing typical RT-PCR products of candidal 
virulence genes (PLB2, and PLC) expressed during RHE infection.
Lanes M, low range MassRuler DNA ladder; RHE infected with C. albicans 
strains: 1, DW1/93; 2, PB1/93; 3, LR1/93; 4, 408/99; 5, 970/00; 6, 324LA/94; 
7, 455rgh/94; 8, H20; 9, PB1/93; 10, LR1/93; 11, H20.
For each strain, band density was expressed as a percentage relative to that 
of the matched EFB1 amplicon (Fig. 3.3).
M 1 2 3  4 5 6 7  8 9  10 11
PLB2 PLC
(154 bp) (150 bp)
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3.4.3.3 ALS gene expression within the RHE model
As seen with PL genes expression, associations between ALS gene 
expression in the RHE model (Table 3.4; Fig. 3.8-3.10) and invasion showed 
that four ALS genes (ALS1, ALS2, ALS3 and ALS4) were detected in 14 of 
the 19 infected RHE samples. Detection of ALS5 (and to a certain extent 
ALS6) was however noticeably lower in infected RHE compared with other 
members of the gene family.
3.4.4 Semi-quantitative comparisons of gene expression using RT-PCR
Semi-quantitative analysis of (Tables 3.5a and b) gene expression using RT- 
PCR indicated varying quantities of mRNA for the expressing strains, 
although these differences could not be related to the previously reported 
(Chapter 2) levels of Candida invasion within the model.
Between the two growth phases (in the presence of RHE - biofilm state and 
without the RHE) there seemed to be a greater incidence of up-regulation of 
PLs gene expression without the RHE, whilst the converse was evident for 
SAPs and ALS gene expression in the biofilm phase. There also appeared 
to be up-regulation of ALS gene expression in high invading strains and more 
down regulation of ALS in low invading and non-invading strains in the 
absence of the RHE.
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M 1 2 3 4 5 6 7 8 9 10 11 12 13 14 15
ALS6 
(152 bp)
ALS7 
(206 bp)
Fig. 3.8 Agarose gels showing typical RT-PCR products of candidal 
virulence genes (ALS6, and ALS7) expressed during RHE infection.
Lanes M, low range MassRuler DNA ladder; RHE infected with C. albicans 
strains: 1, DW1/93; 2, PB1/93; 3, 135BM2/94; 4, 970/00; 5, 705/93; 6, 
1190/97; 7, H20; 8, DW1/93; 9, PB1/93; 10, 135BM2/94; 11, 970/00; 12, 
705/93; 13, 1190/97; 14, H20; 15, low range MassRuler DNA ladder.
For each strain, band density was expressed as a percentage relative to that 
of the matched EFB1 amplicon (Fig. 3.3).
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M 1 2 3 4 5 6 7 8 9 10 11 12 13 14 15
ALS1 
(342 bp)
ALS2 
(366 bp)
Fig. 3.9 Agarose gels showing typical RT-PCR products of candidal 
virulence genes (ALS1, and ALS2) expressed during RHE infection.
Lanes M, low range MassRuler DNA ladder; RHE infected with C. albicans 
strains: 1, 458R/94; 2, 324LA/94; 3, 455rgh/94; 4, 1190/97; 5, H20; 6, 
DW1/93; 7, PB1/93; 8, WK1/93; 9, LR1/93; 10, 408/99; 11, 135BM2/94; 12, 
289T/00; 13, 480/00; 14, 819/99; 15, 970/00.
For each strain, band density was expressed as a percentage relative to that 
of the matched EFB1 amplicon (Fig. 3.3).
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Fig. 3.10 Agarose gels showing typical RT-PCR products of candidal 
virulence genes (ALS1) expressed during RHE infection.
Lanes M, low range MassRuler DNA ladder; RHE infected with C. albicans 
strains: 1, DW1/93; 2, PB1/93; 3, WK1/93; 4, LR1/93; 5, 408/99; 6, 
135BM2/94; 7, 289T/00; 8, 480/00; 9, 819/99; 10, 970/00; 11, 40/01; 12, 
243/00; 13, PTR/94; 14, 705/93; 15, 848/99.
For each strain, band density was expressed as a percentage relative to that 
of the matched EFB1 amplicon (Fig. 3.3).
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Table 3.5a Detection of gene families associated with pathogenesis during planktonic culture using RT-PCR.
Secreted aspartyl proteinase (SAPI-9) Phospholipase genes (B-D) Agglutinin- like sequence genes (ALS1-7, ALS9)
Candida albicans 1-3 4-6 7 8 9 B1 B2 C D 1 2 3 4 5 6 7 9
135BM2/94* 0 19 0 80 ■ 48 0 0 48 87 88 ■ 107 0 0 ■ 0
970/00a 351 m 0 m 0 150 44 26 27 192 148 328 230 0 0 422 264
PTR/94* m 243 0 57 0 0 48 80 0 m 0 406 178 0 0 16 0
324LA/94* 162 m 0 96 0 154 m 0 0 0 0 60 0 0 0 0 0
1190/97* 542 u 0 85 0 0 0 0 0 664 136 467 312 0 0 0 0
705/93* 842 348 0 504 0 245 88 605 85 480 178 1040 137 0 0 120 0
DW1/93* 188 0 0 5 0 32 0 0 68 ■ ez 388 75 0 0 0 422
PB1/93* iW 414 0 m m 282 tie 378 387 878 0 926 359 0 0 0 0
243/00* 143 84 0 102 49 85 38 84 27 67 72 105 m 0 56 29 125
455rgh/94* 828 320 0 8 278 m 82 0 0 176 89 363 164 0 0 0 0
LR1/93* 81 27 0 66 0 m m 24 ■ 56 0 111 14 0 0 0 0
289T/00* m 58 0 20 0 0 0 0 0 23 0 69 24 0 0 0 0
480/00* 56 0 0 2 0 0 0 0 0 m 113 199 172 0 0 ■ 0
819/99* 67 55 0 96 36 76 30 0 38 30 0 0 0 0 0 0 0
408/99* m m 0 m 0 25 0 ■ 0 68 60 125 87 0 0 M 0
848/99* ■ 0 0 180 m 76 59 0 0 m 103 265 45 0 0 30 0
458R/94* 0 21 0 42 0 1 » 0 0 91 101 145 182 0 0 38 0
WK1/930 0 0 0 0 0 8 0 0 0 9 0 0 0 0 0 0 0
40/01c 56 49 0 91 ■ 25 0 0 8 0 0 52 0 0 0 0 0
For all RT-PCRs control gene expression was routinely detected. The numbers represent the relative quantity (as a percentage) of PCR amplicon compared with the 
housekeeping gene product (EFB1). aHighly invasive. *Low invading strain. cNon-invasive. Percentages highlighted in |>in| show where up-regulation in gene 
expression occurred compared to the RHE model. Percentages highlighted in yellow show where down regulation in gene expression occurred compared to the RHE 
model.
Table 3.5b Detection of gene families associated with pathogenesis during RHE infection using RT-PCR.
Secreted aspartyl proteinase (SAP1-9) Phospholipase genes (B-D) Agglutinin like sequence genes (ALS1-7, ALS9)
Candida albicans 1-3 4-6 7 8 9 B1 B2 c D 1 2 3 4 5 6 7 9
135BM2/94aF m 180 m 1 0 0 0 0 0 53 17 95 ■ 0 m 121 32
970/00a 249 28 0 92 0 30 20 0 0 246 126 311 m 0 m 192 561
PTR/94a 34 108 0 57 0 0 0 0 0 60 n 143 0 0 0 0 0
324LA/943 433 1384 0 m 0 122 70 0 ■ 0 22 m 0 0 0 0 0
1190/973 163 211 0 m 589 0 0 0 0 108 21 196 172 0 38 205 219
705/93* 279 104 0 144 188 319 0 0 66 237 209 616 820 0 148 293 267
DW1/93* 0 m 0 82 ■ 0 1 0 0 54 40 85 125 0 53 m 56
PB1/93* 109 82 0 0 43 96 21 85 53 111 192 203 293 0 0 m 242
243/00* m m 0 207 1010 310 0 0 0 388 462 680 0 0 0 0 0
455rgh/94* 31 56 0 29 0 1 15 0 1 62 3 46 7 0 0 0 0
LR1/93* 236 788 0 340 0 61 210 18 35 254 132 403 832 0 0 263 m
289T/00* 23 22 ■ 19 0 8 0 0 0 60 00 m m 20 0 60 m
480/00* m m 0 « 0 0 0 0 0 116 1 156 282 57 0 43 64
819/99* M 0 0 96 0 0 0 0 0 240 m 325 630 0 0 249 0
408/99* 60 112 0 11 80 0 48 0 0 41 74 13 0 0 0 0 0
848/99* 127 0 0 181 0 ■ 0 0 0 27 77 336 631 0 0 0 0
458R/94* 216 0 0 m 0 0 0 0 0 687 387 028 595 0 0 377 0
WK1/93C 69 0 38 ■ 0 0 0 0 0 m 1 V® 26 0 ■ 1 0
40/01c 580 0 0 m 0 0 0 0 0 m 82 113 m 30 0 ■ ■
For all RT-PCRs control gene expression was routinely detected. The numbers represent the relative quantity (as a percentage) of PCR amplicon compared with the 
housekeeping gene product (EFB1). aHighly invasive. *Low invading strain. cNon-invasive. Percentages highlighted in |)in | show where up-regulation in gene 
expression occurred compared to the RHE model. Percentages highlighted in yellow show where down regulation in gene expression occurred compared to the RHE 
model.
3.5 Discussion
Compared to bacteria, there has been little work looking at C. albicans gene 
expression, or, indeed, at gene expression in fungal biofilms generally 
(Douglas, 2003). However, it has been shown that Candida albicans 
expresses several virulence factors that contribute to pathogenesis 
(Calderone and Fonzi, 2001). Genes associated with virulence factors 
include those linked with adhesion to the host tissue (e.g. ALS genes), 
morphogenesis, and hydrolytic enzymes, such as SAPs, and PLs (Jayatilake 
et al., 2005; Schaller et al., 2005). The main role of the hydrolytic enzymes is 
to provide nutrition for the cells, to aid penetration and invasion and to evade 
immune responses (Naglik et al., 2003) by degrading cellular substrates.
In various Candida infections, these gene families may be differentially 
regulated and prevention and control of expression might be achieved by 
pharmacological or immunological tools specifically designed to modulate or 
inhibit these virulence factors (Schaller et al., 2005). This present Chapter 
compared the expression of specific candidal virulence factors in an in vitro 
RHE model and, as a control, devoid of tissue.
It was apparent in this study that those strains previously categorised as ‘high 
invaders’ (Chapter 2) consistently expressed SAPs4-6 despite the level of 
expression being strain variable. It is important to note that 4 “high invading” 
strains (135BM2/94, PTR/94, 324LA/94, 1190/97) and 4 “low-invading” 
(705/93, 455rhg/94, 848/99 and 458R/94) that originated from CHC infections 
all expressed SAPs1-3, and six of them expressed SAPs4-6 (135BM2/94, 
PTR/94, 324LA/94, 1190/97, 705/93 and 455rhg/94). These findings may 
suggest that SAPs play a role in oral Candida infections, such as CHC. 
However, some of the “low invaders” also expressed SAP1-3 and SAP4-6 
which may suggest that host factors, including tobacco smoking, denture 
wearing and regular alcohol intake, also play an important role in the 
development of CHC (Bartie et al., 2004). Furthermore, SAP genes 4-6 were 
not detected for the two non-invading strains (WK1/93 and 40/01). SAP 
genes 4-6 are believed to be important in controlling the yeast to hyphal
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transition (Naglik et al., 2003) and so an indirect role for these enzymes in 
tissue invasion can readily be envisaged. These results might be considered 
to contrast with those of Korting et al (2003), who used efg1/cph1 mutants of 
C. albicans SC5314 (which are known to exhibit reduced expression of the 
hyphal-associated genes SAP4-SAP6) to demonstrate that SAP1 and SAP3 
were important causes of epithelial cell damage in the same RHE model. In 
those studies, epithelial cell injury was determined by lactate dehydrogenase 
(LD) release and this correlated with the presence of SAP1 and SAP3 
transcripts (Korting et al., 2003). Unfortunately, the model of RHE invasion 
used in this study did not incorporate the LDH release assay, and so any 
associations between SAP expression, invasion and tissue damage could not 
be confirmed. Since SAP1-3 transcripts were detected in the majority of 
strains, it may be the case that tissue damage was still occurring, even for 
strains where limited RHE invasion was detected. In addition, gene 
expression was also assessed for C. albicans strains cultured in the tissue 
maintenance medium in an identical culture environment but in absence of 
the RHE tissue. A comparison of gene expression revealed a largely 
consistent expression of SAPs between the two growth environments. 
However, there were some notable differences, with an up-regulation of 
some SAPs evident in the presence of the RHE, which may suggest that 
external factors such as the growth environment play an important role.
A relationship between RHE invasion and agglutinin-like sequence (ALS) 
gene expression was not evident. However, there may have been up- 
regulation of these genes for some C. albicans strains in the presence of the 
RHE; in particularly this was seen with ALS2, ALS6, ALS7 and ALS9. The 
ALS gene family designated ALS1-ALS7 and ALS9 has recently been 
implicated with facilitating candidal adherence to host tissues (Green et al., 
2004; Hoyer, 2001). Garcia-Sanchez et al (2004) also looked at differences 
in ALS gene expression between biofilm and planktonic populations and 
contrary to this present work ALS1 was dramatically over-expressed in all the 
biofilm populations and ALS7 was under-expressed compared to planktonic 
ones. However, those differences could be explained by different culture
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conditions and these investigators were not looking at gene expression in 
conjunction with the RHE model. However, the expression of ALS genes in 
this study, agreed in part, with those reported previously by Green et al. 
(2004), who also used a similar RHE infection model. Green et al. (2004) 
found consistent expression of ALS1, ALS2, ALS3 and ALS4, in contrast to 
the more sporadic detection of ALS6 and ALS7 genes. In this present 
investigation, a lower incidence of ALS5 and ALS6 was found (3/19 and 6/19 
strains respectively). However, only four C. albicans strains were used by 
Green et al. (2004) as opposed to the 19 strains from specifically-defined oral 
infections used in this study, which may account for these apparent 
differences.
Phospholipase expression similarly did not appear to correlate with RHE 
invasion (Table 3.4), as exemplified by the fact that three highly invasive 
strains did not produce mRNA for any PLs, whilst the poorly invasive C. 
albicans PB1/93 and C. albicans LR1/93 were positive for expression of all 
four PL genes. Furthermore, PL gene expression actually seemed to be 
higher in the absence of the RHE which might suggest the possible induction 
of PL genes through a starvation trigger as opposed to contact with tissue. 
Damage of the RHE during infection may negate this ‘starvation’ trigger 
through the release of nutrients for the infecting organism.
Phenotypic differences between biofilm and planktonic organisms are often 
regarded as important pathogenic determinants. These phenotypic changes 
may manifest through differential gene control arising from environmental 
triggers. For example, adherent organisms within a biofilm may express a 
pattern of genes different from that of their planktonic counterparts (Becker et 
al., 2001). It has been demonstrated with Escherichia coli that levels of gene 
expression between biofilm and planktonic populations differ significantly 
(Becker et al., 2001). Understanding gene expression patterns might 
therefore be useful for determining when certain proteins are generated in C. 
albicans and enhance our understanding on the pathogenicity of this 
organism (Green et al., 2004). This study showed that some of the strains
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which are from conditions such as CHC express SAPs 4-6 (important for 
hyphal development). Potentially, screening of clinical isolates for these or 
other expressed virulence genes could maybe indicate the patient’s possible 
risk of CHC and other invasive diseases.
Previous studies have assessed C. albicans biofilm transcriptional profiles to 
identify genes that were involved in the biofilm development process (Yeater 
et al., 2007). Garcia-Sanchez etal. (2004) used microarray transcript profiling 
to investigate a gene expression pattern specific to C. albicans biofilms. 
Genes involved in protein synthesis were over expressed in biofilms as well 
as genes that encoded proteins with secretion signals and adhesion-like 
domains (Garcia-Sanchez et al., 2004). Another study identified genes that 
were differentially expressed during biofilm development using microarray 
analysis (Yeater et al., 2007). Yeater et al. (2007) showed that genes were 
differentially expressed in the biofilm state compared to planktonic cells 
independent of the strain of C. albicans used or the substrate on which the 
biofilm was grown. Candida albicans biofilms expressed changes in gene 
expression by the expression of specific subsets of genes at different 
developmental stages as a result of adjusting to diverse requirements during 
development (Yeater et al., 2007).
A combination of real-time PCR and microarray analysis could be used to 
verify the findings in this present study. It would be also interesting to look at 
C. albicans strains from different body locations and to detect any relevant 
gene expression pattern compared to oral strains. This could give a link to 
pathogenicity of C. albicans strains in general.
3.6 Summary
In summary, this study and previous work on the in vitro RHE model 
illustrated that sufficient material can be obtained for the molecular analysis 
of gene expression (Schaller et al., 1998). Our findings support the 
hypothesis that C. albicans has a number of virulence factors associated with
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its pathogenicity and that tissue infection is a result of the interaction of 
physical, mechanical and enzymatic processes (Jayatilake et al., 2005).
1) The in vitro expression of C. albicans virulence factors was largely 
consistent between the two growth phases (without the RHE and RHE biofilm 
state). Importantly there were some notable differences, e.g. up-regulation of 
certain SAPs and ALS expression in the presence of the tissue, and up- 
regulation of PLs expression without the RHE; implying that the culture 
environment was an important factor in phenotype determination. In the case 
of PLs, a starvation response might be occurring in the presence of 
maintenance medium alone. However, in the case of SAPs, a starvation 
response was not evident. The interaction with the RHE may trigger SAP 
gene expression which could induce hyphae production.
2) It was evident though, that a heterogeneous behaviour with regards to 
gene expression existed for isolates of C. albicans, from a variety of clinical 
origins. All strains associated with CHC expressed SAPs 1-3 (important for 
tissue damage) and some of them expressed SAPs 4-6 (important for 
hyphae development).
3) Some strain types (high invaders) were consistent producers of SAPs 4-6 
and may possibly be equipped to have enhanced adherence and invasion. It 
is appropriate to conclude that isolate-specific differences exist in the 
invasive ability of C. albicans and the expression of certain putative virulence 
genes.
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Chapter 4 
Development of in vitro biofilm 
models for chronic wound
bacteria
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4.1 Introduction
4.1.1 Chronic wounds
Chronic wounds can be defined as wounds that do not heal within the normal 
expected time-frame. These wounds are considered to be a worldwide 
health problem with an estimated incidence of 1% of the world’s population 
suffering from them (James et al., 2007). Chronic wounds are often an 
unrecognised cause of disease and disability of the elderly population despite 
having a great impact on the quality of life of the patients affected (Davies et 
al., 2007). Chronic wounds are also a source of frustration to both physician 
and patient due to requirements for lengthy treatment, a high incidence of 
treatment failure and long periods of patient compliance.
Recently, much attention has been focused on the ability of bacteria within 
chronic wounds to form and exist in a biofilm (James et al., 2007). Moreover, 
the wound environment is capable of supporting, and indeed, favours the 
growth of biofilms, in that such wounds tend to be both moist and warm.
There is evidence to show that bacteria are able to form biofilms within the 
wound environment (Mertz, 2003; Percival and Rogers, 2005). Microscopic 
studies of chronic wound specimens have revealed the presence of densely 
aggregated colonies of bacteria often surrounded by an extracellular matrix 
(James et al., 2007).
It is important to recognise that bacteria in chronic wounds exist within a 
polymicrobial environment. Therefore, treatment regimes need to be 
targeted against all the microorganisms present, not just to individual species 
or genera of bacteria when the wound is critically colonised (Percival and 
Bowler, 2004; Percival et al., 2005) or infected (Hansson et al., 1995). To 
study biofilms effectively, a thorough characterisation of the individual 
bacteria in these wound environments is required.
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4.1.2 Bacterial infection of chronic wounds
All skin wounds are colonised by bacteria. The key factors that determine 
whether skin wounds colonised with bacteria become infected are, as yet, 
still not completely understood (Edwards and Harding, 2004). The definition 
of bacterial infection is the process by which microorganisms bind to tissue, 
multiply and then invade viable tissue and elicit a marked host response 
(Bowler et al., 2001). In patients with chronic wounds, the risk of infection is 
increased due to underlying systemic conditions such as possible receipt of 
steroid therapy, old age and poor vascularisation; all of which reduce immune 
function and hence increase the risk of bacterial invasion (Bowler et al., 
2001; Davies et al., 2001). Actual wound infection is defined as the presence 
of replicating organisms within a wound with subsequent induction of host 
injury (Jones et al., 2004a).
4.1.3 Biofilm formation in chronic wounds
Moist environments such as those found in chronic wounds are optimal for 
the formation of biofilms. In chronic wounds, it is apparent that the biofilm is 
not eradicated through host defence mechanisms nor are they necessarily 
removed following administration of systemic or topical antibiotics.
Serralta et al. (2001) investigated the ability of P. aeruginosa to assemble a 
biofilm in an experimental pig dermal wound model. Their data showed that 
two bacterial populations were present; a population of bacteria adherent to 
the wound that required excessive scrubbing to be removed and a planktonic 
population that was easily removed. Akiyama et al. (2002) also showed that 
S. aureus could produce a glycocalyx on the surface of traumatic wounds in 
mice and this biofilm could be visualised by Confocal Laser Scanning 
Microscopy (CLSM). Davis et al. (2008) used a porcine model to create a 
biofilm associated wound. Partial thickness wounds were inoculated with a 
S. aureus wound isolate and treated with topical antimicrobial agents. They 
showed aggregates of microcolonies of bacteria embedded within and 
attached to the wound bed and increased antimicrobial resistance of these 
biofilm communities was also demonstrated (Davis et al., 2008). Another
145
investigation revealed by microscopic analysis aggregated colonies of 
bacteria in chronic wounds which seemed to be coated with EPS. 
Polymicrobial communities and anaerobic bacteria were also identified by 
denaturing gradient gel electrophoresis (DGGE) (James et al., 2007).
4.1.4 Treatment of chronic wounds
The aetiology of a chronic wound is likely to be multi-factorial. Many of the 
patients who have chronic wounds are elderly, have contemporaneous 
medical problems and other factors such as poor diet, poor vascular supply 
or other systemic factors which play a role in poor wound healing (Hill et al., 
2003; Jones et al., 2004b). The clinical approach to treatment of chronic 
wounds needs to consider all of these factors for the best outcome. It is 
vitally important to establish an accurate diagnosis, as clinically distinct 
wound types (e.g. venous, arterial, pressure) are treated in different ways. 
Typical treatments involve decreasing the infection risk (wide variety of 
dressings are available) and stimulating an acute wound healing response. 
For instance, debridement reduces the bacterial bioburden along with any 
secreted toxins and also clears devitalized tissue, reducing the source of 
nutrients for remaining bacteria (Bowler et al., 2001; McGuckin et al., 2003). 
The formation of new blood vessels (angiogenesis) to supply nutrients and 
oxygen is also essential to allow growth of new tissue (Li et al., 2007). A 
wound presenting with a clinical infection (characterised by erythema, 
bleeding tissue, pain, oedema, and odour) may require both topical 
antimicrobial and systemic antibiotic therapy.
Iodine (polyvinylpyrrolidone iodine complex, PVP1) is a bacteriostatic 
antimicrobial that is commonly used as a topical agent in both the treatment 
and prophylaxis of wound infection (Mertz et al., 1999). Early iodine-based 
products caused allergic responses manifested in the form of pain, irritation 
and skin discolouration. However, the development of iodophores (povidone- 
iodine and cadexomer iodine) post 1949, has yielded safer and less irritating 
formulations, lodophors are iodine-carrying complexes in which iodine is 
solubilised by surface active agents whilst retaining its bactericidal activity
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and losing its undesirable properties (Russell, 2003). Overall observations 
from animal models have indicated a degree of cytotoxicity by iodine (at a 
concentration of approximately 1%) against granulocytes and monocytes 
(Van den Broek et al., 1982), keratinocytes (Lineaweaver et al., 1985) and 
fibroblasts (Lineaweaver et al., 1985). However, no studies have looked at 
the PVP1 levels required to kill bacteria when in the biofilm state.
4.1.5 Analysis of bacterial biofilms
There are different methods available to analyse wound biofilms (Table 4.1). 
In this study, an in vitro microtitre plate assay and the use of the Constant 
Depth Film Fermenter (CDFF) were evaluated (section 4.1.5.1 and section 
4.1.5.2). A simple model of bacterial attachment was used in our preliminary 
studies using a microtitre plate assay. To overcome some recognised 
limitations of the microtitre plate assay, a more established and complex 
laboratory model, the CDFF was also used.
4.1.5.1 Microtitre plate assay system
The microtitre plate assay is one of the most frequently employed in vitro 
methods to measure the biofilm forming ability of bacterial and fungal isolates 
(Kennedy and O'Gara, 2004; Ramage et al., 2005; Ramage et al., 2001). 
This semi-quantitative method for measuring biofilm formation involves 
growing microbial cultures in individual wells of 96-well polystyrene plates 
before fixing the developed biofilm and staining with 1% (w/v) crystal violet 
solution. The extent of biofilm formation can then be measured indirectly by 
the degree of crystal violet staining. It is a simple and sensitive assay, which 
permits the semi-quantification of biofilm formation and a high throughput of 
samples is possible. The major disadvantage of the crystal violet staining is 
that it is an indirect indication of the level of biofilm produced and it is a 
closed batch model (Djordjevic et al., 2002).
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Table. 4.1 Methods of analysing bacterial biofilms.
Indirect methods Reference
Standard plate counts (An and Friedman, 2000; 
Djordjevic et al., 2002)
Sonication (An and Friedman, 2000; 
Djordjevic et al., 2002)
Radiolabelled Bacteria (An and Friedman, 2000; 
Djordjevic et al., 2002)
Enzyme-Linked Immunosorbent Assay 
Direct methods
(An and Friedman, 2000; 
Djordjevic et al., 2002)
Confocal Laser Scanning Microscopy (Costerton et al., 1995, Lawrence
Light and Transmission Electron 
Microscopy
etal., 1991, Wagner et al., 1994)
Scanning Electron Microscopy (Caddy et al., 2003)
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4.1.5.2 Constant Depth Film Fermenter (CDFF)
The CDFF (Chapter 1, Fig. 1.12) allows reproducible biofilms of fixed 
thickness to be grown in vitro. The instrument houses 15 
polytetrafluoroethylene (PTFE) pans located within a rotating carousel in the 
main body of a fermenter. Each PTFE pan contains five recessed PTFE 
plugs. The top stainless steel plate contains ports allowing entry of inoculum, 
sterile medium and gas to the chamber. The sample can be lifted free from 
the turntable under aseptic conditions. Media is pumped into the CDFF via 
the inlet port using a peristaltic pump (30 ml min'1 flow rate). The PTFE 
scraper blade situated above the rotating turntable distributes the media over 
the surface of the PTFE discs and also controls the depth of the biofilm by 
constantly shaving the uppermost layer. The bottom stainless steel plate 
contains a port for effluent drainage and has a site for the attachment of the 
motor to drive the turntable.
The CDFF has previously been used to model biofilms of bacteria from non­
wound environments e.g. oral and waste water biofilms (Allan et al., 2002, 
McBain et al., 2003, Wilson, 1999) and has also been used for testing 
antimicrobials such as chlorhexidine, sodium hypochlorite, tetracycline and 
silver on biofilm growth (Deng et al., 2004; Mulligan et al., 2003; Norwood 
and Gilmour, 2000; Ready et al., 2002b). The CDFF has also been used to 
study aspects of biofilm physiology such as transport, structure and stability, 
bacterial immigration and emigration, cell viability and viability mapping, and 
gene transfer (Al-Bakri et al., 2004, Hope and Wilson, 2003, Hope and 
Wilson, 2006).
The CDFF is unable to reproduce a number of physiological processes seen 
in vivo, for example, a host defence mechanism cannot obviously be 
incorporated. However since the CDFF is a simplified system with few 
variable factors; it has great merit in the initial evaluation of biofilms. The use 
of the CDFF is of great value in allowing the investigation of specific aspects 
of antimicrobial action and therapeutic interventions in isolation from other 
factors.
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Initial experiments in this present study using the CDFF were designed to 
determine whether biofilms could be produced and maintained using 
bacterial isolates from chronic wound patients. Once biofilms were 
successfully produced, analysis of an antimicrobial wound therapeutic agent 
was tested in vitro. The antimicrobial examined was povidone-iodine (PVP1), 
commonly prescribed for chronic wound patients. Iodine is one of the most 
frequently employed therapeutic constituents of wound dressings, e.g. 
Inadine (Johnson & Johnson) and is also used in antiseptic pre-surgical 
scrubs and other antiseptics.
4.2 Aims
The aims of this study were:
1. To confirm the species identity of chronic wound isolates to be used in 
these studies using 16S rRNA gene sequencing.
2. To develop in vitro models of biofilm formation for the identified wound 
bacterial isolates.
3. To compare the ability of these wound bacteria to produce biofilms and 
determine whether synergism or antagonism occurred in mixed biofilm 
populations.
4. To assess the susceptibility of the wound bacterial biofilms to PVP1.
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4.3 Methods
4.3.1 Preparation of bacterial species
Bacterial species were selected from a previous prospective study of 70 
patients with chronic venous leg ulcers (Davies et al., 2007, Davies et al., 
2004) and included representation of four species most frequently 
encountered and with distinctive colony morphologies namely: 
Staphylococcus aureus, Pseudomonas aeruginosa, Micrococcus luteus and 
Streptococcus oralis. Isolates were routinely grown on blood agar (BA) 
supplemented with 5% (v/v) sheep blood. BA plates were incubated 
aerobically at 37°C for 24 h. Confirmation of identification of these isolates 
in this present study was through 16S rRNA gene sequencing (section 4.3.2).
4.3.2 DNA extraction from test bacterial isolates
16S rRNA gene sequencing was used to confirm the identification of the four 
isolates selected for this study. The previous presumptive identification of 
these isolates, which had been based upon biochemical profiling using API 
ID strips (BioMerieux sa, Marcy L’Etoile, France), was S. aureus, P. 
aeruginosa, M. luteus and S. oralis. DNA was extracted from an overnight 
culture in Brain Heart Infusion (BHI) broth of each pure bacterial isolate using 
a Puregene® DNA isolation kit (Gentra Systems, Minneapolis, USA) by 
following the “DNA Isolation From 1 ml Gram-positive Bacteria Culture 
Medium” protocol (http://www.gentra.com/technical_assistance 
/protocols, asp).
4.3.3 Amplification of 16S rRNA genes from bacterial isolates
Extracted DNA was quantified using the Nanodrop ND-1000 
Spectrophotometer (NanoDrop Technologies, Fisher, UK) and stock DNA 
concentrations of 200 pg ml'1 were prepared. PCR was used to amplify 
targeted sequences of the 16S rRNA using the universal bacterial primer pair 
of 27F and 1492R (0.5 pM of each; oligonucleotides synthesized by 
Invitrogen Ltd. Paisley, UK), both sequences of which were specific for the 
domain Bacteria (Dymock et al 1996; Table 4.2).
151
Table 4.2 Oligonucleotide primers used for sequencing of bacterial DNA 
extracted from wound isolates.
Primer Nucleotide sequence Reference
27F 5’-GT GCT GC AGAG AGTTT GAT CCT GGCT C AG-3’ (Dymock et
al.1996)
1492R 5’-C ACGG AT CCTACGGGTACCTT GTTACG ACTT-3’ (Dymock et
al. 1996)
357F 5’-CTCCTACGGGAGGCAGCAG-3’ (Lane,1991)
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PCR was performed in a total reaction volume of 50 pi and used 1.5 U of Taq 
DNA polymerase, 200 pM of each deoxynucleotide, 0.5 pM of each primer, 
and the working concentration of appropriate magnesium-free buffer 
(Promega, Southampton, UK). Additionally, 2.0 mM of MgCI2 (Promega) was 
used, with 5 pi of DNA extract as template.
A touchdown PCR protocol was used, whereby, in the first cycle, 
denaturation at 95°C for 1 min was followed by primer annealing at 65°C for 
1 min, and primer extension at 72°C for 2 min. This cycle was then followed 
by denaturation 1 min with the annealing temperature subsequently 
decreased by 2°C for each cycle (11 cycles), after which 25 cycles were 
performed under the same primer annealing conditions (45°C). In the final 
cycle, primer extension was performed for 12 min. PCR was undertaken 
using a PTC-200 thermal cycler (MJ Research Ltd., GRI, Braintree, UK).
PCR products were purified by precipitation and washed with pure ethanol. 
Firstly, 15 pi of 5 M NaCI (Sigma-Aldrich, Steinheim, Germany) and 15 pi of 
40% polyethylene glycol (Mol. Wt. 8000; Sigma) were added to each PCR 
tube. This mix was centrifuged (16,000 g for 15 min) and the supernatant 
aspirated and replaced with 200 pi of 70% ethanol (v/v in water; Fisher 
Scientific, Loughborough, UK). Centrifugation, aspiration and ethanol 
washing steps were repeated (3* in total). Following another centrifugation 
step, the PCR products were dried under a fume hood (EDF1200, Envair, 
Rossendale, UK) overnight, and resuspended with DNA-free and nuclease- 
free water (30 pi). Products were then stored at -20°C until required.
4.3.4 Sequencing of 16S rRNA genes
Purified and cleaned PCR products were sequenced using ABI Prism BigDye 
terminator cycle sequencing ready reaction kits (Applied Biosystems, 
Warrington, UK). A total reaction volume of 20 pi was used and contained 
the working concentrations of BigDye Sequencing Buffer and Ready 
Reaction Premix (Applied Biosystems), 0.5 pM of an oligonucleotide primer 
(Table 4.2, synthesized by Invitrogen), and 6 pi of purified PCR-product
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(approx. 5-20 ng). For all isolates, sequencing was performed using the 
universal bacterial primer 357F (Lane, 1991; Table 4.2). Reactions were 
performed in a PTC-200 thermal cycler (MJ Research Ltd.) and comprised of 
1 min of denaturation at 94°C, followed by 30 cycles of denaturation at 94°C 
(15 s), annealing at 50°C (30 s) and extension at 60°C (5 min).
Extension products were purified, firstly by precipitating via the addition of 1 
pi sodium acetate (3M; Sigma) and 1 pi ethylenediaminetetraacetic acid 
(EDTA, pH 8.0, 0.5 M; Sigma), and then by adding 80 pi of chilled absolute 
ethanol, to each reaction mix. The supernatant was aspirated following 
centrifugation (16,000 g, 15 min), and replaced with chilled 70% ethanol (200 
pi). This was repeated once and after a final centrifugation and drying under 
vacuum, products were re-suspended in 100% (v/v) formamide (30 pi) and 
run on an automated DNA sequencer (ABI PRISM 3100 Genetic Analyser; 
Applied Biosystems). This procedure was expected to generate reliable 
sequences of greater than 500 base pairs (bp) that could be compared to 
sequences in the Genbank and EMBL public databases, which is sufficient 
for species level identification (Clarridge, 2004).
4.3.5 Identification of bacterial isolates by 16S sequence analysis
Sequences obtained in this study were identified by comparison to the 
GenBank DNA sequence database EMBL (Benson et al 2004) using the 
FASTA sequence homology search program
(http://www.ebi.ac.uk/services/index.html: Pearson, 1990).
A >99% homology to the 16S rRNA gene sequence of the type strain, or 
other suitable reference strain, was the criterion used to identify an isolate to 
the species level. Where more than one reference species exhibited >99% 
sequence homology, the match with the greatest homology was taken as the 
identity, wherever the sequence was shown to be reproducible and reliable.
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4.3.6 In vitro biofilm formation by chronic wound bacteria
Preliminary studies were undertaken to identify a culture medium and 
incubation time that allowed growth and biofilm formation by all isolates to be 
studied. A total of four different culture media were evaluated. These 
included Brain Heart Infusion broth (BHI; Oxoid, Hampshire, UK), Tryptone 
Soya Broth (TSB; Oxoid), BM medium (Appendix I) (McKee et al., 1985) and 
a simulated wound fluid (Appendix I) previously described by Addison et al 
(2004). The latter medium was modified by adding 2 g I'1 glucose to provide 
an additional carbon source.
4.3.7 Preparation of wound cultures for an in vitro microtitre plate assay
Micrococcus luteus (B81), S. oralis (B52), P. aeruginosa (D40) and S. aureus 
(D76) were cultured at 37°C for 24 h in 10 ml of BHI, TSB, BM or simulated 
wound fluid medium.
Standardised bacterial preparations were then made by adjusting the culture 
concentration to an optical density of 0.4 (absorbance measured at 600 nm) 
in PBS. After the required dilution for this OD measurement was identified 
using PBS, fresh medium was added to the overnight cultures, to adjust the 
bacteria to the required level.
4.3.8 Microtitre plate biofilm assay
Microtitre plate biofilm formation involved growing bacterial cultures in 
individual wells of 96-well microtitre plates (flat bottomed, Greiner, UK). A 
range of culture concentrations were tested in separate plates by performing 
two-fold serial dilutions (in appropriate culture medium) of the standardised 
bacterial preparation. A 100-pi volume of bacterial culture was then added to 
the wells of the microtitre plate. The microtitre plates were then sealed with 
parafilm to prevent dehydration (American National Can Group, USA) and 
incubated at 37°C for 24 h, 48 h, 72 h and 96 h.
Biofilm formation was subsequently assessed by one of 2 methods: a) crystal 
violet staining or b) total viable count estimation.
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4.3.9 Semi quantification of microtitre plate biofilms by crystal violet 
staining
After the appropriate incubation period, culture medium was removed and the 
microtitre plate wells washed three times with sterile distilled water to remove 
loosely associated bacteria. Plates were dried at 56°C for 45 min and each 
well was stained with 150 pi of 1% v/v crystal violet solution (in water) for 45 
min. After staining, plates were again washed three times with sterile distilled 
water. At this point, biofilms were visible by purple staining formed on the 
side of each well. The quantitative analysis of biofilm production was then 
performed by adding 200 pi of 95% ethanol to destain the cells. After 5 min, 
100 pi from each well was transferred in a new microtitre plate and the level 
of the crystal violet present in the de-stain solution was measured at 540nm. 
This method has previously been described by Djordjevic et al. (2002).
4.3.10 Statistical analysis of the crystal violet microtitre plate assay
Statistical analyses were done on the data obtained from the crystal violet 
microtitre plate assays. The Friedman, Wilcoxon and Kruskal-Wallis tests 
are all non-parametric statistical tests. The Friedman test and the Wilcoxon 
Signed Rank test were used to measure any differences in biofilm formation 
when different starting inocula were used. The Kruskal-Wallis test is an 
extension of the Wilcoxon rank sum test. All statistical analysis was done 
using the Statistical Package for the Social Sciences (SPSS) software.
4.3.11 Assessment of biofilm formation by single and mixed bacterial 
isolates using the microtitre plate assay and viable count estimation
The ability of the test isolates to produce biofilms in both single species and 
mixed species population was also determined using the microtitre plate 
assay. Using the identified optimal growth conditions, single and mixed 
species biofilm experiments were undertaken to determine whether any 
synergy or antagonism between species occurred with regards to biofilm 
formation.
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Briefly, in the case of mixed species biofilms, equal volumes of isolate 
combinations (total final volume of 100 pi) were mixed, added to the wells of 
the microtitre plate and incubated for 24 and 48 h in BHI medium.
After incubation the planktonic phase of growth was carefully removed from 
the microtitre plates. A 100-pl volume of PBS was added to each well to re­
suspend the biofilms. The biofilms of 6 wells were then pooled and serially 
diluted in PBS. Dilutions (100 pi) were plated on to BA plates which were 
incubated aerobically at 37°C for 24 h. Enumeration of each species was 
confirmed by visual inspection of the plates and representative colonies of 
each species recorded at 24-48 h.
4.3.12 Use of the CDFF to develop biofilms using chronic wound 
bacteria
In the present study, the CDFF was fully assembled with the PTFE plugs 
recessed within the pans to a depth of 400 pm using a gauged recessing 
tool. The CDFF was then autoclaved at 121°C for 45 min, and allowed to 
cool. For the duration of each experiment, the CDFF was maintained in an 
incubator at 37°C and ambient air was allowed to diffuse into the CDFF via 
sterile air filters. For all CDFF experiments the turntable speed was operated 
at 20 revs min'1. Initial experiments in the CDFF were performed to 
determine whether a stable biofilm wound model could be produced using 
bacterial isolates from chronic wound patients.
4.3.12.1 Inoculation of chronic wound bacteria for the in vitro biofilm 
model using the CDFF and preparation of planktonic cells
Chronic wound bacteria were routinely grown on BA and incubated 
aerobically at 37°C, as described previously (section 4.3.1). Isolates were 
then subcultured in 10 ml BHI broth for 24 h at 37°C in a shaking incubator. 
Isolates were tested for their ability to form biofilms in both single and mixed 
inocula. Five ml of each wound bacterial culture (section 4.3.1) was added to 
1 L of BHI or BM broth and this preparation was recirculated through the 
CDFF for 24 h to ‘seed’ the inoculum in the system. After this time, the
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inoculum was disconnected and fresh media was fed into the CDFF without 
recirculation and the CDFF waste was collected in an effluent bottle. Medium 
was delivered at a flow rate of 30 ml min-1 using a peristaltic pump (Watson- 
Marlow, Falmouth, UK). Purity plates were performed at the time of 
inoculation to ensure that no contamination occurred in the CDFF inoculum.
Planktonic mixes of the bacteria were also assessed in parallel to the 
biofilms. For planktonic cell preparation 100 pi from the overnight culture of 
each organism was added to fresh 19.9 ml BHI medium. Seven replicate 
broths were incubated with shaking at 37°C for 7 d. Each day the cells were 
centrifuged, the supernatant removed and new media was added. At each 
24 h time point, 100 pi of one of the replicates suspensions was serial diluted 
in PBS and plated onto BA plates for viable counts of planktonic growth. The 
remainder of the suspension was centrifuged and the pelleted cells were 
stored in RNAIater® (Ambion, UK) for subsequent investigation of gene 
expression profiles (see Chapter 6).
4.3.13 Recovery of biofilms established in the CDFF
A single pan holding 5 plugs was aseptically removed at each sampling time 
point from the CDFF for microbial analysis of the wound microflora. The 
samples were lifted from the turntable with a dedicated tool under aseptic 
conditions every 24 h for 7 d. Individual plugs were then removed aseptically 
from the pan. The 5 plugs were each placed in 2.5 ml of PBS and serial 
decimally diluted. Dilutions (100 pi) were plated on to BA plates and the 
plates incubated aerobically at 37°C for 24 h.
4.3.14 PVP1 susceptibility of CDFF generated biofilms
Antimicrobial testing of the biocide, povidone-iodine (PVP1) in the CDFF was 
performed against a mixed biofilm consortia. Bacteria used for the inoculum 
were S. aureus (D76), P. aeruginosa (D40), M. luteus (B81) and S. oralis 
(B52) cultured for 24 h in BM medium at 37°C. In addition to these aerobic 
species, Bacteroides fragilis (B11) and Peptostreptococcus anaerobius (B12) 
were prepared in fastidious anaerobe broth (FAB; LabM Ltd., UK) for 72 h in
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an anaerobic cabinet (10% v/v C 02, 20% v/v H2j 70v/v N2; Don Whitley 
Scientific Ltd., Shipley, UK) at 37°C. The inoculum for the biofilm consisted 
of 5 ml of each of these bacterial species, which were added to the growth 
medium and used to inoculate the CDFF as previously described (4.3.12.1). 
PVP1 (final concentration of 1% w/v in BM) was added to the medium of the 
CDFF once a fully mature biofilm had been established (after 5 d incubation). 
The PVP1 concentration of 1 % used was thought to be representative of the 
concentration of iodine that is effectively available to the wound bed in 
commonly used commercially available dressings which contain 10% PVP1 
(http ://www.d ressi ngs. org/d ressi ngs/i nad ine. htm I).
4.3.15 Biofilm recovery from the CDFF during PVP1 testing
The CDFF was sampled every 48 h over a total experimental run of 29 d. A 
single pan containing 5 plugs was again removed from the CDFF at each 
sampling point. Two sets of two plugs were taken from each pan and 
separately vortexed in 5 ml PBS for 2 min to disperse the biofilm. Serial 
dilutions were then made of each of the resulting bacterial suspensions to a 
dilution factor of 107 fold. Then, 100 pi of each dilution was plated onto BA 
and FAA plates which were incubated at 37°C under aerobic and anaerobic 
conditions, respectively. Colony counts of each species on the plates after 
24-48 h incubation were then recorded.
Resulting growth from the ‘biofilm’ cultures were also subsequently tested for 
susceptibility to PVP1 using a broth culture minimum bactericidal 
concentration (MBC) test (see section 4.3.16). This enabled an assessment 
to be made on possible acquired resistance development of these isolates 
during prolonged PVP1 exposure in the CDFF.
4.3.15.1 Live/dead staining of biofilms treated with PVP1
In addition to total viable count estimation, a smear of the biofilm was also 
stained with the Live/Dead® BacLight™ stain (Live/Dead® BacLight™ Bacterial 
Viability Kit, Invitrogen Ltd). The live/dead stain consisted of two nucleic acid 
stains: the green fluorescent SYT09 and the red-fluorescent propidium
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iodide stains are used in combination to discriminate live and dead bacteria 
in a mixed population. Bacterial cells with a compromised membrane that 
are considered to be dead or dying stain red, whereas cells with an intact 
membrane appear green.
Three pi of each stain was added to 300 pi PBS, mixed and 20 pi added to 
the biofilm smear. The preparation was left for 1 min and then viewed by 
standard fluorescence microscopy (Olympus Provis AX70 Digital Microscope; 
Olympus U.K. Ltd., Middlesex, U.K.), at a total magnification of x600.
4.3.16 Planktonic cell susceptibility to PVP1
In order to determine whether an elevated resistance to PVP1 occurred in 
chronic wound biofilms it was also necessary to establish the susceptibility of 
planktonic equivalent cells. These experiments were undertaken using a 
microtitre plate assay susceptibility test based on the CLSI (Clinical 
Laboratory Standards Institute; previously known as the National Committee 
for Clinical Laboratory Standards; NCCLS) guidelines for broth microdilution 
testing with some modifications. Tests were undertaken using cation- 
adjusted Mueller-Hinton broth (CAMHB; Lab114, LabM, Bury, England) or 
BM medium. PVP1 was diluted in the culture medium and serial two-fold 
dilutions of PVP1 ranging from 2% w/v to 0.004% w/v were used.
Bacterial isolates were grown on BA plates at 37°C overnight and then used 
to inoculate 10 ml BM broth which was incubated at 37°C overnight. The 
bacterial suspension was then washed by centrifugation. The cell pellet was 
re-suspended in PBS and the turbidity was adjusted to a 0.5 McFarland 
standard (approximately 108 CFU ml'1). Based on the required dilution to 
establish the 0.5 MacFarland standard, an equivalent dilution preparation 
was made in the appropriate growth medium for study. A proportion of the 
standardised suspension was diluted 1:100 (106 CFU ml'1) with BM broth or 
Mueller-Hinton broth. One hundred pi of the bacterial suspension was added 
to a microtitre plate well already containing 100 pi of diluted PVP1. A volume 
(100 pi) of the inoculum was plated on to BA to check for purity and inoculum
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density. Broth not containing PVP1 was inoculated as a control for organism 
viability, and a further control of broth without inoculum was also included. 
The microtitre plate was sealed in parafilm and incubated at 37°C for 24 h, 48 
h, 72 h and 96 h before minimum bactericidal concentrations (MBCs) were 
determined.
The lowest concentration of PVP1 found to completely inhibit visible growth 
of the organism was recorded as the MBC at all time points. This was 
confirmed by the total absence of growth on BA plates after sub-culturing a 
loopful of broth from the identified MBC dilution.
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4.4 Results
4.4.1 16S rRNA gene sequence identification of test bacterial isolates
Results for the highest sequence match from 16S rRNA gene sequencing of 
bacterial wound isolates used in this study are shown in Table 4.3. All isolate 
sequences showed a high homology (> 99.4%) to at least one database 
sequence (actual sequences, Appendix I).
4.4.2 Comparison of biofilm formation by test species using the 
microtitre plate assay (crystal violet)
Figures 4.1 - 4.3 demonstrate the levels of biofilm formed by the test species 
in BHI, TSB and BM media respectively. In simulated wound fluid (with or 
without glucose) the bacteria were not found to produce biofilms. There were 
no statistical differences for each species in the biofilm level generated at 
each time point when different starting inocula were used (Fig. 4.1 - 4.3).
The level of biofilm formation by the test bacterial species was, however, 
found to vary with different growth media (BHI and TSB) over a time period of 
24-96 h.
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Table 4.3 16S rRNA gene sequencing: Identification of wound isolates.
Isolate Species match Accession
number
% homology to 16S 
rRNA gene sequence 
in database
B52 Streptococcus oralis 
ATCC 35037;
AY485602 99.8
Streptococcus sanguinis 
ATCC 29667;
AY281085 98.9
B81 Micrococcus luteus; 
DSM 20030
AJ536198 99.6
D40 Pseudomonas aeruginosa 
DSM 50071
Z76672 99.4
D76 Staphylococcus aureus ssp. 
anaerobius ATCC 35844;
D83355 99.8
S. aureus ssp. aureus 
ATCC 12600;
X68417 99.8
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Fig. 4.1 Relative biofilm formation for different inocula levels of individually 
grown wound bacteria using the microtitre plate assay and BHI medium for a) 
24h, b) 48h, c) 72h and d) 96h. Error bars represent standard deviation of 8 
replicates.
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Fig. 4.2 Relative biofilm formation for different inocula levels of individually 
grown wound bacteria using the microtitre plate assay and TSB medium for 
a) 24h, b) 48h, c) 72h and d) 96h. Error bars represent standard deviation of 
8 replicates.
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Fig. 4.2 continued
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Fig. 4.3 Relative biofilm formation for different inocula levels of individually 
grown wound bacteria using the microtitre plate assay and BM medium for a) 
24h, b) 48h, c) 72h and d) 96h. Error bars represent standard deviation of 8 
replicates.
168
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Using BHI, all the test species produced biofilms, although after 48 h the 
extent of biofilm formation decreased dramatically (Fig. 4.1). In BHI, the 
hierarchy of biofilm formation (as determined by OD) over 24-48 h was M. 
luteus > S. oralis £ S. aureus > P. aeruginosa with M. luteus producing a 
much thicker biofilm than the other organisms.
In experiments using TSB (Fig. 4.2), the most consistent levels of biofilms 
were again evident over 24-48 h, however the relative hierarchy of biofilm 
formation was found to change compared to that previously evident in BHI. 
In TSB medium, P. aeruginosa produced the greatest quantity of biofilm 
followed by S. oralis, S. aureus and M. luteus. All results were consistent, 
even when different starting inocula were used. In experiments using BM 
medium (Fig. 4.3) the levels of biofilm formation were lower, with no relative 
hierarchy of biofilm formation found between the species over 24-96 h 
incubation. Pseudomonas aeruginosa appeared to do best at 24 h, whilst M. 
luteus was predominant at 48 h and S. aureus at 96 h, presumably reflecting 
slower growth rates in this more defined medium.
Based on crystal violet staining results, subsequent microtitre experiments 
aimed at examining mixed species biofilms used a starting inoculum of 108 
cells ml'1 with analysis after 24 h (Figs. 4.4 - 4.6). Figure 4.4 demonstrates 
the relative ability of single bacterial species to produce biofilms in BHI and 
TSB. As previously shown in Figs. 4.1 and 4.2, the relative hierarchy of the 
different species can clearly be seen.
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Experiments investigating the extent of biofilm formation by different 
combinations of bacterial species were undertaken to assess whether 
synergism or antagonism occurred. Figures 4.5 and 4.6 demonstrate the 
findings of mixed species biofilm formation in BHI when compared with those 
of the single species. When M. luteus and P. aeruginosa were combined 
(Fig. 4.5a), a biofilm level intermediate to that generated by the respective 
single species was evident. Mixing of S. oralis and S. aureus (Fig. 4.5b) in 
the same growth medium resulted in a significant reduction of biofilm 
formation when compared to single S. oralis biofilm studies. Pseudomonas 
aeruginosa was also found to reduce the level of biofilm formation of S. 
aureus when the two species were cultured in combination (Fig. 4.6a). 
Similarly, P. aeruginosa was also found to greatly reduce the biofilm forming 
ability of S. oralis (Fig. 4.6b).
To obtain information on the composition of these biofilms, viable counts 
were obtained at 24 and 48 h (Table 4.4). These studies showed that, for 
example, M. luteus only grew in combination with S. oralis. When combined 
with either P. aeruginosa or S. aureus, M. luteus did not grow. Streptococcus 
oralis also did not compete well with P. aeruginosa in these biofilm studies 
without any growth again being recorded. The viable counts of the P. 
aeruginosa and M. luteus mixed culture (M. luteus no growth, P. aeruginosa 
8.7x10® cfu ml'1) support the idea of elevation of P. aeruginosa numbers in 
this mixed inoculum biofilm. In the case of S. oralis and S. aureus, the data 
suggest that there has been a decrease in the numbers of the former species 
(Fig. 4.5b).
4.4.3 Comparison of biofilm formation by test species using the CDFF
CDFF biofilm formation was evident for all four wound bacterial species when 
each was used as single species inocula (Fig. 4.7). In terms of cfu ml'1 from 
the recovered biofilms, the highest growth appeared to occur with S. aureus 
and P. aeruginosa throughout the 7 day incubation period (about 109 cells). 
Similar growth levels were detected for S. oralis and M. luteus (about 107 
cells) which were much lower than those for P. aeruginosa and S. aureus.
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Table 4.4 Analysis of a) single and b) mixed biofilms by total numbers in the 
microtitre plate assay in BHI medium for 24h and 48h.
a)
single species 24h; (cfu ml'1) 
mean (n=3)
48h; (cfu ml"1) 
mean (n=3)
P. aeruginosa (D40) 3.2 x108 7.3x10®
S. aureus (D76) 9x10® 5.4x10®
M. luteus (B81) 1.1 x 10® 1.3 x107
S. oralis (B52) 2.5x10® 1.3x10®
b)
Mixed species 24h; (cfu ml"1) 
mean (n=3)
48h; (cfu ml'1) 
mean (n=3)
M. luteus + S. oralis B81: 2 x 107 
B52: 3.7 x108
B81:1.8x10® 
B52: 4.8x10®
M. luteus + S. aureus B81: 0
D76: 5.6 x108
B81: 0
D76: 5.7x10®
M. luteus + P. aeruginosa B81: 0
D40: 8.7 x108
B81: 0
D40: 4.7x10®
S. oralis + S. aureus B52: 3.4 x108 
D76: 4.3 x108
B52: 3.2x10® 
D76: 1.1 x 109
S. oralis + P. aeruginosa B52: 0 
D40: 1 x 108
B52: 0
D40: 2.2x10®
S. aureus + P. aeruginosa D76: 2.3 x 108 
D40: 5 x 108
D76:1.2x10® 
D40: 5 x 107
Data shown is the mean of 3 replicate experiments.
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Figure 4.8 illustrates the ability to differentially enumerate the recovered 
bacterial species from CDFF generated biofilms. It was also noted that 
subcultures of P. aeruginosa from biofilms (Fig. 4.8) appeared to have 
different colony morphology compared to their planktonic equivalents (Fig. 
not shown). Using mixed species biofilms (Fig. 4.9), similar numbers of both 
S. aureus and P. aeruginosa were detected as previously reported in the 
single species experiments (108-109 cfu ml'1). However, there was an 
apparent increase in the numbers of S. oralis compared with its single culture 
equivalent. In contrast, no growth of M. luteus in these mixed species 
biofilms was again detected throughout the experimental period. 
Interestingly, a similar loss of M. luteus was also noted in control mixed 
planktonic cultures of these isolates over 7 d incubation (Fig. 4.10). The 
viable count numbers for S. aureus and S. oralis were similar in both biofilm 
and planktonic mixed cultures, whereas counts for P. aeruginosa were at 
least one order of magnitude lower when grown in the planktonic state.
4.4.4 Planktonic test species’ susceptibility to PVP1
The MBCs of planktonically cultured isolates against PVP1 were determined 
as the total inhibition of visible growth and the absence of viable bacteria 
growth. The latter was determined by taking a loopful of test solution and 
plating it onto BA. An example of a P. aeruginosa MBC using a microtitre 
plate assay is shown in Fig. 4.11. The MBC of PVP1 against P. aeruginosa 
and S. aureus was 1%, against S. oralis and M. luteus it was 0.25 % and 
0.03%, respectively.
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Fig. 4 .8  Suspension of biofilms of chronic wound flora generated in the 
CDFF, shows colonies of a) P. aeruginosa (large colonies), b) S. aureus 
(smaller white discrete colonies) and c) S. oralis (small, haemolytic).
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Fig. 4.11 Minimum bactericidal concentration (M BC) of planktonic P. 
aeruginosa to PVP1 in BM medium using a microtitre plate assay.
The MBC of P. aeruginosa was 1% PVP1. Even though the 0.5%  PVP1 
dilution seems clear, growth on BA plates was evident.
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4.4.5 Susceptibility of CDFF generated biofilms to PVP1
Figure 4.12 shows the effect of 1% povidone-iodine (PVP1) on an 
established CDFF biofilm. Here, only two (P. aeruginosa and S. aureus) of 
the six bacterial species (P. aeruginosa, S. aureus, M. luteus, S. oralis, B. 
fragilis, and P. anaerobius) were detected at any sampling stage after initial 
inoculation. Addition of iodine to the medium between 6 and 13 d resulted in 
a reduction in the numbers of S. aureus and P. aeruginosa. Between days 
14-20, when PVP1 addition was stopped, the bacterial numbers in the biofilm 
rapidly returned to pre-treatment levels. PVP1 was again added for the same 
period of time, (between days 21 and 28), and as encountered previously 
there was again a decrease in the growth of both S. aureus and P. 
aeruginosa (one order of magnitude). However, within 1-2 days of 
terminating PVP1 treatment, the counts of these bacteria had returned to pre­
treatment levels. The experiment was repeated twice and interestingly, M. 
luteus, S. oralis and the anaerobic species B. fragilis and P. anaerobius were 
not detected at any stage within the biofilm consortia.
After each PVP1 experiment a single colony of both S. aureus and P. 
aeruginosa was taken from a BA colony count plate and was inoculated into 
fresh BM medium and retested for PVP1 susceptibility. These planktonically 
grown cells were shown to be still susceptible to PVP1 at the original levels, 
with the MBC for both S. aureus and P. aeruginosa again being determined 
as 1%.
4.4.5.1 Live/dead stain of CDFF biofilms treated with PVP1
Figure 4.13 illustrates the viability of biofilm cells after PVP1 exposure. 
Biofilm cells were tested on day 27, after 6 d PVP1 treatment. Using this 
stain, dead cells appeared red and viable cells green. It was evident from 
analysing the PVP1 treated biofilms that the majority of cells in the biofilm 
preparation were red staining.
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Fig. 4.13 Live/Dead® staining of a PVP1 treated biofilm smear using the 
BacLight™ bacterial viability stain. Live cells appear green and dead cells 
appear red.
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4.5 Discussion
A biofilm is often described as a community of microorganisms attached to a 
surface and encased within an extracellular polysaccharide matrix (EPS). In 
the laboratory, the microtitre plate assay is one of the most frequently used 
methods to measure the biofilm-forming ability of bacteria (Kennedy and 
O'Gara, 2004). In this present study, the microtitre plate assay was used to 
examine the in vitro biofilm formation of chronic wound bacterial species and 
in particular, to directly compare biofilm development of single (Fig. 4.4a and 
b) and mixed wound bacterial species (Fig. 4.5-4.6a and b).
The benefits of using the microtitre plate assay were that it enabled the rapid 
analysis of biofilm formation of multiple bacterial strains in a way that was 
inexpensive and relatively simple to use. The microtitre plate biofilm model 
does however have limitations. Principal amongst these is that it is a closed 
model (batch system) which ultimately limits the level of biofilm formation 
through depletion of nutrients and accumulation of waste products. However, 
this could partially be overcome in any future experiments by replenishing the 
growth medium at specific time intervals. The microtitre plate assay was also 
labour intensive to prepare, particularly when many isolates were being 
tested. Furthermore, inclusion of more than one species per plate can 
promote contamination problems between neighbouring wells.
Throughout the study, species differences in the level of biofilm generated in 
the microtitre plate assay were evident, and consistent for any given medium. 
The hierarchy of biofilm formation altered with the medium and this highlights 
the importance of the environmental milieu on biofilm development, which is 
consistent with ideas presented by Kennedy et al. (2004). These differences 
in the biofilm forming ability between the species could either be a result of 
the different growth rates of the species in the chosen media, or a reflection 
of the adherence properties of the species to the microtitre plate surface. 
Previous work has indeed demonstrated that bacteria adhere more 
favourably to some materials than others (Simoes et al., 2007a). 
Furthermore, differences in the adherence capability to polystyrene microtitre
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plates has been found between strains of some species, including S. aureus 
(Stepanovic et al., 2000).
For all subsequent experiments using mixed species analysis, BHI, was used 
as the growth medium, since this was found to be the most consistent of the 
tested media in supporting biofilm formation for all the bacterial species. BHI 
has also been widely used and validated in previous work (Fitzpatrick et al., 
2005; Kennedy and O'Gara, 2004; Parsek and Singh, 2003).
It was interesting to note that in mixed species biofilms, both P. aeruginosa 
and S. aureus appeared to antagonise the biofilm forming ability of S. oralis 
and M. luteus. Such an effect could occur for a variety of reasons including 
occurrence of inter-species competition for surface attachment sites, 
competition for nutrients within the growth medium or by production of a less 
stable biofilm architecture. Furthermore, a motile organism like P. 
aeruginosa can readily be envisaged as having an advantage over non- 
motile counterparts within a biofilm environment. As the biofilm matures it is 
inevitable that areas will develop that are restricted with respect to nutrient 
and gaseous availability. In theory, a motile organism could migrate to areas 
of the biofilm that are more suitable for its growth.
Simoes et al. (2007b) also reported antagonism between bacterial species 
isolated from drinking water in biofilms generated within 96 well microtitre 
plates. The microbial interactions were compared between single and dual 
biofilms. Weak biofilm production was found between Sphingomonas 
capsulate and Mycobacterium mucogenicum, S. capsulate and Acinetobacter 
calcoaceticus and between M. mucogenicum and Staphylococcus spp. 
(Simoes et al., 2007b). Kreth et al. (2005) also showed that S. mutans and 
S. sanguinis engage in antagonistic interactions in dental biofilms.
The predominant microorganisms in chronic wounds have been determined 
as P. aeruginosa and Staphylococcus spp. found in 34.8% (surface), 31.8% 
(tissue), and 71.2% (both surface and tissue) of patients (Davies et al.,
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2007). However, it is still unclear whether all four of the microorganisms 
used in this study occur simultaneously within the same wound and therefore 
whether the relative proportions of these species within a wound environment 
reflects that found in these in vitro studies. Further clinical research of 
chronic wounds is required to understand the relationship between biofilm 
communities and the wound healing process. Extrapolating the results in the 
present in vitro study to wounds might suggest that P. aeruginosa would be 
expected to predominate over organisms such as M. iuteus. Chronic wounds 
do show considerable diversity in the species of bacteria present, although S. 
aureus and P. aeruginosa do appear to be the predominant organisms 
encountered (James et al., 2007; Jones et al., 2004b).
Generally a lack of synergy between the bacterial species in the microtitre 
plate assay and in the CDFF was observed with the exception of P. 
aeruginosa which appeared to perform much better in the presence of M. 
luteus (although this was to the detriment of the Micrococcus species; Fig. 
4.5a). The ability of strains to compete in this in vitro environment could 
theoretically be related to the relative bacterial numbers encountered in a 
wound environment. Davies et al. (2007) in a study examining the 
relationship between bacterial load and wound status, quantified both S. 
aureus and P. aeruginosa from the same chronic wounds and showed that 
the relative proportions of these two species was variable depending on 
patients (results not shown). Equivalent results for Micrococcus species 
were not however available.
The inability to extrapolate the in vitro findings of this present study to those 
obtained from the work of Davies et al (2007) highlight the role of other 
factors that are present in the wound, including the presence of other 
microorganisms and host defence processes. In all microbial communities, a 
degree of competition between species is expected despite the fact that a 
stable community exists.
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It could be hypothesised that M. luteus represents a wound contaminant from 
the skin with only a transient occurrence in chronic wounds, whilst the 
presence of P. aeruginosa and/or S. aureus could be indicative of the 
pathogenic state. However, Micrococcus spp. were found to be present in 
64% of patients (Davies et al., 2007) suggesting that this species is a true 
coloniser of chronic wounds. In this regard, treatment options targeting P. 
aeruginosa would be advocated. Further work is still needed on clinical 
samples to confirm this hypothesis.
Due to the previously mentioned limitations of the microtitre plate assay the 
Constant Depth Film Fermenter (CDFF) was also used to compare wound 
bacterial biofilms. The advantages of the CDFF over the microtitre plate 
system included, 1) the medium could be constantly replenished and the 
waste components of the medium removed; 2) many replicates of equivalent 
biofilms could be obtained; 3) the flow rate of the medium and any 
supplements could be introduced as required; 4) almost any material could 
theoretically be incorporated into the CDFF and serve as the biofilm 
substratum. The CDFF model also has the potential to be adapted to 
simulate the wound environment further, for example by the addition of fixed 
volumes of collagen or fibronectin. However, the model also has limitations, 
in that it is not able to simulate the effects of host factors, it is an abiotic 
surface and lacks the presence of components of the host immune system 
(Chapter 5 describes the use of a skin equivalent system that addresses 
some of these limitations). Additionally, it is important to be aware of the 
potential risk of contamination from airborne bacteria being introduced when 
opening up the system daily to take samples. Nevertheless, it remains 
important to gain an understanding of biofilm physiology by studying various 
aspects of a biofilm in isolation, and the CDFF is an ideal model for such 
analysis.
Results from the CDFF again showed that all four bacterial species grown 
individually in the CDFF were able to form biofilms and that these biofilms 
were readily maintained (Fig. 4.7). Interestingly, the relative species
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hierarchy of biofilm formation using BHI medium was different between the 
microtitre plate assay and the CDFF. In the microtitre plate assay, the 
hierarchy of biofilm formation was M. luteus > S. oralis > S. aureus > P. 
aeruginosa. In the CDFF, S. aureus produced the highest level of biofilm 
followed by P. aeruginosa, S. oralis and M. luteus. The explanation for these 
differences in biofilm hierarchy could be that the CDFF provided an open 
system where fresh media was being constantly replenished and this may 
have been of greater benefit to those species with higher growth rates. In 
addition, the actual surface for attachment of the bacteria was different in the 
the two models which could influence initial adherence and subsequently the 
relative growth of the respective species.
Whilst it was evident that multispecies biofilms of chronic wound bacterial 
species were able to be established and maintained within the CDFF model, 
it was apparent that anaerobes could not be detected when included in mixed 
species biofilm consortia. This could be because the CDFF did not provide a 
truly anaerobic environment since anaerobic gas was not infused into the 
fermenter for these experiments. Bradshaw et al. (1998) did however find 
that anaerobes can flourish in a primarily aerobic environment as they utilise 
specific anaerobic pockets within the biofilm. For this to occur however, the 
anaerobic niches have to develop prior to loss of the anaerobic bacteria 
within the system. Furthermore, it is also possible that in this present study 
the anaerobes required a richer growth medium to be supported instead of 
Brain Heart Infusion (BHI) medium. BHI had been selected based on the 
previous microtitre plate experiments which did not include anaerobic 
bacterial species.
In this present study, all bacterial species were added simultaneously and it 
is important to note that under such situations the anaerobes would have had 
to compete with aerobic organisms in an entirely aerobic environment. It has 
been suggested that in a wound environment, the early contaminants are 
most likely to be skin flora (e.g. Staphylococcus epidermidis and Micrococcus 
species), which adhere to the wound, proliferate and synthesise EPS
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(Percival and Bowler, 2004). These pioneer colonisers are then followed by 
Gram-negative bacilli which populate the biofilm, utilise oxygen and provide 
growth factors for anaerobes to establish themselves within the biofilm 
(Percival and Bowler, 2004). Future work could therefore attempt to create 
such a succession of colonisation of the biofilm through a later introduction of 
the anaerobic bacteria into the system.
In the CDFF experiments that combined all four bacterial species, M. luteus 
appeared to be ‘out-competed’ by the other organisms present (Fig. 4.10). 
These results would therefore confirm those earlier findings of the microtitre 
plate assay (section 4.4.2). The analysis of viable counts from biofilm 
cultures also showed that M. luteus did not grow in combination with both S. 
aureus and P. aeruginosa (Table 4.6 b). Since M. luteus was able to form 
biofilms in single culture it is possible that this organism can rapidly colonise 
the substratum used and thus as a non motile organism provide the base of 
the maturing biofilm. Given such a location in the biofilm structure and the 
associated limitations in terms of nutrients and oxygen at this site it is 
possible that a dormant state or even a completer loss of viability might occur 
for these organisms (Hill et al., 2003). However, the fact that M. luteus also 
appeared to be ‘out-competed’ within a planktonic (Fig. 4.11) mixed culture 
does support the likelihood of a true competition for nutrients with the other 
bacteria as opposed to a strictly biofilm related factor.
It is also worth noting that subcultures of P. aeruginosa from the mixed 
biofilms generated in the CDFF appeared to have a different colony 
morphology compared to those of planktonic origin, suggesting that there 
were phenotypic variations occurring for the P. aeruginosa in the two different 
growth phases (Fig. 4.8). This phenotypic switch not only highlights the 
successful biofilm development in the CDFF but also validates the 
importance of subsequent investigations into any associated gene 
expression changes within these biofilms (Chapter 6). It has been suggested 
that under stress conditions, bacteria might possess diverse mechanisms 
that may lead to an increase in genetic and phenotypic variability (Webb et
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al., 2004). These mechanisms include adaptive mutation (Bjedov et al., 
2003; Oliver et al., 2000; Taddei et al., 1995), phase variation (Drenkard and 
Ausubel, 2002) and enhanced gene transfer (Hausner and Wuertz, 1999; 
Molin and Tolker-Nielsen, 2003).
In the present study, the CDFF was also used to model the sensitivity of a 
biofilm comprising chronic wound bacteria to PVP1. PVP1 is a bacteriostatic 
antimicrobial which is commonly used as a topical agent in the treatment of 
wound infections (Mertz et al., 1999). Similar studies with antimicrobials 
have been done previously using the CDFF. Ready et al. (2002a) used the 
CDFF to examine the effect of tetracycline on the composition and antibiotic 
resistance profile of dental plaque. However, that study examined the effect 
of a single pulse of antibiotic rather than continuous administration (Ready et 
al., 2002a). Also, their group did not compare the sensitivities of bacteria 
recovered from the biofilm to the antibiotic when subsequently grown in the 
planktonic state
Initial experiments with PVP1 in the present study, showed that planktonic 
organisms were susceptible to a 1% concentration of PVP1. This is the 
concentration that is believed to be available to the wound surface from 
PVP1 impregnated dressings such as Inadine (Kumar et al., 2004). In 
contrast, results showed that 1% PVP1 had only a slight effect on CDFF 
generated bacterial biofilms. However, when colonies from S. aureus and P. 
aeruginosa were recovered from the CDFF and then grown planktonically, 
they remained susceptible to this 1% PVP1 concentration. This suggests 
that the PVP1 resistance of the CDFF biofilms was associated with the 
biofilm phenotype rather than being the result of an acquired resistance by 
individual organisms exposed to the agent. The data presented in this study 
concurs with that of Anderl et al. (2003) who suggested that planktonic cells 
in stationary phase rapidly regain antibiotic susceptibility upon dilution in 
fresh medium, which provides nutrients and also might dilute protective cell­
cell signalling pathways (Anderl et al., 2003). This reversibility in
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antimicrobial sensitivity indicates that biofilm tolerance of antimicrobials 
represents a phenotypic rather than a genotypic alteration (Fux et al., 2005).
One mechanism of biofilm resistance to antimicrobials could be explained by 
the ‘persister cell’ theory. As previously mentioned, bacteria embedded deep 
within a biofilm are likely to be less metabolically active because of poor 
access to essential nutrients, including oxygen, and may have problems with 
the accumulation of waste metabolites in their surroundings. This reduced 
activity has been linked to the finding that surface biofilm cells are normally 
large in size whilst the biofilm embedded cells are often smaller (Anwar et al., 
1992). Embedded cells, or ‘persister cells’ are at a stage of ‘dormancy’ 
thereby making them phenotypically better equipped to persist in hostile 
environments (Anwar et al., 1992; Rhoads et al., 2007). It was interesting to 
note that live/dead staining of PVP1 biofilms indicated a majority of ‘dead’ 
cells. This could be indicative of ‘persister cells’ existing in the established 
biofilm, which are dormant but culturable as seen by the viable counts. 
Another reason could be that PVP1 does not actually kill the bacteria but 
might only damage the cell membrane which is then reflected as the bacteria 
staining ‘dead’ by the live/dead stain. It is important to note that on 
withdrawal of treatment with PVP1, the level of bacterial numbers within the 
biofilm rapidly reverted to those seen before treatment. This observation 
might have important clinical implications in terms of the duration of treatment 
with topical PVP1.
The antimicrobial activity of an agent on a biofilm can occur by two 
mechanisms. Firstly, there is the direct effect of the agent on the microbial 
cells themselves. PVP1 clearly demonstrates effective killing against the 
cells used in this study as seen from the planktonic cell inhibition work. It has 
also been proposed that topical antimicrobials enhance the recruitment of 
polymorphonuclear neutrophils (PMNs) to the site of biofilm occurrence 
(Akiyama et al., 2003). For example, treatment of S. aureus skin infections 
with 2% fusidic acid ointment resulted in 100 times lower numbers of bacteria 
in normal mice than in neutropenic mice 12 h after treatment (Akiyama et al.,
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2002). As a consequence, whilst 1 % PVP1 appears to have limited value in 
combating ‘wound biofilms’ in vitro, the in vivo effects may be higher through 
synergism with patient host defence mechanisms.
This present study showed that the CDFF was an effective and reliable 
model to generate in vitro sustainable growth of multispecies biofilms from 
chronic wound bacteria, as evident by viable count determination (and later 
by CLSM images of the biofilms; see Chapter 5). The PVP1 experiments 
highlight the value of the CDFF for future in vitro experiments examining both 
conventional and novel therapeutic interventions. The CDFF model also has 
great potential to be adapted to allow investigation of a wide range of other 
medically important biofilm-related infections, with wide reaching implications.
4.6 Summary
1. This study demonstrated the development of in vitro biofilm models by 
identified wound bacterial species.
2. Wound bacteria were able to produce biofilms in both a microtitre plate 
assay and in the CDFF. The CDFF allowed multiple, identical and 
reproducible biofilms to be grown simultaneously. Species differences in 
terms of level of biofilm formation were evident for any given growth 
medium and species antagonism occurred in mixed species biofilms for 
certain bacterial combinations.
3. Susceptibility of the wound bacterial biofilms generated in the CDFF to 
PVP1 was limited compared with planktonic cell susceptibility and any 
effects observed rapidly returned to pre-treatment levels once PVP1 
treatment was stopped.
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Chapter 5 
Structural analysis of biofilms 
generated by wound bacteria
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5.1 INTRODUCTION
Previous chapters of this thesis have described the use of in vitro models to 
construct biofilms using oral (Candida albicans) and wound (bacterial 
isolates) microorganisms. Although a lot of research has been done in the 
study of oral plaque biofilms (Gu et al., 2005), there have been limited 
studies undertaken on wound biofilms despite the recent proposed role of 
biofilm involvement in delaying wound healing (Davies et al., 2007; Mertz, 
2003).
Sophisticated molecular techniques have been applied in many fields of 
microbiology. However, in the application of molecular techniques to 
biofilms, little information is generally obtained regarding biofilm morphology 
or architecture. For example, in the case of DNA/RNA extraction, cells are 
often pooled and any tissue/biofilm destroyed in the extraction process. 
Traditional microscopical analyses and bacterial stains, like the Gram or 
Ziehl-Neelsen stain (Moter and Gobel, 2000) are useful, but limited, as they 
often rely on prior cultivation of the bacteria. Whilst Gram staining provides 
information on the type of bacterial cell wall it does not allow for species 
identification (Moter and Gobel, 2000). It is important to highlight that 
microbial communities are fundamental in the functioning of all ecosystems 
(Tyson, 2004). Since cultivation techniques tend to work only for a minority 
of species (only 2-3% of bacteria are thought to be cultivable using currently 
available media), the development of alternative methods for the 
identification and visualisation of bacteria has become a necessity (Amann, 
2001; Moter and Gobel, 2000).
5.1.1 Bacterial detection and distribution in a biofilm community
Biofilm formation is a dynamic process involving continuous changes in 
structure and composition through microbial attachment, detachment, growth 
of different species and the production of extracellular polysaccharides (EPS) 
(Gu et al., 2005). An ambitious goal in microbiology is to have rapid and 
accurate identification of pathogenic bacteria within biofilm communities. 
Effective monitoring of the organisms within a biofilm is a crucial step in
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assessing the possible risk or the status of a disease (Gu et al., 2005). 
Marsh et al. (2003) established a connection between the proportions of 
certain bacterial species in the oral biofilm (plaque) and the absence or 
presence of dental caries. Marsh et al. (2003) suggested that changes in the 
environment (e.g. nutrition, oxygen, pH, long term use of medication) alter 
the pattern of gene expression of oral bacteria, so that the competitiveness of 
the species associated with disease is increased, while that of organisms that 
normally prevail in health is reduced (ecological plaque hypothesis). Dental 
caries is associated with an increase in the proportion of acidogenic and 
aciduric bacteria (e.g. Streptococcus mutans, S. sobhnus and lactobacilli) 
which demineralise the enamel, and in periodontal diseases anaerobic 
bacteria including Gram-negative proteolytic species are increased. These 
plaque mediated diseases could be prevented by interfering with the 
environmental factors as well as by inhibiting the putative pathogens (Marsh,
2003). The work on dental plaque therefore highlights the potential 
importance in analysing the diversity and distribution pattern of pathogenic 
organisms which reside within chronic wounds or any other biofilm-related 
infections.
5.1.2 Biofilm structure within a community
In the majority of natural habitats, microorganisms exist as biofilms, which 
usually comprise (although not exclusively) of a variety of species and 
genera. Biofilms are formed after attachment and growth of microorganisms 
on a broad range of surfaces (Thurnheer et al., 2004). Biofilms are 
comprised of water, cells, cell aggregates and microcolonies embedded in an 
EPS matrix (Costerton et al., 1995; Costerton et al., 1999). The biofilm 
architecture and the physiological status within this community is the main 
interest for clinical, industrial and environmental microbiology (Thurnheer et 
al., 2004). Further detail on biofilm structure is provided in the Literature 
Review (section 1.2.2).
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5.1.3 Fluorescence in situ hybridisation
Fluorescence in situ hybridisation (FISH) is a relatively recent and now 
frequently used culture-independent approach for detecting and visualising 
microorganisms. This technique detects nucleic acid sequences within cells 
using fluorescently labelled probes that hybridize specifically to their 
complementary target sequences within intact cells (Moter and Gobel, 2000). 
FISH therefore combines the precision of molecular genetics with the visual 
imaging of fluorescent microscopy. Hence it permits visualisation and 
identification of individual cells within their natural habitat or diseased tissue 
(Moter and Gobel, 2000). The FISH procedure includes the following steps 
(Fig. 5.1): a) fixation of the specimen; b) preparation of the sample, including 
specific pre-treatment steps if required; c) hybridisation with probes for 
detecting the respective target sequences; d) washing steps to remove 
unbound probes; e) mounting and visualisation (Moter and Gobel, 2000).
More often, probes are used that target ribosomal RNA molecules as these 
are functionally conserved, abundant and present in all cells. The small 
subunit (16S and sometimes 23S) rRNA molecules are ideal targets for 
bacterial detection because they are stable and have high a copy number of 
molecules per cell (usually more than 10,000), which means that probing can 
be highly sensitive (Perry-O'Keefe et al., 2001b). As 16S rRNA sequence 
data is readily available for a wide variety of species, probes can be designed 
either to target signature sequences of specific species or chosen groups, or 
to hybridise with sequences conserved in all known bacteria (Amann, 2001). 
The probes used in FISH are typically 15 to 30 nucleotides in length and 
covalently linked at the 5’ end to a single fluorescent dye molecule (Wagner 
et al., 2003b). Suitable fluorophors include carbocyanide dyes, 
tetramethylrhodamine and fluorescein (Amann, 2001).
One of the major disadvantages of FISH when using oligonucleotide probes 
is that sometimes insufficient penetration of probes into bacteria occurs due 
to their thick cell wall, e.g. the walls of Gram-positive bacteria.
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a) cell fixation in 4% 
paraformaldehyde
b) preparation
bacteria
bacteria
c) hybridisation of 
probe
d) washing to remove 
excess or unhybridised 
probe
e) mounting
f) Visualisation by
fluorescent
microscopy
microscope slide 
FISH probe
i t  % %
Fig. 5.1 A  schematic diagram summarising the typical steps of a FISH  
protocol.
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5.1.4 Peptide Nucleic Acid (PNA) probes
Recently, PNA probes have been incorporated into FISH applications. PNA 
probes are DNA-analogues (pseudopeptides) with an uncharged polyamide 
backbone instead of conventional sugar phosphates. PNA probes hybridise 
to complementary nucleic acid targets obeying the Watson-Crick base pairing 
rules (Moter and Gobel, 2000; Perry-O'Keefe et al., 2001b). Due to their 
uncharged backbone, PNA probes have superior hybridisation 
characteristics, including higher specificity and more rapid hybridisation 
kinetics. PNA probes also hybridise independently of the salt concentration 
and readily diffuse through hydrophobic cell walls, thus allowing detection 
without any pre-treatments (Moter and Gobel, 2000; Perry-O'Keefe et al., 
2001b). As hybridisation with PNA probes can be performed in a low salt 
buffer, a decrease in the stability of the rRNA secondary structure can be 
induced, thereby allowing PNA probes to hybridise to otherwise less 
accessible targets (Perry-O'Keefe et al., 2001b). Hence PNA probes have 
considerable advantages over DNA probes, but unfortunately are significantly 
more expensive to synthesize.
5.1.5 Applications of FISH
FISH targeted towards 16S rRNA sequences has been applied to many 
diverse bacterial systems, often in conjunction with other molecular-based 
profiling approaches such as denaturing gradient gel electrophoresis (DGGE) 
or gene sequencing. The first uses of the FISH technique were in the 
detection and identification of bacteria in environmental specimens, including 
activated sludge granules (Sekiguchi et al., 1999) and marine sediments 
(Amann, 2001). In clinical samples, FISH has been applied to the study of 
potentially medically important bacteria, such as Escherichia coli in human 
faecal samples (Jansen et al., 1999; Vaahtovuo et al., 2005) and 
polymicrobial specimens from the oral cavity (Thurnheer et al., 2004). In the 
case of oral bacteria, FISH has been employed in the detection of organisms 
within samples of human carious dentine (Banerjee et al., 2002), dental 
plaque (Banerjee et al., 2002; Thurnheer et al., 2004; Thurnheer et al., 2001; 
Wecke et al., 2000), periapical endodontic lesions (Sunde et al., 2003) and
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buccal epithelial cells (Rudney et al., 2001; Rudney et al., 2005). PNA FISH 
has been less extensively used, although in recent years the approach has 
been applied for fast visualisation and identification of clinically relevant 
mycobacteria in clinical specimens and tissue (Lefmann et al., 2006). 
Examples of bacteria detected by PNA probes include clinically relevant 
Enterococcus species (Wellinghausen et al., 2007), Helicobacter pylori in 
gastric biopsy specimens (Guimaraes et al., 2007) and the identification of S. 
aureus directly from positive blood culture bottles (Oliveira et al., 2002).
5.2 AIMS
The aims of the present study were:
1. To establish a reliable FISH methodology using both DNA and PNA 
probes to detect specific wound bacterial species.
2. To evaluate FISH and CLSM in examining the spatial organisation of 
bacteria in biofilm models and wound tissue.
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5.3 Methods
To establish a reliable FISH methodology two separate FISH protocols were 
initially evaluated against planktonic bacteria and after validating these 
methods were extended to determine the spatial organisation in mixed 
species biofilm modes of growth. The two protocols were: A) detection of 
fixed bacteria using a universal DNA probe- EUB338 and B) PNA probe 
detection of bacteria (PNA FISH). The probes and their conditions are 
summarised in Table 5.1.
5.3.1 Universal DNA EUB338 probe
The universal bacterial DNA probe EUB338 is complementary to a portion of 
the 16S rRNA gene conserved in the domain Bacteria, and has been used to 
visualise the entire bacterial population of biofilms (Amann et al., 1990; 
Banerjee et al., 2002; Sunde et al., 2003). The probe EUB338, was 
synthesised commercially (MWG Biotech, Ebersberg, Germany) and at the 5’ 
end-labelled with fluorescein isothiocyanate (FITC).
The NON338 probe (Amann et al., 1990) which is complementary to the 
universal bacterial probe EUB338 was used in this study as a negative 
control for non-specificity. As an additional negative control, RNase treated 
cells were also probed to confirm that the probes specifically targeted RNA.
5.3.2 Peptide nucleic acid probes (PNA)
Initially, PNA probe sequences to target two bacterial species (P. aeruginosa, 
S. aureus) and the Bac-Uni1 universal bacterial PNA probe were used (Table 
5.1). The sequences of these probes were partially adapted from Perry- 
O’Keefe et al. (2001b). The probes were manufactured by Boston Probes 
(Foster City, USA) for Applied Biosystems (Warrington, UK) and were 
labelled either with FITC, cyanine 5 (CY5) or cyanine 3 (CY3) and designed 
to target the 16S rRNA. All probes were pre-validated using the PNA probe 
designer software (Applied Biosystems) before synthesis.
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Table 5.1 Probes used and their conditions.
Probes Target Nucleotide sequence Hybridisation 
conditions: 
temp. [°C] 
formamide [%]
Fluorescent
label
Working
Cone.
[nM]
Excitation
wavelengths
[nm]
References
EUB338 Universal
probe
(Eubacteria)
5’-GCTGCCTCCCGTAGGAGT -3’ 46°C 
no formamide
FITC 0.2-0.5 nM 488 (Amann et 
al., 1990)
Non
EUB338
Non-sense
EUB338
5’-CG ACGG AGGGC AT CCT C A-3’ 46°C 
no formamide
FITC 0.2-0.5 pM 488 (Amann et 
al., 1990)
Psaer PNA
P.
aeruginosa
5’-OOAACTT GCT GAACCAC-3’ 55°C 
no formamide
FITC 300 488 (Coull and 
Hyldig- 
Nielsen, 
2003)
Sta
16S03
PNA
S. aureus
5’-OOGCTT CT CGT CCGTTC-3’ 55°C 
30% formamide
CY5 500 633 (Perry- 
O'Keefe et 
al., 2001)
Bac-
Uni1
PNA
Universal
probe
(Eubacteria)
5’00CTGCCTCCCGTAGGA-3’ 55°C 
no formamide
CY3 150 561 (Perry- 
O'Keefe et 
al., 2001)
5.3.3 Development of fluorescence in situ hybridisation (FISH) for 
planktonically grown bacteria
5.3.3.1 Protocol A: Detection of fixed planktonic bacteria using the 
universal bacterial DNA EUB338 probe
Bacteria were prepared and detected by EUB338 using two methods. The 
first of these involved culturing bacteria overnight (in BHI broth) at 37°C. The 
growth was pelleted by centrifugation (7000 g, 5 min at 4°C) and 
resuspended in 0.85% (w/v) saline. This procedure was repeated to produce 
a washed pellet. A portion of the suspension was taken (100 pi) and three 
volumes of 4% paraformaldehyde added (giving a final concentration of 
paraformaldehyde of 3%). The cell suspension was then vortexed and 
stored overnight at 4°C. The cells were then centrifuged (7000 g, 5 min at 
4°C) and the bacterial pellet was again resuspended twice in 0.85% saline to 
its original volume, before dilution with paraformaldehyde. Subsequently, the 
suspension was incubated in 50 mM Tris-EDTA (pH 8; TE, Sigma) buffer 
containing lysozyme (10 mg ml'1; Sigma) for 20 min at 37°C (60 pi). The cell 
suspension was centrifuged and resuspended in half its original volume (50 
pi). An equal volume of 96% ethanol was then added. The suspension was 
vortexed for 30 s and stored at -20°C. Prior to staining with the DNA probe a 
portion of these fixed cells (10 pi) was deposited on to a microscope slide 
and air dried.
Pre-warmed hybridisation buffer (300 pi) containing 0.5 pM (in H2O) of 
oligonucleotide probe EUB338 (FITC-labelled), was carefully applied to the 
slide. Following incubation for 3.5 h in a dark humid chamber at 46°C, slides 
were washed with distilled water, air-dried in the dark and subsequently 
mounted with FluoroSave™ (Calbiochem, Merck Biosciences Ltd., 
Nottingham, UK).
The second method of preparing and detecting bacteria involved the 
resuspension of a colony of the bacteria from an agar plate into PBS.
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A smear was then made on a microscope slide that was air dried, flamed 
briefly to fix and then immersed in 4% paraformaldehyde overnight at 4°C. 
Slides were then washed with distilled water twice and dried at 37°C. To 
permeabilise the cells for entry of the oligonucleotide probe, slides were 
incubated in 50mM Tris-EDTA (pH 8) buffer containing lysozyme (10mg ml-1) 
for 20 min at 37°C. Slides were washed with distilled water, air-dried and 
incubated in 50mM TE buffer (pH 8) containing proteinase K (7pg ml'1) at 
37°C for 20 min. Slides were then washed again with distilled water, air-dried 
and pre-incubated at 48°C for 20 min in a hybridisation buffer (300 pi) 
containing 0.9 M sodium chloride (Sigma, Poole, UK), 20mM Tris-HCI (pH 
7.4, Sigma), and 0.5% SDS (Sigma). EUB338 hybridisation was then 
performed as described above.
5.3.3.2 Protocol B: Detection of fixed planktonic bacteria using the PNA 
probes
The first step was to confirm the specificity of the PNA probes on planktonic 
bacteria in a mixed fixed population using the three PNA probes; the 
universal probe (Bac-Uni1CY3), the P. aeruginosa specific probe 
(PsaerFITC) and the S. aureus specific probe (Sta16S03).
Cell fixation and PNA FISH was performed as described by Perry-O’Keefe et 
al. (2001a). Overnight bacterial cultures were pelleted by centrifugation 
(16,000 g, 5 min) and resuspended in PBS (7 mM Na2HP04, 7 mM 
NaH2P0 4 , 130 mM NaCI). Cell suspensions were centrifuged again (16,000 
g, 5 min), resuspended in PBS with 4% (w/v) paraformaldehyde (Sigma) and 
fixed for 1 h. The fixed cells were rinsed in PBS, resuspended in 50% (v/v) 
ethanol and incubated for at least 30 min at -20°C prior to use.
A 100-pl volume of fixed cells was pelleted by centrifugation, the cell pellet 
was rinsed with PBS and resuspended in 100 pi of hybridisation buffer (25 
mM Tris-HCI, pH 9.0; 100mM NaCI; 0.5% (w/v) SDS) containing 150-500 nM 
fluorescently labelled PNA probe. The cells were incubated at 55°C for 30
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min, centrifuged at 16,000 g for 5 min and resuspended in 500 pi of wash 
solution (10 mM Tris pH 9.0, 1 mM EDTA). After a further incubation at 55°C 
for 10 min the cells were pelleted by centrifugation. This was repeated twice 
for a total of three washes. Following the last wash, cells were resuspended 
in 100 pi wash solution and 2 pi of this cell suspension was spread on a 
clean microscope slide and allowed to air dry. Vectashield mounting medium 
was applied to the dried cells which were overlaid with a coverslip (Perry- 
O'Keefeetal., 2001a).
5.3.4 Development of biofilms for fluorescence in situ hybridisation 
(FISH) detection
Prior to bacterial detection and determination of bacterial spatial organisation 
in the biofilm mode of growth using FISH, biofilms had to be established 
using different models (CDFF, RHE). The preliminary steps for this are 
described below. The chronic wound biopsies were also processed as 
described below prior to FISH imaging.
5.3.4.1 Production of biofilms in the CDFF
Prior to FISH detection, biofilms were grown in the constant depth film 
fermenter (CDFF; Chapter 4, section 4.3.12.1). The temperature of the 
fermenter was maintained at 37°C by housing it in an incubator. The plugs 
were recessed to a depth of 400 pm, and the turntable speed of the CDFF 
was at 20 revs min'1. Wound bacteria (Staphylococcus aureus D76, 
Streptococcus oralis B52, Micrococcus luteus B81, and Pseudomonas 
aeruginosa D40) were grown overnight at 37°C in 10 ml BHI, and five ml of 
each wound isolate was added to 1 L of BHI medium. This inoculum was 
recirculated through the CDFF for 24 h to seed the system. After this time, 
the inoculum was disconnected and fresh media fed into the CDFF. Biofilms 
were grown in the CDFF for 7 d. Fresh medium was delivered at a rate of 30 
ml min'1, using a peristaltic pump (Watson-Marlow, Falmouth, UK) and 
biofilm samples were taken for analysis over a period of 7 days every 24 h.
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5.3.4.2 Fixation of CDFF generated biofilms
Biofilm samples (including the PTFE pin) generated in the CDFF were 
placed in molten agarose (2% w/v; Sigma) for 24h; fixed in 2% 
paraformaldehyde solution for 24 h and then embedded in paraffin wax using 
standard histological techniques.
5.3.4.3 Preparation of bacteria for infection of an in vitro Reconstituted 
Human Epidermidis (RHE) model
SkinEthic Laboratories cultivate a 0.5 cm2 reconstituted human epidermis in 
vitro on a polycarbonate filter at the air liquid interface in chemically defined 
medium lacking antibiotics for 17 days. The RHE consists of normal human 
keratinocytes (human foreskin derived) with a well differentiated epidermis 
consisting of basal, spinous, granular layers and a stratum corneum. At least 
four viable cell layers are present. This RHE was different to the oral 
epithelium used previously in Chapter 2.
Bacterial wound species (S. aureus D76, S. oralis B52, M. luteus B81, and P. 
aeruginosa D40) were cultured on blood agar (LAB M, Bury, UK) at 37°C 
overnight. The resulting growth was used to inoculate 10 ml of BHI and 
incubated at 37°C for 24 h. Bacterial cells were then harvested by 
centrifugation and washed (*3) with PBS. The pelleted bacterial cells were 
resuspended in RHE tissue maintenance medium (supplied by SkinEthic 
Laboratories, Nice, France; chemically defined medium MCDB 153 
containing 5 pg ml'1 insulin and 1.5 mM calcium chloride with no antibiotic) 
and 200 \x\ of the resulting bacterial suspension added to the RHE.
Additionally to simulate a skin wound, the surface of the RHE model was on 
occasion scratched with a sterile pipette tip prior to infection with bacteria.
5.3.4.4 Culture of infected RHE
Infected RHE was incubated for 24-28 h at 37°C in a humidified atmosphere, 
enriched with 5% C02as described previously (Chapter 2, section 2.3.2.4).
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5.3.4.5 Processing of infected RHE
After incubation, the whole RHE was fixed in 10% (v/v) formalin for 24 h and 
then embedded in paraffin wax using standard histological techniques (as 
previously described (Chapter 2, section 2.3.2.4.3).
5.3.4.6 Processing of biopsies from non- infected venous leg ulcers
Wound biopsies had previously been obtained with ethical approval and 
patient informed written consent from non-infected venous leg ulcer patients 
attending the Wound Healing Research Unit Clinic at the University Hospital 
of Wales, Cardiff between 1999 until 2002 and stored at -20°C until required 
(Davies et al., 2007). Biopsies were fixed in 10% (v/v) formalin for 24 h and 
then embedded in paraffin wax using standard histological techniques.
5.3.4.7 Preparation of biofilms (CDFF and RHE) and biopsies
Prior to FISH, all processed biofilm sections (20 pm; see above) were placed 
on to Histobond+ coated microscope slides (Raymond A Lamb, East Sussex, 
England), de-waxed and processed through xylene and ethanol to water 
before probe hybridisation. To hybridise the PNA/DNA probes to the fixed 
bacteria, sections were directly treated with 100 pi lysozyme (10 mg ml'1; 
Sigma) and incubated at 37°C for 30 min. Sections were then briefly washed 
in pre-warmed wash solution (10 mM Tris pH 9.0, 1 mM EDTA) prior to probe 
hybridisation.
5.3.4.8 Hybridisation of RHE derived biofilms with the universal EUB338 
DNA probe
Sections of RHE developed biofilms (RHE, 20 pM) were pre-incubated for 20 
min at 48°C in hybridisation buffer (300 pi) containing 0.9 M sodium chloride 
(Sigma), 20mM Tris-HCI (pH 7.4, Sigma), and 0.5% SDS (Sigma). Pre­
warmed hybridisation buffer (300 pi) containing 0.2-0.5 pM of FITC-labelled 
EUB338 oligonucleotide probe, (MWG Biotech, Ebersberg, Germany) was 
carefully applied to the RHE section. Following incubation for 3.5 h in a dark 
humid chamber at 46 °C, slides were washed with dH20, air-dried in the 
dark.
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5.3.4.9 Hybridisation of PNA probes to bacteria in RHE and CDFF 
biofilms and wound biopsies
One hundred and fifty pi of pre-warmed hybridisation buffer (25 mM Tris-HCI, 
pH 9.0; 100mM NaCI; 0.5% (w/v) SDS) containing 150-400 nM of 
fluorescently labelled PNA probe (see Table 5.1), was added to each CDFF 
biofilm/RHE tissue and wound biopsy section (20 pM), which was placed in a 
dark, humidified chamber and incubated at 55°C for 90 min. The stringency 
was adjusted by adding 30% (v/v) formamide to the hybridisation buffer for 
the S. aureus specific probe (Sta16S03). After incubation, each slide was 
washed with pre-warmed wash solution using a magnetic stirrer for 30 min.
5.3.4.10 Staining of RHE keratinocytes
For nuclear context, sections were counterstained with Hoechst 33258 
(Sigma) 2 pg ml-1 for 20 min, before washing in wash-solution and mounted 
using Vectashield fade-retarding mountant (Vector Laboratories Ltd., 
Peterborough, UK).
5.3.4.11 Haematoxylin and eosin
Additionally, biofilm and RHE sections were stained by the routine 
haematoxylin and eosin (H and E) procedure (Cross, 2004). Sections were 
processed using a Shandon Linistain machine (Shandon, Runcorn, UK) in 
the following order. Sections were first de-waxed, rinsed in 100% ethanol and 
then rinsed in H2O. After the washing steps, sections were stained with 
Harris’ haemotoxylin (Sigma) for 5-6 min, rinsed briefly in 1% acidic alcohol, 
followed by a brief rinse in Scott’s tap water substitute (blue, Sigma, UK) and 
counterstained with 1% aqueous eosin for 30 s to 1 min. Sections were 
dehydrated in alcohol, cleared in saline and mounted with DPX mounting 
medium (Raymond A Lamb Ltd., Eastbourne, UK).
5.3.4.12 Gram stain
Sections were first de-waxed, rinsed in 100% ethanol and then rinsed in H20. 
After the washing steps, sections were stained with Crystal violet (0.5% w/v) 
in 25% alcohol for 3 min, rinsed briefly in H20  and then stained with Gram’s
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iodine for 3 min. Sections were rinsed briefly in H2O, acetone decolourised 
for few seconds and again briefly rinsed in H2O. Subsequently sections were 
stained with neutral red for 3 min, dehydrated in alcohol, rinsed briefly in 
saline and mounted with DPX mounting medium.
5.3.5 Confocal Laser Scanning Microscopy (CLSM)
Stained sections were viewed and analysed by CLSM using a Leica TCS 
SP2 AOBS spectral confocal microscope (Leica, Wetzlar, Germany). The 
sections were scanned through the full depth using appropriate settings for 
single, double or triple channel fluorescence recordings of FITC, CY5, CY3 or 
Hoechst 33258 as detailed in Table 5.2. For multi-channel recordings, 
fluorochromes were scanned sequentially to eliminate spectral overlap 
between probes. Selected images were presented either as single confocal 
optical sections or maximum intensity type reconstructions.
209
Table 5.2 Scan parameters used for the simultaneous excitation and 
detection of the four probes used for CSLM.
Fluorochrome Laser Excitation Line 
(nm)
Emissions Detected 
(nm)
Hoechst 33258 405 410-485
FITC 488 498-540
CY3 543 550-610
CY 5 633 635-700
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5.4 RESULTS
5.4.1 Analysis of planktonic cell detection and RHE biofilms using the 
universal EUB338 probe
To establish a reliable FISH protocol the universal EUB338 probe was initially 
evaluated on planktonic and biofilm cells. Using the EUB338 probe, all the 
bacteria species could be detected (Fig. 5.2). However, strong 
autofluorescence of planktonic cells and the tissue and weak hybridisation 
signals were evident on RHE sections (Fig. 5.2c).
5.4.2 Bacterial specificity of PNA probes
The FISH protocol using PNA probes was established and widely used in this 
study on fixed and non-fixed bacteria. Figure 5.3 is a composite of three 
micrographs that show detection of all four test bacteria (S. aureus D76, S. 
oralis B52, M. luteus B81, and P. aeruginosa D40). Figure 5.3a illustrates 
detection of all bacteria using the PNA universal probe (Bac-Uni1CY3) with 
all cells visualised red. Figure 5.3b shows detection of P. aeruginosa only 
with the PsaerFITC. In this figure only a proportion of the population stain 
green, identifying P. aeruginosa. Cells which did not stain with the 
PsaerFITC also clearly had a distinct coccus type morphology. Figure 5.3c is 
an overlay of all the CLSM channels and shows detection of all bacteria 
stained with the three different fluorescent markers. Pseudomonas 
aeruginosa cells appear yellow in this overlay as a result of hybridising with 
both the Bac-Uni1CY3 and with the PsaerFITC probe. Blue/purple cells were 
S. aureus, as a result of hybridising with both the Bac-Uni1CY3 and the 
Sta16S03 probes. Red staining cells were either M. luteus or S. oralis as 
these hybridised only with the Bac-Uni1CY3 probe. Multiplex PNA staining 
demonstrated that these combined probe preparations remained effective for 
species identification.
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Detection of bacteria
Fig. 5.2 Detection of bacteria by universal EUB338 probe on (a) on fixed 
planktonic bacteria (b) on a C D FF biofilm sm ear (c) on a RHE section; x 100 
magnification.
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Fig. 5.3 Detection of mixed planktonic bacteria using three PNA probes, 
a) Universal bacterial probe (Bac-Uni1CY3)-all bacteria stain red, b) 
Pseudomonas aeruginosa probe (PsaerFITC)-only a proportion of the 
population stain green c) Multiplex PNA staining P. aeruginosa (yellow cells 
have hybridised with universal probe & P. aeruginosa specific probe). S. 
aureus (purple cells have hybridised with universal & S. aureus probes; 
Sta16S03CY5-blue). Micrococcus luteus and Streptococcus oralis (red only 
cells have hybridised with the universal probe).
5.4.3 Analysis of CDFF generated biofilms using PNA FISH
The PNA FISH technique was applied to mixed species biofilm growth of the 
target bacteria. Biofilms generated in the CDFF (single and mixed) were 
successfully processed and stained with the PNA FISH probes. Using all 
three PNA probes, target bacteria could be detected in appropriate sections 
of the biofilms examined. Examples of biofilm sections prepared in the CDFF 
containing fluorescently-labelled bacteria are shown in Fig. 5.4.-5.7. In a 
mixed species biofilm hybridised with all three PNA probes, distinct zones of 
each bacterial population were observed, and Fig. 5.4 confirms that the 
mixed biofilm is heterogeneous with respect to the species composition. 
Within these mixed biofilms P. aeruginosa seemed to be the predominant 
organism (Fig. 5.4-5.7). The biofilm mass was principally of bacillus-shaped 
bacteria (P. aeruginosa), with cocci found in isolated pockets (Fig.5.4-5.7). 
Pseudomonas aeruginosa was detected throughout the biofilm whilst S. 
aureus was concentrated towards the surface of the biofilm (Fig. 5.4c). The 
other bacteria (M. luteus and S. oralis) used in this system appeared to 
concentrate in the middle and lower sections of the biofilm (Fig. 5.4d). A 
mixed biofilm section showing staining with the P. aeruginosa specific probe 
and S. aureus specific probe reveals that the biofilm is mostly comprised of 
P. aeruginosa which encircle the S. aureus cells (Fig. 5.7). Figure 5.8 
illustrates spaces devoid of bacteria within the biofilm, suggestive of being 
water channels.
Analysis of biofilms over 7 days (day 3, day 5 and day 7) show how the 
mixed biofilms altered over time (Fig. 5.9). Figure 5.9a shows a 3 day old 
biofilm, where some of the bacteria are loose and the morphology of the 
community is clear. Figure 5.9b shows a 5 day old biofilm, which is very 
dense, especially on the top and on the base of the biofilm. Figure 5.9c 
shows a 7 day old biofilm which is very dense and features spaces devoid of 
bacteria characteristic of water channels.
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Fig. 5.4 PNA FISH on mixed bacterial species biofilms prepared in the 
CDFF, hybridised with 3 PNA probes a) universal bacterial probe (Bac- 
Uni1CY3-red), b) P. aeruginosa specific (PsaerFITC-green), c) S. aureus 
specific (Sta16S03CY5-blue) and d) all 3 channels. P. aeruginosa (yellow  
cells have hybridised with universal probe & P. aeruginosa specific probe). 
S. aureus (blue cells have hybridised with universal probe & S. aureus 
specific probe). M. luteus and S. oralis (red only, cells have hybridised with 
the universal probe).
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Fig. 5.5 PNA FISH on mixed C D FF biofilms using all 3 PNA probes a) 
universal bacterial probe (Bac-Uni1CY3-red), b) P. aeruginosa specific 
(PsaerFITC-green), c) S. aureus specific (S ta16S03C Y5-blue) and d) overlay 
of all 3 channels. P. aeruginosa (yellow cells have hybridised with universal 
probe & P. aeruginosa specific probe). S. aureus (blue cells have hybridised 
with universal probe & S. aureus specific probe). M. luteus and S. oralis (red 
only, cells have hybridised with the universal probe).
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Fig. 5.6 PNA FISH on mixed C D FF biofilms using all 3 PNA probes a) universal 
bacterial probe (Bac-Uni1CY3-red), b) P. aeruginosa specific (PsaerFITC- 
green), c) S. aureus specific (S ta16S03C Y5-blue) and d) overlay of all 3 
channels. P. aeruginosa (yellow cells have hybridised with universal probe & P. 
aeruginosa specific probe). S. aureus (blue cells have hybridised with universal 
probe & S. aureus specific probe). M. luteus and S. oralis (red only, cells have 
hybridised with the universal probe).
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Fig. 5 .7  PNA FISH on mixed C D FF biofilms using 2 PNA probes, a) P. 
aeruginosa specific (PsaerFITC-green), b) S. aureus specific (S ta16S 03C Y5- 
blue) and d) overlay of the 2 probes.
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Fig. 5.8 PNA FISH on a P. aeruginosa C D FF biofilm using P. aeruginosa 
specific probe (PsaerFITC-green), spaces devoid of bacteria indicated in 
white arrows.
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Fig. 5 .9  A 3D reconstruction of a mixed biofilm generated on the C D FF and 
stained with universal PNA probe (Bac-Uni1CY3). Structure of a) early 
stage, 3 day [showing cells that are loose and in aggregates] b) middle stage, 
5 day, [showing that cells are dense on the bottom of the biofilm and on the 
top. In the middle of the biofilm cells are more loosely structured] and c) late 
stage mixed biofilm, 7 day [showing spaces devoid of bacteria as well as 
dense areas with bacteria].
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5.4.4 Analysis of RHE biofilms using PNA FISH
Biofilms generated on the RHE were successfully processed and stained by 
both standard Gram staining (Fig. 5.10) and with the PNA FISH probes (Fig. 
5.11-5.17). The Hoechst stain, which was used to stain the nuclei of the 
RHE model, also stained the DNA of the bacterial organisms that were not 
detected by any of the species-specific PNA probes (i.e. non-S. aureus or P. 
aeruginosa organisms). Figure 5.10b shows a scratched RHE with limited 
bacterial invasion into the deep tissue.
5.4.5 Analysis of unfixed RHE biofilms using PNA FISH
In the infected (mixed population), unfixed RHE, bacteria were only detected 
on the tissue surface and not within the RHE. The detected bacteria tended 
to be present in clusters or aggregates on the surface of the RHE with no 
evidence of RHE invasion (Fig. 5.11-5.12). However, when a 3D motion 
video was created from the CLSM data, bacteria were seen as a multilayered 
community of cells deeper within the tissue (Fig. 5.12).
5.4.6 Analysis of fixed RHE biofiims using PNA FISH
Formalin fixed and paraffin-embedded RHE sections were also successfully 
processed and stained with the PNA FISH probes although only a few 
bacteria were found to be present (Fig. 5.13-5.15). These sections were 
infected with single species inocula. It was noticeable that bacterial 
colonisation was restricted to the surface of the RHE tissue with no bacterial 
invasion evident. Figures 5.16-5.17 confirm that bacteria actually invade the 
tissue when the tissue surface is damaged. It seemed that bacteria within 
the scratch wound tissue model were more abundant at the site of tissue 
damage compared with intact tissue. These results suggest that once the 
integrity is destroyed bacteria are able to move freely around and invade the 
tissue.
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stained are surface 
associated
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Keratinocytes
insert
membrane
b
RHE 
V Keratinocytes
Fig. 5 .10 Gram stain of RHE infected with two bacterial species (P. 
aeruginosa and S. aureus) a) x60 magnification, b) scratched RHE x100  
magnification.
Bacterial cells, darkly 
stained invade the tissue
/
insert
membrane
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Fig. 5.11 Detection of a mixed population of bacteria in the infected RHE  
model (unfixed). Stained with P. aeruginosa specific probe (PsaerFITC - 
green), with S. aureus specific probe (S ta16S 03C Y5-red) and counterstained 
with the Hoechst stain (blue). Pseudomonas aeruginosa predominated with 
only a limited number of S. aureus seen.
20|jm
Fig. 5 .12  Detection of mixed population of bacteria in infected RHE model 
(unfixed). Stained with P. aeruginosa specific probe (PsaerFITC-green), with 
S. aureus specific probe (S ta16S 03C Y5-red) and counterstained with the 
Hoechst stain (blue).
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Fig. 5.13 Fixed RHE samples infected with S. aureus (D76) and stained with
a) Hoechst, b) universal bacterial PNA probe (Bac-Uni1CY3-red) and c)
overlay of both channels.
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Fig. 5.14 Fixed RHE samples infected with Streptococcus oralis (B52) and
stained with a) Hoechst, b) universal bacterial PNA probe (Bac-Uni1CY3-red)
and c) overlay of both channels.
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Fig. 5.15 RHE infected with Micrococcus luteus (B81) and stained with a)
Hoechst, b) universal bacterial PNA probe (Bac-Uni1CY3-red) and c) overlay
of both channels.
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Fig. 5 .16  Scratch wounded RHE tissue infected with Streptococcus oralis 
(B52), Micrococcus luteus (B81), P. aeruginosa (D 40) and S. aureus (D 76) 
and stained with a) Hoechst, b) universal bacterial PNA probe (Bac- 
Uni1CY3-red) and c) overlay of both channels.
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Fig. 5 .17  Scratch wounded RHE specimen infected with Streptococcus oralis 
(B52), Micrococcus luteus (B81), P. aeruginosa (D 40) and S. aureus (D 76) 
and stained with Hoechst (nuclei-blue), universal bacterial PNA probe (Bac- 
Uni1CY3-red) and P. aeruginosa specific probe (PsaerFITC-green).
P. aeruginosa cells are yellow because they hybridise with universal probe 
and with P. aeruginosa specific probe. Pseudomonas aeruginosa appear to 
predominate with limited colonisation seen by the other organisms.
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4A.7 Analysis of wound biopsies using PNA FISH
Biopsy sections from chronic wounds were successfully processed and 
stained by both Qram-stain (Fig. 5.18) and with the universal bacterial PNA 
FISH probes. Using the universal PNA probe, bacteria could be detected 
within the biopsies sections. Examples of sections containing fluorescently 
labelled bacteria are shown in Fig. 5.19-5.21. The bacteria visualised 
appeared to be present both individually and in larger aggregates.
Sample 1 (Fig. 5.19) from a non-infected venous leg ulcer of a patient shows 
relatively few bacteria. This wound ultimately healed. Sample 2, a biopsy 
sections from a 73 year old female neurodiabetic patient with lower limb 
ischaemia and peripheral vascular disease were also successfully stained 
with universal PNA probe. Bacteria could again be detected (Fig. 5.20). A 
third sample, showing a biopsy section of a diabetic 71 year old female with 
lower leg ischaemia was taken from the pre-ulcer region showed bacteria on 
the surface of the section. Once the focal plane was moved inside the 
section, nuclei were detected but no bacteria, suggesting that they were 
surface associated (Fig. 5.21 animation on CD).
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Fig. 5 .18  Gram stain of Biopsy sections from non-infected chronic venous 
leg ulcers, a) x100 magnification; b-c) x 60 magnification; Bacteria are 
indicated by black arrows.
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Fig. 5 .19  Sections from a biopsy sam ple from a non-infected chronic venous 
leg ulcer patient (female, 64 year old) stained with the universal bacterial 
PNA probe (Bac-Uni1CY3-red) and the Hoechst stain.
The biopsy was taken from the centre of the wound bed.
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Fig. 5 .20  Sections from a Biopsy sample from a 73 year old female, 
neurodiabetic with lower limb ischaemia and PVD. Ulcer present for 5 years. 
Section is stained with universal bacterial PNA probe (Bac-Uni1CY3-red) and 
the Hoechst stain (nuclei-blue).
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Fig. 5.21 Sections from a Biopsy sample from a 71 year old female, diabetic 
with lower limb ischaemia, a) biopsy was taken from a pre ulcer region, b) 
biopsy was taken 3 cm away from the ulcer region. Section is stained with 
universal bacterial PNA probe (Bac-Uni1CY3-red) and the Hoechst stain 
(nuclei-blue).
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f5.5 Discussion
The impact of microorganisms on wound healing is poorly understood but 
there is strong evidence to suggest that bacteria within chronic wounds delay 
the wound healing process (Edwards and Harding, 2004; Percival and 
Bowler, 2004; Percival and Rogers, 2005). The production of destructive 
enzymes and toxins by bacteria results in tissue damage and indirectly 
promotes an inflammatory state (Percival and Rogers, 2005; Stephens et al.,
2003). Bacteria, such as P. aeruginosa release proteinases (e.g. matrix 
metalloproteinases) which are known to affect growth factors and many other 
tissue proteins necessary for wound healing (Kim et al., 2000; Percival and 
Rogers, 2005; Steed et al., 1996; Travis et al., 1995; Vaalamo et al., 1997). 
Removal of bacteria by host defence mechanisms and antimicrobial therapy 
is difficult in wound environments where biofilms have been established.
In this study, FISH was used to identify the presence of specific bacteria and 
to examine their spatial organisation within “in vitro” biofilms established 
using the CDFF and RHE models, as well as “in vivo” in actual chronic 
wound biopsy sections.
In the preliminary study, a universal eubacterial DNA probe, EUB338 was 
used to detect bacteria in planktonic suspension and in biofilms. One 
problem of using the EUB338 probe was its relatively low signal intensity, 
possibly as a consequence of insufficient penetration of the probe into the 
bacterial cells (Moter and Gobel, 2000). The enzymatic treatment of the 
sections in this study, with both lysozyme and proteinase K was employed in 
an effort to counter this problem. However, even after enzymatic treatment 
poor fluorescence of the target bacteria was evident.
In contrast, much stronger fluorescence of bacteria occurred when the PNA 
probes were used. Due to the neutral backbone of PNA probes they are able 
to diffuse readily through hydrophobic cell walls and membranes thereby 
allowing detection of bacteria without the need for any pretreatment to 
enhance cell permeabilisation. The high copy number of 16S rRNA in
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wreplicating and metabolically active bacteria provides a sufficiently high target 
molecule for probes used in FISH. Potential problems of using RNA probing 
techniques are that the ribosomal content can differ between cells. Although 
normally abundant, the amount of rRNA is dependent on the physiological 
state of the bacterium and can vary significantly between bacterial species 
(Kemp et al., 1993; Moter and Gobel, 2000; Poulsen et al., 1993; Wallner et 
al., 1993). Another potential issue of targeting rRNA is the 3-dimensional 
structure of the rRNA. This means that not all sequences are equally 
accessible to probes (Moter and Gobel, 2000). These issues make probe 
design a critical factor for the successful application of PNA FISH.
In this study, a PNA - FISH methodology was developed and validated for 
three PNA probes to identify and visualise polymicrobial paraffin embedded 
biofilms and clinical specimens. To verify the PNA probe specificity, a 
planktonic preparation was again firstly analysed, before applying the probe 
to biofilms and biopsy sections. The use of PNA probes in this bacterial 
specific FISH protocol permitted the simultaneous identification of mixed 
bacterial species in planktonic suspension (Fig. 5.3). Subsequent application 
to bacterial biofilm populations using the differently labelled PNA probes 
revealed a much higher signal intensity compared to the previously used 
universal bacterial DNA probe. As a result, the PNA probes were used for 
later investigations of biofilms and wound biopsies. A significant advantage 
of PNA probes is the ability to hybridise under low salt concentrations, a 
condition that promotes the destabilisation of rRNA secondary structure and 
results in improved access to target sequences that can be elusive using 
conventional FISH (Perry-O'Keefe et al., 2001a; Perry-O'Keefe et al., 2001b). 
Hence, in this present study hybridisation was carried out under low salt 
concentration (100mM NaCI), high-temperature (55°C) and high pH (pH 9.0) 
conditions. Surprisingly, the S. aureus specific PNA probe (CY5 labelled) 
was very weak in fluorescence compared to the universal PNA bacterial 
probe (CY3 labelled) and the P. aeruginosa specific PNA probe (FITC 
labelled). To improve the fluorescence intensity, it was absolutely necessary 
to expose biofilms containing the Gram-positive organisms to lysozyme pre­
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treatment for 15 min at 37°C and to add 30% formamide to the hybridisation 
buffer when using S. aureus specific PNA probe. Without lysozyme 
treatment and the addition of formamide, biofilms hybridised with the S. 
aureus specific probe (Cy5 labelled) showed none or only weak 
fluorescence. This has been previously observed in several other studies, 
(Hartmann et al., 2005; Lefmann et al., 2006; Wellinghausen et al., 2007). 
Perry-O’Keefe et al. (2001a) described a method using PNA probes for the 
simultaneous identification of Gram-positive and Gram-negative organisms. 
In their protocol, a 1 h paraformaldehyde fixation treatment was sufficient to 
permeablise Gram-positive cells (Thurnheer et al., 2004). This was not the 
case for the mixed biofilms in the present study.
Biofilms generated in the CDFF showed the characteristics of a typical biofilm 
architecture, e.g. the presence of confirmed spaces devoid of bacteria, which 
could potentially be water channels (Fig. 5.8). The function of channels is to 
facilitate and exchange nutrients and waste products (Hall-Stoodley et al.,
2004). The 3D reconstruction of a mixed biofilm analysed by CLSM clearly 
shows the progression of biofilm establishment over a 7 d period. Initially, it 
is clearly apparent that on day 3 the bacterial community is composed of 
loosely associated cells compared to day 7. By day 5 the bacteria start to 
aggregate and the community is very dense on the top and on the base of 
the biofilm. On day 7 a typical biofilm structure is evident with spaces devoid 
of bacteria. Furthermore, use of the species-specific PNA probes showed 
that the spatial organisation of the organisms in the community grew in 
aggregates in distinct zones, suggesting that the organisms did not integrate 
well with one another under these conditions. The main constituent of these 
mixed species CDFF biofilms seemed to be P. aeruginosa followed by cocci 
bacteria.
In fixed RHE sections, few bacteria were detected on the surface and only a 
sparse biofilm was formed. This could be explained by the processing 
technique used, which could inadvertently have washed the bacteria off the 
tissue. However, in scratch wounded RHE sections, it was apparent that
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bacteria started to penetrate the tissue and to migrate beneath the damaged 
surface layer. This suggests that once the integrity of the epithelial barrier 
has been disrupted (as would be encountered in a wounding situation) the 
bacteria were able to invade into the tissue. In fresh (unfixed) RHE sections, 
bacteria were restricted to the surface and the different species were not 
found to have integrated with one another. These data indicate that a well 
established biofilm was not produced in the RHE under the conditions 
applied in this study without wounding. In Chapter 2 the suitability of the oral 
mucosal as an in vitro model was illustrated and showed Candida albicans’ 
ability to invade and form a biofilm. Unlike bacteria, however the fungus 
possesses the filamentous form, with hyphae actually able to penetrate the 
epithelium and multiply within the tissue.
A further limitation of the RHE system is the lack of certain host immune 
responses, although proinflammatory cytokine responses by in vitro epithelial 
cell lines, in a reconstituted oral epithelium model (Chapter 2), have been 
reported to be maintained (Schaller et al., 2002; Villar et al., 2005). Hence, 
the RHE has drawbacks as a chronic wound model but has to be considered 
as the closest related “in vitro” model to date for human epithelial cells, and 
has the benefit of avoiding the ethical issues that are associated with working 
with clinical human samples. Importantly, both models (CDFF and RHE) 
revealed heterogeneous biofilm structures with discrete clusters of bacterial 
species, with P. aeruginosa as the predominant organism. It is likely that the 
bacterial species within the biofilms compete with each other for space, 
attachment or nutrients. The high level of detection of P. aeruginosa by FISH 
in RHE and CDFF biofilms correlates closely with the cultural findings in 
Chapter 4. Two possible factors for the predominance of P. aeruginosa in 
these mixed biofilms could be its twitching and flagella-mediated motility, 
allowing P. aeruginosa to migrate to optimal growth localities as the biofilm 
matures as well as its faster growth rate. The other species used in this 
study were all non motile organisms. It seems that P. aeruginosa has 
adapted to use these surface structures, flagella and pili, to its own particular 
needs (Davey and O'Toole, 2000). Interestingly, P. aeruginosa did not
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appear to do so well in single species biofilms (Chapter 4) and so seems to 
benefit synergistically from associations with other organisms.
Obviously, these experiments do not reflect exactly the in vivo situation within 
a chronic wound. In vivo, different microbial species could well be expected 
to colonise at different times with specific species acting as pioneer 
colonisers. In our experiments, all four bacteria species were added to the 
RHE simultaneously. It would therefore be interesting to add the species in a 
successive manner. For instance, P. aeruginosa could be added to the 
model first to form a base for the biofilm, with other species added 
subsequently to determine if they were able to grow to a greater extent on 
the biofilm surface. Since it was observed in this study that P. aeruginosa 
appeared to out-compete the other organisms it might also be of interest to 
see whether staging of the infection times allows the other species to grow at 
higher levels before P. aeruginosa is added to the system.
Analysis of chronic wound biopsies by FISH using the universal bacterial 
PNA probe showed the presence of bacteria. Unfortunately, maintaining the 
integrity of the biopsy tissue during processing and storage proved difficult 
even when the tissue had been paraffin-wax embedded. Also, establishing 
the orientation of the tissue was problematic, as it had been archived for a 
considerable time. Therefore, it was difficult to analyse the results from 
biopsy samples. Routine haematoxylin and eosin staining as well as PNA 
FISH detection confirmed that a few but not many bacteria were present in 
those biopsy sections. Previous work on chronic wound specimens has 
revealed the presence of densely aggregated colonies of bacteria 
surrounded by an extracellular matrix by microscopic studies (Bjarnsholt et 
al., 2008; James et al., 2007).
In future studies, it would be of interest to incubate the infected RHE for 
longer than 24 h to see if this would indeed result in greater infiltration of the 
bacterial cells within the RHE. The use of a different culture media that 
promotes bacterial growth as opposed to the tissue maintenance medium
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could also be used. In addition, it would be interesting to detect the presence 
of any EPS matrix generated by the chronic wound bacterial biofilms. Due to 
time constraints EPS analysis was not pursued but it would be interesting to 
counterstain the EPS using for example, calcofluor white, after completion of 
FISH probing. Thurnheer et al. (2004) showed detection of organisms in a 
multispecies biofilm of supragingival plaque using FISH and combined this 
with EPS staining using calcofluor white.
Now that a basic protocol for using PNA FISH to examine biopsy sections 
has been established, the technique could be used in future studies on new 
‘fresh’ chronic wound tissue. This could provide important information on the 
various species present in the chronic wound tissue and how they are 
spatially arranged on and within the tissue. Ideally, this approach could also 
be used to compare the species present within chronic wounds with those in 
healthy control tissue, either from the same patients, or from other, age- 
matched patients without chronic wounds.
PNA -  FISH was shown to be a rapid and versatile tool for both research 
purposes and potentially for clinical microbiology diagnostics when used in 
conjunction with CLSM. CLSM has been established as a valuable tool for 
obtaining high-resolution images and three-dimensional reconstructions of 
fluorescently labelled biofilms and biological samples (Lopez et al., 2005; 
Sunde et al., 2003; Thurnheer et al., 2004; Wagner et al., 2003a). The future 
application of this technique to clinical biofilms from infected tissues or 
indwelling medical devices could facilitate the identification and estimation of 
the relative proportions of bacteria within a biofilm without the need for 
bacterial culture. This approach could be used to assess biofilm 
management strategies or evaluate the effectiveness of antimicrobials 
against members of the biofilm consortium. Importantly, this technique could 
potentially be applied to clinical samples for identifying significant bacterial 
infections.
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6.6 Summary
1. This study showed that it was possible to simultaneously detect and 
identify several members of a four-species biofilm consortium, comprised of 
both Gram-positive and Gram-negative bacteria.
2. The spatial organisation of bacteria in biofilm models and wound tissue 
was assessed by PNA FISH and CLSM. This modified FISH technique 
enabled the visualisation of the arrangement of the microbial population as 
well as the typical architecture of the biofilms depicting spaces devoid of 
bacteria which could potentially be water channels. The different species did 
not appear to integrate well with each other, with distinct, discrete clusters of 
each species evident. The main constituent of the established biofilms was 
P. aeruginosa, which supports previous culture evaluations (Chapter 4).
240
Chapter 6 
Gene expression in bacterial
biofilms
6.1 Introduction
The aetiology of chronic wounds is poorly understood, but evidence suggests 
that chronic wounds support a diverse microbial flora, which may contribute 
both indirectly and directly to the failure of the normal wound healing process. 
Bacteria can express numerous virulence factors that contribute to 
pathogenesis and host invasion. Typical examples of bacterial virulence 
factors include hydrolytic enzymes such as proteinases, DNAses, and 
phospholipases. In the past, evaluating the potential role of such agents in 
pathogenicity has involved detection of the protein or its activity in clinical 
specimens. However, with the advent of high technology molecular analysis 
it has become possible to detect expression of bacterial virulence factors 
through analysis of specific messenger RNAs.
The roles of bacterial virulence factors in promoting the chronic wound 
phenotype have, as yet, not been elucidated. Examples of P. aeruginosa 
virulence factors include the possession of pili, flagella, lipopolysaccharide, 
proteases, quorum sensing molecules, exotoxin A, exoenzymes and alginate, 
which all contribute to its pathogenic importance (Bjarnsholt et al., 2008; 
Lyczak et al., 2000). It has been suggested that proteases promote infection 
and dissemination, whilst elastase degrades collagen and non-collagen host 
proteins and disrupt the integrity of the host basement membrane (Lyczak et 
al., 2000). It can be readily envisaged how the expression of these enzymes 
that either degrade host tissue or destroy the protective immune cells or their 
products could contribute to delayed wound healing.
In recent years it has been postulated that bacterial biofilms may play a role 
in the prevention of the normal wound healing process (James et al., 2007). 
Biofilm bacteria are reported to be less susceptible to the immune system 
and also to administered antimicrobial agents and therefore a biofilm 
associated wound infection may persevere and progress from an acute to a 
chronic infection state (Percival and Rogers, 2005).
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It has been hypothesised that the phenotypic changes observed in 
microorganisms as they attach to a surface are due to the differential 
expression of genes within biofilms (O'Toole et al., 2000a). However, it 
appears that biofilm development occurs differently according to nutritional 
and environmental conditions and consequently there may be many 
pathways and stages involved in biofilm development (Klausen et al., 2003).
6.1.1 The bacterial microflora of chronic wounds
The significance of microorganisms in chronic wounds has been extensively 
studied and different approaches used to elicit their possible role in non­
healing wounds. Studies have included assessing the impact of microbial 
populations on clinical outcome (Madsen et al., 1996) and observations of 
the occurrence of particular species (Schraibman, 1990) or groups of 
organisms within specific wounds (Davies et al., 2007; Wall et al., 2002). 
Previous studies using molecular (Davies et al., 2004; Davies et al., 2001; 
Hill et al., 2003; James et al., 2007) and culture-based approaches (Bowler 
and Davies, 1999) have indicated the presence of polymicrobial bacterial 
communities in chronic wounds. The most frequent isolates include 
staphylococci, streptococci and Pseudomonas sp. (Davies et al., 2001). 
Cultural analysis has also shown Acinetobacter sp. and Proteus sp. to be 
prevalent in chronic wounds (Hill et al., 2003) and have also documented that 
staphylococci, streptococci, enterococci and facultative Gram-negative bacilli 
are the principle bacterial groups that are recovered from chronic venous leg 
ulcers (CVLU) (Davies et al., 2007; Hansson et al., 1995). In addition to 
these aerobic bacteria, anaerobic organisms have also been identified in 
chronic wounds, such as Peptostreptococcus spp., Bacteroides spp. (Davies 
et al., 2007) and pigmented and non-pigmented Prevotella and 
Porphyromonas spp. (Bowler and Davies, 1999; James et al., 2007).
6.1.2 Genotypic differences between planktonic and biofilm populations
It is believed that microorganisms present in chronic wounds contribute to the 
non-healing phenotype and may exist within wounds as part of a biofilm 
community (Davies et al., 2007; Mertz, 2003; Serralta et al., 2001). Biofilm
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associated infections are typically persistent; they develop slowly, are rarely 
resolved by immune defences and respond transiently to antimicrobial 
therapy (James et al., 2007; Parsek and Singh, 2003). For example, Gram- 
negative bacterial components such as colonic acid (in Escherichia coli), 
alginate, glucose and mannose-rich Pel (product of the pellicle formation 
gene) and Pis (product of the polysaccharide synthesis locus) matrix 
components (in P. aeruginosa), cellulose and p-1-6-GlcNac polymer (in 
Salmonella and E. coli), have been reported to play important roles in biofilm 
formation (Beloin and Ghigo, 2005; Friedman and Kolter, 2004; Matsukawa 
and Greenberg, 2004).
As described previously (see section 6.1) and in the Literature Review 
(Chapter 1, section 1.9.2), P. aeruginosa and S. aureus are recognised key 
organisms in chronic wounds and consequently provide a major focus for this 
chapter.
6.1.3 Gene expression in P. aeruginosa and S. aureus biofilms
There are many genes whose expression has been associated with the 
virulence of P. aeruginosa and S. aureus (Table 6.1). Examples of genes 
important in biofilm formation are described below.
6.1.3.1 Periplasmic glucans synthesis in P. aeruginosa
Periplasmic glucans may contribute to antibiotic resistance by reducing the 
diffusion of antibiotics into the cell (extracellular sequestering) thereby 
allowing the bacteria additional time to adapt to an antibiotic challenge (Mah 
et al., 2003; Whiteley et al., 2001).
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Table 6.1 Genes involved in biofilm formation
Regulatory genes Function Reference
Gram positive bacteria (S. aureus, S. epidermidis)
icaADBC Mediates cell-cell adhesion (Arciola et al., 2001, Beenken et al., 2004, Conlon et al., 2002a, Conlon
et al., 2002b, Mack et al., 1996, Rohde et al., 2005, Yazdani et al.,
2006)
Accessory gene regulator (agt) Regulates virulence factors / (Ben Ayed et al., 2006, Shopsin et al., 2003)
Involved in cell detachment
Staphylococcal accessory Production of surface associated & (Beenken et al., 2003, Beenken et al., 2004)
gene regulator (sarA) secreted virulence factors
SigmaB Activates biofilm formation (Knobloch et al., 2004)
Gram negative bacteria (P. aeruginosa)
Chaperone-usher pathways Assembly of novel fimbrial (Croft et al., 2000, Vallet et al., 2001)
(cupA. cupB, cupC) structures
rpoS Important for biofilm formation and (Heydom et al., 2002, Whiteley et al., 2001, Xu et al., 2001)
antibiotic susceptibility
Crc Activation of type IV motility (O'Toole et al., 2000)
mvaT Reduces adhesion via cup gene (Vallet et al., 2004)
repression
rpoN Role in initial adhesion & biofilm (Thompson et al., 2003)
formation
ps?W
The extracytoplasmic mode of antibiotic sequestration might be expected to 
interfere with the passage of antibiotics through the periplasmic space to their 
site of action in the cytoplasm. For the synthesis of periplasmic glucans 
ndvB is required. The ndvB gene encodes for a glucosyltransferase that is 
required for the synthesis of cyclic-P-(1, 3)-glucans (Mah et al., 2003; 
Whiteley et al., 2001). Mah et al. (2003) also predicted that ndvB is 
preferentially expressed in biofilm grown cells.
Cyclic glucans are circular polymers of glucose, which play a role in 
adaptation to low osmotic media, flagella-mediated motility and plant-microbe 
interactions. These glucans are located in the periplasm and also secreted 
into the extracellular medium (Breedveld and Miller, 1994; Mah et al., 2003). 
It has been suggested that the glucose polymers may prevent antibiotics 
from reaching their sites of action by sequestering antimicrobial agents in the 
periplasm (Breedveld and Miller, 1994; Mah et al., 2003).
The impermeability of bacteria to antibiotics involves several factors, 
including the tolA gene product (Rivera et al., 1988) and terminal electron 
transport proteins (Bryan and Kwan, 1983; Bryan et al., 1980; Whiteley et al., 
2001). The tolA gene product affects the LPS structure, resulting in 
decreased aminoglycoside affinity for the outer membrane. Evidence 
indicates that tolA is an essential P. aeruginosa gene, but mutants that 
under-produce tolA are hypersensitive to aminoglycoside antibiotics (Rivera 
et al., 1988). Therefore, the tolA gene could contribute to biofilm resistance 
to aminoglycosides.
6.1.3.2 Alginate genes of P. aeruginosa
Alginate is a viscous exopolysaccharide, consisting of D-mannuronic and L- 
guluronic acids. Alginate production by P. aeruginosa is regarded as a 
virulence factor that appears to promote biofilm formation, thus enhancing 
host colonisation. Furthermore, alginate induced biofilms have also been 
shown to confer resistance to antibiotics (Hershberger et al., 1995), promote 
bacterial adherence, sen/e as a barrier to phagocytosis and provide a
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mechanism to neutralise oxygen free radicals (Edwards and Saunders, 
2001).
It has been suggested that alginates play an important role in P. aeruginosa 
infection of cystic fibrosis (CF) patients, urinary tract infections, the fouling of 
man-made materials and in biofilm formation on abiotic surfaces in the 
natural environment (Davies et al., 1993). Strains of P. aeruginosa isolated 
from the lungs of CF patients have been observed to have a mucoid 
phenotype with production of exopolysaccharide alginate (Edwards and 
Saunders, 2001). Alginate is thought to have a protective function in a 
relatively harsh environment in which the bacteria are continually subjected 
to oxidative stress and challenge by the immune system (Krieg et al., 1988; 
Simpson et al., 1988; Simpson et al., 1989).
Even though most P. aeruginosa strains have the ability to produce alginate, 
the majority of strains exhibit a non-mucoid phenotypes (Hershberger et al., 
1995). The switch to the mucoid phenotype is also thought to promote 
persistence of P. aeruginosa (Hentzer et al., 2001). Mucoid production has 
further been shown to aid bacterial survival in nutrient poor environments 
(Hershberger et al., 1995). In a biofilm state or in a condition such as cystic 
fibrosis, P. aeruginosa must adapt to its environment and this is manifested 
by overproduction of alginate.
Alginate production is regulated by at least two mechanisms. Firstly, by a 
response regulator involved in a bacterial signal transduction system which is 
controlled by environmental factors. Secondly, by a gene cluster containing 
the sigma factor algU (Fig. 6.1) (Edwards and Saunders, 2001). The algU 
gene is autoregulated and has two negative regulators encoded by mucA 
and mucB. Inactivation of either mucA or mucB results in activation of algD 
through enhanced expression of algU, and so leads to overproduction of 
alginate (Edwards and Saunders, 2001). Although alginate production may 
not be required for biofilm formation, it undeniably affects the biofilm 
architecture (Stapper et al., 2004).
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Fig. 6.1 Pathway leading to alginate production in Pseudomonas aeruginosa. (Adapted from Jain and Ohman (1998).
6.1.3.3 Accessory gene regulator (agr) of S. aureus
The agr system regulates the coordinated production of several virulence 
factors (Shopsin et al., 2003). The agr operon encodes a two-component 
signalling system (Chapter 1, Fig. 1.6; agrC is the signal receptor and agrA is 
the response regulator) which is driven by a quorum sensing autoinducing 
peptide, encoded by the agrD gene (Ben Ayed et al., 2006).
Staphylococcus aureus isolates can be classified into four (l-IV) specific agr 
groups on the basis of the autoinducing peptide specificity for its signal 
receptor (agrC) (Ben Ayed et al., 2006; Shopsin et al., 2003). It has been 
suggested that strains of one group can cross-activate the agr system of 
other strains in the same group to produce a response, e.g. an up regulation 
of virulence factors in other strains of the same group. Conversely, inhibition 
of the agr response of members of other groups (Camara et al., 2002) could 
also occur. It is important to note that these genotypes can also be 
correlated with specific phenotypes, e.g. most menstrual toxic shock 
syndrome strains belong to agr group III (Fischetti, 2006). The agr system 
coordinates the production of virulence factors during different phases of the 
cell cycle, which help with the organisms’ ability to invade and its 
pathogenicity, e.g. it can down-regulate the production of cell wall-associated 
proteins and up-regulate secreted proteins at late to stationary growth 
phases in vitro (Camara et al., 2002; Fischetti, 2006).
6.1.3.4 Intercellular polysaccharide adhesin (ica) of S. aureus
Over 90% of clinical S. aureus strains possess capsular polysaccharides. 
Capsule production is believed to decrease phagocytosis in vitro, and has 
been shown to enhance S. aureus virulence in a mouse bacteriaemia model 
(Harris et al., 2002).
Biofilm formation can be described as a two step process that first requires 
adhesion of bacteria to a surface followed by cell-cell adhesion, forming 
multiple layers of the biofilm. This process in S. aureus is associated with the 
polysaccharide intercellular adhesin (PIA), which is composed of linear P-1,
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6-linked glucosaminylglycans. The ica locus is thought to mediate cell-cell 
adhesion and PIA production (Cramton et al., 1999). The locus itself is 
comprised of four intercellular adhesion genes (icaA, icaB, icaC and icaD) 
and one regulator gene (/caP) which appears to function as a repressor 
(Cafiso et al., 2004; Conlon et al., 2002a; Gotz, 2002; Mack et al., 1996; 
Ziebuhr et al., 1999). IcaA and icaD play a significant role in S. aureus and
S. epidermidis biofilm formation (Yazdani et al., 2006). The product of icaA is 
a N-acetylglucosamine transferase, icaC and icaD encode membrane 
proteins and icaB encodes a signal peptide that is secreted into the medium 
(Fig. 6.2) (Gelosia et al., 2001).
6.1.4 Reverse Transcriptase Polymerase Chain Reaction (RT-PCR)
Previous studies have examined gene expression in bacterial biofilms 
including those produced by S. aureus and P. aeruginosa (Arciola et al., 
2001; Conlon et al., 2002a; Cramton et al., 1999; Gelosia et al., 2001; Mah et 
al., 2003; Sakoulas et al., 2002). For example, Cafiso et al. (2004) used this 
approach to determine the expression of the icaADBC operon in S. 
epidermidis strains isolated from catheter related and nosocomial infections 
and correlated expression to biofilm production. Mah et al. (2003) used RT- 
PCR to identify expression of the ndvB locus which is required for the 
synthesis of periplasmic glucans in P. aeruginosa. RT-PCR is a sensitive 
method but is at best only semi-quantitative. To overcome this limitation a 
quantitative real-time PCR can be employed which allows monitoring the 
formation of the product in real time. The monitoring of product is 
accomplished using various types of fluorescent dyes.
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icaR icaA ic
Fig. 6.2 Schematic of the ica locus.
The operon is composed of the icaR (regulator gene) and icaADBC 
(biosynthesis) genes. The icaR gene is transcribed divergently from the 
other four genes and the icaA, B, C and D genes appear to be translated 
from a single transcript.
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6.1.5 Microarray study
‘array’ refers to the regular arrangement of oligonucleotide or cDNA 
representations of genes on a solid support such as nylon membranes and 
plastic or glass microscope slides (Whatling et al., 2003). Many complete 
genomic sequences of microorganisms are now available. The analysis of 
bacterial genomes has already contributed to our understanding of the 
molecular evolution and diversity of human pathogens including 
Campylobacter jejuni, Vibrio cholerae, Streptococcus pyogenes, Helicobacter 
pylori, Mycobacterium bovis and S. aureus. Such information has been 
invaluable in the development of microbial microarray techniques. 
Microarrays are now increasingly being used for bacterial genome analysis 
and the approach has proven to be of great value in helping elucidate the 
genomic diversity and evolutionary relationships within species (Fitzgerald et 
al., 2001; Saunders et al., 2004a).
However, gene expression analysis is the most common application of 
DNA/oligonucleotide microarrays. In this technique, RNA isolated from two 
samples (control and test sample) is fluorescently labelled, generally with 
cyanine 3 (CY3 green) and with cyanine 5 (CY5 red) before being hybridised 
to a microarray consisting of large numbers of oligonucleotides orderly 
arranged on the surface of a glass microscope slide (Fig. 6.3). These two 
cyanine dyes have different absorption and emission spectra. After 
hybridisation, a high resolution scanner records the signal. Green or red 
signals indicate that only one of the targets has hybridised to the probe, and 
yellow shows that both control and test sample have hybridised (Ljperen and 
Saunders, 2004).
Microarrays represent a relatively recent method for analysing bacterial 
genotypes. The advantages of microarrays lie in their flexibility, the versatility 
in the use of probes to test sample material and the fact that probes can be 
used to detect DNA sequences linked to specific phenotypic characteristics 
(Ljperen and Saunders, 2004).
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Test sample Prepare Control sample
target mRNA
Label with 
fluorescent dye
Combine equal amounts
I
Hybridise target mixture 
to microarray
I
Scan and analyse data
Generate microarray
Fig. 6.3 Schematic procedure involved in microarray analysis.
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- Microarray studies have been used to identify global gene expression profiles 
of biofilms (Lazazzera, 2005). Whiteley et al. (2001) performed the first DNA 
microarray study to analyse gene expression in P. aeruginosa planktonic and 
biofilm cells. This initial microarray showed that approximately 1 % of genes 
were differentially expressed between biofilm and planktonic growth phases 
and that rpoS gene expression was important in both biofilm formation and 
resistance to the antibiotic tobramycin (Whiteley et al., 2001). Resch et al. 
(2005) carried out a microarray analysis to determine which genes were up- 
regulated in S. aureus biofilms. Their data reported up-regulation of the ica 
genes in early biofilms (6-8 h of growth) compared to planktonic cells, 
suggesting that ica up-regulation was not needed after attachment and 
biofilm formation had begun (Resch et al., 2005). Resch et al. (2005) found 
that a range of virulence factors (e.g. proteases) and toxins were up- 
regulated in planktonic cells, which could be useful to cause acute infection 
and to invade cells. It has been suggested that toxins and proteases are not 
important for biofilm persistence once established (Resch et al., 2005).
Printed arrays can be used for either Comparative Genome Hybridisation 
(CGH) or expression profiling work. The S. aureus microarray used in this 
study consists of 720 oligonucleotide probes representing the virulence and 
housekeeping genes of S. aureus. Data derived from the array will allow 
comparative analysis of gene expression by isolates from S. aureus biofilms 
generated on the CDFF and from planktonic S. aureus in exponential and 
stationary phase.
6.2 AIMS
The aims of this chapter were:
To use both RT-PCR and microarray analysis to examine the in vitro biofilm 
gene expression of two chronic wound bacterial species, namely S. aureus 
and P. aeruginosa. Biofilms were generated for this study using the Constant 
Depth Film Fermenter as described in Chapter 4.
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6.3 Methods
6.3.1 Processing of CDFF biofilms
Biofilms were prepared using the CDFF as described previously (Chapter 4, 
section 4.3.12). CDFF biofilms for RT-PCR were recovered and stored in a 2 
ml microtube with 1.5 ml RNAIater® (Ambion Europe Ltd, Huntington, UK) 
solution before RNA extraction (section 6.3.3) and were maintained at -80°C 
until required.
6.3.2 Preparation of bacteria for planktonic growth
In addition to growth in a biofilm state (section 6.3.1), gene expression was 
also assessed for planktonic strains of P. aeruginosa D40 and S. aureus D76 
cultured in BHI medium at 37°C.
As described previously (Chapter 4, section 4.3.12.1), overnight cultures 
were initially prepared to generate inocula for planktonic growth experiments. 
This overnight culture was diluted two hundred-fold in 20 ml BHI (an identical 
dilution factor as used for the CDFF inoculum) and 7 broths for each bacterial 
species were incubated with shaking at 37°C for 7 d. Each day, the cells 
were centrifuged and the supernatant removed and new medium was added. 
At each 24 h time point, the cells from one of the broths were harvested by 
centrifugation and stored in a 2 ml microtube with 1.5 ml RNAIater® (Ambion, 
Europe Ltd, Huntington, UK) solution prior to RNA extraction. The pelleted 
cells in RNAIater were stored at -80 °C until processed.
6.3.3 RNA extraction
RNA was extracted using two different methods, employing either a RiboPure 
Bacteria Kit (Ambion Ltd., Warrington, UK) or a Qiagen RNeasy Kit (Qiagen, 
West Sussex, UK). RNA samples were kept on ice throughout the RNA 
extraction whenever possible. For the RiboPure Bacteria Kit, biofilm and 
planktonic cells from the RNAIater were collected by centrifugation for 5 min 
(16,000 g). The supernatant was decanted and 350 pi RNAwiz (Ambion, 
RiboPure Bacteria Kit) added to the bacteria which were resuspended by
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vortexing vigorously for 15 s. The bacteria were transferred to a tube 
containing 250 |jl of sterile zirconia beads and then homogenised for 2-5 min 
using a Mini-BeadBeater-8 (Stratech Scientific Ltd., Soham, UK). After 
disruption, cells were centrifuged for 5 min at 4°C at 16,000 g and the 
bacterial lysate transferred to a fresh 1.5 ml tube. The lysate volume was 
estimated (200 - 250 pi) and 0.2x volumes of chloroform (Sigma, Poole, UK) 
added and shaken vigorously for 30 s prior to incubation for 10 min at room 
temperature. After centrifugation (5 min, 4°C, 16,000 g) the aqueous phase 
containing the partially purified RNA (150 - 200 pi) was transferred to a fresh
1.5 ml eppendorf tube and 0.5x volumes of absolute ethanol added. The 
lysate/ethanol mixture was transferred to a filter cartridge, which was placed 
into a 2 ml collection tube, and centrifuged for 1 min. The flow-through was 
discarded and the RNA washed according to the manufacturer’s 
recommended protocol.
For the Qiagen RNeasy Kit, 200 pi of biofilm cells or planktonic cells from the 
RNAIater were collected by centrifugation for 5 min at 4°C (16,000 g). The 
supernatant was decanted and the cells re-suspended in 200 pi lysis buffer, 
containing 2x TE buffer, 1.2% Triton X-100, 0.3 mg ml'1 lysozyme, 0.03 mg 
ml'1 lysostaphin and nuclease free water. The mixture was incubated at 
37°C for 45 min. To the lysate, 350 pi RLT extraction medium (Qiagen, 
Crawley, UK) was added and mixed thoroughly by vortexing vigorously. The 
RNeasy Mini Kit (Qiagen) was used to complete total RNA extraction 
according to the manufacturer’s recommended protocol. Potential DNA 
contamination of all samples was then removed using RNase-Free DNase I 
(Qiagen) treatment following the manufacturer’s instructions.
6.3.4 cDNA synthesis
50 ng pi'1 of total RNA starting material or a nuclease free water control was 
placed into 0.2 ml thin-walled eppendorf tubes. To each sample, the 
following components were added: 5 pi (x10) thermophilic DNA polymerase 
buffer (100 mM Tris-HCI, 500 mM KCI and 1% Triton X-100), 5 pi 10 mM 
dNTPs, 10 Ml (25 mM) MgCI, 4 pi (10 U pi'1) RNase inhibitor, 2.5 pi (500 ng
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ml'1) random hexamers and 1 pi (200 U pI"1) MMLV reverse transcriptase 
(Promega, Southampton, UK). The final volume was made up to 50 pi with 
nuclease free diethyl-pyrocarbonate (DEPC) treated water. Addition of 
nuclease free water in replacing the constituents described above provided a 
non-RT control. All samples were vortexed, centrifuged for 1 min at 8,000 g 
and incubated at 25°C for 10 min, 42°C for 60 min and 95°C for 5 min to 
generate cDNA. The samples were subsequently cooled to 4°C and stored 
at -20°C until required for PCR.
6.3.5 PCR on cDNA samples
PCR targeted a number of virulence gene families of P. aeruginosa and S. 
aureus including outer membrane protein genes, alginate genes, the 
intercellular adhesion locus (ica) and the accessory gene regulator (agr). For 
each gene, a specific primer pair was used to yield an amplicon of distinct 
size (Tables 6.2-6.3). A variety of ica primers were examined, which were 
previously described (Cafiso et al., 2004; Knobloch et al., 2002). In the case 
of icaA, two primer sets were used, S. aureus specific and those previously 
used for S. epidermidis. Additionally ica primers for icaA, icaB, icaC, icaD 
and icaR were designed in this study using the software program Primer3 
(Rozen and Skaletsky, 2000).
The primers and reaction conditions (Table 6.4) were as previously described 
for agr (Ben Ayed et al., 2006; Shopsin et al., 2003), alginate (Edwards and 
Saunders, 2001) and for outer membrane proteins (Mah et al., 2003). The 
constitutively expressed gene encoding the 50S ribosomal protein L21 (rplil) 
was used as a control for P. aeruginosa (Mah et al., 2003) and the phosphate 
acetyltransferase (pta) house-keeping gene of S. aureus was also amplified 
as a RT-PCR control (Enright et al., 2000). Additional controls for each 
reaction included, genomic DNA, DNAse I treated RNA not treated with 
reverse transcriptase (to establish that genomic DNA amplification was not 
present) and a water template control. A typical reaction mix contained 5 pi 
of cDNA template, together with 1.5 mM MgCfe, 2.5 U of Taq polymerase, 
0.25 mM of each primer, 5x Taq buffer and 0.2 mM dNTP mix.
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Table 6.2 Primers used to amplify virulence factors (ica, agr genes) of S.
aureus.
Primer Sequence (5f-3’) 
Forward/Reverse
Target Expected
product
size
(bp)
Reference
icaAa F TGG CTG TAT TAA GCG AAG TC icaA 669 (Knobloch et al.,
icaAa R CCT CTG TCT GGG CTT GAC C specific 2002)
icaRa F 
icaRa R
CCA AAT TTT TGC GAA AAG GA 
TAC GCC TGA GGA ATT TTC TG
icaR 186 In-house
designed
IcaAb F 
IcaAb R
CGC ACT CAA TCA AGG CAT TA 
CCA GCA AGT GTC TGA CTT CG
icaA 240 In-house
designed
IcaDa F 
IcaDa R
ACC CAA CGC TAA AAT CAT CG 
GCG AAA ATG CCC ATA GTT TC
icaD 211 In-house
designed
IcaBa F 
IcaBa R
CAC ATA CCC ACG ATT TGC AT 
TCG GAG TGA CTG CTT TTT CC
icaB 240 In-house
designed
agr 1 R GTC ACA AGT ACT ATA AGC 
TGC GAT
agr 440 (Shopsin et al., 
2003)
agr II R GTA TTA CTA ATT GAA AAG 
TGC CAT AGC
agr 572 (Shopsin et al., 
2003)
agr III R CTG TTG AAA AAG TCA ACT 
AAA AGC TC
agr 406 (Shopsin etai., 
2003)
agr IV R CGA TAA TGC CGT AT ACC CG agr 588 (Shopsin et al., 
2003)
pan-agr
F
ATG CAC ATG GTG CAC ATG C agr (Shopsin et al., 
2003)
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Table 6.2 continued: Primers used to amplify virulence factors (ica, agr
genes) and control genes of S. aureus.
Primer Sequence (5’-3’) 
Forward/Reverse
Target Expected
product
size
(bp)
Reference
pta F 
pta R
GTT AA ATC GTA TTA CCT GAA GG 
GAC CCT TTT GTT GAA AAG CTT AA
pta
control
474 (Enright et 
al., 2000)
icaRb F 
icaRb R
TAC TGT CCT CAA TAA TCC CGA A 
GGT ACG ATG GTA CTA CAC TTG 
ATG
icaR 453 (Cafiso et al., 
2004)
icaDb F 
icaDb R
CAG ACA GAG GCA ATA TCC AAC 
ACA AAC AAA CTC ATC CAT CCG
icaD 225 (Cafiso et al., 
2004)
icaBb F 
icaBb R
ATG GCT TAA AGC ACA CGA CGC 
TAT CGG CAT CTG GTG TGA CAG
icaB 526 (Cafiso et al., 
2004)
icaC F 
icaC R
ATC ATC GTG ACA CAC TTA CTA 
ACG
CTC TCT TAA CAT CAT TCC GAC 
GCC
icaC 934 (Cafiso et al., 
2004)
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Table 6.3 Primers used to amplify virulence factors and control genes of P. 
aeruginosa.
Primer Sequence (5’-3’) 
Forward/Reverse
Target Expected
product
size
(bp)
Reference
cupA1 F 
cupA1 R
CAT GCG CAG TGG TAT TGG CCT TTG 
GAA CAG GGT GGT GAA ATG CTC GTC
cupA1 251 (Mah et 
al., 2003)
ndvB F 
ndvB R
CGA ACA GAT GCG CAC CGA CC 
CGC AGG TAG ATG GCC TGG TC
ndvB 650 (Mah et 
al., 2003)
tolA F 
to!A R
CAC GTT CTG ATC TTC GCC ATG CTG 
GTC GGT CGT ATC CGA AAG GAA CTC
tolA 620 (Mah et 
al., 2003)
algD F 
algD R
GCG ACC TGG ACC TGG GCT 
TCC TCG ATC ACG GGG ATC
alginate D 145 (Edwards
and
Saunders,
2001)
algUF
algUR
GCT CGC GGG CGT CGG C 
CGC AAA TCC TCG GGC AAC
alginate U 167 (Edwards
and
Saunders,
2001)
mucA F 
mucA R
GGA AAC TCT GTC CGC TGT GAT GGA 
GGC TCG CGG TGC ATG ACG
alginate
mucA
141 (Edwards
and
Saunders,
2001)
mucB F 
mucB R
GCT GCC GAC GCT TCC GAC TGG CT 
CGC TGT CCA CGC GAT GCC
alginate
mucB
130 (Edwards
and
Saunders,
2001)
rplU F 
rplUR
CGC AGT GAT TGT TAC CGG TG 
AGG CCT GAA TGC CGG TGA TC
rplU
control
293 (Mah et 
al., 2003)
Table 6.4 PCR conditions used for amplification of each of the primer pairs (virulence factors) in this study
Bacteria P. aeruginosa S. aureus
Target gene algD, algU, 
mucA, mucB
ndvB tolA,
cupA1,
rplU
icaA agr icaA,
icaB,
icaD,
icaR
pta
Denaturating
step
97°C (1 min) 95°C (2 min) 95°C 
(2 min)
94°C (5 min) 94°C (3 min) 94°C (2 min) 95°C (5 min)
Cycles 35 35 35 35 30 30 30
Denaturing
temp.
94°C (1 min) 95° C (30 sec) 95°C
(30
sec)
94°C (30 sec) 94°C (1 min) 94°C (30 sec) 55°C (1 min)
Annealing
temp.
50°C (1 min) 64°C (1 min) 56°C 
(1 min)
60°C (30 sec) 55°C (1 min) 55°C (30 sec) 72°C (1 min)
Extension
temp.
72°C (1 min) 72°C (1 min) 72°C 
(1 min)
72°C (30 sec) 72°C (1 min) 72°C (1 min) 95° C 1 min)
Final extension 72°C (5 min) 72°C (10 min) 72°C
(10
min)
72°C (1 min) 72°C (3 min) 72°C (5 min) 72°C (5 min)
6.3.6 Confirmation of PCR products by gel electrophoresis
PCR products (10 pi) were visualised following standard gel electrophoresis 
in a 0.75 % agarose gel (Sigma, UK) with ethidium bromide staining (10 pg 
pi'1). Gel images were obtained using a Gel-Doc 2000 (Bio-Rad, Hemel- 
Hempstead, UK) and the average band densities for each PCR product were 
measured using the Discovery Series™ Quantity One® (Bio-Rad) software. 
Estimation of semi-quantitative values involved defining lanes and bands on 
the gel image following the Quantity One user guide. After defining lanes, a 
lane-based background subtraction was performed with bands identified 
using the Detect Bands command and then the values of a standard (a 
quantitative MassRuler DNA Ladder; low range, Fermentas, York, UK) being 
entered. The quantity of PCR product in the experimental bands was 
determined using this standard.
To obtain additional confirmation of the PCR product size and sequence, 
PCR products were cleaned using the QIAquick PCR Purification Kit 
(Qiagen) and sequenced as described previously in Chapter 4 (section 
4.3.2).
6.3.7 Microarray study for S. aureus gene expression
The microarray study was done in collaboration with Dr Nick Saunders at the 
Health Protection Agency in Colindale, London, UK. The keywords used for 
virulence searches in the original design of this array were toxin, leukocidin, 
coagulase, adhesion, protease, nuclease, lipoprotein, lipase, capsular 
polysaccharide, binding regulatory peptidase, staphylococcal cassette 
chromosome (SCC) and iron (Saunders et al., 2004a). This original array 
(Saunders et al., 2004a) has since been adapted to accommodate an 
additional 337 S. aureus virulence associated genes whose sequences have 
been obtained. A further 30 E. coli gene sequences were also added to the 
array as negative controls. Therefore the revised array comprised of probes 
for 750 genes in total (Appendix III). The microarray described here was 
originally used to provide an insight into the pathogenicity of the S. aureus 
strains. In this present study this microarray was used in the comparative
analysis of virulence gene expression between S. aureus biofilms and S. 
aureus planktonic cultures (exponential and stationary growth phases). RNA 
was extracted from the S. aureus biofilms and planktonic growth as 
described in section 6.3.3.
6.3.7.1 CDFF biofilm samples for microarray study
Staphylococcus aureus biofilms were prepared using the CDFF as described 
previously (Chapter 4, section 4.3.12). The only difference was that the 
biofilms were recovered only after 7 d incubation period instead of every 24 h 
for 7 d.
6.3.7.2 Preparation of planktonic growth for microarray analysis
In addition to the biofilm study, gene expression for S. aureus’ (D76) was 
also assessed for planktonic cultures. The planktonic samples were 
harvested at various points along the growth curve, namely in exponential 
phase (3 h) and in stationary phase (10 h). Overnight cultures were used to 
set up planktonic exponential and planktonic stationary phase and diluted 
1:500. An aliquot (1 ml) was added to wells of a 24 microtitre well plate and 
placed in the plate reader (Fluostar Optima, BMG Labtech, UK). The 
absorbance was measured at 600 nm for 48h (at 37°C, with agitation).
6.3.7.3 DNA extraction for comparative genome hybridisation
DNA was extracted from an overnight culture in BHI broth of each pure 
bacterial isolate using a Puregene® DNA isolation kit (Gentra Systems, 
Minneapolis, USA) by following the “Gram-positive extraction” protocol 
(http://www.aentra.com/technical assistance/protocols.aspV
6.3.7.3.1 Indirect labelling of DNA for comparative genome hybridisation
DNA (1 M9) was mixed with 2 pi of random nonamers (Invitrogen, Paisley, 
UK) and the volume was adjusted with water to 16 pi in total. The mixture 
was heated to 95°C for 30 s in a PCR thermal cycler then cooled on ice and 
4 pi of the following master mix added: 2 pi exo-Klenow buffer (10x; New 
England BioLabs, Ipswich, UK) 1 pi dNTP mix (20x 1:1 aa-dUTP mix;
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Invitrogen) 1 pi exo-Klenow (5 units). The preparation was incubated at 
room temperature for 30 min followed by subsequent incubation at 37°C for 
60 min. For the cleanup step, the ‘Minelute Reaction Cleanup1 (Qiagen) kit 
was used and the manufacturer’s instructions followed before proceeding to 
hybridisation (see section 6.3.7.7).
6.3.7.4 RNA extraction
RNA from S. aureus biofilms and planktonic growth was extracted using the 
Qiagen RNeasy Kit protocol and the maufacturer’s recommended protocol 
(6.3.3).
6.3.7.4.1 Aminoallyl cDNA synthesis protocol for total RNA extraction
For all steps, the ChipShot indirect labelling kit was used (Promega, 
Southampton, UK).
For each indirect synthesis reaction, the following mix was prepared, 1 pg of 
total RNA, 1 pi of random primers (3 pg pi'1), and nuclease free water to a 
volume of 20 pi. The RNA/primer solution was incubated at 70°C for 10 min 
and then placed on ice. Twenty pi of extension mix containing 8 pi ChipShot 
Reverse Transcriptase (5x) reaction buffer, 4.8 pi magnesium chloride (25 
mM), 4 pi aminoallyl-dNTP mix and 3.2 pi ChipShot Reverse Transcriptase 
was added to the RNA/primer solution, vortexed, spun briefly and incubated 
at 22-25°C for 10 min, followed by incubation at 42°C for 2 h. To each cDNA 
synthesis reaction 1 pi RNase H and 0.35 pi RNase solution was added, 
mixed gently and incubated at 37°C in a thermal cycler for 15 min.
6 .3.7.4.2 Aminoallyl cDNA purification
To 40 pi of the synthesised cDNA, 4 pi sodium acetate (3M; pH 5.2) and 225 
pi of binding solution (Promega Kit, proprietary contents) was added and 
vortexed gently for 5-10 min. The solution was applied to a ChipShot 
membrane on a spin column, which was placed into a collection tube. The 
column was incubated for 5 min at RT, then spun down at 10,000 g for 1 min 
and the flow-through discarded. The column was washed 3 times with 500 pi
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80% ethanol, centrifuged at 10,000 g for 1 min. To remove traces of ethanol, 
the column was centrifuged again at 10,000 g for 1 min. After the washing 
steps, the column was placed in a clean collection tube and purified cDNA 
eluted with 65 pi of 100 mM sodium bicarbonate (pH 9.0). The column was 
incubated at RT for 1 min and centrifuged at 10,000 g for 1 min. Sixty pi of 
cDNA was recovered after centrifugation. The cDNA was then labelled and 
purified for microarray analysis as described below.
6. 3.7.4.3 Conjugation of CyDye NHS Ester to Aminoallyl cDNA
To prevent photo bleaching, the reactive dyes were protected from light at all 
times. To each dry aliquot of CyDye NHS ester (Amersham, UK) 5 pi of 
dimethyl sulphoxide (DMSO) was added and mixed gently to ensure that the 
CyDye NHS ester was thoroughly resuspended. Two pi of CyDye solution 
was added to each eluted 60 pi aminoallyl cDNA, vortexed gently and 
incubated at 23°C in a thermal cycler for 1 h. Planktonic samples were 
stained with CY5 and biofilm samples were stained with CY3 dyes.
6. 3.7.4.4 Purifying CyDye labelled cDNA
To the 60 pi of the synthesised and labelled cDNA, 8 pi of sodium acetate 
(3M, pH 5.2) and 440 pi of binding solution (ChipShot indirect labelling kit, 
Promega) was added. The mixture was vortexed gently for 5-10 s and 
applied to a ChipShot membrane column (ChipShot indirect labelling kit, 
Promega) which was placed into a collection tube. The column was 
incubated at room temperature for 5 min and then centrifuged at 10,000 g for 
1 min. The flow-through was discarded and the column was washed (x3) 
with 500 pi 80% v/v ethanol, centrifuged again at 10,000 g for 1 min and 
followed by a final centrifuge step to remove traces of ethanol. The column 
was placed in a clean collection tube and 30 pi elution buffer (Promega Kit, 
proprietary contents) was added, incubated at RT for 1 min and centrifuged 
at 10,000 g for 1 min. The elution step was repeated with another 30 pi 
elution buffer as described above. Eluted cDNA was stored in a light proof 
container at 4°C until required for the microarray study.
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6.3.7.5 Printing
Slides were printed using a Genetix Qarray Mini platform. The 
oligonucleotides probes were printed in replicates of four, arranged in a 
random pattern using Telechem Arraylt Stealth pins (Genetix Limited, 
Hampshire, UK).
6.3.7.6 Slide processing
Printed microarray slides were placed in a chamber at 42°C with 50-75% 
relative humidity provided by a saturated solution of NaCI for 16-18 h. 
Excess spotting solution was washed off with 0.2% SDS by agitation in a 
slide washer for 2 min at 20-25°C. The slides were then washed, with 
shaking, three times in sterile distilled water for 1 min each wash. The 
microarrays were then incubated for 20 min at 50°C in distilled water, dried 
by centrifugation (10,000 g for 5 min) and stored in the dark at room 
temperature (Saunders et al., 2004a).
6.3.7.7 Hybridisation
Hybridisation was performed using the Lucidea SlidePro Hybridisation 
Instrument (GE Healthcare, Chalfont St Giles, UK). The software was 
programmed to perform a series of washes to the hybridisation chambers 
and their respective tubing on dummy slides before inserting the arrays and 
initiating the pre-hybridisation process. The hybridisation mix was then 
injected and hybridisation allowed to take place for up to 7 h. Any unbound 
probe mix was washed away with isopropanol and the arrays were air dried 
ready for analysis (Saunders et al., 2004a).
6.3.7.8 Scanning and Data analysis
The arrays were scanned using the Gentix aQuire Scanner. Fluorescent 
signals for the differentially labelled samples were detected at wavelengths of 
532 nm for Cy3 and 639 nm for Cy5. The images were analysed using 
QScan software (Genetix). The software enables superimposing of two 
images, subtraction of background and calculation of the ratio of the two 
colour signals for comparative analysis.
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6.4 Results
For RNA extraction, two different methods were employed, the RiboPure 
Bacteria Kit and the Qiagen RNeasy Kit. Results obtained with the Qiagen 
RNeasy Kit were more consistent and the RNA yield was generally higher 
than obtained with the RiboPure Bacteria Kit. Whenever possible the Qiagen 
RNeasy Kit was used to generate RNA.
6.4.1 RT-PCR
The housekeeping genes rplU and pta were successfully amplified from P. 
aeruginosa and S. aureus, respectively, indicating that gene expression 
could be routinely and consistently detected (Fig. 6.4-6.7).
6.4.2 Expression of genes encoding outer membrane surface proteins 
of P. aeruginosa
Messenger RNA from the tolA gene was detected from biofilm samples after 
day 3, whilst cupA1 was expressed from day 1 to day 6 and not expressed 
on day 7. In contrast, no expression of ndvB was observed in any of the 
biofilm samples over the 7 d of the experiment.
Inconsistent expression of the outer membrane proteins was observed in the 
planktonic samples. TolA was only expressed on day 1 and day 3 and was 
not expressed on any of days 2, 4, 5, 6 and 7. The cupA1 gene was only 
expressed on day 5, day 6 and day 7. Again no expression of ndvB was 
observed (Table 6.5).
6.4.3 Expression of alginate genes by P. aeruginosa
RT-PCR was performed on biofilm and planktonic samples from day 1 to day 
7 of incubation. The target genes algD, mucA and mucB were expressed in 
all biofilm samples throughout the 7 d analysis. AlgU expression in biofilm 
samples was only detected after day 3. In comparison, analysis of planktonic 
cultures also demonstrated expression of these target genes, although for 
each gene, expression was inconsistent over the 7 d study period (Table 6.5; 
Fig. 6.4-6.5).
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Table 6.5 Detection of gene families associated with P. aeruginosa biofilm
formation.
Samples algD a lg il mucA mucB tolA1 cupA1 ndvB
Day 1 
Day 2 
Day 3 
Day 4 
Day 5 
Day 6 
Day 7
Biofilm + - + + I I -
Planktonic + - + + + -
Biofilm i _ i i _ i _
Planktonic - - - - - - -
Biofilm + + + + + + _
Planktonic + + + + + - -
Biofilm + + + + i i _
Planktonic + + + + - - -
Biofilm i i i i i + _
Planktonic - - - - - + -
Biofilm + + + + i + _
Planktonic + + + + - + -
Biofilm + + + + i I -
Planktonic + + + + - + -
For all RT-PCR s control gene expression (rplU) was routinely detected. +, 
detected; not detected; highlighted in pink are samples where differences 
in gene expression from planktonic mode of growth were seen.
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alg il (167 bp)
rplU (293 bp)
Fig. 6 .4  Agarose gel showing typical R T-PC R  products during RHE infection 
of P. aeruginosa housekeeping (rplU) and virulence (algU) genes.
Lanes: M, low range MassRuler DNA ladder (Fermentas, UK); 1-3, biofilm 
samples day 3; 4, planktonic sample day 3; 5-6, biofilm samples day 4; 7, 
planktonic sample day 4; 8-9, biofilm samples day 5; 10, planktonic sample 
day 5; 11-13, biofilm samples day 6 , 14, planktonic sample day 6; 15, biofilm 
sample day 7
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b£ M 1 2 3 4 5 6 7 8 9 10 11 12 13 14 15
500-
200 -
100-
300-
200 ' ■ M M j
-mucA (141 bp)
-rplU (293 bp)
< rrr ►algU mucA
Fig. 6 .5 Agarose gel showing typical R T-PC R  products during RHE infection 
of P. aeruginosa housekeeping (rplU) and virulence (algU, mucA) genes. 
Lanes: M, low range MassRuler DNA ladder (Fermentas, UK); 1, biofilm 
sample day 7; 2, planktonic sample day 7; 3, H20 ; 4, pure RNA; 5, genomic 
DNA; 6-8, biofilm samples day 1; 9, planktonic sample day 1; 10, biofilm 
sample day 2; 11-13, biofilm samples day 3, 14, planktonic sample day 3; 15, 
biofilm sample day 4
270
6.4.4 Expression of accessory gene regulator {agr) in S. aureus
All biofilm and planktonic samples expressed the agr gene for all 7 days 
(Table 6.6).
6.4.5 Expression of the intercellular adhesion (ica) genes in S. aureus
RT-PCR using three sets of primers was undertaken. RT-PCR products 
were generated using icaAa primers (Knobloch et al., 2002) targeting the 
entire ica locus of S. aureus, in biofilm samples from day 3 to day 7 (Fig. 6.6- 
6.7). However, no expression of the icaAa gene was evident in any of the 
planktonic samples. In contrast, RT-PCR products were not detected using 
alternative primers {icaBb, icaCb, icaDb and icaRb) specific to the ica operon 
of S. epidermidis (Cafiso et al., 2004).
Using a third set of ‘in-house’ prepared primers, S. aureus ica genes were 
found to generate RT-PCR products for all biofilm samples from 2 d onwards, 
with icaDa expressed only in biofilm samples from day 3. Using these 
primers on planktonic samples, icaAb expression was evident on days 4-6, 
icaBa expression occurred on days 6 and 7 and icaDa and icaRa were 
expressed on days 3-6 (Table 6.6).
6.4.6 Semi-quantitative comparison of gene expression using RT-PCR
Semi-quantitative analysis using RT-PCR for all the target genes indicated 
varying quantities of mRNA for the expressing strains.
The majority of the biofilm specific genes in P. aeruginosa were upregulated 
in the biofilm state (27 out of 42). However, algU, mucA and mucB appeared 
to be down regulated in the biofilm state from day 5 onwards (Table 6.7). 
Between the two growth phases, there appeared to be greater up regulation 
of ica gene expression in the biofilm state, with only three samples 
demonstrating an apparent down regulation compared to the planktonic 
state. The majority of agr genes were upregulated in the biofilm state, 6 out 
of 7 (Table 6.8).
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Table 6.6 Detection of gene families associated with S. aureus biofilm
formation.
Sam ples icaAa icaAb icaBa icaDa icaRa agr
Biofilm +
Day 1 Planktonic - - - - +
Day 2 Biofilm
+ + + +
Planktonic I I - I +
Day 3 Biofilm |
+ + + + +
Planktonic I I + + +
Day 4
Biofilm + + + + +
Planktonic + I + + +
Day 5 Biofilm
+ + + + +
Planktonic + I + + +
Day 6 Biofilm + + + + +Planktonic + + + + +
Day 7
Biofilm | + + + + +
Planktonic l + I I +
For all RT-PCR s control gene expression (pta) was routinely detected. +, 
detected; not detected; highlighted in pink are samples where differences 
in gene expression from planktonic mode of growth were seen.
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M 1 2 3 4 5 6 7 8 9 10 11 12 13 14 15
500— H
Fig. 6.6 Agarose gel showing typical R T-PC R  products during RHE infection 
of S.aureus housekeeping (pta) and virulence (icaA) genes.
Lanes: M, low range MassRuler DNA ladder (Fermentas, UK); 1-3, biofilm 
samples day 3; 4-6, biofilm samples day 4; 7-9, biofilm samples day 5; 10, 
biofilm sample day 6; 11-12, biofilm samples day 7, 13, H20 ; 14, pure RNA; 
15, genomic DNA
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M 1 2 3 4 5 6 7 8 9 10 11 12 13 14 15
Fig. 6 .7  Agarose gel showing typical R T-PC R  products during RHE infection 
of S. aureus housekeeping (pta) and virulence (icaD) genes.
Lanes: M, low range MassRuler DNA ladder (Fermentas, UK); 1-2, biofilm 
samples day 3; 3, planktonic sample day 3; 4-6, biofilm samples day 4; 7, 
planktonic sample day 4; 8-10, biofilm samples day 5; 11, planktonic sample 
day 5; 12-13, biofilm samples day 6; 14, planktonic sample day 6; 15, biofilm 
sample day 7.
Table 6.7 Detection of gene families associated with pathogenesis of P.
aeruginosa showing semi-quantification of RT-PCR products produced.
S am ples algD algU mucA mucB tolA1 cupA1 ndvB
Day 1
Biofilm - ■ - -
Planktonic 74 - 110 86 99 - -
Day 2
Biofilm 7® - 111 92 - 202 -
Planktonic - - - - - - -
Day 3
Biofilm m 94 ■ 89 04 192 -
Planktonic 61 96 95 85 53 - -
Day 4
Biofilm 80 m 145 110 160 17® -
Planktonic 62 92 92 75 - - -
Biofilm n 83 92 77 102 214 -
Day 5
Planktonic 70 106 108 98 - - -
Biofilm 68 84 97 75 54 _
Dav 6
Planktonic 67 96 112 106 - 134 -
Biofilm 76 86 85 87 76 _ -
Dav 7
Planktonic 69 125 141 101 - 164 “
For all RT-PCR s control gene expression was routinely detected. The  
numbers represent the relative quantity (as a percentage) of PCR amplicon 
compared with the constitutively expressed gene product rplU. Highlighted in 
■ I  indicates samples where up-regulation in gene expression occurred in 
the biofilm state. Highlighted in yellow indicates samples where down- 
regulation in gene expression occurred in the biofilm state.
Table 6.8 Detection of gene families associated with S.aureus biofilms
showing semi-quantification of RT-PCR products produced.
Samples icaAa icaAb icaBa icaDa icaRa agr
Day 1
Biofilm - - - - 68
Planktonic - - - - - 80
Day 2
Biofilm - 41 43 - 106
Planktonic - - - 80
Day 3
Biofilm 75 88 ■ 170 81
Planktonic - - - 105 55 78
Day 4
Biofilm 94 88 97 134 146 74
Planktonic - 90 - 102 100 113
Day 5
Biofilm 80 98 103 243 58 190
Planktonic - 75 - 117 72 112
Day 6
Biofilm 100 218 m 87 121
Planktonic - 144 169 62 103 95
Day 7
Biofilm 96 60 82 ■ 6? 109
Planktonic - - 61 - - 92
For all RT-PCR s control gene expression was routinely detected. The  
numbers represent the relative quantity (as a percentage) of the PCR  
amplicon compared with the constitutively expressed gene product pta. 
Highlighted in pink indicates samples where up-regulation in gene expression 
occurred in the biofilm state. Highlighted in yellow indicates where down- 
regulation in gene expression occurred in the biofilm state.
6.4.7 Microarray study for S. aureus gene expression
6.4.7.1 Comparative genome hybridisation
In comparative genome hybridisation experiments, two genomic DNA 
samples one from wound isolate S. aureus D76 and the other from S. aureus 
MW2 (Baba et al., 2002) were simultaneously hybridised to the microarray 
and detected using different fluorochromes. In this study the presence and 
absence of the genes on the array for the genome of the test strains was 
confirmed. Hybridisation with the S. aureus D76 strain was found to occur 
with signals evident for 486 genes and with S. aureus MW2, 550 genes were 
present. The majority of these genes present in S. aureus D76 were 
hypothetical proteins related to the ATP-binding protein, exotoxins and 
capsular polysaccharide synthesis enzymes. The intercellular adhesion 
proteins icaA, icaB, icaD and the regulator icaR were also present as well as 
the staphylococcal accessory regulator A (sarA), which is implicated in 
biofilm formation (Appendix IV). Virulence factors such as proteases, zinc 
metalloproteinase, thermonuclease, adhesins, alpha-, beta-, gamma- 
haemolysin were also present. It seems that the D76 strain carries drug 
resistance in various forms including a hypothetical protein, which is similar 
to tetracycline resistance proteins as well as multidrug resistance proteins. 
Interestingly, phage related proteins, such as staphylococcal phage phi11, 
phage integrase family, hypothetical protein which is similar to Enterococcus 
faecalis plasmid pPD1 and a lytic regulatory protein truncated with Tn554 
were also present in the S. aureus D76 strain which could promote gene 
transfer (Appendix IV).
6.4.7.2 Staphylococcus aureus gene expression as determined using 
the microarray
Comparative gene expression between S. aureus D76 biofilm samples after 
7 d of incubation in the CDFF was compared against both stationary and 
exponential phase planktonic growth. Microarray analysis revealed that both 
growth phases exhibited common expression of the majority of genes, 
although some differences were found. Figure 6.8 (biofilm against
277
exponential phase) and Fig. 6.9 (biofilm against stationary phase) illustrate 
the up-regulation of genes between the two growth phases. The genes 
which are distributed around the line at 1 are non changeable. The genes 
above this line are up-regulated in the biofilm phase and the genes beneath 
the line are up-regulated in the planktonic phase (Appendix III, for detailed 
gene names).
Figure 6.10 shows expression of genes of interest in biofilm phase against 
exponential planktonic phase. For example, the regulatory genes such as 
the accessory gene regulator (agrC1 -  groupl) and the sarA were more 
highly expressed in the biofilm state than in the exponential planktonic phase 
as well as few hypothetical proteins such as SA1999 (hypothetical protein, 
similar to the regulatory protein SIR2 family), MW0596 (hypothetical protein, 
similar to iron dependent repressor) and MW2499 (hypothetical protein, 
similar to short chain oxireductase). However, several hypothetical genes 
seemed to be up-regulated in the exponential planktonic growth phase 
compared to biofilm growth mode such as MW0595 (hypothetical protein, 
similar to the ABC transporter ATP-binding protein), MW0339 (hypothetical 
protein, similar to GTP-binding protein), MW0283 (hypothetical protein, 
similar to branched chain amino acid uptake carrier), MW0384 (Exotoxin 18, 
Genomic island nu Sa alpha 2) and MW2217 (secretory antigen precursor).
Figure 6.11 shows expression of genes of interest in the biofilm phase 
against the stationary planktonic phase. Genes which are up-regulated in the 
biofilm phase compared to the stationary planktonic phase included MW1834 
(hypothetical protein, similar to ferritin), MW0396 (hypothetical protein), 
MW1041 (hypothetical protein, similar to fibrinogen binding protein), SA0857 
(hypothetical protein, similar to negative regulator of genetic competence 
mecA), SAV0151 Cap8c (capsular polysaccharide synthesis enzyme Cap8c), 
SA1174 (SOS regulatory LexA protein) and MW2129 hysA (hyaluronate 
lysate precursor).
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In comparison hypothetical proteins such as MW0757, MW1744, MW0579 
(similar to esterase/lipase), MW1508 (similar to ABC transporter ATP-binding 
protein) and SA2272 were up-regulated in the stationary planktonic growth 
phase.
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Fig. 6.11 Expression of genes of interest in biofilm against stationaryl growth phase of S. aureus D76.
r6.5 Discussion
In the past, research has largely focused on the in vitro study of organisms 
grown in liquid media. However, in recent years it has been recognized that 
in their natural settings bacterial cells are most often found in close 
association with surfaces and interfaces, in the form of aggregates referred to 
as biofilms (Branda et al., 2005). It has been suggested that adherent and 
biofilm bacteria behave differently (Literature Review, section 1.1.1, Table 
1.1) and hence may express a different pattern of genes compared with their 
planktonic counterparts (Becker et al., 2001; Beloin and Ghigo, 2005). 
Whiteley et al. (2001) showed that gene expression in P. aeruginosa biofilm 
cells was remarkably similar to their planktonic counterparts under similar 
environment conditions but that there were a small number of significant 
differences. Such differences in gene expression could perhaps explain 
important phenotypic traits of biofilms including the high antibiotic resistance 
of biofilm cells, or even aid in the development of rapid screens for agents 
that block biofilm maintenance (Whiteley et al., 2001).
The present study focused on comparing specific gene expression for both P. 
aeruginosa and S. aureus when cultured in biofilms and in planktonic states. 
The significance of this work was that the detection, albeit in vitro, of an up- 
regulated biofilm gene product could be important if also manifested in a 
chronic wound biofilm state. Differential expression between the two growth 
states could theoretically provide evidence of virulence mechanisms or 
strategies promoting the survival of the bacteria in biofilms. This knowledge 
could in the future be exploited in the development of management and 
treatment regimes (Beloin and Ghigo, 2005).
The selected bacterial species were studied as these organisms have 
previously been shown to be frequently encountered in chronic wounds 
(Davies et al., 2007; Davies et al., 2004) and in chronic infections (Parsek 
and Singh, 2003). In addition, previous chapters reported in this thesis 
(Chapter 4 and Chapter 5) have shown that these organisms predominated 
over other bacterial species in biofilm models.
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it.
The specific aims of this Chapter were to examine the expression of 
previously proposed ‘biofilm specific genes’ and to compare their expression 
in planktonic and biofilm growth phases. It addition exploratory studies were 
also performed using a microarray analysis.
Bacteria growing in biofilms possess characteristics distinct from their 
planktonic counterparts, e.g. biofilm bacteria are more resistant to 
antimicrobial treatments (Whiteley et al., 2001). The outer membrane 
surface proteins are of particular interest in P. aeruginosa due to their 
involvement in the transport of antibiotics (Stover et al., 2000). Mah et al. 
(2003) proposed a mechanism of biofilm-specific antibiotic resistance 
wherein periplasmic glucans bind to, and sequester antibiotics. It has been 
suggested that the gene, ndvB is required for the synthesis of periplasmic 
glucans (Mah et al., 2003). However, in this study ndvB was not found to be 
expressed in P. aeruginosa biofilms. This contrasts with the results of Mah et 
al. (2003) who predicted and showed that ndvB was exclusively expressed in 
biofilm grown cells using a microtitre plate assay for biofilm formation. 
Although Mah et al. (2003) data supports an involvement for ndvB in biofilm 
antibiotic resistance, it may be that some strains of P. aeruginosa have 
compensatory mechanisms for ndvB mutations or because of strain 
variations.
Previous studies have examined how alginate overproduction influences P. 
aeruginosa biofilm development and function, using a non-mucoid P. 
aeruginosa wild type and a mucoid alginate overproducing mutant strain 
(Hentzer et al., 2001). These studies showed that in cystic fibrosis (CF) 
patients, conversion to the mucoid phenotype resulted in an altered biofilm 
structure and increased antimicrobial resistance. RT-PCR of alginate gene 
expression in P. aeruginosa in the present study did not show a direct 
correlation with biofilm formation. The majority of planktonic samples were 
also found to express algD, algil, mucA and mucB. These data might 
suggest that some bacteria in the broth cultures had biofilm phenotypes or 
that expression of these genes is not an exclusive property of biofilms. In
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fact Lazazzera et al. (2005) suggests that subsets of genes expressed in 
biofilms are also expressed under different planktonic conditions.
The expression of S. aureus virulence factors is controlled by the quorum 
dependent accessory gene regulator (<agr) and can be classified into 4 (l-IV) 
specific agr groups (Shopsin et al., 2003; Yarwood et al., 2002). Group I and 
II have been linked with enterotoxin mediated and invasive disease, while 
groups III and IV have been associated with non-invasive and exfoliating- 
producing disease (Jarraud et al., 2002). The S. aureus wound isolate D76 
used in this study expressed agr I in all biofilm and planktonic samples. It 
may therefore be possible that this S. aureus strain plays a role in impaired 
healing by the production of this toxin which then attacks the patient epithelial 
cells.
Studies have shown that PIA, a homoglycan consisting of (3-1,6-linked N- 
acetylglucosamine which is encoded by the ica operon, is required for biofilm 
formation (Conlon et al., 2002b; Mack et al., 1996). Mack et al (1999; 1996) 
suggested that PIA mediates intercellular adhesion and that bacteria have no 
direct contact to the surface following the accumulative phase but remain in 
the biofilm via mechanisms mediating cell-to-cell adhesion (Rohde et al., 
2005). Staphylococcus epidermidis, a commensal of human skin and 
mucous membranes, is also a predominant cause of foreign-body-associated 
infections. PIA is a significant virulence factor and essential for S. 
epidermidis and S. aureus cell accumulation (Knobloch et al., 2004). 
However, investigations into the relationship between the ica genotype and 
biofilm formation of S. aureus has in the past led to contradictory results by 
different investigators (Knobloch et al., 2002). Cramton et al. (1999) 
characterised S. aureus isolates that were ica positive and showed that 
deletion of the ica genes eliminated the ability to produce polysaccharide 
intercellular adhesion (PIA) and form a biofilm in vitro. In contrast, Yazdani et 
al. (2006) evaluated the biofilm forming capacity and the presence of icaAD 
(associated with slime production) among S. aureus isolated from wound 
infections. All fifty strains identified, were found to carry the icaAD genes,
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with only 26 of the strains found to produce a biofilm in vitro. Hence, this 
study indicated that whilst there was a high prevalence of the icaAD genes 
amongst the S. aureus isolates, their presence was not always associated 
with biofilm formation in vitro (Yazdani et al., 2006). Despite the importance 
of ica genes, not much is known about the regulation of the ica locus itself 
(Jefferson et al., 2003). Numerous recent publications report on factors 
influencing PIA or biofilm production in vitro. Such factors include the level of 
glucose and other sugars in the culture medium, extent of osmolarity and 
anaerobiosis, low levels of ethanol, and iron restriction (Cramton et al., 2001; 
Fluckiger et al., 2005; Jefferson et al., 2003; Rachid et al., 2000a; Rachid et 
al., 2000b).
The observation that biofilms are not wholly dependent upon expression of 
the ica operon is also supported by the findings of Muller et al. (1993) who 
found that a few S. epidermidis strains were able to form a biofilm with no 
apparent production of polysaccharide (Cramton et al., 2001). Importantly, 
the majority of clinical S. aureus strains contain the ica operon (Arciola et al., 
2001; Cramton et al., 1999; Fitzpatrick et al., 2005; Rohde et al., 2005), and 
expression of the ica operon and biofilm production is controlled under in 
vitro conditions (Cramton et al., 2001; Fitzpatrick et al., 2005; O'Gara, 2007).
In the present investigation, RT-PCR detection of expressed genes of the S. 
aureus ica operon used primers previously validated by Knobloch et al. 
(2002), primers designed by Cafiso et al. (2004) and also ‘in-house’ designed 
primers. The failure of the Cafiso et al. (2004) primers to yield PCR products 
with any of the specimens likely relates to sequence variations between S. 
epidermidis and S. aureus, as the former species was used as the basis of 
the primer design by Cafiso et al. (2004).
It was evident from the results (Table 6.6) that ica genes were expressed in 
both biofilm and planktonic samples. As mentioned previously for P. 
aeruginosa strains, a biofilm occurrence within the planktonic samples could 
be envisaged due to the extended incubation time of the culture (7 days)
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even though the broth was replenished at 24 h intervals. A possible 
improvement could be to generate continuous planktonic growth within a 
dedicated fermenter (e.g. a chemostat).
After 48 h, all biofilm samples were found to express icaA, icaB and icaR 
whilst icaD was expressed only after 72h. This data suggests that using the 
CDFF for biofilm formation, 48 h incubation was necessary to get an 
established biofilm of S. aureus.
Semi-quantification of the RT-PCR products indicated that for the majority of 
targeted genes, expression was up-regulated in the biofilm samples 
compared to the planktonic ones. The up-regulation of the ica genes in the 
biofilm mode of growth is consistent with previous work (Resch et al., 2005). 
The data therefore suggests that whilst there is differential gene expression 
between biofilm and planktonic cultures, expression does vary with other 
factors including culture age and for the studied genes, expression did not 
appear exclusive to a particular mode of growth. Previous studies also 
highlight that environmental signals such as temperature, osmolarity, pH, iron 
and oxygen play a role in biofilm development and therefore alter gene 
expression (Costerton et al., 1995). It also highlights the uniqueness of 
biofilms and that a universal biofilm gene-expression pattern still remains a 
wide-open area of investigation (Beloin and Ghigo, 2005).
The detection of biofilm specific genes in this present study seemed to be 
more complex than expected and it also appeared to be very difficult to 
maintain for 7 d planktonic cultures. Further studies are still required to fully 
elucidate the genetics of bacterial growth (Waite et al., 2005). Considering 
these contrasting results, the findings could be indicative that a wide range of 
genes influence biofilm development under specific conditions. More work 
remains to be done, e.g. the discovery of other genes which are critical for 
biofilm development. Improved understanding of which genes and proteins 
are differentially expressed under biofilm and planktonic growth conditions 
and how the morphology and physiology of biofilm cells differs from those of
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planktonic cells is needed to understand the high persistence and 
antimicrobial resistance of biofilm cells (Resch et al., 2005). It is also 
important to highlight how widespread biofilms are with more than 99.9% of 
bacteria found to grow in biofilms (Donlan and Costerton, 2002) and that 
biofilm research encompasses studies of multispecies communities (Lewis,
2001).
In this present study, exploratory experiments using the microarray technique 
at the Health Protection Agency in Colindale were employed. The microarray 
used in this study was designed to look for potential virulence associations 
(section 6.3.8.7) and not only for biofilm-specific genes. Therefore a direct 
comparison of the microarray data with the RT-PCR results was difficult. Of 
the genes targeted by RT-PCR, only agr and ica genes were housed on the 
microarray. Comparative genome hybridisation was first used to confirm if 
the genes on the array were present or absent within the S. aureus D76 
genome. The 486 genes present included the ica proteins, the sarA gene, 
virulence factors, phage related proteins which are involved with gene 
transfer events and multidrug resistance proteins.
The microarray expression work showed that several regulatory genes 
including agrC1 (accessory gene regulator, group 1) and SA0573 sarA 
(staphylococcal accessory regulator A) had a higher expression in biofilm 
samples compared with planktonic exponential samples. Significantly, agr 
expression was also confirmed previously by RT-PCR in all biofilm and 
planktonic samples. By RT-PCR the majority of agr genes were up-regulated 
in the biofilm state, 6 out of 7. It is important to note that a network of 
regulatory genes including agr and sar operons control the expression of S. 
aureus virulence factors (Saunders et al., 2004b). The microarray data 
provided detailed information concerning gene carriage and increase or 
decrease in the level of gene between planktonic and biofilm mode of growth 
in the S. aureus D76 wound isolate. In this microarray study there was no 
evidence for the expression of the ica genes. This correlates with previous 
findings reported by Resch et al (2005) who suggested that these genes
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were not needed after initial attachment and start of biofilm formation as the 
biofilm samples used for this study were 7 d old. Transcriptomic analysis 
opens the door for future work and provides a powerful tool to assess 
differential gene expression patterns under biofilm and planktonic growth 
conditions (Resch et al., 2005) as well as in other systems. However, more 
work still needs to be done to fully understand the genetics of bacterial 
biofilm growth (Waite et al., 2005).
In future studies, it would be interesting to examine gene expression from a 
mixed biofilm population and compare it with a mixed planktonic population. 
In this present study, mixed biofilms prepared in the CDFF and mixed 
planktonic preparations were generated but due to time constraints, the RT- 
PCR process was not pursued with these populations. It would certainly be 
valuable to extend the current study to apply a real-time PCR to detect, 
identify and quantify the relevant genes of interest over time between the 
planktonic and biofilm modes of growth to confirm the apparent up-regulation 
of the genes identified in this study. The real-time technique would allow 
more accurate monitoring of gene expression over time.
In general, microarray technology whilst providing a significant amount of 
information does suffer from the disadvantage of relating the findings to the 
role of the gene products, simply due to our currently limited knowledge 
concerning the hypothetical proteins and their relevant role in biofilm 
formation. Therefore, it would be helpful to actually identify first biofilm 
related genes and then to monitor the expression in samples. So far neither 
the microarray nor the RT-PCR study provided any direct indications related 
to genes associated with chronic wound biofilms. In future, and 
accompanying the development of these techniques it would be interesting to 
look at bacterial gene expression within actual clinical wound samples, and 
maybe compare specimens from both the normally healing phenotype and 
those that fail to heal.
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6.6 Summary
In summary, this present study showed:
1. That the majority of the examined P. aeruginosa and S. aureus genes 
previously associated with biofilm formation were expressed in biofilm 
samples. Some of these genes were also expressed in planktonic samples 
suggesting that there might be a biofilm phenotype present or that the 
expression of the genes was not exclusive to specific growth modes.
2. Semi-quantification of the RT-PCR products from these genes did indicate 
that the majority were up-regulated in the biofilm samples compared to 
planktonic ones.
3. Altered gene expression between biofilm and planktonic samples was also 
apparent from exploratory microarray studies of S. aureus. In particular, 
confirmation of up-regulation of agrC1, sarA and the capsular polysaccharide 
synthesis enzyme Cap8c in biofilm grown cells was evident using the array 
method.
291
General Discussion
The significance of biofilm related infections is becoming increasingly evident 
and it has been suggested that over 65% of all hospital infections have their 
origin in biofilms (Costerton et al., 1999; Donlan, 2001; Donlan and 
Costerton, 2002; Douglas, 2003; Ramage et al., 2006). As a consequence, it 
is not surprising that much research in recent years has been focussed at 
improving our understanding of biofilms and the options available to combat 
them. The debate surrounding what a biofilm actually is remains an ongoing 
one. It is always difficult to define a biofilm and to compare biofilms with 
other studies due to the lack of standardised systems and protocols (Parsek 
and Singh, 2003). In this study, a biofilm was classed as being formed once 
the microorganisms (in this work C. albicans or chronic wound bacteria) were 
attached to a surface and produced multilayered structures.
Biofilms are ubiquitous throughout natural, industrial and clinical 
environments (Parsek and Singh, 2003). A distinguishing feature of these 
biofilms is the presence of aggregated microcolonies of cells that are 
attached to a surface (Hall-Stoodley et al., 2004). In the clinical environment, 
biofilms provide a reservoir of potentially pathogenic organisms that are often 
resistant to standard antibiotic concentrations. Elevated antibiotic resistance 
might be affected by phenotypic changes in the organisms which make up a 
biofilm. These changes include slower growth rate and expression of new 
multi-drug-resistant pumps (Anwar et al., 1992; Hoyle and Costerton, 1991; 
O'Toole et al., 2000). Another clinical problem of biofilms is that they can 
cause device failure when adhered to biomaterials used in medical devices 
(Lewis, 2001; Mah and O'Toole, 2001). Indeed, once a biofilm is established, 
the removal of bacteria by host defence mechanisms is also very difficult, 
and in the case of medical devices, often the only treatment option is the 
removal and replacement of the medical device.
Candida albicans is a commensal fungus of humans, commonly found in the 
oral cavity, gastrointestinal tract, female genital tract and occasionally on the 
skin (Hube and Naglik, 2001; Watts et al., 1998). Although considered as a 
commensal of healthy individuals, this fungus frequently causes superficial
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infections when the normal microbial flora is unbalanced or there is a 
debilitation in the hosts’ defence mechanisms. Hence, in 
immunocompromised patients, C. albicans may invade the tissue, penetrate 
the blood vessels and cause life threatening systemic infections (Felk et al.,
2002).
In this study, it was shown that C. albicans strains isolated from different oral 
conditions were capable of forming biofilms and invading a reconstituted 
human oral epithelium (RHE) model. Using CLSM a heterogeneous invasion 
pattern of the tissue was evident with the strains of C. albicans, with the 
surface mainly colonised by the yeast form and a complex network of 
filaments occurring within the tissue. These filamentous hyphae were seen 
to physically penetrate the cells and exhibited budding within the tissue. 
Hyphae are indeed considered to be the principle invasive forms of C. 
albicans and are frequently identified in infected tissue (Felk et al., 2002). At 
the time of writing no other CLSM investigations regarding C. albicans biofilm 
formation ability and invasion in an in vitro model have been reported. In this 
present study, the ability of C. albicans to invade the RHE appeared to 
correlate with the isolates’ capacity to exhibit a yeast/hyphal transition and in 
all but one case, isolates categorised as the ‘high invaders’ revealed a 
predominance of the hyphal morphology within the tissue. It was also evident 
that four of the five strains identified as high invaders had previously been 
isolated from chronic hyperplastic candidosis conditions. This could suggest 
that there is a particular strain type associated with this form of oral 
candidosis. It was clear from the pattern of RHE infection that C. albicans is 
heterogenous with respect to tissue invasion by strains, and whilst the host 
condition obviously plays an important role in the occurrence of infection, this 
study suggests that inherent strain virulence could also contribute.
Destruction of host tissues by Candida may be facilitated by the release of 
hydrolytic enzymes into the environment. The most widely studied hydrolytic 
enzymes of C. albicans are the secreted aspartyl proteinases (SAPs) and 
phospholipases (PLs). At present, 10 different genes have been identified
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that encode for candidal SAPs (Hube, 1996; Hube et al., 1997; Sanglard et 
al., 1997). The exact role of these enzymes in virulence remains unclear, 
however their ability to degrade host extracellular matrix proteins, cell 
membranes, host surface molecules and their involvement in host tissue 
invasion are obvious pathogenic factors (Naglik et al., 2003). The production 
of phospholipases could contribute to host cell membrane damage which 
could promote cell lysis or expose receptors to facilitate adherence 
(Ghannoum, 2000; Ibrahim etal., 1995).
In addition to hydrolytic enzymes, adherence factors of C. albicans are also 
regarded as being important in its virulence. Recently, a gene family 
collectively referred to as ‘agglutinin-like-sequences’ (ALS) genes have been 
studied with respect to their role in promoting Candida infection. Eight 
Candida ALS genes encoding large glycoproteins have been shown to 
promote candidal adhesion to host surfaces (Guar and Klotz, 1997; Hoyer et 
al., 2001).
In this present study, the expression of these ALS genes together with those 
encoding for hydrolytic enzymes were analysed to determine whether 
expression correlated with biofilm formation and pattern of RHE infection. As 
reported in Chapter 3, C. albicans strains that had previously been 
categorised as ‘high invaders’ (Chapter 2) were also found to be consistent 
producers of SAPs 4-6 despite the level of expression of these genes being 
strain dependent. SAP genes 4-6 are believed to be important in controlling 
yeast to hyphal transition (Naglik et al. 2003) and therefore might have had 
an indirect link with invasion through promoting hyphal development. Whilst 
there was a largely consistent expression pattern observed between the 
planktonic and the biofilm growth phases of the Candida strains examined, 
there were some notable differences. These included up-regulation of 
certain SAPs and ALS expression in the presence of the tissue and up- 
regulation of PLs expression in the planktonic state. The findings would 
appear to imply that culture environment was an important factor in inducing 
expression of these genes. The fact that phospholipase genes were up-
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regulated in the absence of RHE could indicate that expression results from a 
‘starvation trigger’ that may not be present when the tissue is available as a 
contributing source of additional nutrients. The up-regulation of both ALS 
and SAP genes in environments containing the tissue could, in contrast, 
relate to adhesion based triggers. Further work is required to investigate and 
validate these hypotheses.
An additional area of work using this RHE model could be in the investigation 
of non-C. albicans Candida (NCAC) species. Several studies have shown an 
increase in the incidence of candidaemia and a shift from the involvement of 
NCAC species, namely Candida parapsilosis, C. tropicalis, C. guilliermondii, 
C. glabrata, C. krusei, C. lusitaniae, C. kefyr and C. dubliniensis (Bassetti et 
al., 2006; Nucci and Colombo, 2007; Pfallerand Diekema, 2002; Weinberger 
et al., 2005). C. tropicalis has emerged as the second most frequent species 
of all candidemias after C. albicans (Nucci and Colombo, 2007; Weinberger 
et al., 2005). Other NCAC species frequently isolated from blood include C. 
glabrata and C. parapsilosis (Bassetti et al., 2006). It has been observed that 
the prevalence of NCAC species from the oral cavities of patients with 
advanced cancer is also increasing. An explanation for this could be the 
increased use of antifungal drugs (e.g. fluconazole) or the advancements in 
methods for identifying the recovered yeast species (Bassetti et al., 2006; 
Davies et al., 2002). This recent recognition of the importance of NCAC 
species in human infection would support studies examining the biofilms 
produced by these species and assessing their roles in infection. Therefore, 
analysis of clinical NCAC species biofilms within the RHE model could aid in 
clarifying their role in both candidemia and oral candidosis.
With regards to chronic wound biofilms (produced by P. aeruginosa, S. 
aureus, M. luteus and S. oralis) differences in biofilm formation were again 
evident between the species examined. Several in vitro models were used to 
study these biofilms, including a microtitre plate assay, the constant depth 
film fermenter (CDFF) and the RHE system. Chronic wound bacteria were 
able to form biofilms (both individually and in mixed culture) in all these
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models, although in the case of the RHE, invasion only occurred once the 
integrity of the epithelium barrier was disrupted. It is also important to 
highlight that biofilm formation in the CDFF was observed over a period of 7 
d, in contrast to the formation on the RHE, which was only observed between 
24-28 h. It may be that greater levels of biofilm might have occurred on the 
RHE if a prolonged incubation time had been utilised, and again this is an 
area for potential future development.
To assess whether synergism or antagonism occurred between the studied 
bacterial species in the microtitre plate assay, different combinations of 
bacteria in mixed biofilms were analysed. In these mixed species biofilms, 
both P. aeruginosa and S. aureus appeared to antagonise the biofilm forming 
ability of S. oralis and M. luteus. In the case of the CDFF, all four bacterial 
species were added simultaneously and M. luteus appeared to be ‘out- 
competed’ in these situations by the other organisms present and S. oralis 
was often at the limits of detection. Micrococcus luteus is not generally 
considered to be a human pathogen, whereas both P. aeruginosa and S. 
aureus are. It is tempting to speculate that in chronic wound situation the 
introduction of either P. aeruginosa or S. aureus to the environment may 
cause replacement of harmless skin commensals such as M. luteus, thus 
causing an ecological shift to the infected state. Such a situation has indeed 
previously been postulated to occur in plaque mediated diseases (Marsh,
2003). To confirm this hypothesis, there is a need for more in depth cultural 
analysis of the chronic wound environment, and identification of the bacterial 
species involved. Potentially, if this situation did occur, then there may be a 
possible role for probiotic therapy in chronic wounds that could reverse the 
microbial ecology to a healthy state. The CDFF would provide an ideal 
system in which to model such interactions.
In this present study, an attempt was made to add anaerobic bacteria 
simultaneously with aerobic bacteria to form a ‘wound’ biofilm consortium in 
the CDFF. However, the anaerobic species were not subsequently detected 
when the mixed species biofilm was cultured and therefore these organisms
297
were not included in further studies. The reason for this ‘loss’ of the 
anaerobic bacteria could be that the CDFF did not provide a truly anaerobic 
environment, as anaerobic gas was not infused into the fermenter. 
Alternatively, it may have been that the anaerobic species needed a richer 
growth medium than that provided by the BHI broth used. It is known from 
previous research that it is sometimes difficult to maintain anaerobic culture 
within such environments. Denaturing Gradient Gel Electrophoresis (DGGE) 
is a technique that could be used on DNA recovered from the biofilms to 
confirm the presence of the anaerobic organisms as low number constituents 
within the biofilm. DGGE is a more sensitive technique than traditional 
culture techniques, whereby total population DNA is amplified by PCR, 
enabling detection of organisms even when present in very low numbers 
(Spratt, 2004).
To test the statement that biofilms are inherently more resistant to 
antimicrobial and bactericidal agents, povidone-iodine (PVP1) was used. 
PVP1 is a bacteriostatic and antimicrobial agent which is commonly used as 
a topical agent in the treatment of wound infections (Mertz et al., 1999). 
Initial experiments with PVP1 showed that planktonic organisms were 
susceptible to 1% PVP1 which is the concentration that is believed to be 
available to the wound surface from PVP1 integrated wound dressings such 
as Inadine (Johnson & Johnson). Against CDFF generated biofilms however, 
1% PVP1 had little long term effect on the number of viable cells. It was 
interesting to see that after live/dead staining of PVP1 biofilms, a majority of 
‘dead’ cells was evident. ‘Persister cells’ may be in existence in the 
established biofilm, which, whilst dormant are less susceptible to 
antimicrobial activity but are able to effect re-colonisation of the biofilm after 
treatment is stopped. Another possible explanation for this staining pattern 
could be that PVP1 did not actually kill the bacteria and only damaged the 
cell membrane which is reflected as appearing ‘dead’ by the live/dead stain. 
However a reduction in viable cell numbers was observed following culture, 
which lends more support to the ‘persister’ cell theory. It would have been 
interesting to test other antimicrobial agents on CDFF generated biofilms.
298
For example, Rasmussen and Givskov (2006) have suggested that quorum 
sensing inhibitors (QSI) may have value as potentially new antimicrobial 
agents to eradicate in vitro biofilms and such molecules could readily be 
tested in the future using the CDFF model. Garlic extract, carrots, chilli, 
water lily, and patulin and penicillic acid (both compounds produced by some 
members of the fungal genus Penicillium) have all been found to inhibit QS 
and could be tested in this way (Ramsey and Wozniak, 2005; Rasmussen et 
al., 2005; Rasmussen and Givskov, 2006).
Whilst much is known of the physiology of organisms in biofilms little is 
known about biofilm architecture. An important aim of this study was to 
examine the spatial distribution and structure of chronic wound bacterial 
biofilms in both in vitro models and in actual wound tissue. Chronic wounds 
are known to be colonised by a diverse microflora, including anaerobic 
bacteria, and it has been speculated that bacteria exist in these highly 
persistent biofilm communities (James et al., 2007). Fluorescent in situ 
hybridisation (FISH) with peptide nucleic acid probes (PNA) was used to 
assess biofilm architecture. The data showed that in bacterial biofilms 
established in the CDFF, the organisms grew as aggregates and in species 
specific zones, suggesting that the bacterial species did not integrate well 
with one another under these conditions. Pseudomonas aeruginosa was the 
predominant constituent of these CDFF generated biofilms as demonstrated 
by FISH and indeed previously by viable count estimation. The distribution of 
mixed organisms confirmed the previous cultural findings, suggesting that 
species antagonism occurred within the community. Bjarnsholt et al. (2008) 
analysed sections from chronic wounds by PNA FISH using a P. aeruginosa 
specific (Texas red labelled) and a universal bacterial (FITC labelled) probe 
and also found distinct microcolonies of P. aeruginosa and cocci shaped 
bacteria when viewed by CLSM. Another study using a porcine model, 
inoculated partial thickness wounds with a S. aureus wound isolate strain and 
showed aggregates of microcolonies of bacteria embedded within and 
attached to the wound bed (Davis et al., 2008). James et al. (2007) also 
observed Gram-positive cocci in large aggregates in all acute and chronic
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wounds. Unfortunately in this study, the presence of any EPS matrix 
generated by the chronic wound bacterial biofilms was not established.
Unlike the findings seen with C. albicans, none of the bacterial species were 
able to invade the tissue model and these bacterial biofilms were found to be 
limited using an undamaged RHE surface. Subsequent analysis of chronic 
wound biopsies showed the presence of bacteria, but it was difficult to 
confirm whether an actual biofilm was present due to the condition of the 
archived biopsy tissue analysed. These samples were from chronic wounds 
which clinically were not regarded as infected. Certainly, in the case of 
clinically infected wounds, biofilms are evident on the surface of many patient 
wounds particularly when P. aeruginosa is involved, as it has a characteristic 
green colouration and strong odour.
Bacteria possess adhesins which are thought to be involved in biofilm 
formation. For example, Love et al (1997) showed that antigen I/ll 
polypeptides are involved in the attachment of oral streptococci to collagen 
and that their activity may be crucial for penetration of human root dentinal 
tubules and infection of the tooth root canal system and pulp. Pseudomonas 
aeruginosa also promotes attachment and biofilm formation through its 
twitching and flagella mediated motility. Furthermore, some bacteria have 
the ability to actually invade the tissues, as evident with spirochetes, 
Salmonella, Escherichia, Shigella and Yersinia spp. (Barocchi et al., 2002). 
There are, however, no specific bacterial morphological forms that actually 
promote epithelium invasion as seen with the hyphae of C. albicans.
Prokaryotic (bacteria) as well as eukaryotic organisms (fungi) produce 
destructive enzymes, such as proteinases, phospholipases and DNases, 
which damage the epithelial cells and tissues, and indirectly promote an 
inflammatory response (Percival and Rogers, 2005). In addition, recent 
studies have also identified numerous bacterial genes or factors as being 
‘essential’ or ‘required’ for biofilm formation (Caiazza and O'Toole, 2003; 
Cramton et al., 1999; Hall-Stoodley et al., 2004; Valle et al., 2003). These
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genes regulate or express surface-adhesion proteins, appendages such as 
pili, flagella and the EPS matrix (Hall-Stoodley et al., 2004). Bacterial surface 
proteins contribute significantly to adhesion and include the autolysin AtlE of 
Staphylococcus epidermidis, the biofilm associated protein (Bap) and the 
accumulation associated protein (AAP) (Hall-Stoodley et al., 2004).
Staphylococcus aureus and P. aeruginosa biofilms generated in the CDFF 
were used to detect biofilm and virulence related genes by RT-PCR. 
Staphylococcus aureus gene expression was further analysed by microarray 
technology at the Health Protection Agency in Colindale, London, UK. The in 
vitro study showed that the majority of the examined genes, previously 
associated with biofilm formation by S. aureus and P. aeruginosa were 
expressed in biofilm samples. Some of these genes were also expressed in 
planktonic samples, suggesting that there might be some organisms with a 
biofilm phenotype present, or that the expression of the genes was not 
exclusive to the biofilm mode of growth. Furthermore, semi-quantification of 
the RT-PCR products from these genes indicated that the majority were ‘up 
regulated’ in the biofilm samples compared to the planktonic ones. Altered 
gene expression for S. aureus between biofilm and planktonic samples was 
also apparent from the exploratory microarray data. The expression of S. 
aureus virulence associated factors is controlled by a network of regulatory 
genes including agr and the sar operon (Saunders et al., 2004). 
Confirmation of up-regulation of agr and sarA was evident using the 
microarray method in this present study. Beenken et al. (2004) similarly 
investigated differential gene expression in a mature S. aureus biofilm and 
revealed that genes which were part of the sarA regulon were also 
differentially expressed in biofilms.
Following study of these chronic wound isolates, several areas for further 
investigation have been identified. Additional molecular analysis e.g. 
quantitative real time PCR (qRT-PCR) for gene quantification would prove 
valuable in elucidation the role of individual genes in a biofilm state. qRT- 
PCR would provide more accurate quantitative data on specific gene
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expression compared with the semi-quantitative RT-PCR used here. qRT- 
PCR allows quantification of the gene product and could also be used to 
validate the microarray data. Biofilm related gene expression could be 
further assessed with mixed species biofilm samples and with biofilm 
samples that have been treated with PVP1 or other antimicrobial agents.
FISH and CLSM analysis on fresh or well preserved clinical biopsies (CHC 
and chronic wounds) could be used to highlight the location of causative 
organisms within the tissue. This could actually aid in the determination of 
which species act as primary colonisers of the infection and which organisms 
actually invade the tissue and cause harm. The FISH technique could 
facilitate estimation of the relative proportions of organisms within the biopsy 
and could be valuable in assessing biofilm management strategies or 
evaluating the effectiveness of antimicrobials against the biofilm consortium 
in vivo. The application of such tests in the clinical setting in the not too 
distant future seems highly probable. It is still not clear to what extent 
microorganisms in a wound are surface colonisers or how deep they 
penetrate the wound tissue. This could affect the outcome for the patient and 
the strategy for treatment. For instance, whether prescription of systemic 
antibiotics is necessary or whether antimicrobial wound dressings are 
sufficient.
Succession studies for biofilm formation represents an area that appears to 
be neglected by researchers and warrants future investigation. Even in this 
present study, all species were added simultaneously to the CDFF. Without 
time constraints, it would have been interesting to add the species of interest 
in a successive manner, e.g. i) first add suspect commensal species and 
then the pathogenic organisms or, ii) aerobic organisms and then in a mature 
biofilm add anaerobic ones. This could give a better understanding of how 
biofilms form in vivo.
The characterisation of biofilms as shown in this study is extremely complex. 
The RHE used is by far, the closest model to the in vivo situation for studying
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biofilm formation. Only with further knowledge can our understanding of 
‘biofilms’ be improved. Such research is warranted, as it may facilitate the 
development of new diagnostic tools and techniques which could be applied 
to any biofilm related infections.
Biofilms are currently a subject of intense research interest and a major 
public health issue in the emergence of antimicrobial resistance. This study 
attempted to characterise biofilms associated with infections and their feature 
that promote virulence and resistance to antimicrobial agents. In conclusion, 
principal findings of this study showed
• that strain and species variation in terms of biofilm formation, infection 
type and invasion of the RHE tissue was evident, particularly for 
Candida albicans.
• Bacterial interaction studies highlighted that P. aeruginosa was the 
predominant organism in mixed species biofilms using in vitro studies 
which could have importance when extrapolated to the clinical 
situation.
• The limited long term effect of PVP1 on biofilms has potential 
significance in how chronic wounds are therapeutically managed.
• However, it is still difficult to determine, whether the presence of either 
S. aureus or P. aeruginosa in chronic wounds reflects microbial 
infection or colonisation. If the former, then the occurrence of these 
organisms might be valuable indicators of the likely occurrence of a 
non-healing wound phenotype.
• Moreover, the appreciation that biofilms are involved in chronic 
wounds reinforces the need for continued study of this subject with 
particular emphasis directed at the involvement of both S. aureus and 
P. aeruginosa.
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Appendix I. Bacterial media
Constituents of BM medium (McKee et al., 1985)
BM medium g r
Proteose peptone (Oxoid, Unipath Ltd. Basingstoke, UK) 10
Trypticase peptone ( Becton-Dickson UK Ltd, Oxford, UK 5
Yeast extract (Oxoid, UK) 5
potassium chloride (Sigma, Poole) 2.5
Glucose (BDH, WWR International, Lutterworth, UK) 10
Cysteine HCI 0.5
Haemin (Sigma, Poole) 0.005
Vitamin K1 0.001
Glucose 10
H20 1000 ml
Two other reagents, 0.5 gl'1 cysteine hydrochloride (BDH, WWR International, 
Lutterworth, UK) and 0.001 gl'1 vitamin K (Sigma, Poole), were each filter sterilised 
separately, and added aseptically to the autoclaved BM media after cooling.
Constituents of simulated wound fluid (Addison et al., 2004)
Simulated wound fluid g r 1
calcium-chloride 1.5
Sodium-chloride 12
Tris-HCI 5
Bovine Serum Albumin (BSA), pH 7.5 20
H20 1000 ml
The medium was modified by adding 2 gl'1 glucose to provide an additional carbon 
source and sterilised by autoclaving.
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Appendix II
Sequences of 
Streptococcus oralis (B52), 
Staphylococcus aureus (D76), 
Pseudomonas aeruginosa (D40), 
Micrococcus luteus (B81)
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Sequence of Streptococcus oralis (B52)
S/N G 346 A 199 T182 C229  
KB.bcp
KB 1.1.1 Cap:13
B52_013_G11
B52
KB_3100_POP6_BDTv1 .mob 
Pts 960 to 13500 Pk1 Loc:960 
Version 5.1.1 HiSQV Bases: 813 Sladiana Malic
Inst Model/Name 3100/1338-040-1338-040 
Jill 19.2005 04:46PM. BST 
Jut 19.2005 05:29PM. BST 
Spadng:15.94 Pts/Panel1000 
Plate Name: 15.07.05
G A C  G G A A T T C  T G A C C G A G C A A C  0  C C OC G T G A  G T O A A G A A G G T T T T C  G G A  T  C G T A A  A G C T C T O T  T G T A A G A G A A G A A C G A G T G  
1 8 15 22 29  3 6  43  50 5 7  64 71 78
a . a / W L A /w A ^ a  N\A/V\ Aa/WI
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Sequence of Streptococcus oralis (B52) continued
AfcttSm,
S/N G:346 A:199 T:182 C:229 
KB.bcp
KB 1.1.1 C«p:13
B52_013_G11
B52
KB_3100_POP6_BDTv1. mob 
PtS 960 to 13500 Pk1 Loc:960 
Version 5.1.1 HiSQV Bases: 813 Sladiana Malic
Inst Model/Name 3100/1338-040-1338-040 
Jul 19,2005 04:46PM, BST 
Jul 19.2005 05:29PM, BST 
Spadng:15.94 Pts/Panel1000 
Plate Name: 15.07.05
3 79365 372 393 400 407337 344 351 358 414
449 456 463 470 484421 428 4 35 442 477 491 498
505 512 526 533 540 554 561 568 575 582
617 6 31 666589 5 9 6 603 610 624
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Sequence of Staphylococcus aureus (D76)
D76_011_F11 Inst Model/Name 3100/1338-040-1338-040
D76 Jul 19,2005 04:46PM, BST
KB_3100_POP6_BDTv1 .mob Jul 19,2005 05:29PM, BST
Pts 600 to 13501 Pk1 Loc:600 Spacing: 16 13 Pts/Panel1000
Version 5.1.1 HiSQV Bases: 696 Sladiana Malic Plate Name: 15.07.05
A T T A  S 6  ET A  A T  C T T C C O C A A T G  G G C G A A A G  C C T  S A C  S S  A S  C A A C  S C  C S C  G T S  A S  T S A T  S A A S S T C T  T C G  S A  T C  G T A A A A C  T C  
1 e I S  22  29  36  43  SO 57 64 71 78
T O T  T A  T T A  S S O A A S A A C  C T A  T O T  8 T A A O  T A A C  T S T S C A C A  T C  T T S A C S S T A C C T A A  T C A S A A A S C C A C  S S C T A A C T A C S T S C  C X I  
8S 92 99 106  113  120  127  134 141 148 155  162
C A G C  C G C  G G T A A T  A C  G T A G  G T S G C A A G  C O T T A T C C  G G  A A T T A  T T  G G G C  G T A A A G  C G C  S C  G T A G  G C  G 6 T T T T T T A A 6 T  C T G A T  
169  176  183 1 9 0  197  204  211  218  2 2 5  232  239  246
T G A  A  A  G C C C A C  G G C  T C A A C  C G T G G  A G G  G T C A  T T  G G  A A A C  T G G A A A A C  T T 6 A G  T 6 C A G A A 6 A G  G A A A G  T 6 G A A T  T C  C A  T O  T G T  A  <
2 5 3  2 6 0  267  2 7 4  281  288  2 9 5  302 309  316  323 330
S/N G:1499 A1639 T:1908 C:1870 
KB.bcp
KB 1.1.1 Cap:11
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Sequence of Staphylococcus aureus (D76) continued
Inst Model/Name 3100/1338-040-1338-040 
Jul 19,2005 04:46PM, BST 
Jul 19,2005 05:29PM, BST 
Spadng:16.13 PWPanellOOO 
_________________ Plato Mama: 15.07.05
C G G T S A A A T 6 C  G C A G A G  A T A T G G A G G A A C A C  C A G T G G C  G A A G G C  G A C T T T C T G G T C T G T A A C  T O A C G C  T G A T  G T S C 6 A A A G C  C 
3 37  344  351  358  365  372  3 7 9  3 8 6  393  4 0 0  407  414
T  G G 8 G  A T  C A A A C A G G A T  T A  G A T A C C  C T O G T A O T C C A C  G C  C G T A A A C  G A T G A G T O C  T A A G  T G T T A G  G G G G T T T C C G C C C C T T A C
4 2 1  4 2 8  4 3 5  4 4 2  4 4 9  456  4 6 3  4 7 0  4 7 7  484  491  498
T G C  T G C A G C  T A  A C  G C A T  T A A G C A C  T C C G C  C T G G G G A G  T A C  G A C C  G C A A G G T T G A A A C T C A A A G G  A A T T G A C G G G G A C  C C  G C A
5 0 5  5 1 2  5 1 9  5 2 6  5 3 3  5 4 0  547  SS4 S61 568  575  581
C A A G C G G T G G  A G C A T  G T G  G T  T T A  A  T T C  G A A G C A A C  G C  G A A G A A C C T T A C  C A A A T  C T T  G A C A T C  C T  T T G A C A A  C T  C T A G A G A T J  
5 8 9  5 9 6  6 0 3  6 1 0  617  624 631  6 3 8  6 4 5  652  659
MR t t f S S Systems
S/N G1499 A: 1639 T:1906 C:1870 
KB.bcp
KB 1.1.1 Cap:11
D76_011_F11
D76
KB_3100_POP6_BDTv1 .mob 
Pts 600 to 13501 Pk1 Loc:600 
Version 5.1.1 HiSQV Bases: 696 Sladiana Malic
Printed on: Wed Jul 20,2005 09:24AM, BST Electropherogram Data Page 2 of 2
Sequence of Pseudomonas aeruginosa (D40)
PiR t t g S L -
S/N G:743 A:468 T:403 C 510 
KB.bcp
KB 1.1.1 Cap:9
D40_009_E11 
D40
KB_3100_POP6_BDTv1 .mob 
Pts 615 to 13501 Pk1 Loc:615 
Version 5.1.1 HiSQV Bases: 826 Sladiana Malic
Inst Model/Name 3100/1338-040-1338-040 
Jut 19,2005 04:46PM, BST 
Jul 19,2005 05:29PM, BST 
Spacing:16.17 Pis/Panel 1000 
Plate Name: 15.07.05
G T G G G T A A T A  T T  G G  C C A A T G G G C  G A  A  A  O C C T  O A T  C CA G C C A T G  C C G C O T G T O T  G A  A  G A A G G T C T T C G G A T T G T A A A G  C A C  T  
1 6 15 22  2 9  36  4 3  50  57 64 71 7B
a/^ aAamM^&aMA/vi a/)(\aaMAA A/V\ AaAaAa
G A A A T C C C C  G G G C  T C A A C  C T G  G G A A C  T  G C A T  C C A A A A C  T A C  T G A G  C T A G  A G T A C  G G T A G  A G G  G T G  G T G G A A T T T C  C T G T G T A G C  
2 5 3  2 6 0  2 6 7  274  2 * 1  2 8 8  2 9 5  302  3 0 9  3 1 6  3 2 3  330
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Sequence of Pseudomonas aeruginosa (D40) continued
GJ
00
AfcgSSj&lms
S/N G:743 A468 T:403 C:510 
KB.bcp
KB 1.1.1 Cap:9
D40_009_E11 
D40
KB_3100_POP6_BDTv 1 mob 
Pts 615 to 13501 Pk1 Loc 615 
Version 5.1.1 HiSQV Bases: 828 Sladiana Malic
Inst Model/Name 3100/1338-040-1338-040 
Jul 19.2005 04:46PM, BST 
Jul 19.2005 05:29PM, BST 
Spadng:16.17 Pts/Panel1000 
Plate Name: 15.07.05
G G T G A A A T G C  G T A 6  A T A T A G G A A G G A A C A C  C A G T G G C  G A A G G C G A C C A C  C T  G G  A C  T G A T A C  T G A C A C  T G A G G T 6 C  G A A A G C  G T G  
3 37  344  351  358  3 6 5  3 72  3 79  3 8 6  3 93  4 0 0  407  414
5 G G A G C A A A C A G G A T T A G  A T A C C C  T G G  T A G  T C C A C  G C  C G T A A A C  G A T  G T C G A C  T A G C  C G T T G G G A T C C T T 6 A G A T C T T A G  T G G C  
421  428  4 3 5  4 4 2  4 4 9  4 5 6  4 6 3  4 7 0  477  4 84  491  498
G C A G C  T A  A  C G C  G A T A A G T C  G A C  C G C  C T G G G G  A G  T A C  G G C  C G C A A G G T  T A A A A C  T C A A A T  G A A T T  G A C  G G G G  G C  C C G C A C A A C  
5 0 5  5 1 2  5 19  5 2 6  5 33  540  547  554 561  568  5 75  582
I G G T G G A G C A T G T G G T  T T A A T  T C G A A G C A A C G C G A A G A A C  C T T A C  C T  G G C  C T T G A C A T  G C  T G A G A A C  T T T C C A G A G A T G G A T T  
589  5 9 6  6 0 3  6 10  6 1 7  624  6 31  638  6 4 5  652  659  66€
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Sequence of Micrococcus luteus (B81)
A_003_B07 Inst Model/Name 3100/BARR IE-1338040
Jun 19,2006 06:02PM, BST
KB_3130_POP7_BDTv3.mob Jun 19,2006 06:16PM, BST
Pts 2122 to 13660 Pk1 Loc:2122 Spacing:13.31 Pts/Penel 1000
Version 5.2 Patch2 HiSQV Bases: 848 Sladjana Malic Plato Name: 16.06.06
~C~G C C G T T G G  G GG  C A  T G  G G C G  A G C C T C  A I G  C A G  C G A C  G C C G  C O  T O  A G G G f  T  G A C  G G C C T  T C G  G G T T O T A A A C C T C T
1 8 15 22 2 9  36  43  50  57 64 71
T T C A G  T A  G G G A A G A A G C  G A A A G T  G A C  G G T A C C  T G C A  G A A G A A G C A C C  G G C T  A  A  C T A C  G T G C C A G  C A  G C C  G C  G G T A A T A C  G T A G  G G
8 85  92 99  106  1 1 3  1 20  1 27  134  141  1 48  155  162
T G C  G A G C G T T A T C C  G G A A T T A T T  G G G C  G T  A A A  G A G C T  C G  T A G  G C  G G T  T T  G T  C G C  G T C T G  T C  G T  G A A A G T C C  G G G G C T T A A C C C C
169  1 7 6  183  190  197  2 04  2 1 1  2 1 8  2 2 5  2 3 2  2 39  2 4 6
g a t c t g c g g t g g g t a c g g g c a g a c t a g a s t g c a g t a g g g g a g a c t g g a a t t c c t g g t g t a g c g g t g g a a t g c g c a g a t a t c a g
2 5 3  2 6 0  2 6 7  2 7 4  2 8 1  2 88  2 9 5  302  309  3 1 6  323  330
A&M&ns
S/N G:413 A306 T:202 C 256 
KB.bcp
KB 1.2 Cap:3
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Sequence of Micrococcus luteus (B81) continued
S/N G:413 A 306 T:202 C:256 
KB.bcp
KB 1.2 Cap:3
A_003 B07
KB_3130_PdP7_BDTv3.mob 
Pts 2122 to 13860 Pk1 Loc:2122 
Version 5.2 Patch2 HjSQV Bases: 848 Sladiana Malic
Inst Model/Name 3100/BARRIE-1338040 
Jun 19,2006 06:02PM, BST 
Jun 19,2006 06:16PM, BST 
Spacing:13.31 Pts/Panel1000 
Plate Name: 16.06.06
<lumww
Printed on: Tue Jun 20,2006 08:47AM, BST Electropherogram Data Page 2 of 2
Appendix III. Microarray gene list
ORF Gene
agrC1 af210055 agrC
agrC2 af001782 agrC
agrC3 af001783 agrC
agrC4 af288215 agrC
bbp 024 bbp
clfA MW0764 clfA
clfB MW2551 clfB
coa MW0206 coa
comGC MW1494 comGC
E16-0102c E16-0102c E16 102c
E16-0463 E16-0463 E16 463
E16-0467 E16-0467 E16 467
E16-0469 E16-0469 E16 469
E16-0475 E16-0475 E16 475
E16-0776 E16-0776 E16 776
E161084c E16-1084c E16 1084c
E161208c E16-1208c E16 1208c
E16-1212c E16-1212c E16 1212c
E16-1213c E16-1213C E16 1213c
E16-1949 E16-1949 E16 1949
E16-2023C E16-2023C E16 2023c
E16-2024C E16-2024C E16 2024c
E16-2025C E16-2025C E16 2025c
E162027c E16-2027C E16 2027c
E162040c E16-2040C E16 2040c
E16-2041 c E16-2041 c E16 2041c
E16-2042C E16-2042C E16 2042c
E162902c E16-2902C E16 2902c
E16-2979C E16-2979C E16 2979c
E16465 E16-0465 E16465
E16472 E16-0472 E16 472
ebhA SA1267 ebhA
ebhB SA1268 ebhB
efb strain 4074 efb
epbS MW1369
bacteriophage
epbS
eta phi ETA eta
etb etb plasmid etb
fhuA MW0609 fhuA
fhuB MW0610 fhuB
fhuG MW0611 fhuG
fnbB MW2420 fnbB
geh MW0297 geh
gi|46019590 agr
gi|46019594 agr
gi|46019594 agr
gi|46019602 agr
gi|46019606 agr
gi|46019610 agr
gi|78172207 agr
gi|78172207 agr
gi|78172212 agr
Product
group 1 accessory gene regulator
group 2 accessory gene regulator
group 3 accessory gene regulator
group 4 accessory gene regulator
sdrE homolog (bone sialoprotein binding protein)
fibrinogen-binding protein
clumping factor B
staphylcoagulase precursor
exogenous DNA-binding protein
TCRTETB/TCRTETA
BACTRLTOXIN
TOXICSSTOXIN/BACTRLTOXIN
TOXICSSTOXIN
TOXICSSTOXIN
SECYTRNLCASE
V8PROTEASE
BICOMPNTOXIN
TOXICSSTOXIN
TOXICSSTOXIN
BLACTAMASEA
V8PROTEASE
V8PROTEASE
V8PROTEASE
V8PROTEASE
BACTRLTOXIN
BACTRLTOXIN
BACTRLTOXIN
THERMOLYSIN
SUBTILISIN
TOXICSSTOXIN/BACTRLTOXIN 
TOXICSSTOXIN/BACTRLTOXIN 
similar to streptococcal adhesin emb 
similar to streptococcal adhesin emb 
fibrinogen-binding protein 
elastin binding protein
Staphylococcus aureus exfoliative toxin A 
Staphylococcus aureus exfoliative toxin B 
ferrichrome transport ATP-binding protein 
ferrichrome transport permease 
ferrichrome transport permease 
fibronectin-binding protein homolog 
glycerol ester hydrolase 
type 2 7-11 27 
type 2 
type 2 7-11
type 3 subst specific 4 5 
type 3 subst specific 4 
type 3 subst specific 3-6 26 
type 4 subset specifi 214 24 
type 4 specific 
type 1 subset specific 1 12 25
351
gi|78172212 agr
gmk MW1092 gmk
hla MW1044 hla
hlb MW1881 hlb
hlgB MW2344 hlgB
hlgC MW2343 hlgC
hlgll MW2342 hlgA
hu MW1362 hu
icaA MW2586 icaA
lepA MW 1536 lepA
igt MW0723 igt
lip MW2590 lip
Isp MW1079 Isp
modA MW2197 modA
modC MW2195 modC
msmX MW0189 msmX
mupR j2870 mupR
MW0031 MW0031 mecA
MW0040 MW0040 MW0040
MW0042 hypothetical protein
MW0043 hypothetical protein
MW0045 hypothetical protein
MW0047 hypothetical protein
MW0051 MW0051 seh
MW0052 MW0052 MW0052
MW0053 hypothetical protein
MW0062 MW0062 MW0062
MW0063 MW0063
MW0064 MW0064
MW0065 MW0065
MW0066 MW0066 MW0066
MW0074 hypothetical protein
MW0077 MW0077 MW0077
MW0079 MW0079 MW0079
MW0085 MW0085 sarH1
MW0092 MW0092 MW0092
MW0105 MW0105 MW0105
MW0108 MW0108 MW0108
MW0111 MW0111 MW0111
MW0120 MW0120
MW0147 MW0147 MW0147
MW0161 MW0161 MW0161
MW0167 MW0167 MW0167
MW0171 MW0171
MW0172 MW0172 MW0172
MW0178 MW0178 MW0178
MW0182 MW0182 oppB
MW0190 MW0190 MW0190
MW0198 MW0198 MW0198
type 1 subset specific 1 12 16 17 20 25
guanylate kinase
alpha toxin; alpha haemolysin
beta haemolysin
gamma-hemolysin component B
gamma-hemolysin component C
gamma haemolysin chain II
DNA-binding protein II
intercellular adhesion protein A
GTP-binding protein
prolipoprotein diacylglyceryl transferase
triacylgiycerol lipase precursor
lipoprotein signal peptidase
probable molybdate-binding protein
molybdenum transport ATP-binding protein
multiple sugar-binding transport ATP-binding protein
isoleucyl tRNA synthetase
penicillin binding protein 2 prime
hypothetical protein
hypothetical protein
hypothetical protein
hypothetical protein
hypothetical protein
staph enterotoxin h
truncated hypothetical protein, similar to enterotoxin SEO
hypothetical protein similar to macrolide-efflux determinant 
portal protein
hypothetical protein, similar to transcriptional regulator (LysR 
family)
terminase large subunit
hypothetical protein, similar to transcriptional regulator
hypothetical protein, similar to transcription regulator 
AraC/XylS family
hypothetical protein similar to transmembrane efflux pump 
protein
staphylococcal accessory regulator A homologue 
hypothetical protein similar to multi-drug resistance efflux 
pump
hypothetical protein, similar to capsular polysaccharide 
synthesis protein 14H
hypothetical protein
hypothetical protein similar to tetracyclin resistance protein 
truncated replication initiator protein 
hypothetical protein similar to membrane lipoprotein SrpL 
hypothetical protein, similar to isochorismatase 
hypothetical protein, similar to transcription regulator 
hypothetical protein
hypothetical protein, similar to ABC transporter ATP-binding 
protein
hypothetical protein, similar to ABC transporter ATP-binding 
protein
truncated hypothetical protein, similar to oligopeptide ABC 
transporter permease
hypothetical protein, similar to maltose/maltodextrin-binding 
protein
hypothetical protein, similar to two-component response
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MW0200 MW0200 MW0200
MW0213 MW0213 MW0213
MW0240 MW0240 MW0240
MW0250 MW0250 MW0250
MW0263 MW0263 MW0263
MW0283 MW0283 MW0283
MW0286 MW0286 MW0286
MW0310 MW0310 MW0310
MW0311 MW0311 MW0311
MW0323 MW0323 MW0323
MW0327 MW0327 MW0327
MW0339 MW0339 MW0339
MW0345 MW0345 MW0345
MW0355 MW0355
MW0368 MW0368
MW0372 MW0372
MW0374 MW0374
MW0376 MW0376 MW0376
MW0378 MW0378
MW0379 MW0379
MW0381 MW0381 MW0381
MW0382 MW0382 set16
MW0383 MW0383 set17
MW0384 MW0384 set18
MW0385 MW0385 set19
MW0386 MW0386 set20
MW0387 MW0387 set21
MW0388 MW0388 set22
MW0389 MW0389 set23
MW0390 MW0390 set24
MW0391 MW0391 set25
MW0394 MW0394 set26
MW0395 MW0395 MW0395
MW0396 MW0396 MW0396
MW0397 MW0397 IpMO
MW0398 MW0398 Ipl11
MW0399 MW0399 Ipl12
MW0400 MW0400 Ipl13
MW0401 MW0401 Ipl14
MW0402 MW0402 MW0402
MW0416 MW0416 MW0416
MW0418 MW0418 MW0418
MW0513 MW0513 MW0513
MW0531 MW0531 yqii
MW0543 MW0543 pta
MW0552 MW0552
MW0553 MW0553
MW0554 MW0554
regulator
hypothetical protein similar to periplasmic-iron-binding protein 
BitC
hypothetical protein, similar to nickel ABC transporter nickel- 
binding protein
hypothetical protein, similar to transcription regulator GntR 
family
hypothetical protein, similar to proton antiporter efflux pump 
conserved hypothetical protein, similar to diarrheal toxin 
incomplete ORF
hypothetical protein, similar to branched-chain amino acid 
uptake carrier
hypothetical protein, similar to ABC transporter ATP-binding 
protein
hypothetical protein, similar to transcription regulator 
conserved hypothetical protein 
conserved hypothetical protein
hypothetical protein, similar to ABC transporter ATP-binding 
protein
hypothetical protein, similar to GTP-binding protein 
hypothetical protein, similar to exotoxin 2 
hypothetical protein
hypothetical protein, similar to AbiD1 [Genomic island nu Sa 
alpha2
GenomicislandnuSaalpha2 
GenomicislandnuSaalpha2 
hypothetical protein 
GenomicislandnuSaalpha2 
Genomicis!andnuSaalpha2 
conserved hypothetical protein MW0381 
exotoxin 16 
exotoxin 17 
exotoxin 18 
exotoxin 19 
exotoxin 20 
exotoxin 21 
exotoxin 22 
exotoxin 23 
exotoxin 24 
exotoxin 25 
exotoxin 26 
hypothetical protein 
hypothetical protein 
hypothetical protein 
hypothetical protein 
hypothetical protein 
hypothetical protein 
hypothetical protein 
hypothetical protein
hypothetical protein, similar to ABC transporter ATP-binding 
protein
hypothetical protein similar to lactococcal lipoprotein 
hypothetical protein, similar to Cu binding protein (Mn 
oxidation)
acetyl-CoA c-acetyltransferase 
phosphotransacetylase 
major tail protein 
conserved hypothetical protein 
putative primase
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MW0558 MW0558 conserved hypothetical protein
MW0559 MW0559 conserved hypothetical protein
MW0560 MW0560 hypothetical protein
MW0573 MW0573 MW0573 hypothetical protein similar to iron-binding protein 
hypothetical protein similar to iron(lll) ABC transporter
MW0574 MW0574 MW0574 permease protein
MW0579 MW0579 MW0579 hypothetical protein similar to esterase/lipase
MW0593 MW0593 MW0593 lipoprotein, Streptococcal adhesin PsaA homologue
MW0594 MW0594 MW0594 conserved hypothetical protein
hypothetical protein, similar to ABC transporter ATP-binding
MW0595 MW0595 MW0595 protein
MW0596 MW0596 MW0596 hypothetical protein similar to iron dependent repressor
MW0617 MW0617 MW0617 hypothetical protein similar to lipase LipA
MW0623 MW0623 vraF ABC transporter ATP-binding protein
MW0651 MW0651 MW0651 hypothetical protein
MW0681 MW0681 MW0681 hypothetical protein, similar to anion-binding protein 
hypothetical protein, similar to ABC transporter ATP-binding
MW0682 MW0682 MW0682 protein
hypothetical protein, similar to choline transport ATP-binding
MW0684 MW0684 MW0684 protein
hypothetical protein similar to ferrichrome ABC transporter
MW0695 MW0695 MW0695 permease
hypothetical protein similar to ferrichrome ABC transporter
MW0696 MW0696 MW0696 permease
hypothetical protein similar to ferrichrome ABC transporter
MW0697 MW0697 MW0697 ATP-binding protein
MW0698 MW0698 MW0698 lipoprotein, similar to ferrichrome ABC transporter
MW0736 MW0736 tpi triosephosphate isomerase
MW0746 MW0746 hypothetical protein (Genomic island)
MW0751 MW0751 hypothetical protein (Genomic island)
MW0754 MW0754 hypothetical protein (Genomic island)
MW0755 MW0755 hypothetical protein (Genomic island)
MW0756 MW0756 hypothetical protein (Genomic island)
MW0757 MW0757 hypothetical protein (Genomic island)
MW0758 MW0758 ear Ear (Genomic island)
MW0760 MWQ760 sel2 extracellular enterotoxin I
MW0765 MW0765 MW0765 truncated secreted von Willebrand factor-binding protein
MW0766 MW0766 MW0766 truncated secreted von Willebrand factor-binding protein
MW0767 MW0767 ssp extracellular ECM and plasma binding protein
MW0790 MW0790 MW0790 ABC transporter ATP-binding protein homologue
MW0795 MW0795 MW0795 ABC transporter ATP-binding protein homologue 
oligopeptide transport system ATP-binding protein OppD
MW0870 MW0870 oppD homologue
MW0871 MW0871 oppF oligopeptide transport ATP-binding protein
MW0872 MW0872 MW0872 hypothetical protein, similar to peptide binding protein OppA 
hypothetical protein, similar to oligopeptide ABC transporter
MW0873 MW0873 MW0873 oligopeptide-binding protein
MW0874 MW0874 MW0874 oligopeptide ABC transporter ATP-binding protein homologue 
oligopeptide transport system ATP-binding protein AppF
MW0875 MW0875 appF homologue
hypothetical protein, similar to multidrug resistance protein-
MW0897 MW0897 MW0897 related protein
hypothetical protein, similar to UDP-glucose:polyglycerol
MW0919 MW0919 phosphate glucosyltransferase
MW0921 MW0921 MW0921 hypothetical protein similar to ferrichrome ABC transporter
MW0962 MW0962 MW0962 hypothetical protein
spermidine/putrescine ABC transporter, ATP-binding protein
MW0982 MW0982 potA homolog
MW0985 MW0985 MW0985 spermidine/putrescine-binding protein precursor homoiog
MW0986 MW0986 MW0986 conserved hypothetical protein
MW1015 MW1015 MW1015 hypothetical protein similar to ferrichrome ABC transporter
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MW1016 MW1016 MW1016 hypothetical protein similar to ferrichrome ABC transporter
MW1040 MW1040 MW1040 fibrinogen-binding protein
MW1041 MW1041 MW1041 hypothetical protein, similar to fibrinogen-binding protein
MW 1047 MW1047 MW1047 hypothetical protein, similar to exotoxin 1
MW1048 MW1048 MW1048 hypothetical protein, similar to exotoxin 4
MW1049 MW1049 MW1049 hypothetical protein, similar to exotoxin 3
MW1091 MW1091 MW1091 hypothetical protein, similar to fibrinogen binding protein 
hypothetical protein, similar to transcription regulator GntR
MW1160 MW1160 MW1160 family
hypothetical protein, similar to 3-oxoacyl- acyl-carrier protein
MW1163 MW1163 MW 1163 reductase homolog ymfl
MW1182 MW1182 gipF glycerol uptake facilitator
MW1185 MW1185 MW1185 hypothetical protein similar to lysophospholipase 
hypothetical protein, similar to GTP-binding protein proteinase
MW1189 MW1189 MW1189 modulator homolog ynbA
MW1197 MW1197 hypothetical protein
MW1206 MW1206 MW1206 ABC transporter (ATP-binding protein) homolog
MW1261 MW1261 femA factor essential for expression of methicillin resistance
MW1262 MW1262 femB FemB protein
MW1280 MW1280 MW 1280 ABC transporter (ATP-binding protein) homolog
MW1287 MW1287 MW1287 hypothetical protein, similar to alanine racemase
MW 1364 MW1364 MW1364 hypothetical protein, similar to GTP binding protein
MW1378 MW1378 lukF Panton-Valentine leukocidin chain F precursor
MW1379 MW1379 lukS Panton-Valentine leukocidin chain S precursor
MW1386 MW1386 conserved hypothetical protein (Bacterioophage)
MW1393 MW1393 conserved hypothetical protein (Bacterioophage)
MW1400 MW1400 hypothetical protein (Bacterioophage)
MW1401 MW1401 hypothetical protein (Bacterioophage)
MW1405 MW1405 hypothetical protein (Bacterioophage)
MW 1408 MW1408 hypothetical protein (Bacterioophage)
MW1493 MW1493 MW1493 hypothetical protein, similar to competence protein
MW1507 MW1507 MW1507 hypothetical protein, similar to ABC transporter 
hypothetical protein, similar to ABC transporter ATP-binding
MW 1508 MW1508 MW1508 protein
MW1519 MW1519 bex GTP-binding protain Era homolog
MW1532 MW1532 dnaK DnaK protein
MW1547 MW1547 aroE shikimate dehydrogenease
MW1552 MW1552 MW1552 enterotoxin homolog
MW1572 MW1572 MW1572 iron-sulfur cofactor synthesis protein homolog 
hypothetical protein similar to iron-sulfur cofactor synthesis
MW1659 MW1659 MW1659 protein nifZ
MW1742 MW1742 hypothetical protein
MW1744 MW1744 hypothetical protein
MW1748 MW1748 hypothetical protein
MW1749 MW1749 hypothetical protein
MW1752 MW1752 splF serine protease
MW1753 MW1753 spIC serine protease
MW1754 MW1754 splB serine protease
MW1755 MW1755 splA serine protease
MW1757 MW1757 hypothetical protein, similar to Ear protein (Genomic island)
MW1758 MW1758 bsaG hypothetical protein, similar to EpiG
MW1759 MW1759 bsaE hypothetical protein, similar tpo EpiE
MW1760 MW1760 bsaF hypothetical protein, similar to EpiF
hypothetical protein, similar to EPIDERMIN LEADER
PEPTIDE PROCESSING SERINE PROTEASE EPIP
MW1761 MW1761 MW1761 PRECURSOR [Genomic island nu Sa beta2]
MW1762 MW1762 bsaD hypothetical protein, similar to lantibiotic epidermin
pbiosynthesis protein EpiD 
hypothetical protein, similar to lantibiotic epidermin
MW1763 MW1763 bsaC biosynthesis protein EpiC
hypothetical protein, similar to lantibiotic epidermin
MW1764 MW1764 bsaB biosynthesis protein EpiB
MW 1765 MW1765 bsaA2 hypothetical protein, similar to gallidermin precursor
MW1766 MW1766 bsaA1 hypothetical protein, similar to gallidermin precursor
MW1767 MW1767 LukD leukotoxin
MW1768 MW1768 LukE leukotoxin
MW1769 MW1769 [Genomic island nu Sa beta2] hypothetical protein (Genomic island)
MW1798 MW1798 MW1798 glutamate ABC transporter ATP-binding protein
MW1806 MW1806 MW1806 ABC transporter (ATP-binding protein) homolog 
hypothetical protein, similar to teichoic acid translocation ATP-
MW1811 MW1811 MW1811 binding protein tagH
MW1814 MW1814 sgtB hypothetical protein, similar to penicillin-binding protein 1A/1B
MW1828 MW1828 map methionyl aminopeptidase map
MW1834 MW1834 MW1834 hypothetical protein, similar to ferritin
hypothetical protein, similar to ABC transporter, ATP-binding
MW1872 MW1872 MW1872 protein
hypothetical protein, similar to ABC transporter, ATP-binding
MW1874 MW1874 MW1874 protein
MW 1882 MW 1882 MW1882 hypothetical protein
MW1885 MW1885 sak staphylokinase precursor
MW 1889 MW 1889 sea staph enterotoxin a
MW 1896 MW1896 MW1896 hypothetical protein
MW1897 MW 1897 MW1897 hypothetical protein
MW 1898 MW1898 MW1898 hypothetical protein
MW1899 MW1899 MW1899 hypothetical protein
MW1900 MW1900 MW 1900 hypothetical protein
MW1901 MW 1901 MW1901 hypothetical protein
MW1902 MW1902 MW1902 hypothetical protein
MW1903 MW1903 MW1903 hypothetical protein
MW 1904 MW1904 MW1904 hypothetical protein
MW1905 MW 1905 MW1905 hypothetical protein
MW1906 MW1906 MW1906 portal protein
MW1907 MW1907 MW1907 hypothetical protein
MW1908 MW1908 MW1908 hypothetical protein
MW1909 MW1909 MW1909 hypothetical protein
MW1910 MW1910 MW1910 hypothetical protein
MW1911 MW1911 MW1911 hypothetical protein
MW1912 MW1912 MW1912 hypothetical protein
MW1913 MW1913 MW1913 hypothetical protein
MW1914 MW1914 MW1914 hypothetical protein
MW1915 MW1915 MW1915 hypothetical protein
MW1916 MW1916 MW1916 hypothetical protein
MW1917 MW1917 MW1917 hypothetical protein
MW1921 MW1921 MW1921 single-strand DNA-binding protein
MW1926 MW1926 MW1926 hypothetical protein
MW 1929 MW1929 MW1929 hypothetical protein
MW1933 MW1933 MW1933 hypothetical protein
MW1935 MW1935 MW1935 hypothetical protein
MW1937 MW1937 seg staph enterotoxin g
MW1938 MW1938 sek2 staph enterotoxin k
MW1939 MW1939 int integrase
hypothetical protein, similar to synergohymenotropic toxin
MW1941 MW1941 MW1941 precursor - Staphylococcus intermedius
MW1942 MW1942 MW1942 hypothetical protein similar to leukocidin chain iukM precursor
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MW1988 MW 1988 sigB sigma factor B
MW1991 MW1991 rsbl) sigmaB regulation protein RsbU
MW1999 MW1999 kdpC probable potassium-transporting ATPase C chain
MW2000 MW2000 KdpB probable potassium-transporting ATPase B chain
MW2002 MW2002 kdpD sensor protein KdpD
MW2013 MW2013 MW2013 lipoprotein precursor
hypothetical protein, similar to single strand DNA binding
MW2021 MW2021 MW2021 protein
hypothetical protein, similar to ABC transporter (ATP-binding
MW2079 MW2079 MW2079 protein)
MW2093 MW2093 MW2093 hypothetical protein, similar to multidrug resistance protein
MW2095 MW2095 MW2095 hypothetical protein, similar to multidrug transporter 
hypothetical protein similar to ferrichrome ABC transporter
MW2101 MW2101 MW2101 (permease)
hypothetical protein similar to ferrichrome ABC transporter
MW2102 MW2102 MW2102 (permease)
hypothetical protein similar to ferrichrome ABC transporter
MW2103 MW2103 MW2103 (binding prote)
MW2125 MW2125 hypothetical protein, similar to YnaE
MW2129 MW2129 hysA hyaluronate lyase precursor
hypothetical protein, similar to ABC transporter (ATP-binding
MW2140 MW2140 MW2140 protein)
(ATP-binding protein) hypothetical protein, similar to ABC
MW2141 MW2141 MW2141 transporter
MW2179 MW2179 MW2179 hypothetical protein, similar to acriflavin resistance protein 
hypothetical protein similar to ferrichrome ABC transporter
MW2202 MW2202 MW2202 fhuD precursor
MW2217 MW2217 MW2217 secretory antigen precursor SsaA homoiog
MW2259 MW2259 MW2259 conserved hypothetical protein 
ATP-binding protein) hypothetical protein, similar to ABC
MW2261 MW2261 MW2261 transporter
MW2273 MW2273 MW2273 hypothetical protein, similar to multidrug resistance protein 
hypothetical protein, similar to ABC transporter, ATP-binding
MW2280 MW2280 MW2280 protein
MW2292 MW2292 hypothetical protein, similar to export protein
MW2328 MW2328 MW2328 hypothetical protein similar to Zn-binding lipoprotein adcA 
hypothetical protein, similar to ABC transporter, periplasmic
MW2336 MW2336 MW2336 amino acid-binding protein
MW2337 MW2337 MW2337 hypothetical protein, similar to multidrug resistance protein 
hypothetical protein, similar to ABC transporter, ATP-binding
MW2351 MW2351 MW2351 protein
hypothetical protein similar to lipoprotein inner membrane
MW2352 MW2352 MW2352 ABC-transporter
hypothetical protein, similar to integral membrane efflux
MW2368 MW2368 MW2368 protein
hypothetical protein, similar to chloramphenicol resistance
MW2376 MW2376 MW2376 protein
hypothetical protein, similar to ABC transporter (ATP-binding
MW2378 MW2378 MW2378 protein)
MW2396 MW2396 MW2396 hypothetical protein, similar to glucose 1-dehydrogenase
MW2403 MW2403 MW2403 hypothetical protein, similar to oxidoreductase
MW2409 MW2409 conserved hypothetical protein
MW2421 MW2421 fnb fibronectin-binding protein homolog (for fnbA?)
MW2431 MW2431 MW2431 hypothetical protein, similar to glucarate transporter
MW2437 MW2437 MW2437 conserved hypothetical protein
hypothetical protein, similar to ABC transporter (ATP-binding
MW2446 MW2446 MW2446 protein)
MW2447 MW2447 MW2447 conserved hypothetical protein
MW2448 MW2448 srtA sortase
MW2471 MW2471 MW2471 ferrous iron transport protein B homolog
MW2479 MW2479 MW2479 hypothetical protein, similar to mercuric ion-binding protein
MW2498 MW2498 MW2498 hypothetical protein, similar to transcription regulator acrR
MW2499 MW2499 MW2499 hypothetical protein, similar to short chain oxidoreductase
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MW2503 MW2503 MW2503
MW2534 MW2534
MW2543 MW2543 MW2543
MW2553 MW2553 arc
MW2557 MW2557 MW2557
MW2558 MW2558 aur
MW2565 MW2565 MW2565
MW2566 MW2566 MW2566
MW2574 MW2574 MW2674
MW2612 MW2612 cna
MW2627 MW2627 MW2627
MWrRNA02 MWrRNA02 MWrRNA02
MWrRNA05 MWrRNA05 MWrRNA05
nuc MW1211 nuc
obg MW1594 obg
oppF oppF
pbp3 MW 1504 pbp3
pbpA MW1064 pbpA
pstB MW1274 pstB
rip MW0184 rip
RNAIII MW1959 RNAIII
rot MW1705 rot
SA0022 SA0022
SA0024 SA0024
SA0040 SA0040 mecl
SA0041 SA0041 xylR
SA0047 SA0047
SA0054 SA0054
SA0059 SA0059
SA0061 SA0061
SA0066 SA0066 kdpE
SA0072 SA0072
SA0073 SA0073
SA0074 SA0074
SA0076 SA0076
SA0077 SA0077
SA0102 SA0102
SA0103 SA0103
SA0104 SA0104 SA0104
SA0141 SA0141
SA0142 SA0142
SA0190 S A0190
SA0191 SA0191
SA0192 SA0192
SA0193 SA0193
SA0195 SA0195
SA0196 SA0196
SA0197 SA0197
SA0211 SA0211 SA0211
hypothetical protein similar to ferrous iron transporter protein 
B
hypothetical protein
hypothetical protein, similar to ABC transporter (ATP-binding 
protein)
carbamate kinase
hypothetical protein, similar to arginine repressor
zinc metalloproteinase aureolysin
hypothetical protein, similar to autolysin precursor 
hypothetical protein, similar to N-Carbamoylsarcosine 
Amidohydrolase
hypothetical protein, similar to preprotein translocase secY 
collagen adhesin precursor
hypothetical protein, similar to DNA-binding protein SpoOJ-like 
homolog
23S ribosomal RNA (RNA02)
16S ribosomal RNA (RNA05) 
thermonuclease
SpoOB-associated GTP-binding protein
penicillin-binding protein 3
penicillin-binding protein 1
phosphate ABC transporter ATP-binding protein
RGD-containing lipoprotein
from agr (hid)
repressor of toxins
hypothetical protein, similar to 5'-nucleotidase 
hypothetical protein
methicillin resistance regulatory protein 
xylose repressor homologue 
hypothetical protein in transposon Tn554 
hypothetical protein 
hypothetical protein 
hypothetical protein
hypothetical protein, similar to kdp operon transcriptional 
regulatory protein
hypothetical protein
hypothetical protein
hypothetical protein
hypothetical protein
hypothetical protein, similar to serine/threonine protein kinase 
67 kDa Myosin-crossreactive streptococcal antigen 
homologue
conserved hypothetical protein
hypothetical protein, similar to transcription regulator GntR 
family
hypothetical protein
hypothetical protein, similar to DNA-binding protein 
hypothetical protein 
conserved hypothetical protein
hypothetical protein, similar to ABC transporter ATP-binding 
protein
hypothetical protein, similar to Enterococcus faecalis plasmid 
pPD1 bad
hypothetical protein
conserved hypothetical protein
hypothetical protein, similar to ABC transporter ATP-binding 
protein
acetyl-CoA acetyltransferase
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SA0251 SA02S1 lytR two-component response regulator
SA0276 SA0276 conserved hypothetical protein, similar to diarrheal toxin 
hypothetical protein, similar to branched-chain amino acid
SA0294 SA0294 SA0294 uptake carrier
SA0298 SA0298 SA0298 hypothetical protein, similar to regulatory protein PfoR
SA0377 SA0377 [Pathogenicity island SaPln2] hypothetical protein
SA0378 SA0378 [Pathogenicity island SaPln2] hypothetical protein
SA0396 SA0396 Ipl1 hypothetical protein
SA0397 SA0397 Ipl2 hypothetical protein
SA0398 SA0398 Ipl3 hypothetical protein
SA0400 SA0400 Ipl4 hypothetical protein
SA0401 SA0401 Ipl5 hypothetical protein
SA0404 SA0404 Ipl8 hypothetical protein
SA0405 SA0405 Ipl9 hypothetical protein
SA0573 SA0573 sarA staphylococcal accessory regulator A
SA0598 SA0598 pbp4
SA0610 SA0610 hypothetical protein, similar to lipase LipA 
hypothetical protein, similar to two-component response
SA0614 SA0614 SA0614 regulator
hypothetical protein, similar to AraC/XylS family
SA0622 SA0622 SA0622 transcriptional regulator
hypothetical protein, similar to LysR family transcriptional
SA0627 SA0627 SA0627 regulator
conserved hypothetical protein, similar to transcriptional
SA0641 SA0641 SA0641 regulator
SA0661 SA0661 saeR response regulator
hypothetical protein, similar to ABC transporter ATP-binding
SA0675 SA0675 protein
lipophilic protein affecting bacterial lysis rate and methicillin
SA0702 SA0702 llm resistance level
SA0704 SA0704 conserved hypothetical protein
SA0726 SA0726 gapR glycolytic operon regulator
hypothetical protein, similar to extracellular matrix and
SA0745 SA0745 plasma binding
hypothetical protein, similar to transcription regulator LysR
SA0836 SA0836 SA0836 family
hypothetical protein, similar to negative regulator of genetic
SA0857 SA0857 SA0857 competence MecA
hypothetical protein, probable ATL autolysin transcription
SA0904 SA0904 SA0904 regulator
SA0907 SA0907 COL seb staph enterotoxin b
SA1010 SA1010 hypothetical protein, similar to exotoxin 4
SA1013 SA1013 SA1013 hypothetical protein, similar to carbamate kinase
SA1139 SA1139 gigp glycerol uptake operon antiterminator regulatory protein 
hypothetical protein, similar to two-component response
SA1159 SA1159 SA1159 regulator
SA1174 SA1174 lexA SOS regulatory LexA protein
SA1217 hypothetical protein, similar to negative regulator
SA1195 SA1195 SA1195 PhoU
SA1208 SA1208 hypothetical protein
SA1217 hypothetical protein, similar to negative regulator
SA1217 SA1217 SA1217 PhoU
SA1247 SA1247 SA1247 truncated (putative response regulator ArIR (truncated-arIR) 
truncated (putative response regulator ArIR [S (truncated-
SA1248 SA1248 SA1248 arlR)
SA1320 SA1320 hypothetical lipoprotein
SA1329 SA1329 SA1329 ferric uptake regulator homolog
SA1337 SA1337 SA1337 transcription regulator AraC/XylS family homolog
SA1341 SA1341 hypothetical protein, similar to export protein SpcT protein
SA1383 SA1383 SA1383 ferric uptake regulator homolog
alkaline phosphatase synthesis transcriptional regulatory
SA1516 SA1516 phoP protein
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SA1539 SA1539 SA1539
SA1552 SA1652
SA1557 SA1557 ccpA
SA1580 SA1580
SA1584 SA1584 SA1584
SA1621 SA1621 SA1621
SA1628 SA1628 spID
SA1632 SA1632 SA1632
SA1633 SA1633 SA1633
SA1635 SA1635 [Pathogenicity island SaPln3]
SA1636 SA1636 [Pathogenicity island SaPln3]
SA1640 SA1640 [Pathogenicity island SaPln3]
SA1641 SA1641 [Pathogenicity island SaPln3]
SA1643 SA1643 sen
SA1644 SA1644 yent2
SA1646 SA1646 sei
SA1647 SA1647 sem
SA1649 SA1649 SA1649
SA1666 SA1666 SA1666
SA1676 SA1676 SA1676
SA1678 SA1678 SA1678
SA1700 SA1700 vraR
SA1748 SA1748 SA1748
SA1766 SA1766 [Bacteriophage phiN315]
SA1768 SA1768 SA1768
SA1769 SA1769 SA1769
SA1770 SA1770 SA1770
SA1771 SA1771 SA1771
SA1772 SA1772 SA1772
SA1773 SA1773 SA1773
SA1774 SA1774 SA1774
SA1775 SA1775 SA1775
SA1776 SA1776 SA1776
SA1777 SA1777 SA1777
SA1778 SA1778 SA1778
SA1791] SA1791
SA1794 SA1794
SA1795 SA1795
SA1797 SA1797 SA1797
SA1800 SA1800 SA1800
SA1804 SA1804 SA1804
SA1805 SA1805 SA1805
SA1806 SA1806]
SA1808 SA1808 SA1808
SA1809 SA1809 SA1809
SA1819 SA1819 tsst-1
SA1822 SA1822 [Pathogenicity island SaPlnl]
SA1826 SA1826 [Pathogenicity island SaPlnl]
SA1828 SA1828 [Pathogenicity island SaPlnl]
SA1829 SA1829 [Pathogenicity island SaPlnl]
SA1833 SA1833 SA1833
SA1834 SA1834 [Pathogenicity island SaPlnl]
hypothetical protein, similar to septation ring formation 
regulator
hypothetical protein
catabolite control protein A
multidrug resistance protein homolog
lysophospholipase homolog
hypothetical protein
serine protease
hypothetical protein
probable beta-lactamase
hypothetical protein
hypothetical protein
conserved hypothetical protein
hypothetical protein
staph enterotoxin n
enterotoxin
staph enterotoxin i
staph enterotoxin m
conserved hypothetical protein
two-component response regulator homolog
hypothetical protein, similar to regulatory protein (pfoS/R)
transcription regulator Fur family homolog
two-component response regulator
hypothetical protein, similar to transcription regulator, GntR
family
hypothetical protein 
hypothetical protein 
hypothetical protein 
hypothetical protein 
hypothetical protein 
hypothetical protein 
hypothetical protein 
hypothetical protein
hypothetical protein, similar to scaffolding protein 
hypothetical protein 
hypothetical protein 
hypothetical protein
hypothetical protein [Bacteriophage phiN315] 
hypothetical protein [Bacteriophage phiN315] 
hypothetical protein [Bacteriophage phiN315] 
hypothetical protein 
hypothetical protein 
hypothetical transcriptional regulator 
repressor homolog
probable ATP-dependent helicase [Bacteriophage phiN315
probable ss-1,3-N-acetylglucosaminyltransferase
hypothetical protein
toxic shock syndrome toxin-1
hypothetical protein
hypothetical protein
hypothetical protein
hypothetical protein
hypothetical protein, similar to transcription regulator 
hypothetical protein
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SA1883 SA1883 kdpE KDP operon transcriptional regulatory protein KdpE 
hypothetical protein, similar to rod shape determining protein
SA1888 SA1888 SA1888 RodA
SA1949 SA1949 SA1949 lytic regulatory protein truncated with Tn554 (truncated-SA)
SA1953 SA1953 tnpC transposition regulatory protein
SA1954 SA1954 tnpB transposition regulatory protein
SA1955 SA1955 tnpA transposition regulatory protein
SA1956 SA1956 SA1956 lytic regulatory protein truncated with Tn554
SA1970 SA1970 hypothetical protein, similar to multidrug resistance protein
SA1999 SA1999 SA1999 hypothetical protein, similar to regulatory protein, SIR2 family 
hypothetical protein, similar to transcription regulator MerR
SA2002 SA2002 SA2002 family
SA2004 SA2004 conserved hypothetical protein
SA2005 SA2005 conserved hypothetical protein 
hypothetical protein, similar to RNA-directed DIMA
SA2010 SA2010 polymerase from retron EC86
SA2011 SA2011 hypothetical protein
SA2012 SA2012 hypothetical protein
hypothetical protein, similar to transcription regulator MarR
SA2060 SA2060 SA2060 family
SA2063 SA2063 moaA molybdenum cofactor biosynthesis protein A
SA2092 SA2092 SA2092 hypothetical protein, similar to transcription regulator 
hypothetical protein, similar to transcription regulator, RpiR
SA2108 SA2108 SA2108 family
SA2115 SA2115 SA2115 hypothetical protein, similar to transcriptional regulator
SA2119 SA2119 SA2119 hypothetical protein, similar to dehydrogenase 
hypothetical protein, similar to transcription regulator LysR
SA2123 SA2123 SA2123 family
SA2124 SA2124 fosB fosfomycin resistance protein fofB 
hypothetical protein, similar to transcriptional regulator
SA2144 SA2144 SA2144 (TetR/AcrR family)
SA2147 SA2147 tcaR TcaR transcription regulator
hypothetical protein, similar to two component response
SA2151 SA2151 SA2151 regulator
hypothetical protein, similar to transcriptional regulator tetR-
SA2165 SA2165 SA2165 family
SA2169 SA2169 SA2169 hypothetical protein, similar to transcription regulatory protein
SA2174 SA2174 SA2174 hypothetical protein, similar to transcriptional regulator
SA2178 SA2178 SA2178 hypothetical protein, similar to transcriptional regulator
SA2259 SA2259 conserved hypothetical protein
SA2272 SA2272 hypothetical protein
SA2286 SA2286 sarH3 staphylococcal accessory regulator A homolog 
hypothetical protein, similar to transcriptional regulator, MerR
SA2296 SA2296 SA2296 family
hypothetical protein, similar to transcription regulator MarR
SA2308 SA2308 SA2308 family
hypothetical protein, similar to ABC transporter (ATP-binding
SA2314 SA2314 protein)
SA2320 SA2320 SA2320 hypothetical protein, similar to regulatory protein pfoR
SA2330 SA2330 SA2330 hypothetical protein, similar to transcription regulator 
hypothetical protein, similar to transcriptional regulator tetR-
SA2340 SA2340 SA2340 family
SA2357 SA2357 SA2357 hypothetical protein, similar to regulatory protein (pfoS/R) 
hypothetical protein, similar to transcriptional regulator tetR-
SA2379 SA2379 SA2379 family
truncated hypothetical protein, similar to giutamyl-
SA2382 SA2382 SA2382 endopeptidase
truncated hypothetical protein, similar to metalloproteinase
SA2389 SA2389 SA2389 mpr precursor
hypothetical protein, similar to two-component response
SA2418 SA2418 SA2418 regulator
SA2421 SA2421 SA2421 hypothetical protein, similar to transcriptional regulator
SA2424 SA2424 SA2424 hypothetical protein, similar to transcription regulator Crp/Fnr
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SA2458icaR SA2458 icaR
SA2472 SA2472 SA2472
SA2483 SA2483
SA2500gidA SA2500 gidA
saeR MW0668 saeR
sarR MW2213 sarR
SAV0149 SAN/0149 capA
SAV0150 SAN/0150 capB
SAV0151 SAV0151 capC
SAV0153 SAVO153 capE
SAV0154 SAN/0154 capF
SAV0155 SAN/0155 capG
SAV0156 SAN/0156 capH
SAV0157 SAN/0157 capl
SAV0158 SAN/0158 capJ
SAV0159 SAV0159 capK
SAV0160 SAV0160 capL
SAV0161 SAV0161 capM
SAV0162 SAV0162 capN
SAN/0163 SAV0163 capO
SAN/0164 SAV0164 capP
SAN/0195 SAV0195 hsdR
SAN/0398 SAV0398 tetM
SAN/0416 SAV0416 SAV0416
SAN/0417 SAV0417 SAV0417
SAN/0418 SAV0418 SAV0418
SAN/0422 SAV0422 set6
SAN/0423 SAV0423 set7
SAN/0424 SAV0424 set8
SAN/0425 SAV0425 set10
SAV0426 SAV0426 set11
SAN/0427 SAV0427 set12
SAV0428 SAV0428 set13
SAN/0429 SAV0429 set14
SAN/0431 SAV0431 hsdM
SAN/0432 SAV0432 hsdS
SAN/0433 SAV0433 set 15
SAN/0993 SAV0993 appF
SAN/1113 SAV1113 SAV1113
SAN/1119 SAV1119 vacA
SAN/1622 SAV1622 thdF
SAN/1827 SAV1827 yentl
SAN/1830 SAV1830 seo
SAN/1948 SAV1948 sep
SAV2009 SAV2009 sec3
SAN/2352 SAV2352 SAV2352
SAN/2499 SAV2499 sarH2
SAN/2662 SAV2662 SAV2662
SAN/2663 SAV2663 SAV2663
SAN/2664 SAV2664 SAV2664
SAV2667 SAV2667 icaD
family protein
ica operon transcriptional regulator IcaR 
hypothetical protein, similar to ATP 
phosphoribosyltransferase regulatory subunit
hypothetical protein
glucose inhibited division protein A
response regulator
staphylococcal accessory regulator A homolog
capsular polysaccharide synthesis enzyme Cap5A
capsular polysaccharide synthesis enzyme Cap5B
capsular polysaccharide synthesis enzyme Cap8C
capsular polysaccharide synthesis enzyme Cap8E
capsular polysaccharide synthesis enzyme Cap5F
capsular polysaccharide synthesis enzyme Cap5G 
capsular polysaccharide synthesis enzyme O-acetyl 
transferase Cap5H
capsular polysaccharide synthesis enzyme Cap5l
capsular polysaccharide synthesis enzyme Cap5J
capsular polysaccharide synthesis enzyme Cap5K
capsular polysaccharide synthesis enzyme Cap5L
capsular polysaccharide synthesis enzyme Cap5M
capsular polysaccharide synthesis enzyme Cap5N
capsular polysaccharide synthesis enzyme Cap80
capsular polysaccharide synthesis enzyme Cap5P
probable type I restriction enzyme restriction chain
tetracycline resistance protein
hypothetical protein
hypothetical protein
probable transposase
exotoxin 6
exotoxin 7
exotoxin 8
exotoxin 10
exotoxin 11
exotoxin 12
exotoxin 13
exotoxin 14
probable type I site-specific deoxyribonuclease Lid I chain 
probable restriction modification system specificity subunit c 
exotoxin 15
oligopeptide transport system ATP-binding protein AppF 
homologue
conserved hypothetical protein 
putative vacuolating cytotoxin paralog 
possible thiophene and furan oxidation protein 
enterotoxin 
enterotoxin 
enterotoxin P 
enterotoxin typeC3 
hypothetical protein
staphylococcal accessory regulator A homolog 
capsular polysaccharide biosynthesis 
capsular polysaccharide biosynthesis 
capsular polysaccharide biosynthesis 
intercellular adhesion protein D
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SAV2668 SAV2668 icaB
SAV2669 SAV2669 icaC
sbi MW2341 sbi
sdhB MW 1032 sdhB
sdrC MW0516 sdrC
sdrD MW0517 sdrD
sdrE MW0518 sdrE
sec4 MW0759 sec4
sed Plasmid plB485 sed
see FRI918 see
sej Plasmid plB485 sej
sirA MW0088 sirA
sirB MW0087 sirB
sirC MW0086 sirC
spa MW0084 spa
ssb MW0342 ssb
sspA MW0932 sspA
sspB MW0931 sspB
sspC MW0930 sspC
ssrP MW0743 ssrP
tagH MW0599 tagH
taxon:1280 taxon:1280 chp
vga MW1971 vga
Type l-F Type l-F
Type l-R Type l-R
Type I l-F Type I l-F
Type I l-R Type ll-R
Type lll-F Type lll-F
Type lll-R Type lll-R
Type IVa-F Type IVa-F
Type IVa-R Type IVa-R
Type IVb-F Type IVb-F
Type IVb-R Type IVb-R
Type IVc-F Type IVc-F
Type IVc-R Type IVc-R
Type IVd-F5 Type IVd-F5
Type IVd-R6 Type IVd-R6
Type V-F TypeV-F
Type V-R Type V-R
MecA147-F MecA147-F
MecA147-R MecA147-R
mecl-F mecl-F
mecl-R mecl-R
IS1272-F IS1272-F
mecR1-R mecR1-R
ccrAB-62 ccrAB-82
ccrAB-2 ccrAB-2
ccrAB-3 ccrAB-3
ccrAB-4 ccrAB-4
ccrC-F ccrC-F
ccrC-R ccrC-R
intercellular adhesion protein B 
intercellular adhesion protein C 
IgG binding protein
succinate dehydrogenase iron-sulfur protein subunit (MW2) 
Ser-Asp rich fibrinogen-binding bone sialoprotein-binding 
protein
Ser-Asp rich fibrinogen-binding bone sialoprotein-binding 
protein
Ser-Asp rich fibrinogen-binding bone sialoprotein-binding 
protein
staph enterotoxin c 
staph enterotoxin d 
staph enterotoxin e 
staph enterotoxin j 
lipoprotein 
lipoprotein 
lipoprotein
IgG binding protein A
single-strand DNA-binding protein of phage phi Sa 2mw
serine protease V8 protease
cysteine protease precursor
cysteine protease
ssrA-binding protein
teichoic acid translocation ATP-binding protein
chemotaxis inhibitory protein
hypothetical ABC transporter ATP-binding protein 
0.048
0.032
0.04
0.104
0.092
0.078
0.28
0.06
0.046
0.08
0.08
0.08
0.08
0.08
0.08
0.08
SAV1661 /SA148 family A24A unassigned peptidases 
MW0251 6/MW1605
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MW1017 
MW 1390
MW1482
MW1501
MW1895
MW1936
SA0509
SA0668
SA0879
SA1360
SA1814
SAV0012
SAV0102
SAV0183
SAV0209
SAV0212
SAV0276
SAV0400
SAV0457
SAV0511
SAV0520
SAV0526
SAV0549
SAV0612
SAV0743
SAV0768
SAV0909
SAV0913
SAV0942
SAV0965
SAV1000
SAV1044
SAV1057
SAV1068
SAV0400
SAV1909/MW18 
50/SA1725 
SAV0913
SAV1247/SA109 
0
SAV0909
SAV2690
MW1017
SAV1384/MW12 
72
SAV1000
SAV0511
SAV1279/MW11
62
SAV0942
SAV1708/MW16 
51
SAV1529
MW1482
SA1360/SAV153 
0
SA1814/MW194
3
SAV1751/MW16
94
SAV0743/SA069
8
SAV1512/MW14
65
SAV2133/SA193 
5
SAV0549/MW05
04
SAV1398/MW12 
86
SAV2329/SA212
0/MW2250
SAV0102/SA009
8/MW0078
SAV1366/MW12
53
SAV2455/SA224
4/MW2379
SAV1745/SA156
6/MW1688
SAV1201
SAV2051/MW19
75
SAV2049/SA185 
4/MW1973 
SAV1262/MW11 
45
SAV0276/SA026
5
MW1895
srtB
ftsH
family C40 unassigned peptidases (SAV0400 protein) 
staphopain A stp
D-aianyl-giycyl peptidase lytA
(staphylococcal phage phi11)
(LytA protein)
D-aianyl-glycyl peptidase lytN
(staphylococcal phage phi11)
(LytN protein)
family C51 unassigned peptidases (SAV0909 protein)
pyroglutamyl- pep
peptidase I 
(prokaryote)
(SAV2690 protein) 
sortase B
oligopeptidase F
oligopeptidase F 
FtsH-2 peptidase 
subfamily M16C unassigned peptidases (SAV1279 protein)
family M17 ampA
unassigned
peptidases
(SAV0942 protein)
Mername-AA019 
peptidase
subfamily M24B non-peptidase homologues (SAV1529 protein) 
subfamily M24B unassigned peptidases (MW1482 protein) 
subfamily M24B unassigned peptidases (SA1360 protein)
subfamily M20A unassigned peptidases (SAV2006 protein)
subfamily M20A unassigned peptidases (SAV1751 protein)
peptidase T pepT
subfamily M20B unassigned peptidases (SAV1512 protein)
subfamily M20D hmrA 
non-peptidase 
homologues (HmrA 
protein)
family M20D unassigned peptidases (SAV0549 protein)
family M20D hipO
unassigned
peptidases
(hippurate
hydrolase)
family M20D unassigned peptidases (SAV2329 protein) 
family M20D unassigned peptidases (SAV0102 protein) 
family M42 unassigned peptidases (SAV1366 protein) 
family M42 unassigned peptidases (SAV2455 protein) 
family M42 unassigned peptidases (SAV1745 protein) 
dihydro-orotase pyrC
family M22 non-peptidase homologues (SAV2051 protein)
family M22 unassigned peptidases (SAV2049 protein)
RseP peptidase
lysostaphin lytM
(peptidoglycan
hydrolase)
subfamily M23B unassigned peptidases (MW1895 protein)
SAV1070
SAV1201
SAV1247
SAV1253
SAV1262
SAV1279
SAV1366
SAV1384
SAV1398
SAV1420
SAV1512
SAV1529
SAV1612
SAV1613
SAV1661
SAV1708
SAV1728
SAV1745
SAV1751
SAV1765
SAV1793
SAV1810
SAV1811
SAV1813
SAV1875
SAV1879
MW 1390
SAV0212/SA020
5/MW0188
SAV1879
SAV1811/SA162
9
SAV1813/SA163
1
SAV1810/SA162
8
SAV1728
SA0879/MW090
3
SAV2596/SA238
9
SAV1070
SAV2154
MW0251/SA026
4
SAV1253
SAV0209/MW01 
85
SA0668
S AV2675/SA246 
7
SAV0520/SA047 
8/MW0475 
SAV1068/MW09 
51
SAV1875
SA0509/MW050
6
SAV2451/MW23
75
SAV1793/SA161 
1/MW1731 
SAV0612/SA056 
9/MW0576 
SAV1765
SAV0012/SA001 
1/MW0012 
SAV0457/SA041 
6
subfamily M23B unassigned peptidases (MW1390 protein) 
subfamily M23B unassigned peptidases (SAV0212 protein)
aminopeptidase S ampS
( S ta p h y lo c o c c u s
a u re u s )
(aminopeptidase
ampS)
SpIC g.p. spIC
( S ta p h y lo c o c c u s
a u re u s )  (m-type 2)
subfamily StB splA
unassigned
peptidases
(exoprotein A)
subfamily S1B splD/splF
unassigned 
peptidases (serine 
protease splf)
subfamily S1C unassigned peptidases (SAV1728 protein)
subfamily S1C htrA
unassigned 
peptidases 
(SA0879 protein)
family S1 unassigned peptidases (SAV2596 protein)
amidophosphoribos purF
yltransferase
precursor
glucosamine- glmS
fructose-6-
phosphate
aminotransferase
family C59 non-peptidase homologues
CodW component cIpQ
of CodWX
peptidase
gamma-glutamyltransferase 1 (bacterial)
family C26 unassigned peptidases
family C56 non- hisH
peptidase
homologues
(imidazole glycerol
phosphate
synthase subunit
HisH)
family C56 non-peptidase homologues
family C56 non- purQ
peptidase
homologues
(phosphoribosylfor
mylglycinamidine
synthase I)
family C56 non-peptidase homologues (orf 1 protein)
family C56 HCHA
unassigned
peptidases
(SA0509 protein)
subfamily S9C non-peptidase homologues (SAV2451 protein)
subfamily S9C unassigned peptidases
family S33 non-peptidase homologues
family S33 non-peptidase homologues 
family S33 unassigned peptidases
family S33 unassigned peptidases
SAV1909
SAV1964
SAV1998
SAV2049
SAV2051
SAV2133
SAV2154
SAV2329
SAV2441
SAV2451
SAV2455
SAV2596
SAV2675
SAV2690
SAV1044/SA089 
7/MW0928 
SAV2441/MW23 
65
SAV1057
SAV1998
MW1936
SAV0965
SAV0526/SA048
4/MW0481
SAV0768
SAV1964
SAV1420
MW1501/SAV15 
49/SA1379 
SAV0183/SA017 
7/MW0157
SAV1613/MW15
63
SAV1612/MW15
62
family S33 unassigned peptidases
family S12 flp
unassigned 
peptidases 
(SAV2441 protein) 
family S12 fmt
unassigned 
peptidases (Fmt 
protein)
family S24 unassigned peptidases (SAV1998 protein)
family S24 unassigned peptidases
signal peptidase spsB 
SpsB
( S ta p h y lo c o c c u s  
a u r e u s )  (SpsB 
protein)
family S16 non- radA
peptidase
homologues
peptidase Clp (type cIpP 
1)
family S14 non-peptidase homologues (SAV1964 protein)
subfamily S41A ctpA
unassigned 
peptidases 
(SAV1420 protein)
family S54 unassigned peptidases (SAV1549 protein)
ornithine argJ
acetyltransferase
precursor
family U32 unassigned peptidases (SAV1613 protein) 
family U32 unassigned peptidases (SAV1612 protein)
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Appendix IV. Genes present by S. aureus D76 as analysed by comparative genome hybridisation.
Gene ID______________ Name____________Function_________________________________
Bbp bbp sdrE homolog (bone sialoprotein binding protein)
clfa Clfa fibrinogen-binding protein
clfb clfb clumping factor B
Coa Coa staphylcoagulase precursor
comGC comGC exogenous DNA-binding protein
E161084C E161084C V8PROTEASE
E16-1949 E16-1949 BLACTAMASEA
E16-2023C E16-2023C V8PROTEASE
E162040c E162040c BACTRLTOXIN
E16-2042C E16-2042C BACTRLTOXIN
E162902c E162902c THERMOLYSIN
ebhA ebhA similar to streptococcal adhesin emb
ebhB ebhB similar to streptococcal adhesin emb
efb efb fibrinogen-binding protein
fhuA fhuA ferrichrome transport ATP-binding protein
fhuB fhuB ferrichrome transport permease
fnbB fnbB fibronectin-binding protein homolog
geh geh glycerol ester hydrolase
gmk gmk guanylate kinase
hla hla alpha toxin; alpha haemolysin
hlb hlb beta haemolysin
hlgB hlgB gamma-hemolysin component B
hlgC hlgC gamma-hemolysin component C
hlgll hlgll gamma haemolysin chain II
hu hu DNA-binding protein II
icaA icaA intercellular adhesion protein A
lepA lepA GTP-binding protein
lip lip triacylglycerol lipase precursor
Isp Isp lipoprotein signal peptidase
modA modA probable molybdate-binding protein
Gene IP Name Function
modC modC molybdenum transport ATP-binding protein
msmX msmX multiple sugar-binding transport ATP-binding protein
MW 0053 MW0053 hypothetical protein
MW0074 MW0074 hypothetical protein
MW 0077 MW0077 hypothetical protein, similar to transcription regulator AraC/XylS family
MW0079 MW0079 hypothetical protein similar to transmembrane efflux pump protein
MW0085 MW0085 staphylococcal accessory regulator A homologue
MW0092 MW0092 hypothetical protein similar to multi-drug resistance efflux pump
MW0105 MW 0105 hypothetical protein, similar to capsular polysaccharide synthesis protein 14H
MW0108 MW0108 hypothetical protein
MW0111 MW0111 hypothetical protein similar to tetracyclin resistance protein
MW0120 MW 0120 truncated replication initiator protein
MW0147 MW0147 hypothetical protein similar to membrane lipoprotein SrpL
MW0161 MW0161 hypothetical protein, similar to isochorismatase
MW0167 MW0167 hypothetical protein, similar to transcription regulator
MW0171 MW0171 hypothetical protein
MW0172 MW0172 hypothetical protein, similar to ABC transporter ATP-binding protein
MW0178 MW0178 hypothetical protein, similar to ABC transporter ATP-binding protein
MW0182 MW0182 truncated hypothetical protein, similar to oligopeptide ABC transporter permease
MW0190 MW 0190 hypothetical protein, similar to maltose/maltodextrin-binding protein
MW0198 M W 0 198 hypothetical protein, similar to two-component response regulator
MW0200 MW0200 hypothetical protein similar to periplasmic-iron-binding protein BitC
MW0213 MW0213 hypothetical protein, similar to nickel ABC transporter nickel-binding protein
MW 0240 MW0240 hypothetical protein, similar to transcription regulator GntR family
MW0250 MW0250 hypothetical protein, similar to proton antiporter efflux pump
MW0251 MW0251 family A24A unassigned peptidases
MW 0263 MW 0263 conserved hypothetical protein, similar to diarrheal toxin incomplete ORF
MW0283 MW0283 hypothetical protein, similar to branched-chain amino acid uptake carrier
MW0286 MW0286 hypothetical protein, similar to ABC transporter ATP-binding protein
MW 0310 MW0310 hypothetical protein, similar to transcription regulator
MW0311 MW0311 conserved hypothetical protein
MW0323 MW0323 conserved hypothetical protein
MW0327 MW0327 hypothetical protein, similar to ABC transporter ATP-binding protein
MW0339 MW0339 hypothetical protein, similar to GTP-binding protein
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Gene ID Name Function
MW0345 MW0345 hypothetical protein, similar to exotoxin 2
MW0355 MW0355 hypothetical protein
MW0368 MW0368 hypothetical protein, similar to AbiD1 [Genomic island nu Sa alpha2]
MW0372 MW0372 GenomicislandnuSaalpha2
MW0381 MW0381 conserved hypothetical protein MW0381 [Genomic island nu Sa alpha2]
MW0382 MW0382 exotoxin 16
MW0383 MW0383 exotoxin 17
MW0384 MW0384 exotoxin 18
MW0385 MW0385 exotoxin 19
MW0386 MW0386 exotoxin 20
MW0388 MW0388 exotoxin 22
MW0389 MW0389 exotoxin 23
MW0390 MW0390 exotoxin 24
MW0391 MW0391 exotoxin 25
MW 0396 MW0396 hypothetical protein
MW0400:lp13 MW0400:lp13 hypothetical protein
MW0416 MW0416 hypothetical protein, similar to ABC transporter ATP-binding protein
MW0418 MW0418 hypothetical protein similar to lactococcal lipoprotein
MW0513 MW0513 hypothetical protein, similar to Cu binding protein (Mn oxidation)
MW0531:yqiL MW0531:yqiL acetyl-CoA c-acetyltransferase
MW0543 MW0543 phosphotransacetylase
MW0553 MW0553 conserved hypothetical protein
MW0554 MW0554 putative primase
MW0558 MW0558 conserved hypothetical protein
MW0559 MW0559 conserved hypothetical protein
MW0560 MW0560 hypothetical protein
MW0573 MW0573 hypothetical protein similar to iron-binding protein
MW0574 MW0574 hypothetical protein similar to iron(lll) ABC transporter permease protein
MW 0579 MW0579 hypothetical protein similar to esterase/lipase
MW0593 MW0593 lipoprotein, Streptococcal adhesin PsaA homologue
MW0595 MW0595 hypothetical protein, similar to ABC transporter ATP-binding protein
MW0596 MW0596 hypothetical protein similar to iron dependent repressor
MW 0617 MW0617 hypothetical protein similar to lipase LipA
MW0623:vraF MW0623:vraF ABC transporter ATP-binding protein
Gene ID Name Function
MW0651 MW0651 hypothetical protein
MW0681 MW0681 hypothetical protein, similar to anion-binding protein
MW0682 MW0682 hypothetical protein, similar to ABC transporter ATP-binding protein
MW0695 MW0695 hypothetical protein similar to ferrichrome ABC transporter permease
MW0696 MW0696 hypothetical protein similar to ferrichrome ABC transporter permease
MW0697 MW0697 hypothetical protein similar to ferrichrome ABC transporter ATP-binding protein
MW0698 MW 0698 lipoprotein, similar to ferrichrome ABC transporter
MW0736:tpi MW0736:tpi triosephosphate isomerase
MW0746 MW 0746 hypothetical protein [GenomicislandnuSaalpha3mw]
MW0751 MW0751 hypothetical protein [GenomicislandnuSaalpha3mw]
MW0754 MW 0754 hypothetical protein [GenomicislandnuSaalpha3mw]
MW0755 MW0755 hypothetical protein [GenomicislandnuSaalpha3mwj
MW0756 MW 0756 hypothetical protein [GenomicislandnuSaalpha3mw]
MW0765 MW0765 truncated secreted von Willebrand factor-binding protein
MW0766 MW0766 truncated secreted von Willebrand factor-binding protein
MW0767:ssp MW0767:ssp extracellular ECM and plasma binding protein
MW0790 MW0790 ABC transporter ATP-binding protein homologue
MW0795 MW0795 ABC transporter ATP-binding protein homologue
MW0871:OppF MW0871:OppF oligopeptide transport ATP-binding protein
MW0872 MW0872 hypothetical protein, similar to peptide binding protein OppA
MW0873 MW0873 hypothetical protein, similar to oligopeptide ABC transporter oligopeptide-binding protein
MW0874 MW0874 oligopeptide ABC transporter ATP-binding protein homologue
MW0875:AppF MW0875:AppF oligopeptide transport system ATP-binding protein AppF homologue
MW0897 MW0897 hypothetical protein, similar to multidrug resistance protein-related protein
MW0921 MW0921 hypothetical protein similar to ferrichrome ABC transporter
MW0962 MW0962 hypothetical protein
MW0982 MW0982 spermidine/putrescine ABC transporter, ATP-binding protein homolog
MW0985 MW0985 spermidine/putrescine-binding protein precursor homolog
MW0986 MW 0986 conserved hypothetical protein
MW1015 MW 1015 hypothetical protein similar to ferrichrome ABC transporter
MW1016 MW1016 hypothetical protein similar to ferrichrome ABC transporter
MW1017 MW1017 family C40 unassigned peptidases (SAV0400 protein)
MW1040 MW1040 fibrinogen-binding protein
MW1041 MW1041 hypothetical protein, similar to fibrinogen-binding protein
Gene ID Name Function
MW1047 MW1047 hypothetical protein, similar to exotoxin 1
MW1048 MW1048 hypothetical protein, similar to exotoxin 4
MW1091 MW1091 hypothetical protein, similar to fibrinogen binding protein
MW1160 MW1160 hypothetical protein, similar to transcription regulator GntR family
MW1163 MW1163 hypothetical protein, similar to 3-oxoacyl- acyl-carrier protein reductase homolog ymfl
MW1182:glpF MW1182:glpF glycerol uptake facilitator
MW1185 MW1185 hypothetical protein similar to lysophospholipase
MW1189 MW1189 hypothetical protein, similar to GTP-binding protein proteinase modulator homolog ynbA
MW1206 MW1206 ABC transporter (ATP-binding protein) homolog
MW1261:femA MW1261:femA factor essential for expression of methicillin resistance
MW1262:femB MW1262:femB FemB protein
MW1280 MW1280 ABC transporter (ATP-binding protein) homolog
MW1287 MW1287 hypothetical protein, similar to alanine racemase
MW1364 MW 1364 hypothetical protein, similar to GTP binding protein
MW1386 MW1386 conserved hypothetical protein [BacteriophagephiSa2mw]
MW1390:stp MW1390:stp stp staphopain A
MW1393 MW1393 conserved hypothetical protein [BacteriophagephiSa2mw]
MW1400 MW1400 hypothetical protein [BacteriophagephiSa2mw]
MW1401 MW1401 hypothetical protein [BacteriophagephiSa2mw]
MW1405 MW1405 hypothetical protein [BacteriophagephiSa2mw]
MW1408 MW1408 hypothetical protein [BacteriophagephiSa2mw]
MW1482: lytA MW1482: lytA D-alanyl-glycyl peptidase (staphylococcal phage phi11) (LytA protein)
MW1493 MW1493 hypothetical protein, similar to competence protein
MW1501:lytN M W 1501: lytN D-alanyl-glycyl peptidase (staphylococcal phage phi11) (LytN protein)
MW1508 MW1508 hypothetical protein, similar to ABC transporter ATP-binding protein
MW1519:bex MW1519:bex GTP-binding protain Era homolog
MW1532:dnaK MW1532:dnaK DnaK protein
MW1547:aroE MW1547:aroE shikimate dehydrogenease
MW1552 MW1552 enterotoxin homolog
MW1572 MW1572 iron-sulfur cofactor synthesis protein homolog
MW1659 MW1659 hypothetical protein similar to iron-sulfur cofactor synthesis protein nifZ
MW1752:splF MW1752:splF serine protease
MW1753:splC MW1753:splC serine protease
MW1754:splB MW1754:splB serine protease
372
Gene ID______
MW1755:splA
MW1757
MW1758:bsaG
MW1759:bsaE
MW1760:bsaF
MW1761
MW1762:
MW1763:
MW1764:
MW 1765
MW1766:
MW1767:
MW1768:
MW1769
MW1798
MW1806
MW1811
MW1814:
MW1828:
MW1834
MW1872
MW1874
MW1882
MW1885:
MW1895
MW1896
MW1897
MW 1898
MW 1899
MW1900
MW1901
MW1902
MW1903
bsaD
bsaC
bsaB
bsaA1
LukD
LukE
sgtB
map
sak
Name____________Function__________________________________________________________________
MW1755:splA serine protease
MW 1757 hypothetical protein, similar to Ear protein (GenomicislandnuSabeta2)
MW1758:bsaG hypothetical protein, similar to EpiG (Genomic island nu Sa beta2)
MW1759:bsaE hypothetical protein, similar tpo EpiE
MW1760:bsaF hypothetical protein, similar to EpiF (Genomic island nu Sa beta2)
MW1761 hypothetical protein, similar to EPIDERMIN LEADER PEPTIDE PROCESSING SERINE
PROTEASE EPIP PRECURSOR [Genomic island nu Sa beta2]
MW1762:bsaD hypothetical protein, similar to lantibiotic epidermin biosynthesis protein EpiD
MW1763:bsaC hypothetical protein, similar to lantibiotic epidermin biosynthesis protein EpiC
MW1764:bsaB hypothetical protein, similar to lantibiotic epidermin biosynthesis protein EpiB
MW1765 hypothetical protein, similar to gallidermin precursor
MW1766:bsaA1 hypothetical protein, similar to gallidermin precursor
MW1767:LukD leukotoxin 
M W 1768: LukE leukotoxin
MW 1769 hypothetical protein [GenomicislandnuSabeta2]
M W 1798 glutamate ABC transporter ATP-binding protein
MW1806 ABC transporter (ATP-binding protein) homolog
M W 1811 hypothetical protein, similar to teichoic acid translocation ATP-binding protein tagH
MW1814:sgtB hypothetical protein, similar to penicillin-binding protein 1A/1B
MW1828:map methionyl aminopeptidase map
M W 1834 hypothetical protein, similar to ferritin
MW1872 hypothetical protein, similar to ABC transporter, ATP-binding pro
MW 1874 hypothetical protein, similar to ABC transporter, ATP-binding protein
MW1882 hypothetical protein
MW1885:sak staphylokinase precursor
MW1895 subfamily M23B unassigned peptidases (MW 1895 protein)
MW 1896 hypothetical protein
MW 1897 hypothetical protein
MW 1898 hypothetical protein
MW1899 hypothetical protein
MW 1900 hypothetical protein
MW1901 hypothetical protein
MW1902 hypothetical protein
MW1903 hypothetical protein
Gene ID Name Function
MW1904 MW1904 hypothetical protein
MW1905 MW 1905 hypothetical protein
MW1906 MW1906 portal protein (phage portal protein)
MW1907 MW 1907 hypothetical protein
MW1908 MW1908 hypothetical protein
MW1909 MW 1909 hypothetical protein
MW1910 MW1910 hypothetical protein
MW1911 MW1911 hypothetical protein
MW1912 MW1912 hypothetical protein
MW1913 MW1913 hypothetical protein
MW1915 MW1915 hypothetical protein
MW1916 MW1916 hypothetical protein
MW1917 MW1917 hypothetical protein
MW1926 MW1926 hypothetical protein
MW1929 MW1929 hypothetical protein
MW1936: pep MW1936: pep pep pyroglutamyl-peptidase I (prokaryote) (SAV2690 protein)
MW1939:int MW1939:int integrase (phage integrase family)
MW1941 MW1941 hypothetical protein, similar to synergohymenotropic toxin precursor - Staphylococcus 
intermedius
MW1942 MW1942 hypothetical protein similar to leukocidin chain lukM precursor
MW1988:sigB MW1988:sigB sigma factor B
MW1991:rsbU MW1991:rsbU sigmaB regulation protein RsbU
MW1999:kdpC MW1999:kdpC probable potassium-transporting ATPase C chain
MW2000:KdpB MW2000:KdpB probable potassium-transporting ATPase B chain
MW2002:KdpD MW2002:KdpD sensor protein KdpD (sensor histidine kinase, OmpR family)
MW2013 MW2013 lipoprotein precursor
MW2021 MW2021 hypothetical protein, similar to single strand DNA binding protein
MW2079 MW2079 hypothetical protein, similar to ABC transporter (ATP-binding protein)
MW2093 MW 2093 hypothetical protein, similar to multidrug resistance protein
MW2095 MW 2095 hypothetical protein, similar to multidrug transporter
MW2101 MW2101 hypothetical protein similar to ferrichrome ABC transporter (permease)
MW2102 MW2102 hypothetical protein similar to ferrichrome ABC transporter (permease)
MW2103 MW2103 hypothetical protein similar to ferrichrome ABC transporter (binding prote)
MW2129:hysA MW2129:hysA hyaluronate lyase precursor
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MW2140 MW2140 hypothetical protein, similar to ABC transporter (ATP-binding protein)
MW2141 MW2141 (ATP-binding protein) hypothetical protein, similar to ABC transporter
MW2179 MW2179 hypothetical protein, similar to acriflavin resistance protein
MW2202 MW2202 hypothetical protein similar to ferrichrome ABC transporter fhuD precursor
MW2217 MW2217 secretory antigen precursor SsaA homolog
MW2259 MW2259 conserved hypothetical protein
MW2261 MW2261 ATP-binding protein, hypothetical protein, similar to ABC transporter
MW2273 MW2273 hypothetical protein, similar to multidrug resistance protein
MW2280 MW2280 hypothetical protein, similar to ABC transporter, ATP-binding protein
MW2328 MW2328 hypothetical protein similar to Zn-binding lipoprotein adcA
MW2336 MW2336 hypothetical protein, similar to ABC transporter, periplasmic amino acid-binding protein
MW2337 MW2337 hypothetical protein, similar to multidrug resistance protein
MW2351 MW2351 hypothetical protein, similar to ABC transporter, ATP-binding protein
MW2352 MW2352 hypothetical protein similar to lipoprotein inner membrane ABC-transporter
MW2368 MW2368 hypothetical protein, similar to integral membrane efflux protein
MW2376 MW2376 hypothetical protein, similar to chloramphenicol resistance protein
MW2378 MW2378 hypothetical protein, similar to ABC transporter (ATP-binding protein)
MW2396 MW2396 hypothetical protein, similar to glucose 1-dehydrogenase
MW2403 MW2403 hypothetical protein, similar to oxidoreductase
MW2421:fnb MW2421:fnb fibronectin-binding protein homolog (for fnbA?)
MW2431 MW2431 hypothetical protein, similar to glucarate transporter
MW2437 MW2437 conserved hypothetical protein
MW2446 MW2446 hypothetical protein, similar to ABC transporter (ATP-binding protein)
MW 2447 MW2447 conserved hypothetical protein
MW2448:srtA MW2448:srtA sortase
MW2471 MW2471 ferrous iron transport protein B homolog
MW2479 MW2479 hypothetical protein, similar to mercuric ion-binding protein
MW2498 MW2498 hypothetical protein, similar to transcription regulator acrR
MW2499 MW2499 hypothetical protein, similar to short chain oxidoreductase
MW2503 MW2503 hypothetical protein similar to ferrous iron transporter protein B
MW2534 MW2534 hypothetical protein
MW2543 MW2543 hypothetical protein, similar to ABC transporter (ATP-binding protein)
MW2553:arc MW2553:arc carbamate kinase
MW2557 MW2557 hypothetical protein, similar to arginine repressor
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MW2558:aur MW2558:aur zinc metalloproteinase aureolysin
MW2566 MW2566 hypothetical protein, similar to N-Carbamoylsarcosine Amidohydrolase
MW2574 MW2574 hypothetical protein, similar to preprotein translocase secY
MWrRNA02 MWrRNA02 23S ribosomal RNA (RNA02)
MWrRNA05 MWrRNA05 16S ribosomal RNA (RNA05)
nuc nuc thermonuclease
obg obg SpoOB-associated GTP-binding protein
pbp3 pbp3 penicillin-binding protein 3
pbpA pbpA penicillin-binding protein 1
pstB pstB phosphate ABC transporter ATP-binding protein
rip rip RGD-containing lipoprotein
rot rot repressor of toxins
SA0074 SA0074 hypothetical protein
SA0102 SA0102 67 kDa Myosin-crossreactive streptococcal antigen homologue
SA0103 SA0103 conserved hypothetical protein
SA0104 SA0104 hypothetical protein, similar to transcription regulator GntR family
SA0190 SA0190 hypothetical protein
SA0191 SA0191 conserved hypothetical protein
SA0192 SA0192 hypothetical protein, similar to ABC transporter ATP-binding protein
SA0193 SA0193 hypothetical protein, similar to Enterococcus faecalis plasmid pPD1 bad
SA0195 SA0195 hypothetical protein
SA0196 SA0196 conserved hypothetical protein
SA0197 SA0197 hypothetical protein, similar to ABC transporter ATP-binding protein
SA0211 SA0211 acetyl-CoA acetyltransferase
SA0251:lytR SA0251:lytR two-component response regulator
SA0276 SA0276 conserved hypothetical protein, similar to diarrheal toxin
SA0294 SA0294 hypothetical protein, similar to branched-chain amino acid uptake carrier
SA0298 SA0298 hypothetical protein, similar to regulatory protein PfoR
SA0509 SA0509:srtB srtB sortase B
SA0573:sarA SA0573:sarA staphylococcal accessory regulator A
SA0598:pbp4 SA0598:pbp4
SA0610 SA0610 hypothetical protein, similar to lipase LipA
SA0614 SA0614 hypothetical protein, similar to two-component response regulator
SA0622 SA0622 hypothetical protein, similar to AraC/XylS family transcriptional regulator
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SA0627
SA0641
SA0661:saeR
SA0668
SA0675
SA0675
SA0702:llm
SA0704
SA0726:gapR
SA0745
SA0836
SA0857
SA0879
SA0904
SA1010
SA1013
SA1139:glgP
SA1159
SA1174: LexA
SA1195
SA1208
SA1217
SA1247
SA1248
SA1329
SA1337
SA1341
SA1360:ftsH
SA1383
SA1516:phoP
SA1539
SA1552
SA1580
SA1584
SA0627
SA0641
SA0661:saeR
SA0668
SA0675
SA0675
SA0702:llm
SA0704
SA0726:gapR
SA0745
SA0836
SA0857
SA0879
SA0904
SA1010
SA1013
SA1139:glgP
SA1159
SA1174: LexA
SA1195
SA1208
SA1217
SA1247
SA1248
SA1329
SA1337
SA1341
SA1360:ftsH
SA1383
SA1516:phoP
SA1539
SA1552
SA1580
SA1584
Function
hypothetical protein, similar to LysR family transcriptional regulator 
conserved hypothetical protein, similar to transcriptional regulator 
response regulator 
oligopeptidase F
hypothetical protein, similar to ABC transporter ATP-binding protein 
hypothetical protein, similar to ABC transporter ATP-binding protein 
lipophilic protein affecting bacterial lysis rate and methicillin resistance level 
conserved hypothetical protein 
glycolytic operon regulator
hypothetical protein, similar to extracellular matrix and plasma binding 
hypothetical protein, similar to transcription regulator LysR family 
hypothetical protein, similar to negative regulator of genetic competence MecA 
oligopeptidase F
hypothetical protein, probable ATL autolysin transcription regulator 
hypothetical protein, similar to exotoxin 4 
hypothetical protein, similar to carbamate kinase 
glycerol uptake operon antiterminator regulatory protein 
hypothetical protein, similar to two-component response regulator 
SOS regulatory LexA protein
SA1217 hypothetical protein, similar to negative regulator PhoU 
hypothetical protein
SA1217 hypothetical protein, similar to negative regulator PhoU 
truncated (putative response regulator ArIR (truncated-arIR) 
truncated (putative response regulator ArIR [S (truncated-arIR) 
ferric uptake regulator homolog 
transcription regulator AraC/XylS family homolog 
hypothetical protein, similar to export protein SpcT protein 
ftsH FtsH-2 peptidase 
ferric uptake regulator homolog
alkaline phosphatase synthesis transcriptional regulatory protein 
hypothetical protein, similar to septation ring formation regulator 
hypothetical protein 
multidrug resistance protein homolog 
lysophospholipase homolog
Gene ID Name Function
SA1621 SA1621 hypothetical protein
SA1628:splD SA1628:splD serine protease
SA1632 SA1632 hypothetical protein
SA1640 SA1640 hypothetical protein (PathogenicityislandSaPln3)
SA1643:sen SA1643:sen staph enterotoxin n
SA1644:yent2 SA1644:yent2 enterotoxin
SA1646:sei SA1646:sei staph enterotoxin i
SA1647:sem SA1647:sem staph enterotoxin m
SA1649 SA1649 conserved hypothetical protein
SA1666 SA1666 two-component response regulator homolog
SA1676 SA1676 hypothetical protein, similar to regulatory protein (pfoS/R)
SA1678 SA1678 transcription regulator Fur family homolog
SA1814 SA1814 subfamily M16C unassigned peptidases (SAV1279 protein)
SA1883: KdpE SA1883: KdpE KDP operon transcriptional regulatory protein KdpE
SA1888RodA SA1888RodA hypothetical protein, similar to rod shape determining protein RodA
SA1949 SA1949 lytic regulatory protein truncated with Tn554 (truncated-SA)
SA1970 SA1970 hypothetical protein, similar to multidrug resistance protein
SA1999 SA1999 hypothetical protein, similar to regulatory protein, SIR2 family
SA2002 SA2002 hypothetical protein, similar to transcription regulator MerR family
SA2004 SA2004 conserved hypothetical protein
SA2005 SA2005 conserved hypothetical protein
SA2060 SA2060 hypothetical protein, similar to transcription regulator MarR family
SA2063:moaA SA2063:moaA molybdenum cofactor biosynthesis protein A
SA2092 SA2092 hypothetical protein, similar to transcription regulator
SA2108 SA2108 hypothetical protein, similar to transcription regulator, RpiR family
SA2115 SA2115 hypothetical protein, similar to transcriptional regulator
SA2119 SA2119 hypothetical protein, similar to dehydrogenase
SA2123 SA2123 hypothetical protein, similar to transcription regulator LysR family
SA2124:fosB SA2124:fosB fosfomycin resistance protein fofB
SA2144 SA2144 hypothetical protein, similar to transcriptional regulator (TetR/AcrR family)
SA2147:tcaR SA2147:tcaR TcaR transcription regulator
SA2151 SA2151 hypothetical protein, similar to two component response regulator
SA2165 SA2165 hypothetical protein, similar to transcriptional regulator tetR-family
SA2169 SA2169 hypothetical protein, similar to transcription regulatory protein
Gene ID Name Function
SA2174 SA2174 hypothetical protein, similar to transcriptional regulator
SA2178 SA2178 hypothetical protein, similar to transcriptional regulator
SA2308 SA2308 hypothetical protein, similar to transcription regulator MarR family
SA2314 SA2314 hypothetical protein, similar to ABC transporter (ATP-binding protein)
SA2330 SA2330 hypothetical protein, similar to transcription regulator
SA2357 SA2357 hypothetical protein, similar to regulatory protein (pfoS/R)
SA2379 SA2379 hypothetical protein, similar to transcriptional regulator tetR-family
SA2418 SA2418 hypothetical protein, similar to two-component response regulator
SA2421 SA2421 hypothetical protein, similar to transcriptional regulator
SA2424 SA2424 hypothetical protein, similar to transcription regulator Crp/Fnr family protein
SA2458:lcaR SA2458:lcaR ica operon transcriptional regulator IcaR
SA2472 SA2472 hypothetical protein, similar to ATP phosphoribosyltransferase regulatory subunit
SA2483 SA2483 hypothetical protein
SA2500:gidA SA2500:gidA glucose inhibited division protein A
saeR saeR response regulator
sarR sarR staphylococcal accessory regulator A homolog
SAV0012 SAV0012 ampA family M17 unassigned peptidases (SAV0942 protein)
SAV0102 SAV0102 Mername-AA019 peptidase
SAV0149:Cap5A SAV0149:Cap5A capsular polysaccharide synthesis enzyme Cap5A
SAV0153Cap8E SAV0153Cap8E capsular polysaccharide synthesis enzyme Cap8E
SAV0154Cap5F SAV0154Cap5F capsular polysaccharide synthesis enzyme Cap5F
SAV0155:Cap5G SAV0155:Cap5G capsular polysaccharide synthesis enzyme Cap5G
SAV0156Cap5H SAV0156Cap5H capsular polysaccharide synthesis enzyme O-acetyl transferase Cap5H
SAV0157Cap5l SAV0157Cap5l capsular polysaccharide synthesis enzyme Cap5l
SAV0158:Cap5J SAV0158:Cap5J capsular polysaccharide synthesis enzyme Cap5J
SAV0159:Cap5K SAV0159:Cap5K capsular polysaccharide synthesis enzyme Cap5K
SAV0161Cap5M SAV0161Cap5M capsular polysaccharide synthesis enzyme Cap5M
SAV0162:Cap5N SAV0162:Cap5N capsular polysaccharide synthesis enzyme Cap5N
SAV0163:Cap8O SAV0163:Cap8O capsular polysaccharide synthesis enzyme C ap80
SAV0183 SAV0183 subfamily M24B non-peptidase homologues (SAV1529 protein)
SAV0195:hsdR SAV0195:hsdR probable type I restriction enzyme restriction chain
SAV0212 SAV0212 subfamily M24B unassigned peptidases (SA1360 protein)
SAV0276 SAV0276 subfamily M20A unassigned peptidases (SAV2006 protein)
SAV0398:tetM SAV0398:tetM tetracycline resistance protein
Gene ID Name
SAV0422:set6
SAV0424:set8
SAV0425:set10
SAV0426:set11
SAV0428:set13
SAV0429:set14
SAV0431hsdM
SAV0433
SAV0457:pepT
SAV0511
SAV0520:hmrA
SAV0526
SAV0549:hipO
SAV0612
SAV0743
SAV0768
SAV0942:pyrC
SAV0965
SAV0993:appF
SAV1000
SAV1044
SAV1057:lytM
SAV1068
SAV1070
SAV1113
SAV1119:vacA
SAV1201
SAV1253
SAV1279:splD/splF
SAV1366
SAV1384:htrA
SAV1420:purF
SAV1512:glmS
SAV1529
SAV0422:set6
SAV0424:set8
SAV0425:set10
SAV0426:set11
SAV0428:set13
SAV0429:set14
SAV0431hsdM
SAV0433
SAV0457:pepT
SAV0511
SAV0520:hmrA
SAV0526
SAV0549:hipO
SAV0612
SAV0743
SAV0768
SAV0942:pyrC
SAV0965
SAV0993:appF
SAV1000
SAV1044
SAV1057:lytM
SAV1068
SAV1070
SAV1113
SAV1119:vacA
SAV1201
SAV1253
SAV1279
SAV1366
SAV1384:htrA
SAV1420:purF
SAV1512:glmS
SAV1529
Function
exotoxin 6 
exotoxin 8 
exotoxin 10 
exotoxin 11 
exotoxin 13 
exotoxin 14
probable type I site-specific deoxyribonuclease Lldl chain 
exotoxin 15 
peptidase T
subfamily M20B unassigned peptidases (SAV1512 protein) 
subfamily M20D non-peptidase homologues (HmrA protein) 
family M20D unassigned peptidases (SAV0549 protein) 
family M20D unassigned peptidases (hippurate hydrolase) 
family M20D unassigned peptidases (SAV2329 protein) 
family M20D unassigned peptidases (SAV0102 protein) 
family M42 unassigned peptidases (SAV1366 protein) 
dihydro-orotase
family M22 non-peptidase homologues (SAV2051 protein) 
oligopeptide transport system ATP-binding protein AppF homologue 
family M22 unassigned peptidases (SAV2049 protein)
RseP peptidase
lysostaphin (peptidoglycan hydrolase)
subfamily M23B unassigned peptidases (MW 1895 protein)
subfamily M23B unassigned peptidases (MW 1390 protein)
conserved hypothetical protein
putative vacuolating cytotoxin paralog
subfamily M23B unassigned peptidases (SAV0212 protein)
SpIC g.p. (Staphylococcus aureus) (m-type 2) 
subfamily S1B unassigned peptidases (serine protease splf) 
subfamily S1C unassigned peptidases (SAV1728 protein) 
subfamily S1C unassigned peptidases (SA0879 protein) 
amidophosphoribosyltransferase precursor 
glucosamine-fructose-6-phosphate aminotransferase 
family C59 non-peptidase homologues
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SAV1613 SAV1613 gamma-glutamyltransferase 1 (bacterial)
SAV1622:thdF SAV1622:thdF possible thiophene and furan oxidation protein
SAV1661 SAV1661 amily C26 unassigned peptidases
SAV1708:hisH SAV1708:hisH family C56 non-peptidase homologues (imidazole glycerol phosphate synthase subunit HisH)
SAV1745:purQ SAV1745:purQ family C56 non-peptidase homologues (phosphoribosylformylglycinamidine synthase I)
SAV1751 SAV1751 family C56 non-peptidase homologues (orf 1 protein)
SAV1765:HCHA SAV1765:HCHA family C56 unassigned peptidases (SA0509 protein)
SAV1793 SAV1793 subfamily S9C non-peptidase homologues (SAV2451 protein)
SAV1810 SAV1810 subfamily S9C unassigned peptidases
SAV1811 SAV1811 family S33 non-peptidase homologues
SAV1813 SAV1813 family S33 non-peptidase homologues
SAV1827:yent1 SAV1827:yent1 enterotoxin
SAV1830:seo SAV1830:seo enterotoxin
SAV1875 SAV1875 family S33 unassigned peptidases
SAV1879 SAV1879 family S33 unassigned peptidases
SAV1909 SAV1909 family S33 unassigned peptidases
SAV1998:fmt SAV1998:fmt family S12 unassigned peptidases (Fmt protein)
SAV2049 SAV2049 family S24 unassigned peptidases (SAV1998 protein)
SAV2051 SAV2051 family S24 unassigned peptidases
SAV2133:spsB SAV2133:spsB signal peptidase SpsB (Staphylococcus aureus) (SpsB protein)
SAV2154:radA SAV2154:radA family S16 non-peptidase homologues
SAV2329:clpP SAV2329:clpP peptidase Clp (type 1)
SAV2352 SAV2352 SAV2352 hypothetical protein
SAV2451 :ctpA SAV2451 :ctpA subfamily S41A unassigned peptidases (SAV1420 protein)
SAV2455 SAV2455 family S54 unassigned peptidases (SAV1549 protein)
SAV2662 SAV2662 SAV2662 capsular polysaccharide biosynthesis
SAV2663 SAV2663 SAV2663 capsular polysaccharide biosynthesis
SAV2664 SAV2664 SAV2664 capsular polysaccharide biosynthesis
SAV2667:icaD SAV2667:icaD intercellular adhesion protein D
SAV2668:icaB SAV2668:icaB intercellular adhesion protein B
SAV2675 SAV2675 family U32 unassigned peptidases (SAV1613 protein)
SAV2690 SAV2690 family U32 unassigned peptidases (SAV1612 protein)
SAV2690 SAV2690 family U32 unassigned peptidases (SAV1612 protein)
sbi sbi IgG binding protein
Gene ID Name Function
sdhB sdhB succinate dehydrogenase iron-sulfur protein subunit (MW 2)
sdrC sdrC Ser-Asp rich fibrinogen-binding bone sialoprotein-binding protein
sdrD sdrD Ser-Asp rich fibrinogen-binding bone sialoprotein-binding protein
sdrE sdrE Ser-Asp rich fibrinogen-binding bone sialoprotein-binding protein
sirA sirA lipoprotein
sirB sirB lipoprotein
sirC sirC lipoprotein
spa spa IgG binding protein A
splE:S.hyicus splE.S.hyicus
ssb ssb single-strand DNA-binding protein of phage phi Sa 2mw
sspA sspA serine protease V8 protease
sspB sspB cysteine protease precursor
sspC sspC cysteine protease
tagH tagH teichoic acid translocation ATP-binding protein
taxon:1280 chp taxon:1280 chp chemotaxis inhibitory protein
vga yga . hypothetical ABC transporter ATP-binding protein
